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Abstract 
 
Persistence of lactase into adulthood varies in frequency worldwide and is attributable to 
several different single nucleotide changes in an enhancer of the LCT gene. One of these is 
at particularly high frequencies in Europeans and several others have been found 
elsewhere. However, information about their worldwide distribution is patchy.  
 
2056 DNA samples from populations of Europe, Asia and the Middle East were sequenced 
to examine the distribution of allelic variants of the LCT enhancer region. It was confirmed 
that -13910*T is also the predominant allele around the periphery of Europe, and that this 
allele extends as far as the South and East of the Arabian Peninsula. Other alleles appear to 
have spread out of Africa or Arabia and most variation was found in the Middle East. No 
new common alleles were found that were likely to be causal. 
 
In previous studies four lactase persistence associated nucleotide substitutions (-13910*T, 
-14010*C, -13915*G and -13907*G) have been studied functionally. In this thesis four 
additional enhancer alleles were examined using enhancer/promoter construct 
transfections and electrophoretic mobility shift assays. Three enhancer variants alter 
transcription factor binding in vitro and/or reporter-gene expression. Bioinformatic tools 
and specific antibodies were used to assist in identifying the transcription factors 
involved. The results show that different mechanisms lead to a disruption of the normal 
down-regulation of lactase in adult life. 
 
Known haplotypic markers were assessed on an overlapping set of samples and a greater 
number of flanking markers was typed in an extended region of 1.8 Mb around LCT, in 
order to chart the evolutionary relationships and extent of historic recombination of the 
chromosomes carrying the derived alleles, as well as those that do not. All of the functional 
alleles tested have longer extended haplotypes than their ancestral counterparts, but so 
also does the derived variant at position -958, a haplotype marker for the B haplotype. The 
finding of an extended region of high linkage disequilibrium in all populations, and an 
extended B haplotype, is discussed in relation to the methods to study selection.  
 
Because phenotypic studies suggest missing functional variants, the immediate promoter 
and a part of intron 2 of LCT were also selected for sequencing. No serious candidates 
were found in intron 2. Two alleles in the immediate promoter were studied by 
transfections but there was little evidence for any in vitro effect of these variants.  
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Abbreviations/Glossary 
 
bp   base pair 
BP   before present 
cal BC    years before Christ, from calibrated C14 data 
cDNA   complementary DNA 
CEPH   Centre d'Etude du Polymorphisme Humain 
ChIP   chromatin immunoprecipitation 
CNV   copy-number variation 
DNA   deoxyribonucleic acid 
EDTA   ethylenediaminetetraacetic acid 
EHH  extended haplotype homozygosity 
EMSA   electrophoretic mobility shift assay 
GWAS  genome-wide association studies 
HWE   Hardy-Weinberg equilibrium 
HT  haplotype (combination of alleles at adjacent locations (loci) on a chromosome 
that are inherited together) 
ID   identification 
kb   kilobase 
kDa   kilodalton 
LCT   lactase gene 
LD   linkage disequilibrium (allelic association) 
LDU   linkage disequilibrium units 
LeCHE   Lactase persistence in the early cultural history of Europe 
LP   lactase persistence 
LNP   lactase non-persistence 
LPH   lactase-phlorizin hydrolase 
Mb   megabase 
MCM6   minichromosome maintenance complex component 6 
mRNA   messenger RNA 
mtDNA  mitochondrial DNA 
OMIM   Online Mendelian Inheritance in Man 
PBS   phosphate buffered saline 
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PHASE  software that determines the chromosomal phase (the maternal or 
paternal chromosome on which the alleles lie in heterozygous individuals) 
by Bayesian inference  
PCO   principal co-ordinates 
PCR   polymerase chain reaction 
RFLP  restriction fragment length polymorphism 
RNA   ribonucleic acid 
SDS   sodium dodecyl sulfate 
SNP   single nucleotide polymorphism 
STR   short tandem repeat 
TF  transcription factor 
UniProtKB  Protein knowledgebase of the Universal protein resource (UniProt) 
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1 Introduction 
Human influence on the global ecosystem has increased and has become substantial, 
especially in recent years, even leading to suggestions of naming a new era, the 
'Anthropocene'. No doubt, human culture has modified environments, but in reverse it was 
the ability to adapt well to environmental changes, phenotypically and culturally, that has 
made Homo sapiens successful as a species, being able to populate most parts of the 
world. Human genetic diversity we see today is the result of past evolutionary processes 
and one example of how adaptation to a new diet and a different lifestyle of former 
populations has shaped present genetic variation is lactase persistence. 
This thesis is concerned with the evolutionary, molecular and population genetics of the 
variation in regulatory sequences responsible for altering the expression of human lactase, 
and leading to adult lactase persistence. This introduction reviews the relevant 
background, and includes information about past migrations and domestication processes, 
previous work related to lactase persistence and the lactase gene and an overview of 
methods for studying genetic variation and detecting selection, followed by the aims and 
an overview of the thesis. 
 
1.1 Neolithisation – a revolutionary cultural change 
The European and Asian continents have been inhabited by modern humans since their 
dispersal out of Africa from about 50,000 years ago (reviewed in Stoneking and Krause 
2011).  
 
The Neolithic era, which marks the transition from a hunter-gatherer lifestyle to farming 
and hence food production, represents a remarkable change in life circumstances which is 
well described by the term ǮAgricultural revolutionǯ coined by Childe (1936). It broadly 
involved the appearance of a package of innovations, also called the ǮNeolithic packageǯ 
within a few thousand years, which included the domestication of plants and animals, the 
use of polished stone tools, the manufacture of pottery and the appearance of permanent 
settlements. However, these innovations developed as gradual processes and at slightly 
different times across the world (Figure 1.1). The boundaries between Mesolithic and 
Neolithic lifestyles also often overlap, as there is evidence of hunting and gathering by 
Neolithic societies and typical Neolithic pottery that was found at Mesolithic 
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archaeological sites. The stepwise development of agriculture, where domesticated plants 
and animals like sheep, goat, pig and cattle increasingly built food resources, allowed the 
settlement of larger groups of people in permanent dwellings. This in turn allowed the 
development of new technologies and changed the social structures within societies, 
presumably accompanied by an alteration of mindset of its members (reviewed in 
Bellwood 2008).  
 
 
Figure 1.1: Origins and approximate expansion of agricultural systems and early farming 
cultural complexes from archaeological records (Diamond and Bellwood 2003). 
 
1.1.1 The Neolithic in Europe 
The process of Neolithisation relevant to Europe began around 15000-12000 years ago 
(Bellwood 2008) in the region of the so called ǮFertile Crescentǯ (Breasted 1916). This ǮNeolithic core zoneǯ extended from the Levant to Southwestern Iran via Southern 
Anatolia. Substantial climate changes took place at that time - the late Pleistocene to early 
Holocene. The temperature started to rise and the world climate became relatively stable, 
which would have allowed a better management of crops (reviewed in Bellwood 2008).  
Hunting and gathering was the only subsistence strategy across Europe before 8500 years 
before present (BP), until farming started to spread from the Neolithic core zone, as 
shown in Figure 1.2. Evidence suggests that the Neolithic culture started to spread from 
the Fertile Crescent to other parts of Asia and Europe and the North of Africa at 
approximately the same time. Two models have been suggested as to how farming could have spread into Europe. The Ǯcultural diffusionǯ or Ǯacculturationǯ model proposes that the 
Neolithic culture was adopted by local hunter-gatherer populations from their farming 
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neighbours, whereas under the Ǯdemic diffusionǯ model the Neolithic lifestyle spread with 
the migration of farmers into new territories (Ammerman and Cavalli-Sforza 1984). In 
fact, it is likely that the Neolithisation process was more complex, with local differences 
(Gronenborn 2007). Palaeogenetic data support a demic diffusion model, but also showed 
the coexistence of hunter-gatherer and farmer populations over longer time periods 
(Bollongino et al. 2013; Bramanti et al. 2009; Pinhasi et al. 2012).  
 
 
Figure 1.2: Approximate arrival dates and expansions of Neolithic cultures across Europe. 
Note that dates are given as years before Christ (cal BC). The picture was taken from Burger and 
Thomas (2011). 
 
1.1.2 Domestication of animals 
Bone assemblages from archaeological sites can reveal information about the 
domestication process. Besides the analyses for species affiliation, morphology, sex, age at 
death and cutting or cooking signs, bones can be directly radio-carbon dated and analysed 
for ancient DNA, which puts them in an archaeological context (Gerbault et al. 2011). 
Differences in morphology can be seen between the wild and domesticated forms of a 
species, which resulted from the break in gene flow between wild and domesticated 
animals and the deliberate breeding for certain traits (Vigne and Helmer 2007).  
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Archaeozoological evidence suggests that goat and sheep were first domesticated about 
11000-10500 years ago in the Levant, followed by taurine cattle and pigs at about 10500-
10000 BP. The domesticates spread rapidly to the areas of central Anatolia and Cyprus but 
are only found outside these areas after 8500 BP (Zeder 2008).  
Archeological and archeozoological information indicated that the spread of the Neolithic 
culture and domesticated animals across Europe followed two routes (Figure 1.2): The first, the ǮMediterranean routeǯ stretched along the Aegean and Adriatic Sea, to )taly, the 
South of France and the Iberian Peninsula. The second, the ǮDanubian routeǯ went from the 
Balkans via the South and West of Central Europe and further to the North. It is not clear 
where the routes have met but Greece, the Rhine valley and Northwest Europe are 
discussed as possible regions, before the Neolithic spread further to the British Isles 
around 6000 BP (Tresset and Vigne 2007).  
 
The evidence for an introduction of domestic goat and sheep into Europe is relatively clear 
as no wild progenitors of these species have been reported. The Anatolian origin of the 
domesticated cattle of Central Europe is supported by ancient DNA analysis that found no 
evidence of mixture with the European wild cattle (Bollongino et al. 2008; Edwards et al. 
2007; Troy et al. 2001). The introduced domestic pigs in contrast seem to have been 
substantially mixed with local wild boar as suggested by ancient DNA data (Larson et al. 
2007). 
1.1.3 Evidence for dairying 
The management strategies of domestic herds are reflected in different patterns of 
slaughtering of animals (reviewed in Vigne and Helmer 2007), called Ǯkill offǯ profiles. The 
interpretation of these profiles can help to distinguish between culling strategies that 
more likely focussed on dairying or on meat production. A study on modern sheep herds 
in Turkey (Payne 1973) showed a massive killing of young and sub-adult males between 
6-18 months, as required for meat production. Specialised dairy farming in contrast was 
characterised by slaughtering of very young lambs, aged below 2 months. This would of 
course only be true for sheep and goat since cows needed their calves to be present to 
stimulate milk production. Traditionally, many calves were kept until weaning in order 
that milk could be obtained from their mothers (reviewed in Vigne and Helmer 2007).  
The earliest evidence from archaezoology for specialised breeding for milk use was found 
after 7500 BP in the Balkan region and 7000 BP in Central Europe. However an earlier 
practise of milking is very likely (Gerbault et al. 2011). Vigne and Helmer (2007) 
concluded from their research that milk procurement may have been at least a motivation 
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for the domestication of sheep, goat and cattle, which developed from stock-keeping by 
hunter-cultivators, to true Neolithic farmers. Because of the low milk yield at the 
beginning of dairying it could not be the only subsistence strategy; people must still have 
been hunting and gathering.  
 
The archeometrical analysis of organic residues in pottery is another method of 
investigating prehistoric dairying activities. The isotopic composition of fatty acids can 
provide information about whether residues originated from milk or adipose fats but it 
cannot distinguish whether fresh or fermented milk was stored in the vessels examined 
(Copley et al. 2003; Dudd and Evershed 1998). With this approach, the earliest evidence 
for milk use was found from 8500 BP in Northwest Anatolia and Thrace (Evershed et al. 
2008) and from further Neolithic sites in the Carpathian basin from around 7900-7500 BP 
(Craig et al. 2005), from Poland 7400-6800 BP (Salque et al. 2013), from Scotland from 
about 6100 BP (Copley et al. 2003) and probably Denmark around 6000 BP (Craig et al. 
2011). Pot shards dated to 7200-5800 BP also revealed evidence for dairying practices in 
Sub Saharan Libya (Dunne et al. 2012).  
 
However, ancient human DNA suggests that the lactase persistence was not common in 
early Neolithic Europe up to about 5070 BP (Burger et al. 2007; Lacan et al. 2011a; Lacan 
et al. 2011b; Malmstrom et al. 2010) which will be further discussed later in this thesis. 
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1.2 Lactase persistence (an example of gene-culture 
coevolution) 
It has been known since Roman times (described by Hippocrates around 400 B.C.) that 
people show differences in their ability to digest milk. Some can handle large amounts of 
fresh milk without problem, others suffer from symptoms of intolerance, like abdominal 
pain, cramps, flatulence or diarrhoea. Much research has been done over the last 50 years, 
which enables us to explain these differences, although there are still unanswered 
questions. About a third of the world human population are capable of digesting the 
lactose in milk into adulthood (reviewed in Ingram et al. 2009a), a trait which is called 
lactase persistence (LP, OMIM #223100), as the result of a process which is seen as a 
remarkable example of coevolution: The interaction between genetics causing lactase 
persistence and the culture of milk drinking. 
1.2.1 Lactase persistence status 
Newborn mammals rely on milk as their first source of nutrition. Lactose is in most cases 
the main carbohydrate in milk, and the enzymatic activity of lactase is necessary to cleave 
lactose into its two absorbable component monosaccharides, glucose and galactose. 
Hence, lactase is present in the intestine of nearly every young eutherian mammal and its 
activity is high during the suckling period, except in the Pinnipedia, for example sea lions, 
where milk lactose is very low and no lactase is expressed (Jenness et al. 1964; Kretchmer 
1971; Pilson and Kelly 1962). The enzyme is located in the brush border membrane of the 
small intestinal mucosa (see also 1.2.6). 
 
After the weaning period the production of the enzyme is usually substantially reduced, to 
about 5-10%. This reduction is seen as the ancestral state, occurring in most humans and 
all other mammals tested (Ingram and Swallow 2009b; Sebastio et al. 1989). However, 
some of us escape this down-regulating mechanism and keep high lactase activity after 
childhood and throughout life, being called lactase persistent (reviewed in Ingram et al. 
2009a). The mechanism for this is not fully understood yet but it was shown that lactase 
expression cannot be induced by prolonged intake of milk (Keusch et al. 1969). 
 
Differences exist in the timing of the decline of human lactase. Decline can start at a young 
age from 1 to 5 as shown in British, Chinese and Thai children (reviewed and shown by 
Wang et al. 1998), whereas in others it takes up to 18-20 years to reach the lowest level of 
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activity as described in Finns (Sahi et al. 1983). It is not yet clear what the reason for this 
variation is, but it may either be due to environmental factors or other genetic influences 
or both. 
1.2.2 The geographic distribution of the lactase persistence trait 
From a European point of view, lactase non-persistence (LNP) was thought to be rare and 
an abnormality until the early 1960s when cases of adult hypolactasia were reported as a 
normal condition (Auricchio et al. 1963; Bayless and Rosensweig 1966; Dahlqvist et al. 
1963). With the collection of more data on worldwide lactase persistence frequencies the 
picture became clearer, that lactase non-persistence is actually the more common 
phenotype (Flatz 1987; Swallow and Hollox 2000), in 65% of the world population 
(Ingram et al. 2009a).  
 
Figure 1.3 shows the worldwide distribution of lactase persistence frequencies, which are 
highest in Northwest Europe, namely Denmark, Ireland and the British Isles. Lactase 
persistence frequency decreases as one moves towards the East and South from Northern 
Europe. A similar gradient has been observed in India with more people being lactase 
persistent in the North (Swallow 2003).  
 
In Africa and the Middle East the picture is different, with a variable lactase persistence 
distribution. Some African and Arabian nomadic tribes that are milk dependent have 
higher lactase persistence frequencies than their neighbouring non-pastoralists (reviewed 
in Ingram and Swallow 2009a; Itan et al. 2010) such as the Beni Amer (pastoralists) and 
Donglawi (non-pastoralists) of Sudan with lactase persistence frequencies of 64% to 20% 
respectively (Bayoumi et al. 1982; Bayoumi et al. 1981; Holden and Mace 1997).  
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Figure 1.3: Geographic distribution of lactase persistence frequencies. White indicates the 
proportion of LP individuals in a population, red LNP individuals respectively. The overall 
frequency for each country is mostly comprised of different ethnic groups with different LP 
frequencies. Note that large differences in LP frequency are sometimes seen for example between 
Bedouin and non-Bedouin groups of Saudi Arabia and Jordan and North Indian and Indian 
populations. Data are taken from Itan et al. (2010). 
 
1.2.3 Clinical definitions of lactase deficiencies  
Lactase non-persistent individuals have a high probability of suffering from symptoms of 
lactose intolerance after consumption of a certain amount of lactose or milk, because the 
low level of intestinal lactase activity may not be sufficient to hydrolyse the quantity 
consumed. Symptoms can then occur when the undigested lactose passes into the small 
intestine, where it builds up an osmotic gradient leading to an inflow of water, causing 
diarrhoea. In the large intestine, colonic bacteria can ferment the lactose and this produces 
gases and fatty acids which can cause symptoms, mainly such as discomfort, flatulence and 
even cramps (reviewed in Hammer and Hammer 2012; Hammer et al. 1996; Hollox and 
Swallow 2002).  
 
Lactose intolerance symptoms vary individually but if present they are usually 
recognisable within a few hours of the lactose consumption. Even quite large amounts of 
lactose can be in the tolerable range for some non-persistent people, as described below, 
while others claim to be able to take little or none. The reason for these inter-individual 
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differences in lactose tolerance are not completely clear but are likely be due in part to 
differences in gut flora composition or a different gastric emptying rate (Hertzler and 
Savaiano 1996; Lee and Krasinski 1998; Lomer et al. 2008; Szilagyi et al. 2004). 
 
The consumption of fermented milk products like cheese and yoghurt can be a way of 
exploiting the nutrients in milk products and avoiding intolerance symptoms, as the 
lactose content of milk products decreases with natural fermentation (Food Standards 
Agency 2002; Swallow 2003). It should however be noted that some soft cheeses and 
commercial yoghurts contain substantial amounts of lactose. Interestingly, clinical trials 
have also shown that psychosomatic effects can influence the perception of symptoms 
(Briet et al. 1997; Peuhkuri et al. 2000). 
 
The normal genetically determined trait of reducing the levels of lactase in adulthood 
(primary adult hypolactasia) is different from secondary loss of lactase due to other 
causes (secondary hypolactasia). Enzyme levels can be reduced when the intestinal 
epithelium is damaged, for example by inflammatory or autoimmune diseases like 
enteritis or coeliac disease. Lactase levels usually go back to normal after treatment of the 
primary disease and restoration of the intestinal epithelium, but this can also take longer if 
the patient is suffering from malnutrition, as shown for kwashiorkor ,and may in some of 
those cases even become permanent (reviewed in Dahlqvist and Lindquist 1971; Villako 
and Maaroos 1994). 
Another very rare condition called Ǯcongenital lactase deficiencyǯ ȋCLD, OM)M #ʹʹ͵ͲͲͲȌ 
describes the absence of lactase from birth. This autosomal recessive disorder can be fatal 
for a new born child if the condition is not identified straight after birth and is attributable 
to mutations in the coding sequence of the lactase gene (LCT, see also 1.2.5) (reviewed in 
Jarvela et al. 2009; Kuokkanen et al. 2006).  
 
It has been suggested that lactase persistence status plays a part in a number of diseases of 
complex aetiology. The influence of lactase non-persistence on osteoporosis has been 
discussed, since an avoidance of milk products as a rich source of easy absorbable calcium, 
without the supplementation of calcium from other dietary sources, may contribute to a 
loss of bone mass and therefore an increased risk for osteoporosis (Lomer et al. 2008; 
Mattar et al. 2012). Several studies also have tried to relate milk consumption and lactase 
persistence/non-persistence to the risk of developing cancer (Larsson et al. 2006; Meloni 
et al. 1999; Shrier et al. 2008), metabolic syndromes (Almon et al. 2010; Corella et al. 
2011; Enattah et al. 2004; Meloni et al. 2001) or gastrointestinal syndromes (Hollox and 
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Swallow 2002; Lomer et al. 2008; Villako and Maaroos 1994). However, a clear effect of 
lactase persistence/non-persistence could mostly not be confirmed and confounding 
effects such as mixed ancestry of the individuals tested are likely to have caused false 
positive associations. 
1.2.4 Diagnosis of lactase persistence and non-persistence 
Because lactase is restricted to the intestine, the only way of determining lactase 
persistence status directly is to take an intestinal biopsy to measure lactase enzyme 
activity. Ideally the measurement should be made in relation to another brush-border 
disaccharide such as sucrase or maltase, which together with histology will allow 
exclusion of secondary hypolactasia (reviewed in Swallow and Hollox 2000). The mRNA 
levels of the human proximal jejunum were shown to correlate well with the lactase 
persistence/non-persistence phenotype (Escher et al. 1992; Fajardo et al. 1994; Lloyd et 
al. 1992).  
 
Population studies however require less invasive methods. Lactose tolerance tests are 
used to infer the levels of lactase indirectly as differences in lactose digestion, and 
volunteers can be categorised as digesters or non-digesters. Tests are carried out after an 
overnight fast and usually a lactose dose of 50 g is given to the volunteer. The 
physiological outcome is measured as difference between levels of blood glucose, urine 
galactose or breath hydrogen before and after the Ǯlactose drinkǯ (reviewed in Ingram and 
Swallow 2009b). As glucose and galactose are cleavage products of lactose, an increase in 
blood glucose or urine galactose indicates a lactase persistent person.  
All methods of testing are affected by a certain error rate but the most accurate test 
(Mulcare et al. 2004) is the breath hydrogen (H2) test, which is now most commonly used 
for large scale tolerance testing. Hydrogen is one of various gases produced by the colonic 
bacteria when they ferment lactose. Partly absorbed through the intestinal mucosa, 
transported through the bloodstream and exhaled by the lungs it can be measured in the 
breath. In lactose maldigesters an increase of hydrogen in the breath is observed, provided 
that appropriate hydrogen producing bacteria are present in the gut. 
 
The term 'lactose intolerant' is often used both by the public and professionals for people 
with lactase non-persistence. This is misleading since lactase non-persistent people do not 
always show symptoms in their everyday life; note that a relatively high dose of lactose 
(equivalent to 1 litre of milk) is used for the tests to clearly distinguish digesters from non-
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digesters (reviewed in Ingram et al. 2009a; Sahi 1994), but that even in these tests breath 
hydrogen production does not necessarily lead to significant symptoms. 
1.2.5 Evidence for a genetic cause and cis regulation 
A genetic cause for lactase persistence was first proposed by Bayless and Rosensweig 
(1966) who examined differences of lactose intolerance in black and white Americans. 
Several family studies followed (reviewed in Swallow 1993), in particular one, using 
lactose tolerance tests on a cohort of large Finnish families, showed the strongest evidence 
for an autosomal dominant inherited trait (Sahi 1974). Later twin studies confirmed this 
pattern of inheritance with the lactase persistence phenotypes of monozygotic twins in 
complete concordance and the phenotype distribution of dizygotic twins matching Hardy 
Weinberg expectations (Metneki et al. 1984). 
 
A trimodal distribution of lactase activity, as expected to be seen phenotypically by the 
combination of two different alleles for hypolactasia and lactase persistence, was first 
suggested by Rosensweig et al. (1967). By further examining the enzyme activity ratios 
(lactase/sucrase or lactase/maltase) of biopsy material this Ǯgene-dosage effectǯ was 
confirmed, with the result of one group being interpreted as homozygous persistent 
(highest lactase activity), one homozygous non-persistent (low lactase activity), and one 
heterozygous (with intermediate activity) (Flatz 1984; Ho et al. 1982). This also suggested 
that only one copy of the lactase gene is fully expressed in heterozygotes suggesting a cis-
acting mechanism (Flatz 1984; Ho et al. 1982) and indeed Wang et al. (1995) were able to 
verify this: The allelic variants of two known exonic SNPs within the lactase gene were 
used to reveal the chromosomal origin of the corresponding lactase mRNA transcripts. 
Lactase persistent individuals who were heterozygous for the SNP marker in most cases 
showed a difference in the amount of transcript from each of the chromosomes, which 
would not exist, had the influencing factor been trans-acting. The conclusion from this 
observation of monoallelic expression was that the causal element must indeed be cis-
acting, being located within or adjacent to the gene.  
 
The lactase coding gene itself, LCT was first characterised by the group of Mantei (1988) 
who investigated the cDNA sequences of the gene of humans and rabbits. They deduced a 
5 domain structure of the enzyme and a primary translation product of 1927 or 1926 
amino acids. They found 17 coding regions (exons) and further conclusions about the 
structure, evolution and processing of the gene were made, as described below. Boll et al. 
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(1991) further examined the fine structure of the gene and compared sequences of 
persistent and non-persistent individuals (see below). 
 
LCT was mapped to chromosome 2 and more specifically to the region 2q21 (Harvey et al. 
1993; Kruse et al. 1988) and additional information about the sequence of LCT was 
collected within the work of the International Human Genome Sequencing Consortium 
(Consortium 2004) and with subsequent annotations of chromosome 2 (for example 
Hillier et al. 2005) which describe the gene to have a length of about 49.3 kb and being 
transcribed from the reverse strand of the chromosome. 
1.2.6 The lactase-phlorizin hydrolase enzyme (LPH) 
Lactase, also called lactase-phlorizin hydrolase, is a Ⱦ-galactosidase and shows two 
distinct enzymatic activities working at different pH and temperature optima (Arribas et 
al. 2000; Naim et al. 1987; Skovbjerg et al. 1981; Wacker et al. 1992; Zecca et al. 1998). The first, lactase ȋEC ͵.ʹ.ͳ.ͳͲͺȌ, hydrolyses lactose and other Ⱦ-galactosides such as 
cellobiose, -triose and -tetrose and has very low activity against cellulose. The second 
activity, phlorizin hydrolase (EC 3.2.1.62), cleaves the glucose from the calchone, phlorizin 
and other Ⱦ-glycosides with large hydrophobic alkyl chains such as aryl- or alkyl-Ⱦ-
glycosides (reviewed in Skovbjerg et al. 1982; Troelsen 2005). Interestingly, studies 
revealed that lactase activity can be inhibited by phlorizin whereas phlorizin hydrolysis is 
unaffected by lactose presence (Leese and Semenza 1973; Skovbjerg et al. 1981). Phlorizin 
hydrolase is active in all vertebrates, whereas lactase seems to be specific for mammals.  
 
The glycosyl and lactosyl ceramides of the fat globules in milk were shown to be 
substrates for phlorizin hydrolase and also cleaves the flavonoids (Day et al. 2000; Nemeth 
et al. 2003). Dietary sources for flavonoids are mainly apples, onions, tea and red wine 
(Ehrenkranz et al. 2005).  
In the human small intestine lactase is mainly expressed in the mid- to lower jejunum 
(Newcomer and McGill 1966; Skovbjerg et al. 1981). Lactase activity is generally not 
present in the stomach or colon, however, some mRNA was detectable in the fetal human 
colon and in the rat colon during the early postnatal period (Freund et al. 1990; Wang et 
al. 1994).  
 
During cellular development from stem cells, epithelial cells migrate from the crypts up 
the villi and differentiate (as shown in Figure 1.5). In the enterocytes of the crypt/villus 
junction lactase mRNA expression but no protein is detected, which changes as the cells 
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migrate up the villus, where the protein is also present (Freund et al. 1995). It was earlier 
shown that lactase protein expression is highest at the middle of the villus, and decreases 
again towards the villus apex (Skovbjerg et al. 1981). 
 
A number of post-transcriptional processes were shown to be necessary to form the final 
transmembrane protein from the LPH mRNA transcript: In humans, the mRNA of 6279 bp 
(Ensembl database, build 37) encoded by LCT is translated into a precursor protein of 
1927 amino acids. This pre-pro LPH consists of a putative signal peptide of 19 amino acids, 
a large pro region of 849 amino acids, and an element of 1061 amino acids forming the 
main (extracellular) part with both active sites, a hydrophobic membrane anchor domain 
and a short hydrophilic cytoplasmatic tail (Figure 1.4). The pre-pro LPH shows an internal 
4 fold homology which is suggested to have evolved in two gene duplication events, each being homologous to a Ⱦ-glycosidase unit. The first two homologous domains (I and II) are 
found in the pro-protein segment, the other two (domains III and IV) in the mature protein 
(Mantei et al. 1988).  
 
Several post-translational modifications take place during LPH maturation (see also Figure 
1.4). First, the signal peptide necessary to translocate the protein through the membrane 
of the endoplasmatic reticulum (ER) is removed proteolytically. The resulting pro-LPH 
becomes N-glycosylated and forms homodimers (Grunberg and Sterchi 1995), an essential 
step for transport capacity and later enzyme activity (Naim and Naim 1996). The pro-
region of the molecule seems to be crucial for folding and dimerisation of the protein and 
intracellular transport (Jacob et al. 2002; Naim et al. 1994; Panzer et al. 1998). The pro-
region and domain III need to interact together for the correct folding of the 'lactase 
domain' IV, which in turn elevates the enzymatic activity of domain III (Behrendt et al. 
2010). The pro-region is cleaved off in the Golgi apparatus after O-glycosylation has taken 
place (Naim and Lentze 1992; Naim et al. 1987). An extracellular cleavage of the mature 
transmembrane protein by luminal trypsin follows, to give rise to its final and active form 
(Jacob et al. 1996; Wuthrich et al. 1996).  
 
The C-terminus of LPH is anchored to the surface of the enterocytes of the microvilli 
extending into the gut lumen. The two active sites are located in each of the domains of the 
mature 160 kDa enzyme, one for phlorizin hydrolase activity in domain III at position 
Glu1273 and the one for lactase activity at Glu1749 in domain IV (Arribas et al. 2000; 
Naim et al. 1987; Wacker et al. 1992; Zecca et al. 1998).  
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Figure 1.4: Structure of the LPH protein and its modification during the maturation process 
(Troelsen 2005). During post-translational processing the signal peptide and the pro-region, 
shown to have chaperone function, are cleaved off the 5 domain Pre-pro-LPH. The mature LPH 
protein consists of two domains, with phlorizin-hydrolase and lactase activities and is C-terminal 
anchored to the microvillus membrane. 
 
1.2.7 Lactase expression during development - the ancestral state 
Lactase down-regulation happens at a characteristic point of the mammalian 
development, depending on the species studied. The same seems to be true for the 
developmental rise of lactase activity. For example lactase mRNA expression is low in 
human foetuses but increases around the time of birth (Wang et al. 1998). Rodents, on the 
contrary, reach the maximum level of lactase activity around 3 days postnatally as their 
intestine is not completely matured at birth (Klein 1989).  
During the post-weaning decline of lactase, a time when mammals switch their diet from 
milk as main food source to plants and meat, other enzymes necessary for plant digestion 
such as sucrase-isomaltase and maltase, are up-regulated in rodents, whereas these 
enzymes are already present in humans before birth (reviewed in Heitlinger et al. 1991; 
Troelsen 2005). This shows that although there are similarities in the developmental 
regulation of lactase expression in humans and other mammals, some patterns are 
different and the reasons for that are not fully understood. 
1.2.8 Transcriptional regulation of the lactase promoter 
Differences in a cis-acting element were suggested to be responsible for the inter-
individual differences in lactase expression (as explained in section 1.2.5). Functional 
studies were performed to identify critical regulatory elements, first looking at the 
immediate promoter region of lactase. This region within the first 150 bp of the LCT 
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transcription initiation site was shown to be highly conserved between rat, mouse, pig and 
human, stressing its importance. Besides the TATA box, several cis elements in the form of 
binding sites for different transcription factors were identified in this region. HNF-ͳȽ, Cdx-
2 and GATA factors were shown to influence the activity of the LCT promoter of all these 
species in Caco-2 cells (reviewed in Troelsen 2005). Caco-2 is a colonic carcinoma cell line 
and the only human cell lines known both to spontaneously differentiate in an enterocyte 
like manner (Pinto et al. 1983a) and to express lactase and other small intestinal proteins 
as normally expressed in the small intestine when grown to confluence (Chantret et al. 
1988; Hauri et al. 1985). 
 
Although this region of the promoter seems to be important, it only directs transcription at 
a relatively low level in Caco-2 cells and a region further upstream was suggested to be 
necessary for full lactase expression (Troelsen et al. 1992). In vivo studies in transgenic 
mice showed that promoter constructs containing 1 kb of the pig or 2 kb of the rat of LCT 
promoter were sufficient for full intestinal-specific expression and the regulation of the 
post-weaning decline (Krasinski et al. 1997; Lee et al. 2002; Troelsen et al. 1994). The 1 kb 
upstream part of the promoter is similar between the mammals studied, with the 
exception of a disruption by two tail to tail Alu elements in humans and other primate 
species (Hollox et al. 1999).  
1.2.9 Transcription factors involved in LCT promoter activity 
Transcription factors shown to be involved in lactase expression are part of the network of 
signalling pathways and transcription factors that play an important role in the 
development of the intestinal epithelium, as shown in Figure 1.5. The factors Cdx-2, HNF-ͳȽ and GATA-4 were shown to synergistically activate the lactase promoter (Mitchelmore 
et al. 2000; van Wering et al. 2004) as seen for sucrase-isomaltase (Boudreau et al. 2002).  
 
A very important factor for the proliferation, differentiation and maintenance of the 
intestinal epithelium is Cdx-2 (Caudal-type homeobox protein 2). This transcription factor 
is exclusive to the postnatal intestine, mainly found in the distal small intestine and 
proximal colon (reviewed in Olsen et al. 2012; Silberg et al. 2000). It is involved in the 
transcription of many genes but the only intestinal specific factor involved in lactase 
expression (Troelsen 2005). As already mentioned, it binds to the immediate promoter of 
the human LCT and has been shown to up-regulate its activity when over-expressed in 
Caco-2 cells (Krasinski et al. 1997; Troelsen et al. 1997). 
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HNF-ͳȽ and (NF-ͳȾ ȋhepatocyte nuclear factor homologues ͳȽ and ͳȾȌ were also shown 
to be important for lactase promoter activity of which HNF-ͳȽ seems to be more activating 
(10 fold higher than HNF-ͳȾȌ and even more in combination with the Oct-1 transcription 
factor (Lewinsky et al. 2005). Both transcription factors are mainly expressed in the liver 
and pancreas but in other organs as well. In the gastrointestinal epithelia they are 
involved in the expression of several genes and essential for cell growth and 
differentiation (Bosse et al. 2006b; Troelsen 2005). HNF-ͳȽ is expressed throughout the 
intestine (Olsen et al. 2012). 
 
 
Figure 1.5: Schematic overview of the development of epithelial cells along the crypt/villus 
of the mammalian small intestine and important transcription factors involved (modified 
from Olsen et al. 2012). From stem cells, proliferating cells migrate either towards the base of the 
crypt or along the villus to the apoptotic zone (A). Cell proliferation (C) and differentiation (B) are 
mediated amongst other factors by differences in transcription factor (TF) expression: Cdx-2 and 
HNF-ͳȽ are highest in the villus but already present in the crypt, GATA-4 is detectable only above 
the crypt and is highest at the tip of the villus. HNF-ͶȽ expression is found equally along the crypt-
villus axis.  
 
Also GATA zinc finger family transcription factors are active in the intestine as well as in 
various other organs where they regulate gene expression, cell proliferation and 
differentiation. GATA-4, GATA-5 and GATA-6 factors have been shown to bind to the LCT 
immediate promoter (Fang et al. 2001; Fitzgerald et al. 1998) with similar affinity 
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(Krasinski et al. 2001). In contrast to GATA-6, highly expressed proliferating crypts of the 
villus, GATA-4 and -5 are mostly active in the differentiated enterocytes. Both were shown 
to interact with HNF-ͳȽ to synergistically activate the LCT promoter but GATA-4 can also 
act independently (van Wering et al. 2004; van Wering et al. 2002). GATA-4 was suggested 
to be the main factor involved in regulating lactase activity (van Wering et al. 2002) and its 
influence is necessary for LCT expression in vivo (Bosse et al. 2006a). Its expression 
decreases from the proximal part to the distal part of the mouse small intestine, which 
highly but not completely correlates with the regional expression of the lactase activity 
which is lower in the proximal small intestine (van Wering et al. 2004). 
1.2.10 Lactase persistence caused by a different enzyme? 
Much research has been conducted in order to explain the full mechanism underlying the 
differences between the enzyme activity of lactose digesters and non-digesters. The first 
suggestion, that the lactase enzyme produced in adults might differ from the one in infants 
was not supported experimentally (Lebenthal et al. 1974; Potter et al. 1985; Skovbjerg et 
al. 1978). Also the structure of the precursor and mature protein was indistinguishable for 
both persistent and non-persistent individuals (Sterchi et al. 1990). The groups of Sterchi 
(1990) and Witte (1990) both found that a decreased lactase biosynthesis accounts for 
low intestinal enzyme levels leading to non-persistence in humans, a similar process as 
previously been shown for the developmental loss of lactase in rats (Jonas et al. 1985).  
However, it was not clear whether the variation in lactase expression was controlled by 
transcription or translation until finally, by comparing mRNA levels with the levels of 
enzyme activity, it was interpreted that it is regulated at the transcriptional stage (Escher 
et al. 1992; Fajardo et al. 1994; Wang et al. 1994), although this did not exclude that other 
mechanisms, for example alterations in mRNA stability, may influence the final enzyme 
level. 
1.2.11 The search for lactase persistence causal variation in and around the 
LCT gene 
Research focussed on regions in and around the LCT gene to search for causal elements 
responsible for lactase persistence. However, cDNA sequencing of the LCT coding regions 
(including flanking intron-exon boundaries) and the LCT promoter, up to 1 kb upstream of 
the gene, did not show 100% association of any SNPs detected with lactase persistence or 
non-persistence (Boll et al. 1991; Lloyd et al. 1992) nor was there any evidence for 
alternative splicing (Boll et al. 1991). Nevertheless several polymorphisms were found 
and although not completely associated they were used as genetic markers in population 
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studies (Boll et al. 1991; Harvey et al. 1995a; Hollox et al. 1999). 11 of these variants in 
linkage disequilibrium across the gene were used to define the LCT 'core haplotypes' 
spanning 60 kb. Only four haplotypes A, B, C and U were common worldwide but a greater 
diversity was found in African populations (Hollox et al. 2001). The A haplotype showed 
an association with lactase persistence and is very frequent in Northern Europeans 
(Harvey et al. 1998; Hollox et al. 2001). The search for a causal allele within and outside 
the 60 kb haplotype region continued as the A haplotype was also shown to be present in 
non-persistent individuals (Harvey et al. 1998; Wang et al. 1998). 
 
Sequencing of more distant regions around the LCT gene identified a SNP about 14 kb (-
13910 bp) upstream of the transcription initiation site of LCT, that was completely 
associated with lactase persistence in Finns (Enattah et al. 2002). It is also highly 
associated in other Northern Europeans, occurring on a very extended A haplotype 
background of about 1 Mb (Bersaglieri et al. 2004; Poulter et al. 2003). This polymorphism 
(-13910 C>T) is located in intron 13 of the adjacent gene MCM6 (minichromosome 
maintenance complex component 6, Figure 1.6), a gene with an important role in cell cycle 
regulation. In contrast to LCT, MCM6 revealed no inter-individual differences in expression 
or tissue specificity (Harvey et al. 1996). Another polymorphism, -22018 G>A, was also 
associated with lactase persistence in the same study of Enattah and colleagues (2002). 
However this -22018*A always occurred with -13910*T but not vice versa and was also 
found in non-persistent individuals (Enattah 2002, Poulter 2003). 
 
 
 
Figure 1.6: Location of the LP associated alleles in the 'LCT enhancer' region in intron 13 of 
MCM6, upstream of LCT. Note that the genes are transcribed in - direction of the chromosome. 
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The -13910*T allele was seen as the likely cause (confirmed functionally later as described 
below) for lactase persistence in Europe and Asia but it did not explain the high lactase 
persistence frequencies of some sub-Saharan African populations or that of the Bedouins 
of the Arabian Peninsula where it is rare (Ingram et al. 2007; Mulcare et al. 2004).  
In these geographic regions other genetic variants have been detected, located very near 
to -13910 C>T in the same intron of MCM6, within a segment which has been shown to 
influence enhancer function (see section 1.2.12). Three of them, -13915*G, -14010*C and-
13907*G, showed clear association with lactase persistence (Enattah et al. 2008; Imtiaz et 
al. 2007; Ingram et al. 2007; Ingram et al. 2009b; Tishkoff et al. 2007), while a further 
allele, -14009*G, showed suggestive evidence of association (Ingram et al. 2009b). 
 
Other rarer alleles in this region may or may not cause lactase persistence but even if all 
are taken into account some lactase persistent individuals carry no enhancer allele. Itan et 
al. (2010) tried to address this question at a worldwide level and compared phenotypic 
data with predicted phenotype frequencies from all four confirmed lactase persistence 
associated alleles. In some parts of the world a lack of correlation between the predicted 
and actual lactase persistence values was apparent (Figure 1.7). This was especially the 
case in parts of Africa, East and South Europe and Asia where genotype data were unable 
to explain lactase persistence frequencies. As most of the values were interpolated and 
sometimes only data for -13910 C>T were taken into account, this could simply be caused 
by sampling problems. Nevertheless, this pattern is striking in some regions and might 
suggest geographic regions under the influence of a novel causal allele resulting in lactase 
persistence occurring at high frequency. For example in the Wolof of Senegal, where 51% 
lactase persistence was reported, none of the four enhancer variants had been found so far 
(Ingram et al. 2009b; Mulcare et al. 2004). 
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Figure 1.7: Lactase persistence genotype-phenotype correlation (taken from Itan et al. 
2010). The map shows the quantitative differences between predicted LP phenotype frequencies 
from genotype data and observed phenotype data (both interpolated). Allele frequency data of 
alleles -13910*T, -13915*G, -14010*C and -13907*G were taken into account to predict the LP 
phenotype frequencies. For geographic regions where no phenotype or genotype data were 
available, values were interpolated and finally predicted LP frequency values subtracted from 
observed values. Colour key on the right: + values represent the genotype under-predicting 
phenotype at a certain location and - values over-predicting it, respectively. Data collection points: 
-13910*T only, x all 4 alleles, ● LP phenotype. 
 
1.2.12 Lactase persistence associated enhancer variants increase LCT 
expression 
With the observation that -13910*T was completely associated with lactase persistence in 
a Finnish population (Enattah et al. 2002) a candidate functional allele had been found. 
And indeed it was subsequently shown in transfection experiments that the region around 
-13910 C>T has a transcriptional enhancer effect on the human and rat promoter of the 
LCT gene (Olds and Sibley 2003; Troelsen et al. 2003). The 450 bp human LCT enhancer 
was able to stimulate transcription about 4 to 7 fold in undifferentiated cells (2 days after 
transfection) and up to 50 fold in differentiated cells (9 days after transfection) compared 
to the promoter alone. The effect of -13910*T was much stronger than of -13910*C with a 3 
to 6 times higher activity in differentiated Caco-2 cells (Troelsen et al. 2003).  
 
One particular transcription factor, Oct-1, binds directly to the site at -13910 but much 
stronger to the *T than the *C variant (Lewinsky et al. 2005). The function of this allele has 
been supported recently in vivo (Fang et al. 2012).The post-weaning decline of transgene 
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luciferase expression in mice, shown previously to be mediated by a 2 kb rat lactase 
promoter (Lee et al. 2002), could be prevented in mice carrying -13910*T but not in those 
carrying the ancestral variant -13910*C. 
 
Subsequently other enhancer variants (section 1.2.11) have been tested for transcription 
factor binding: -13907*G and -13915*G showed binding to Oct-1, -13907*G with a similar 
affinity as the-13910*T variant (Enattah et al. 2008) but -13907*C much less (Ingram et al. 
2007). Each of these variants however increases the activity of the enhancer (Olds et al. 
2011; Tishkoff et al. 2007) as does -14010*C, as will be described in more detail in chapter 
4.  
In addition to Oct-1, further binding sites for transcription factors, namely Cdx-2, GATA-6, 
HNF-ͶȽ and Fox have been identified within the ͶͷͲ bp Ǯenhancer regionǯ and mutation 
analyses revealed that all of them, except Cdx-2, are required for full enhancer activity. 
Further transfection experiments using co-transfection of expression plasmids for the 
different transcription factors themselves suggest that the interaction of Oct-1 with HNF-ͳȽ, shown to bind to the LCT promoter, enables a strong enhancement of reporter gene 
expression and mediates the further increasing effect of the enhancer carrying -13910*T 
compared to the ancestral variant (Lewinsky et al. 2005). 
1.2.13 The cultural practice of milking and selection hypotheses for lactase 
persistence 
It has been observed that milk drinking behaviour is correlated with high frequency of 
lactase persistence and it was suggested that this is due to strong positive selection (Aoki 
1986; Holden and Mace 1997; McCracken 1971b; Simoons 1970a; Simoons 1978).The 
selective forces that drove the increase of lactase persistence in populations with dairying 
practices must have acted since the beginning of animal domestication about 5000-10000 
years ago.  
 
Several theories try to explain this process. Robert McCracken using a large literature 
review was able to classify three groups of human cultures according to their milk product 
dependence (McCracken 1971a; McCracken 1971b). The first has never used dairy 
animals and therefore did not include lactose in their diet after weaning (e.g. Aborigines, 
New Guinea natives, Eskimos and the other American Indians). The second group are 
pastoralists who keep animals but have never used much milk or milk products as part of 
their lifestyle (e.g. Chinese, Thai and Philippines). Thirdly there are populations who 
introduced the practise of milk drinking a long time ago and therefore have a large amount 
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of lactose in their diet (most Europeans, many African and Middle Eastern populations and 
e.g. North Indians).  
 
The close correlation of the distribution of lactase persistence with the extent the 
populations investigated use milk as part of their culture lead to the 'culture historical 
hypothesis' independently proposed by Simoons and McCracken (McCracken 1971a; 
Simoons 1970a). It suggests that the genetically determined trait coevolved with the 
practise of dairying, since with the cultural adaption to animal breeding and milk 
consumption the dependence of adults to milk increased. The selective pressure would act 
in populations consuming lactose-rich forms of milk with otherwise marginal food 
availability and would have favoured those who were lactase persistent, as they benefit 
from the nutritional value of milk, whereas fresh milk consumption may have had adverse 
consequences for non-persistent people. A high selective pressure of this kind would not 
be present in populations that process milk to sour milk and cheeses which would also 
allow non-persistent people to benefit from the nutrients of these products. This might 
explain the presence of populations with a history of dairying but low lactase persistence 
frequencies, as seen for example in Southern Europe (Simoons 1978). 
 
The 'reverse cause hypothesis' is based on the same observations but describes the 
opposite scenario (reviewed in Aoki 2001; first mentioned in McCracken 1971a). It 
suggests that dairying was only adopted by populations that were already largely lactase 
persistent, caused by another, unrelated process. This would mean that milk drinking 
would not necessarily have had any selective advantage. Nei and Saitou (1986) argued 
that lactase persistence is so recent that selection could not have been effective enough to 
cause these frequencies. Drift would have been the main factor, followed by later selection 
(reviewed in Ingram and Swallow 2009a). 
 
The especially high rates of the lactase persistence phenotype in Northern Europe led 
other authors to suggest the 'calcium assimilation hypothesis' (Flatz and Rotthauwe 
1973). This focuses on milk calcium as the nutritional benefit and also the improvement of 
calcium absorption by lactose. Calcium is an essential bone mineral and its absorption in 
the gut is facilitated by vitamin D3 (cholecalciferol). Populations in northern latitudes with 
lower sunlight, especially during winter, have an increased risk of developing rickets and 
osteomalacia due to the lack of photochemically produced cholecalciferol in their skin. In 
contrast to hunter-gatherers, who could balance this with a vitamin D rich diet containing 
marine food, early agriculturalists in Northern Europe mainly relying on cereals might 
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have had a problem in reaching the necessary intake of this vitamin (Cordain et al. 2012; 
Richards et al. 2003).  
Flatz and Rotthauwe (1973) argue that drinking milk could have been an advantage for 
lactase persistent individuals in the Neolithic to prevent these diseases. Milk is not only 
high in calcium it also contains small amounts of vitamin D, and milk proteins and it has 
been reported that lactose additionally promote vitamin D absorption (reviewed in 
Ingram and Swallow 2009a).  
The lack of vitamin D would surely not have been a problem for African nomads or populations from the Middle East. According to the 'arid climate hypothesisǯ these groups 
could survive better in dry regions, with limited access to water and food, using fresh milk 
as relatively clean and uncontaminated fluid (Cook and al-Torki 1975). For lactase non-
persistent people of course this could be extremely disadvantageous if they suffer from 
diarrhoea and dehydration (reviewed in Gerbault et al. 2011). 
 
Holden and Mace (1997) statistically tested the culture historical, calcium absorption and 
arid climate hypotheses adjusting for genetic distances between populations. They found 
that pastoralism alone could explain most the lactase persistence distribution, while solar 
radiation or aridity could not. They suggested from their maximum likelihood approach 
that pastoralism must have been adopted before lactase persistence became frequent.  
This is also supported by palaeogenetic and archaeological data as mentioned in section 
1.1. Ancient DNA samples from Meso- and Neolithic periods of Europe show the absence 
or very low frequency of -13910*T implying that it was very rare or absent in early 
Neolithic (Burger et al. 2007; Lacan et al. 2011a; Lacan et al. 2011b; Malmstrom et al. 
2010). Pottery found in Western Turkey from as early as about 8500 BP contained 
preserved milk residues, which would also support the idea that milk was used before 
lactase persistence reached high enough frequencies (Evershed et al. 2008). However, the 
method used cannot distinguish residues from fresh or fermented milk. 
 
There are however some groups of people who have relatively low lactase persistence 
frequencies like the Dinka and Nuer from Sudan and are traditional camel or cattle 
herders and drink fresh milk like the Somali in Ethiopia (Ingram 2008). Many of the non-
persistent individuals drink more than 500ml of milk per day. It was proposed that an 
adaption of the bacterial gut flora within these people may allow them to drink large 
quantities of milk (Ingram et al. 2009a).  
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The potential role of holding cows as a 'status symbol' should be taken into account too 
when considering the relationship between pastoralism and lactase persistence. In many 
hierarchical cultures keeping livestock is restricted to a 'social elite' who were the ones 
who had access to milk. Reproductive behaviour is also influenced by social status in such 
cultures (Gillis 2003; Ihara 2011; Leonardi et al. 2012; Simoons 1970a). The effect of 
natural selection might therefore even been greater, favouring those who were lactase 
persistent in higher classes who in any case have greater fecundity (Heyer et al. 2005). 
 
An alternative selection hypothesis was proposed that is linked to the negative effect of 
milk consumption, considering malaria as selective force for lactase non-persistence, and 
suggesting that lactase persistence was the ancestral state (Anderson and Vullo 1994; 
Meloni et al. 1996). Anderson and colleagues argue that without milk riboflavin a mild 
deficiency could develop in the red blood cells and as Plasmodium falciparum parasites are 
sensitive to that it would lead to milder malaria.  
On the other hand an opposing hypothesis has been proposed, that selection for lactase 
persistence was driven by malaria. A milk diet would be protective against malaria in 
causing a deficiency of p-aminobenzoic acid, a pre-form of folate, and therefore impairing 
the folate metabolism of Plasmodia (reviewed in Cordain et al. 2012). However, other 
studies could not find evidence for any association with, the prevalence of lactase non-
persistence and malaria incidence (Auricchio 1998; Meloni et al. 1998).  
 
As will be seen below all studies using molecular data and results of modelling imply an 
extremely high positive selection coefficient. However, there is still an ongoing debate 
about the nature of these strong selective forces, which are probably different in Northern 
Europe from those in other parts of the world. Undoubtedly, milk is an edible source of 
protein and fat (also in its fermented forms) and the practice of dairying assures a 
constant food supply, especially in adverse situations such as crop failure. This may be 
particularly important for children after weaning. A selective pressure, even if normally 
weak could have become much stronger under extreme circumstances like famine and 
drought (Gerbault et al. 2011). 
1.2.14 Genetic signatures for lactase persistence under selection  
In summary lactase persistence was suggested to have reached its high frequency in some 
populations due to positive selection acting by providing an advantage to cultures who 
adapted pastoralism as early as the Neolithic (Aoki 1986; Holden and Mace 1997; 
McCracken 1971a; Simoons 1970a; Simoons 1978).  
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At a molecular level, evidence for selection can be detected, for example by looking at the 
haplotype background of trait associated alleles (see also section 1.3.2). As already 
mentioned, the A haplotype is the most common in Northern Europe and shows an 
association with lactase persistence (Harvey et al. 1998). It was subsequently discovered 
that the lactase persistence causal polymorphism -13910*T occurs on the background of 
this A haplotype which extends up to 1 Mb. As this long haplotype is present at high 
frequency, it was thought likely to be a sign of a very recent selective process (Poulter et 
al. 2003).  
 
Bersaglieri et al. (2004) further examined this signal of selection more formally, by looking 
at population differences of allele frequencies of 101 SNPs, spanning a region of about 3.2 
Mb, and the patterns of LD as assessed by extended haplotype homozygosity. They 
detected a regional difference of allele frequencies, with SNPs in vicinity of LCT (over a 1.5 
Mb spanning region) showing high inter population differences, and an unusually frequent 
and long haplotype of the -13910*T carrying chromosomes. They concluded that only 
strong positive selection could have led to this pattern and calculated a timeframe for it to 
have operated between 5000-10000 years and explained their observation with the model 
of allelic 'hitch-hiking' proposed by Braverman et al. (1995). Alleles surrounding the causal variant Ǯhitch-hikeǯ with it to high frequency, creating a region of high LD (see also 
section 1.3 below). For -13910*T this mutation event must have been so recent that time 
was too short to decay the allelic associations in this region by recombination (reviewed in 
Sabeti et al. 2006).  
Studies of microsatellite polymorphisms show similar results: a reduced diversity on the -
13910*T carrying chromosomes (Coelho et al. 2005; Ingram et al. 2009a). 
 
Estimations of the date when the -13910*T dispersion process started range from 7450-
12300 years BP (Coelho et al. 2005) and 7475-10250 years BP (Mulcare 2006), both 
calculated by using closely linked microsatellite variation, to 2188-20650 years BP 
(Bersaglieri et al. 2004), estimated using the extended haplotype homozygosity (EHH) 
approach (see also section 1.3.2.2). The African allele -14010*C was reported to have 
occurred as an unusually extended haplotype, with the age of this variant estimated to be 
between 1200 and 23200 BP using EHH (Tishkoff et al. 2007). It has been observed that 
the variant -13915*G occurs mainly on a C haplotype background (Ingram et al. 2009b) 
and its age in a Saudi population was estimated using a coalescent approach to be about 
4091 (± 2045) years (Enattah et al. 2008). No dating has been done so far for -13907*G but 
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it was shown to occur on an A haplotype background, as does-13910*T (Enattah et al. 
2008; Ingram et al. 2009b). It is evident that lactase persistence evolved independently 
more than once with different causative alleles. 
 
For alleles occurring at such high frequency in many populations, these age estimates are 
extremely young. With drift alone this would not have been possible, certainly not for -
13910*T and-14010*C. However the combination of drift and very strong positive selection 
for lactase persistence could have left such a pattern and indeed the selection coefficients 
are estimated to be very high, between 0.8 and 19% for -13910*T (Bersaglieri et al. 2004; 
Gerbault et al. 2009; Itan et al. 2009) and between 1 and 15% for -14010*C (Tishkoff et al. 
2007).  
1.2.15 Simulation models for the spread of lactase persistence 
From genetic data of modern populations alone it cannot be concluded where a variant 
originated or migrated from. This is especially the case because time and place a genetic 
variant arises does not necessarily correspond to the starting point of the selection 
process. To obtain further insight as to when lactase persistence first occurred and how it 
spread, computer simulations have been applied, since they provide a useful tool to test 
different scenarios. These models can take into account several factors, such as modern 
genetic, palaeogenetic, archaeological and geographic data to inform and to test statistical 
models simulating the migration.  
 
As early as 1986, Aoki developed a model to investigate the coevolution of dairying and 
lactase persistence in Europe with the aim of explaining the incomplete correlation 
between the use of milk and the presence of lactase persistence seen today (Aoki 1986). 
He showed that this pattern could simply be a stochastic effect and is no evidence against 
the culture historical hypothesis. Although a quite simple model, for example not 
considering migration nor effective population sizes other than 100, he suggested that the 
selection coefficient must have been either constantly very high (> 5%) or the coevolution 
must have started much earlier than 6000 years ago. 
 
Gerbault et al. (2009) aimed to test the calcium assimilation hypothesis and added a 
geographic component to their simulation models. Different selection pressures by 
latitude combined with two different diffusion models (Ammerman and Cavalli-Sforza 
1984) were tested. The demic diffusion model assumes the spread of Neolithic over 
Europe and gene flow between the migrating farmers and hunter-gatherer populations. In 
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the cultural diffusion model, only the Neolithic cultural practice would have been 
exchanged between hunter-gatherers and their farming neighbours, without genetic 
admixture between them. Gerbault and colleagues (2009) simulated the selection process 
for a lactase persistence associated allele (present at 1% in LBK cultures) from the 
beginning of Neolithic (10000 years ago) and compared that with lactase persistence 
frequencies from European and Middle Eastern populations today. The results obtained 
would fit with the demic diffusion model and the calcium absorption hypothesis (Gerbault 
et al. 2009). They concluded that a positive selective process would indeed have been 
necessary to explain the high frequency of lactase persistence in Northern Europe. In 
Southern Europe on the other hand the effect of genetic drift alone could explain the 
lactase persistence frequencies observed today. 
 
With a more complex model, Itan et al. (2009) simulated the spread of the lactase 
persistence -13910*T allele across Europe and the Middle East over the last 9000 years, 
allowing for gene flow between non-dairying and dairying farmers and hunter-gatherers. 
They concluded from their best fitting simulations that the -13910*T allele first underwent 
selection among dairying farmers between 6256-8683 years ago. It was also concluded 
that the coevolution process started between the central Balkans and Central Europe 
(Figure 1.8). Interestingly the combination of time and region would agree with the 
occurrence of Linearbandkeramik culture in Central Europe. In contrast to Gerbault et al. 
(2009) they suggest that a selective pressure due to latitude would not have been 
necessary to explain the high lactase persistence frequencies in Northern Europe, 
although they did not explicitly test for this. 
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Figure 1.8: Simulated region of the origin for LP-dairying co-evolution. Best fit simulations 
(dots) are of highest density in the red coloured area between the Central Balkans and Central 
Europe (Itan et al. 2009). 
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1.3 Population genetics and methods to detect selection 
1.3.1 Aspects of the population genetics theory 
Population genetics is a research field that studies evolutionary processes leading to 
genetic diversity, by assessing inter and intra population differences of variation in allele 
and haplotype frequencies of populations. Population genetic models help to disentangle 
how different factors have acted over time and space to result in currently observed 
diversity patterns. Such factors are for example mutation, recombination, genetic drift, 
population subdivision, gene flow and selection. These issues are described in Jobling 
(2013) and presented in summary in the following sections.  
 
New alleles are created by mutation and lead stepwise over time to other allelic forms 
(haplotypes). Mutation rates differ along the genome and depend on the type of mutation. 
Microsatellites for example have a higher mutation rate than SNPs. By knowing the 
mutation rate of a particular genomic region, the allele frequency can be calculated over 
generations with different models of DNA sequence evolution (see Jobling et al. 2013, 
chapter 5). Of course, only the heritable nucleotide changes in germ-cells are of 
evolutionary interest for these models.  
In addition to mutation, meiotic recombination can generate variation and reduce the 
frequency of a haplotype. This process can be studied by looking at non-random 
correlations of alleles in populations, known as linkage disequilibrium (LD) using the D 
statistic. A new arising mutation is linked to all other alleles on that chromosome, being in 
complete LD with them (D max) and forming one haplotype. Over time LD starts to decay as 
recombination breaks up the haplotype and creates new allelic combinations. One useful 
measure of LD is Dǯ which is D/D max. Closely linked loci on the same chromosome are less 
prone to recombination and selection can be detected by looking at their diversity (see 
below). 
 
Whether an allele gets fixed or is lost within a population is mainly due to genetic drift. 
This source of variation is due to the stochastic process of sampling from one generation 
to the next. The extent of genetic drift relates to the size of the sampled population as 
described in the Wright-Fisher model (Wright 1931), if the population stays at a constant 
size, mates randomly and generations don't overlap. Of course, this is not a realistic model 
for human populations as generations do overlap, populations seldom stay at a constant in 
size and in large populations mating is not random. To take these influences into account 
and be able compare the degree of genetic drift between populations, the concept of 
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effective population size was developed. It specifies the size of a randomly mating 
population with the same degree of genetic drift as the actual population. 
In most cases, new alleles will disappear from a population over time due to drift, when no 
selection or mutation is acting. The fixation of a neutral allele only depends on the 
population size. Considering the same mutation rate, an allele becomes fixed earlier in 
smaller than in larger populations and selection can accelerate this process. This means 
that even under neutral conditions past reductions in population size, as seen with 
population bottlenecks and founder effects, have a large influence on present day genetic 
variation. 
 
As mentioned above, human mating may not be random because of mate choice not being 
independent from genetic relatedness, for example due to assortative mating (for example 
preference of phenotypic similar mates) or disassortative mating. Mating is also not 
random when a population is structured, which means it consists of partially isolated and 
smaller subpopulations. If isolated, members of each of these subpopulations are closer 
related than to individuals of all other subpopulations, due to partial genetic 
differentiation. If individuals migrate between these subpopulations they cause gene flow, 
which consequently reduces population differentiation. Population structure can be 
measured by the FST statistics, which shows the genetic distance between subpopulations 
(see also section 2.3.7). 
 
The genetic variation of individuals defines their 'fitness', the ability to survive and 
reproduce in certain environments. Natural selection leads to variable reproduction of 
individuals and resulting in different genotypes in successive generations. Selection can 
operate on phenotypes at any stage of development: Survival to reproductive age (viability 
and mortality), success in mate attraction (sexual selection), the ability to fertilize (fertility 
and gamete selection), and to produce viable offspring (fecundity). These factors 
determine the relative fitness of an individual genotype/phenotype compared with others 
competing for the same resources, which can be measured as the selection coefficient (the 
proportion of fertile progeny relative to those without the genotype, or relative probability 
that a genotype will reproduce-i.e. positive selection w of 0.1 = 1-0.9, where progeny of 
100% (1) for carriers and 90% (0.9) for non-carriers).  
 
Selection can act in different ways. Mutations that increase the fitness of the carrier 
undergo positive selection and may rise in frequency in a population, whereas mutations 
that reduce fitness are subject to negative or purifying selection and are possibly 
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eliminated from the population. However, it is important to take the combination of 
mutations into account when considering their effect on the fitness of a genotype. Two 
alleles on a diploid locus for example can have a different impact on individual fitness. A 
novel allele may increase the fitness of a heterozygote compared to that of both 
homozygotes and possibly decrease their fitness, which is called heterozygote advantage. 
This results in balancing selection, which favours more than one allele, increasing 
diversity but preventing certain alleles from fixation. Another process creating balancing 
selection is frequency-dependent selection, where the frequency of a genotype is crucial 
for its fitness and leads to higher fitness at lower frequencies compared to other 
genotypes.  
1.3.2 Statistical tests to detect selection 
Of special interest for this thesis are methods that detect natural selection. Most of the 
statistical methods that aim to detect selection work in considering significant deviations 
of the observed genetic diversity to that expected under neutrality. The neutral theory of 
evolution, developed by Kimura (Kimura 1968; Kimura 1983), states that most variation 
within and between species is neutral, which means it does not affect the phenotype or 
fitness of individuals and is therefore not under selective pressure. Neutral mutations are 
fixed in a population randomly by genetic drift and most of them stay at low frequencies 
or are lost from a population.  
 
A positive selective sweep reduces the variation within a population but does not lead to 
decreased variation between species. Divergence data build the background to identify 
positive selection between species and diversity data within species. Negative selection 
instead tends to reduce variability within and between species (Nielsen 2005).  
Population genetics distinguishes between hard selective sweeps, soft selective sweeps 
and polygenic adaptation (Jobling et al. 2013). A recent hard selective sweep (or classical 
selective sweep) leads to an increase in frequency of the haplotype carrying the 
advantageous mutation as shown in Figure 1.9. The following paragraphs review the 
methods that aim to detect this type of positive selection, based on their different 
approaches and Figure 1.9 summarises commonly used methods. Positive selection can 
also act over a longer time span and favour more than one variant (soft selective sweep) 
that may even lay within different genes (polygenic adaptation). These forms of selection 
are harder to detect.  
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Figure 1.9: How to detect signatures of positive selection. The upper part of the figure shows 
how the pattern of neutral polymorphisms on different haplotypes changes when an advantageous 
allele (red) arises and increases in frequency and thereby drags along linked neutral 
polymorphisms. This process reduces variation levels surrounding the selected region, causes a 
skew in allele frequency distribution and increases linkage disequilibrium levels. Statistical 
methods commonly used to tests for these signatures are shown below, of which some are further 
described below. The figure was taken from Biswas and Akey (2006). 
 
1.3.2.1 Proportion of function altering mutations 
Variation in gene coding regions can be of two types: synonymous, which usually don't 
alter amino acids and therefore protein structure or their function and non-synonymous, 
which can have serious effects depending on which part of a protein they occur. By 
comparing the ratio of non-synonymous (dN) to synonymous (dS) mutations, selection can 
be detected. Under neutrality, a neutral non-synonymous change would increase in 
frequency in a population at the same rate as a synonymous change and dN/dS will equal 
one. A deleterious non-synonymous mutation will most probably be subject to purifying 
selection and the dN/dS ratio will be less than one whereas a positive selected non-
synonymous change increases its frequency and dN/dS will be greater than one. The latter 
effect is expected to be stronger for species divergence data than within a species and can 
be tested using the McDonald-Kreitman test (McDonald and Kreitman 1991), which 
compares the dN/dS ratio at a specific locus within and between species. This test is useful 
in identifying selected function altering mutations in gene coding regions and it is robust 
against demographic factors (Nielsen 2005). However, it ignores selection of variation in 
gene regulatory elements in non-coding parts of the genome.  
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The application of a modified version of the Hudson-Kreitman-Aguade (HKA) test (Hudson 
et al. 1987), which compares the variation rate within and between species at multiple 
loci, and can be applied to non-coding sequences. 
1.3.2.2 Haplotype based methods 
A recent and strong positive sweep (hard sweep) can be detected when an allele under 
selection has increased in frequency and created a region of LD with neighbouring SNPs, 
which reduces genetic diversity of the neighbouring regions. Two test methods have been 
developed to detect this skewed allele frequency spectrums around a frequent mutation, 
the extended haplotype homozygosity test (EHH) (Sabeti et al. 2002) and the integrated 
haplotype score test (iHS) (Voight et al. 2006). EHH detects a combination of alleles that 
are in LD over a long region (core haplotype) and that are at high frequencies (i.e. common 
homozygosity). The method statistically evaluates the expansion of LD of this core 
haplotype. The extension of the core haplotype is compared to all other haplotypes of that 
region (relative EHH, rEHH) in comparing their EHH decay. The rEHH statistics also takes 
local recombination rates into account. A recently positive selected haplotype should show 
high EHH values at high frequencies, whereas a haplotype under less selective pressure or 
just reaching high frequencies due to genetic drift would have been more prone to 
recombination and mutation as this process takes longer, and would therefore show lower 
EHH values. 
1.3.2.3 Allele frequency spectrum 
Tests considering the site frequency spectrum or allele frequency spectrum take the allele 
frequencies at segregating sites into account. As described above, a positively selected 
allele tends to increase in frequency and causes a reduced frequency spectrum of other 
variants around it. This causes a skew in allele frequencies towards more alleles at low 
frequencies (Nielsen 2005). To detect this, Tajima's D (Tajima 1989) for example tests the 
excess of rare alleles compared to neutrality or the HKS test (Wright and Charlesworth 
2004) the reduction in polymorphism levels. A further test takes the proportion of the 
variants at high frequencies into account that are as a result of this 'hitchhiking' process 
associated with each other. Fay and Wu's H (Fay and Wu 2000) test the excess of derived 
alleles at high frequencies. 
1.3.2.4 Population differentiation 
Population differentiation tests work under the assumption that selection operates 
differently in different populations, especially under different environmental conditions. 
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They can detect selection that occurred after subdivision of a population. Differences in 
allele frequencies might therefore be specific for a population and can be indicated by an 
increased level of genetic differentiation between populations, as measured for example 
by the FST statistic (Wright 1950), further described in chapter 2. However, inter-
population differences can be highly influenced by demographic factors, such as 
population bottlenecks that reduce genetic diversity and FST tests should ideally be 
combined with other tests to get better evidence for selection. 
1.3.3 Detection of different patterns of selection of LCT 
Over the last years the availability of genome wide data and new or modified statistical 
approaches to scan for genomic signatures of adaptations in these datasets have identified 
a range of candidate genes or gene regions under positive selection. As described in above 
these methods mainly investigate variation patterns like allele frequency spectrums at 
certain regions or the reduction of haplotype diversity across populations. The LCT region 
mostly appears in these studies as strongly positive selected in European datasets (with 
chromosomes carrying -13910*T) as shown by long-range haplotype tests , haplotype 
diversity or population differentiation (Akey et al. 2002; Bersaglieri et al. 2004; Hofer et al. 
2012; Sabeti et al. 2002; Sabeti et al. 2006; Voight et al. 2006). Extended haplotype 
homozygosity in combination with a high allele frequency was also reported for -14010*C 
in Kenyans, which supports the notion that a strong selective pressure has also acted on 
this variant (Tishkoff et al. 2007). 
 
Recently, evidence for another type of selection acting on the LCT enhancer was detected 
in an Ethiopian dataset. Our group assessed the signatures of a soft selective sweep (Jones 
et al. 2013) which allows the accumulation of many rare advantageous alleles, causing the 
same phenotype (as described by Hermisson and Pennings 2005; Pennings and Hermisson 
2006a; Pennings and Hermisson 2006b). This was inspired by the findings that several 
lactase persistence associated enhancer alleles were present in the Jaali and Somali groups 
previously investigated and that enhancer sequences of persistent people of these groups 
accumulated more derived alleles than those of non-persistent individuals (Ingram et al. 
2009b). In taking neighbouring genetic regions of the LCT enhancer into account to control 
for demographic and mutational effects a comparison of haplotype and nucleotide 
diversity between lactose digesters and non-digesters revealed a clear pattern of 
reduction in variability only at the enhancer in the non-digesters (Jones et al. 2013). 
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1.3.4 Methods to study LCT regulation 
The function of a gene is to a great extent defined by the protein it codes for. However, the regulation of gene expression Ǯfine-tuneǯ the spatial and temporal expression of genes and 
can have a great impact on the phenotype in for example development processes of an 
organism and adaptation to environments. Inter-individual and inter-population 
differences in gene expression have been noticed (reviewed in Jones and Swallow 2011).  
 
Factors that influence gene expression can be environmental, epigenetic and genetic, with 
elements of the latter acting cis and trans of the gene. Enhancers, silencers, promoters and 
insulators are such cis elements, which can have influence on transcription factor binding 
(trans elements) and mutations in these regions can have substantial effects on the 
expression of a gene. As mentioned earlier, it was shown using mRNA activities assigned 
to certain chromosomes that the transcription of LCT is regulated by a mechanism cis-
acting to the gene (section 1.2.5) and a regulatory network of transcription factors is 
involved for the different lactase expression between lactase persistent and non-
persistent individuals (see also section 1.2.9, 1.2.12).  
 
Evidence for differences in transcription factor binding came from the analysis of DNA-
protein interactions between proteins of the nuclear extract of the lactase expressing 
matured Caco-2 cells and radioactively labelled DNA oligonucleotides with sequence parts 
of the promoter or enhancer of LCT containing different mutations. The broader gene 
regions that are involved in the differential lactase expression were defined in transfection 
experiments in Caco-2 cells with plasmids containing different parts of upstream genetic 
regions of LCT (see also section 1.2.9 and 1.2.12). Details of the procedures are described 
in sections 2.2.6 and 2.2.7 of chapter 2. However further experimental procedures might 
identify other regions or elements that are involved in lactase expression, some of them 
are discussed in chapter 7. 
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1.4 Aims and overview of the thesis 
The general aim of this thesis is to examine the genetic variation in and around the LCT 
gene in human populations with emphasis on Europe and the Middle East, to shed more 
light on the evolution of the lactase persistence. My studies also focus on how specific 
genetic variants can influence lactase expression. 
 
The following specific aims were addressed in each chapter: 
- To investigate the variation of LCT enhancer alleles in Eurasia and the Middle East 
(chapter 3). 
- To study putative functional LCT enhancer alleles in vitro (chapter 4). 
- To examine patterns of linkage disequilibrium and obtain insight into the 
demographic history and origin of these alleles from their haplotypic background 
(chapter 5).  
- To explore new genetic regions for possible missing alleles for lactase persistence 
(chapter 6).
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2 Material and Methods 
2.1 DNA samples and population histories 
All DNA samples analysed within this project were part of University College London, 
G.E.E. DNA collections, mainly of the former TCGA (The Centre for Genetic Anthropology) and of Dallas Swallowǯs group. The Spanish and some of the Catalan DNA samples were 
kindly provided by the laboratory of Professor Andres Ruiz-Linares.  
Samples were collected anonymously with informed consent of the donors (or their legal 
guardian when under 18 years old for a collaborative project with the City of London 
school). The collections are covered by UCL/H ethics approvals (ULCH 99/0196, 01/0236 
and UCL 2670/001) and consents were also obtained from the relevant authorities in the 
countries outside the UK.  
 
The samples were obtained from unrelated individuals, being unrelated at the parental 
and at least grandpaternal level. Information about self declared ethnic 
background/cultural identity (also for parents and grandparents) and sampling locations 
were available in most cases. Individuals were grouped accordingly into population 
groups for analysis. Individual samples were classified to be part of a certain ethnicity 
group if their self declared cultural identity and those of both parents belong to the same 
group, otherwise as mixed within that country or other for that geographic region. 
Samples from individuals of very mixed ancestry were excluded from the study.  
Language classification of populations were done using the ethnologue online resource 
(http://www.ethnologue.com/) (Lewis et al. 2013).  
2.1.1 Samples from Europe and Asia used for the geographic survey of 
chapter 3 
A summary of the population samples used for chapter 3 of this thesis are shown in Table 
2.1. Some of the populations, with a history particularly interesting for this thesis, are 
further described. 
2.1.1.1 Han-Chinese 
Han-Chinese do not have a long history of milk drinking; this only very recently became 
fashionable. According to Murdock (1967) Chinese rely on animal husbandry for up to 6-
15% of their diet, but usually do not milk their animals. China was one of the centres of 
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domestication around 8000 years ago but the domesticated animals were non-milkable 
species like pigs and dogs (Cavalli-Sforza et al. 1994). Except for minority ethnic groups 
and regional influences of pastoralists groups from neighbouring countries, there were 
only two periods when the use of milk and milk products was introduced on a broader 
scale. Between 250 and 1000 AD Northern China was influenced by cattle-breeding 
societies and also 1280-1368 under Mongolian leadership (Simoons 1970b) during the 
Yuan Dynasty. The DNA samples were collected from Han-Chinese individuals living in 
Singapore. Chinese with its several forms belongs to the Sino-Tibetan languages, Mandarin 
is the official national language of China. 
2.1.1.2 Mongols (Mongols and Khalka) 
The Mongolian samples were collected in different parts of Mongolia. Dairy products are 
and have been of great importance to Mongols, especially kumiss, a fermented milk 
product.  
Most of them belonged to different ethnic groups, who speak a language of the Altaic 
language family. Only the samples from the Khalka were enough to build an Ǯown population groupǯ for analysis. The Khalka live to 76 - 85% from animal husbandry. They 
are pastoralists who hold cattle, water buffalo and yaks (Murdock 1967). 
2.1.1.3 Tyroleans 
The three Tyrolean groups sampled have a different historic background. Samples are 
from Bozen, Gadertal and Vinschgau and indviduals speak different languages or dialects 
with Italian, Ladin (a mixture of German and Italian) and German respectively. The Italian 
speakers only recently immigrated from the South of Italy (around 1920) from different 
places of the country. Ladins are suggested to be the closest related to native Tyroleans and Ǯthey acquired the typical Romance Rhaetian language during the Roman invasion of 
the AlpsǮ ȋfrom the ͳst century BC to the 3rd century AD). The German speaking groups 
from South Tyrol are believed to have immigrated around the 5th century from the North 
(Valentina Coia, personal communication).  
2.1.1.4 Sami  
The Sami are traditional hunter-gatherers living in the far North of Scandinavia and Russia 
where they have been indigenous for about 2000 years (Cavalli-Sforza et al. 1994). The 
Sami subsisted mainly from hunting and fishing until they became reindeer herders in the 
recent centuries and many of them live in semi-settlements most of the year (Leonard and 
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Crawford 2002). Samples tested for this thesis originate in Sweden. Sami is part of the 
Uralic language family. 
2.1.1.5 Yakuts 
The Yakuts, or Sakha as they describe themselves, live in the northeastern part of the 
Russian Federation in the Sakha Republic (or Yakutia). They are thought to originate from 
the Lake Baikal region and were forced to move north by the Buryat-Mongols during the 
13th and 14th centuries. 
Yakuts were traditional nomads and Northern and Southern Yakuts are culturally quite 
distinct (Wixman 1984). Northern Yakuts mainly rely on fishing, hunting and reindeer 
breeding whereas Southern Yakuts are cattle and horse breeders. Reindeer and mareǯs 
milk are an important part of the Yakutian diet with koumiss, their traditional drink of 
fermented mare's milk (Zeder 2006). 
The Yakut DNA samples were divided in two sub-groups of differing origin. Samples 
collected in the Abyysky and Allaikhovsky Districts were grouped together as Northern 
Yakuts; samples from the Nyurbinsky, Ust-Aldansky and Vilyuysky Districts and from 
Yakutsk (phenotyped samples) were grouped as Yakuts (South). Yakut is a northern 
Turkic language branch of the Altaic language family. 
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Table 2.1. Population samples used in chapter 3, their location and language family (according 
to: http://www.ethnologue.com/). 
Region Country Population Language family 
  
  
  
Northwest/ Germany Germans Indo-European 
Central Europe 
 
Sorbs Indo-European 
  Ireland Irish Indo-European 
  Netherlands Frisians Indo-European 
  Norway Norwegians Indo-European 
  Slovakia Roma Indo-European 
  Sweden Sami Uralic 
  
 
Swedes Indo-European 
  UK Ashkenazi-Jews Afro-Asiatic 
  
 
English Indo-European 
South Europe Greece Greeks Indo-European 
  Italy Tyroleans Bozen Indo-European 
  
 
Tyroleans Gadertal Indo-European 
  
 
Tyroleans Vinschgau Indo-European 
  Portugal Portuguese Indo-European 
  Spain Catalans Indo-European 
  
 
Spanish Indo-European 
East/ Belarus Belarusians Indo-European 
Southeast  Macedonia Macedonians Indo-European 
Europe Romania Romanians Indo-European 
  Russia Erzya Uralic 
  
 
Moksha Uralic 
  
 
Russians Perm Indo-European 
  Ukraine Ukrainians Indo-European 
Middle East Cyprus Greek Cypriots Indo-European 
  Iran Iranians Indo-European 
  Kuwait Kuwaiti Afro-Asiatic 
  Syria Syrians Afro-Asiatic 
  Turkey Anatolian-Turks Altaic  
  Yemen Yemeni Hadramaut Afro-Asiatic 
  
 
Yemeni Sena Afro-Asiatic 
West Asia Armenia Armenians Indo-Eurpean 
  Azerbaijan Azeri Altaic  
  Georgia Georgians Kartvelian 
Central/ Afghanistan Pashtuns/Afghans Indo-European  
South Asia 
 
Tadjiks Indo-European 
  
 
Uzbeks Indo-European 
  India North Indians Indo-European 
  
 
South Indians Dravidian 
  Nepal Nepalese Indo-European 
  
 
Tharu Indo-European 
  Uzbekistan Uzbeks Altaic 
Central/East/ Mongolia Khalka Altaic 
Southeast  
 
Mongols Altaic 
Asia Russia Northern Yakuts Altaic 
  
 
Yakuts Altaic 
  Singapore Han-Chinese Sino-Tibetan 
    Japanese Japonic 
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2.1.2 African samples 
Information about the African and Middle Eastern samples used in chapters 5 and 6 were 
extracted from the theses of Bryony Jones and Kate Ingram where they were studied in 
detail (Ingram 2008; Jones 2012). Table 2.2 summarises anthropological information such 
as broad geographic location, language families and lifestyle patterns of these populations. 
 
Table 2.2: Summary of geography, language family and subsistence strategy of the African 
and Middle Eastern populations used for comparative analyses (compiled from Ingram 2008; 
Jones 2012). 
 
Populations Country 
Language 
family 
Settlement 
pattern 
Primary 
substistence 
method 
Presence 
of milking 
Predominant 
milked 
animal 
       Afar Ethiopia Afro-Asiatic Nomadic Pastoralism Yes Camels 
Amhara Ethiopia Afro-Asiatic Sedentary Farming Yes Cattle 
Asante Ghana Niger-Congo Sedentary Farming No - 
Beni Amer Sudan Afro-Asiatic Nomadic Pastoralism Yes Camels 
Chagga Tanzania Niger-Congo Sedentary Farming Yes Cattle 
Chewa Malawi Niger-Congo Sedentary Farming No - 
Jaali Sudan Afro-Asiatic Sedentary Pastoralism Yes Cattle 
Mambila Cameroon Niger-Congo Sedentary Farming No - 
Oromo Ethiopia Afro-Asiatic Nomadic Pastoralism Yes Cattle 
Shabo Ethiopia Nilo-Saharan Sedentary Farming, 
hunting, 
gathering 
No - 
Bedouin Israel, 
Jordan, 
Saudi Arabia 
Afro-Asiatic Nomadic Pastoralism Yes Camels 
Israeli Arabs, 
Palestinians 
Israel Afro-Asiatic Sedentary Farming Yes Cattle 
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2.2 Experimental methods 
2.2.1 DNA collection 
DNA samples newly collected during the course of this thesis were obtained from buccal 
cell DNA. For this collection, cotton swabs were rubbed around on the inside of the cheek 
of the sample donors for at least 30 seconds and 10 of the swabs were placed in a 15ml 
Falcon tube containing 2.5ml ǮSlagboomǮ buffer including proteinase K (see 2.5 for 
receipe). The tubes were stored in a dark environment at room temperature until 
extraction. 
2.2.2 DNA extraction 
The samples used in this thesis were extracted by a variety of different procedures, 
depending on the cellular source of the DNA and the laboratory from which they were 
obtained by different adaptations of the phenol-chloroform method or salting out 
precipitation methods.  
2.2.2.1 Within group extraction method 
The buccal cell samples newly collected for this thesis and other buccal samples prepared 
within the Swallow group were extracted by Ranji Araseretnam or Kate Ingram following 
an extraction protocol devised by Freeman et al. (2003). 
Each collection tube containing Slagboom buffer and cotton swabs was incubated at 65°C 
for 2 hours. After removing the cap, the tube was inverted into a clean 50ml tube and both 
centrifuged for 10 minutes at 650x g. The original tube was discarded, the swabs were 
drained and all liquid was transferred into a new 15ml tube. 300µl Yeast Reagent 3 
(Autogen Bioclear, diluted 1:1 with 100% ethanol) was added. This contains potassium 
acetate and phenol and chloroform to denature remaining proteins. The solution was 
vigorously mixed manually for 1 minute and then centrifuged for 25 minutes at 8000x g. A 
repeat of this step followed, after transfer of the supernatant to clean tube and further 
addition of 300µl Yeast Reagent 3. The supernatant containing the DNA was transferred 
again into a clean tube. 1.8ml 100% isopropanol was added and the tube gently inverted 
to mix, and precipitate the DNA. A centrifugation step followed at 8000x g for 25 minutes. 
The supernatant was discarded and the DNA containing pellet washed gently with 1ml 
70% ethanol and centrifuged again at 8000x g for 10 minutes. The ethanol supernatant 
was then discarded and the tube left open to allow the pellet to air dry for 15 minutes. The 
DNA pellet was resuspended in 400µl Puregene DNA hydration solution (1mM EDTA, 
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10mM Tris-CI (pH 7.5), Gentra) and incubated overnight at 4°C on a rocking platform. 
Sample aliquots were stored ad +4°C and -70°C. 
DNA from blood and cell line samples was extracted previously using Puregene DNA 
extraction kits, which involve salting out precipitation, following the manufacturer's 
instructions.  
2.2.2.2 Extraction from dried blood 
The DNA of 43 phenotyped Yakut samples was extracted from blood dried onto filter 
paper, using the QIAamp DNA Mini Kit (QIAGEN). The procedure followed the protocol ǮDNA purification from dried blood spotsǮ: 
Approximately 1cm2 of paper was cut from each blood spot with scissors, cut into 4 
smaller pieces and placed in a 1.5ml eppendorf tube. After each sample the scissors and 
forceps used were washed with 1% Alconox solution (Sigma-Aldrich), rinsed with dH2O 
and 70% ethanol and dried with a separate tissue to avoid cross contamination of the 
samples. 180µl of Buffer ATL was added and the tube and incubated at 85°C for 10 
minutes. The addition of 20µl of proteinase K stock solution (600 mU/ml) followed, the 
mix was vortexed briefly and incubated at 56°C for 1 hour. 200µl lysate buffer (Buffer AL) 
was added to the sample, the solution mixed thoroughly by vortexing and incubated at 
70°C for 10 minutes. 200µl 100% ethanol was added, the mix quickly vortexed and then 
transferred to a QiAamp mini spin column in a 2ml collection tube.  
After centrifuging at 6000x g for 1 minute, the tube with supernatant containing proteins 
and other contaminants was discarded and the column transferred into a new collection 
tube. The DNA absorbed onto the silica membrane of the column was then washed in two 
steps to remove any remaining contaminants. First 500µl Buffer AW1 (96% ethanol) was 
added to the spin column and it was centrifuged at 6000x g for 1 minute. The collection 
tube with the filtrate was emptied and the second washing step followed with the addition 
of 500µl Buffer AW2 (96% ethanol) and centrifugation at 16000x g for 3 minutes. The spin 
column was placed in a 1.5ml eppendorf tube and 150µl Buffer AE (10mM Tris Cl, 0.5mM 
EDTA, pH 9.0) was added to the column and incubated for 1 minute. In the following 
centrifugation step at 6000x g for 1 minute the DNA was eluted from the membrane. The 
samples were stored at -20°C. 
2.2.3 Lactase persistence data and lactose tolerance testing 
As described in section 1.2.4 of the introduction, the classification of the lactase 
persistence status of an individual can be made from biopsy material in measuring lactase 
activity directly or indirectly via lactose tolerance tests. Most of the phenotype data used 
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in chapters 5 and 6 were obtained during the course of several other projects and were 
reassessed for this thesis. Test methods are briefly mentioned below, further details can 
be obtained from the corresponding publications.  
 
The Northern European sample series was first analysed by Harvey et al. (1995b). 
Duodenal biopsy material from hospital patients (UCLH) was examined for lactase and 
sucrase enzyme activity, and checked by histology.  
Phenotypes of the Italian samples were also determined from lactase activity of biopsy 
samples, collected from hospital patients in Naples who underwent jejunal surgery 
(Harvey et al. 1998; Maiuri et al. 1991). 
The Finnish samples were lactose tolerance tested by Dr Riitta Korpela in Helsinki via 
urinary galactose and breath-hydrogen tests. This cohort does not represent a randomly 
chosen population sample as it was collected to contain approximately half lactase 
persistent and non-persistent female individuals inferred from lactose digester/non-
digester status (Harvey et al. 1998; Hollox 2000), which is higher than the population 
average for lactase non-persistence and was therefore only used for analyses in chapter 6. 
Lactose tolerance testing of the Yakut samples was done via blood glucose tests, 
conducted by Sardana Markova and Maria Khandy of the Yakutsk State University (Hollox 
2000). 
 
The volunteers from the African groups were tested by the breath hydrogen method and 
this was done by Mohamed Elamin from Khartoum, Tamiru Oljira from Addis Ababa 
University and Kate Ingram from UCL: The Jaali were from Sudan (Ingram et al. 2007; 
Ingram et al. 2009b) and the Somali camel herders, the Amhara and the Oromo groups 
were from Ethiopia (Jones 2012).  
 
5 individuals from Northern Europe were also newly tested with this method, which can 
be briefly described as follows. The volunteers were given a lactose load of 50g dissolved 
in water after fasting overnight. Breath hydrogen was measured before and every 30 
minutes (up to 3 hours) after drinking the lactose solution, with a MicroH2 meter (Micro 
Medical) (Peuhkuri et al. 1998). Volunteers were classified as lactose non-digesters if they 
showed and maintained an increase in breath hydrogen of at least 20ppm above the 
baseline, and as digesters with values below this. 2 individuals with a baseline and all test 
results lower than 2ppm were excluded as they could have been potential hydrogen non-
producers. 
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2.2.4  Sequencing 
All genomic regions of interest were firstly amplified via polymerase chain reaction (PCR) 
to be later analysed by sequencing: The LCT enhancer region in intron 13 of MCM6; for 
haplotype analysis a control region in intron 4 of MCM6 and 3 sequence regions containing 
the LCT core haplotype defining SNPs (hapdef) previously described by Hollox et al. 
(2001), and the immediate promoter (IP) and parts of intron 2 of LCT (Figure 2.1). 
 
 
Figure 2.1: Overview about the sequenced regions for the different chapters of this thesis. 
 
Some of the data collection was part of undergraduate projects. Most of the data for the 
LCT enhancer and immediate promoter region for South and East Asia (India, China and 
Japan) was collected by Anshua Gosh (Ghosh 2010). Some of the haplotype marker data 
for the Middle Eastern populations of Kuwait, Iran and Syria was accumulated by Lana-
Mai Couzens (Couzens 2011). 
 
The sequences of intron 4 of MCM6, the lactase enhancer and hapdef regions for the 
African populations were obtained from previous projects of Kate Ingram, Pawel Zmarz 
and Bryony Jones (Ingram 2008; Ingram et al. 2009b; Jones 2012; Zmarz 2010). Kate 
Ingram also performed the sequencing of the LCT enhancer and the genotyping of some 
haplotype defining SNPs for the Bedouin, Israeli and Palestinian populations and the 
European phenotyped samples (Ingram et al. 2007).  
All of these sequences were re-checked and re-sequenced if necessary for chapters 5 and 6 
of this project and all remaining samples were tested as part of this project. 
2.2.4.1 Primer design 
Primers for a multiplex PCR were designed to simultaneously amplify two of the haplotype 
marker regions of LCT exon 2/intron 1 and exon 17 of the haplotype defining regions. The 
sequences for the two regions were obtained from the human reference sequence, 
downloaded from the Ensembl database (build 71, GRCh37/hg19) and the FastPCR 
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software (version 5.4.8, Kalendar et al. 2011) was used for primer design. Primer 
specificity was checked with the ǮBLAT searchǮ of the UCSC browser (Kent et al. 2002). The 
primers for LCT intron 2 were also designed during the course of this PhD, by Bryony 
Jones. 
2.2.4.2 PCR 
Sampled DNA was PCR amplified using conditions optimized for each genomic region 
(temperature and cycling conditions). The multiplex PCR needed additional adjustment 
for optimal dNTP and MgCl2 content. Primer sequences and reaction specific PCR cycling 
conditions are summarized in Table 2.3. 
 
PCR reactions were carried out in 96 well plates each in a total volume of 10µl. Standard 
reactions contained 1x Reaction Buffer IV, 0.15mM MgCl2 (0.25mM for Multiplex), 200µM 
dNTPs (400µM for Multiplex), 0.25U Taq DNA polymerase (all Thermo Fisher), 0.25-0.5µM 
of each primer (Sigma-Aldrich) and about 10-20ng genomic DNA. The basic method 
included an initial denaturation step at 95°C for 5 minutes, followed by a variable number 
of cycles of denaturation (95°C for 30sec), annealing (variable temperature for 30sec) and 
elongation (72°C for a variable time). A final elongation step followed for 5 minutes at 
72°C.  
2.2.4.3 Gel electrophoresis 
All PCR products (after the PCR and after the PCR cleanup) were separated on 1 or 2% 
agarose gels in comparison with a DNA ladder (Stretch marker, see 2.5.1), to check their 
quantity and ensure the correct sizes. 2µl of the PCR product mixed with 3µl loading buffer 
was loaded on the gels that were stained with 50ng/ml ethidium bromide (Sigma) that 
was included in the gel. The gels were visualised and photographed under UV light for 
documentation. 
2.2.4.4 PCR cleanup 
To prepare the PCR products for the sequencing process they needed to be purified. The 
PCR cleanup protocol is essentially a polyethylene glycol (PEG) precipitation method: The precipitation solution ȋʹ/͵ ǮMicrocleanǮ, see section 2.5.1) was added to the PCR product 
in 3 fold volume. The plates were mixed thoroughly and centrifuged at 1500x g for 1 hour. 
The supernatant, containing primers, excess nucleotides and salts was then discarded by 
inverting the plate onto tissue and centrifuging at 20x g for 1 minute. A washing step 
followed to remove the remaining PEG and any contaminants with the addition of 150µl 
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70% ethanol, centrifugation for 10 minutes at 1500x g. The ethanol solution was discarded 
as before by inverting and centrifuging of the plate at very low speed (20x g) for 30 
seconds. The DNA pellets were left at room temperature to air dry for at least 15 minutes 
and were then resuspended in 10µl dH2O. 
2.2.4.5 Sequencing 
All sequencing reactions were performed by myself or carried out by Mari-Wyn Burley from ǮThe Centre for Comparative GenomicsǮ at UCL using a standard protocol based on 
the ǮSanger sequencingǮ method (Sanger et al. 1977) and the BigDye Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems, ABI). For the reactions either PCR primers or 
additionally designed sequencing primers were used (Table 2.3).  
Each sequencing reaction was carried out in a 10µl volume with 2-2.5µl cleaned up PCR 
product. The mix further contained 0.35µl BigDye Terminator v3.1, 1x sequencing buffer 
and 0.16µM primer. Thermo cycle sequencing was performed using the following 
parameters: After an initial denaturation at 96°C for 1 minute 25 cycles of 96°C for 1 
minute, 50°C for 5 seconds and 60°C for 4 minutes followed. 
 
Following the sequencing reaction, the DNA was purified by ethanol precipitation to 
remove contaminants. 2.5µl of 125mM EDTA and then 30µl 100% ethanol was added to 
each well. The plate was thoroughly mixed and centrifuged for 1 hour at 3870rpm. The 
supernatant was removed by inverting the plate onto tissue and centrifuging at 300rpm 
for a few seconds. Any remaining contaminants were then removed by the final ethanol 
wash: 30µl of 70% ethanol was added to each well and the plate centrifuged again at 
3870rpm for 10 minutes. The ethanol was removed by inverting the plate onto tissue 
again and centrifugation at 300rpm for a few seconds. The plate with the DNA pellets was 
left at room temperature to air dry for 15 minutes. 
 
To prepare the samples for the run on an ABI 3730xl DNA Analyzer, the pellets were 
resuspended in 10µl HiDi formamide (ABI), denatured at 95°C for 5 minutes and then 
immediately put on ice for at least 5 minutes before they were loaded in the machine. 
2.2.4.6 Sequence analysis 
Sequence chromatograms were analysed using the software ChromasPro (version 1.5, 
Technelysium Pty Ltd) and compared to a reference sequence (Ensembl database, 
GRCh37/hg19). The DNA was mostly sequenced in both directions. New variants were in 
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each case confirmed on both strands or sequencing of at least one additional and 
independent PCR. 
 
The ancestral allelic state at each new locus was inferred by comparing the human 
reference sequence for each genetic region with those of other primate species (see 
Appendix A). The human reference sequence (Feb 2009, GRCh37/hg19) for each region 
was downloaded from the UCSC browser (Kent et al. 2002) using the flanking PCR primers for the Ǯ)n-Silico PCRǮ tool. The corresponding primate sequences were generated using the UCSC ǮBLAT searchǮ with the reference sequence assemblies for chimpanzee ȋFeb 
2011, CGSC 2.1.4/panTro4), orang-utan (July 2007, WUGSC 2.0.2/ponAbe2), gorilla (May 
2011, gorGor3.1/GorGor3) and rhesus macaque (Oct 2010, BGI CR_1.0/rheMac3). The 
BioEdit sequence alignment editor (version 7.0.9.0, Hall 1999) and the integrated 
CLUSTAL W (version 1.81) multiple sequence alignment tool (Thompson et al. 1994) was 
used to align the sequences. 
2.2.5 Genotyping 
2.2.5.1 KASP genotyping 
Genotyping of 880 samples for analysis in chapter 5 was performed externally by LGC 
Genomics (KBioscience) using their KASP (ǮKompetitive allele specific PCRǮ) genotyping 
assay. Results were viewed with SNPviewer2 (version 3.2.2.16), provided by the company.  
Quality control checks were performed after the data were provided. For each population, 
the SNP calls were visually inspected to check they were assigned to the correct genotype. Uncertain calls ȋmarked as Ǯ?ǮȌ that could be clearly grouped with either one of the 
homozygous or the heterozygous genotypes were corrected manually. Finally the data 
were tested as to whether they agree with Hardy Weinberg expectations (as described in 
section 2.3.1). 
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Table 2.3: Primers used for PCR amplification and sequencing at UCL  
 
Genetic region 
Location (bp 5' 
of LCT start of 
transcription) Primer name  Primer sequence (5'-3') 
Product 
length  
Annealing 
temperature (°C ) 
Elongation 
time (sec) cycles 
               
LCT enhancer               
MCM6, intron 13 -14,397 MCM6ex13  ATTTCCAAAGAGTCAGAGGACTTC 940 58 60 39 
    MCM6778  CCTGTGGGATAAAAGTAGTGATTG         
  -14,163 MCM6i13  GGACATACTAGAATTCACTGCAAATAC 706 58 45 38 
    MCM6778  CCTGTGGGATAAAAGTAGTGATTG         
    MCM6ex13  ATTTCCAAAGAGTCAGAGGACTTC 661 58 45 38 
    LAC-C-L2  CTGCTTTGGTTGAAGCGAAGAT         
                
LCT,  -527 LCT IP_f  TCTTCAGACATTTTCCGGGTTC 719 56 45 37 
immediate promoter   LCT IP_r  TGTCTTTGTCCCCTGCTACA         
                
LCT haplotype marker               
LCT, hapdef region -1,162 LCT_far_prom_f  ATCCACATTCTACAGGTGACAA 701 59 60 38 
    LCT_far_prom_r  GACCAACACAAAAACCTCAGAC         
LCT, exon 2 3,762 LCT_Ex2_F  CCTTGCCAACTCTCCAACTGC 502  59 45 38  
    LCT_Ex2_R  ACACTTGACCAAGCAGGAGC        
LCT, exon 17 48,500 LCT_Ex17_F  GATGGGTACCTCCACCTCG 927      
    LCT_Ex17_R  TGGTGAGAAAGCTTAATCGGAGC        
                
LCT, intron 2 5,282 LCT_intron2_f  CTGGGAAGTGAACAGCTTTGG 839 58 60 39 
    LCT_intron2_r  CCACCACATTAAGTCTTGGTCTCC         
                
MCM6, intron 4 30,461 MCM6_intron4f  ACCCTCAGATTTCAGCAGGAC 683 58 45 39 
    MCM6_intron4r  ACTCCATGATGATTCAAGCAGC         
 
65 
Other sequencing primers Primer name Primer sequence (5'-3') 
LCT, inner promoter LCT IP  AGATGGAGTCTCATTCTGTTGC 
LCT, hapdef region LCT-farprom_hap_seq_primer(r)   TTGGTGACCGGGTCTCACTCTG 
MCM6, intron 4 intron4_R2  GACTCCAAATATCTGTTCCATGC 
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2.2.6  Electrophoretic mobility shift assays (EMSAs) 
EMSAs were performed to detect nuclear proteins in the Caco-2 cell line that bind to DNA 
sequences of the LCT enhancer and distinguish possible differences in binding affinity to 
probes containing the derived or ancestral allelic variants. 
2.2.6.1 Cell culture 
Human Caco-2 cells (obtained from Martin Spiess, Basel, passage >80) were cultured in 
180ml tissue culture flasks and kept in a humid environment at 37°C and 5% CO2. The 
cells were grown in 30ml Dulbecco's modified eagle medium (DMEM, with 4.5 g/L Glucose 
and L-Glutamine, BioWhittaker-Lonza), supplemented by 100U/ml penicillin, 100µg/ml 
streptomycin and 10% foetal calf serum (Remal, all Fisher Scientific). At 80% confluence 
(after 3-4 days) the cells were split by trypsinisation. To do this the medium was 
discarded from the Caco-2 monolayer culture and the cells were washed with 5ml 0.05% 
Trypsin-EDTA solution (Gibco, Life Technologies) which was then all discarded with 
exception of a small amount just covering the cells. A short incubation followed for up to 5 
minutes at 37°C until the cells could be detached from the flask surface by tapping the 
flask. 10ml of fresh DMEM 10% FCS, (full culture medium) were added (using the anti-
trypsin in the FCS) to stop the reaction and suspend the cells. To start a new passage of cell 
culture 1ml of DMEM-containing cell solution was transferred to a new culture flask and 
29ml culture medium added. The medium was changed at 2 day intervals. 
2.2.6.2 Preparation of nuclear protein extract 
Caco-2 cells were grown on 20 x 20cm cell culture plates. After 10 days of culture cells had 
grown to confluence and the formation of domes was visible by inspection under a 
microscope as described by Pinto and colleagues (Pinto et al. 1983b) indicating that they 
had become differentiated.  
Nuclear protein extract was prepared from differentiated Caco-2 cells 13 days after 
seeding following the protocol described in Ausubel (2002). The medium was removed 
from the cells, they were washed twice in phosphate-buffered saline (PBS, pH 7.4, Gibco, 
Life technologies) and harvested by scraping them off the surface in 40ml PBS. A 
centrifugation step followed at 3000rpm for 10 minutes and the supernatant was 
discarded. The cell pellet was immediately resuspended in hypotonic buffer (see 2.5) of 5x 
the volume of the cell pellet and centrifuged for 5 minutes at 3000rpm to remove salt from 
the PBS solution for effective swelling in the next step. The supernatant was discarded and 
the cell pellet resuspended again in hypotonic buffer to a final volume of 3x the first pellet 
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volume and allowed to swell on ice for 10 minutes. In the following step the cells were 
homogenized in a glass Dounce homogenizer by 10 very slow up-and-down strokes with a 
type B pestle to lyse the cells and release the nuclei. Cell nuclei were collected by 
centrifuging at 3300x g for 15 minutes and after that resuspended in low-salt buffer of half 
the volume of the nuclear pellet. This was followed by application of the same volume (half 
the original nuclear pellet) of high-salt buffer (for recipes see 2.5.1) dropwise with 
continuous and gentle stirring and the nuclei were allowed to extract under further gentle 
mixing for 30 minutes. The lysed nuclei were pelleted by centrifugation at 20000x g for 30 
minutes and the nuclear extract in form of the supernatant placed in dialysis tubing 
(Visking dialysis membrane, diameter size 6.3mm, volume 0.3ml/cm, molecular weight 
cut-off 12-14 kDa, Medicell) and left to dialyse against 50 volumes of dialysis buffer 
overnight. The extract of the dialysis bag was then centrifuged at 14500rpm for 20 
minutes and the clean extract between the pellet and precipitates on the supernatant 
surface was removed, aliquoted and stored at -80°C. 
 
The protein concentration of the nuclear extract was measured by the method of Bradford 
(1976) using the ǮBio-Rad Protein AssayǮ microassay procedure. ͷ dilutions of the protein 
standard (Protein standard II, bovine serum albumin, Bio-Rad), to create a standard curve, 
and 2 dilutions of the nuclear extract with PBS in a 10µl volume were made in duplicate. 
10µl of dialysis buffer was added and the mixture made up to 800µl with dH2O. 200µl of 
dye (protein assay dye reagent concentrate, Bio-Rad) was added to each tube and after 
vortexing the tubes were incubated at room temperature for 5 minutes. The absorbance 
was measured at 595nm in a photometer and the protein concentration of the extract 
calculated from the standard curve. 
2.2.6.3 EMSA oligonucleotide design 
Gel shift assays were performed with labelled DNA probes and nuclear extract, 
competition experiments with the addition of unlabelled short DNA sequences and 
supershift experiments with the addition of antibodies specific for a certain transcription 
factor (see also chapter 4). 
Two complementary oligonucleotides for each of the five enhancer variants tested (-
14028*C, -14011*T, -14009*G, -13779*C and 14010*C as control) and their corresponding 
ancestral sequences were designed by visual inspection of the sequence from the human 
reference sequence template (GRCh37/hg19). They were designed to be between 22 and 
31 bp in length with the ancestral or mutated base near the centre and an extra 5' base on 
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both the sense and antisense oligonucleotide to create an overhang during later annealing, 
which is important for the labelling of the probe.  
For EMSA competition experiments oligonucleotides with known transcription factor 
affinity sites were used, of which some had already been designed and tested by other lab 
members. Others were newly designed after bioinformatic analysis of the regions around 
the five enhancer variants (see section below and chapter 4). The core sequences 
consisting of matrices for predicted transcription factor binding sites were complemented 
with random bases at both sides to reach an oligonucleotide length of 25 bp. The 
oligonucleotide sequences were re-checked bioinformatically for binding specificity and 
the core flanking sequences modified accordingly. A 5'A base was added to both 
complementary oligonucleotides in case they would later be needed as probes. All double 
stranded oligunucleotide sequences used in EMSA experiments can be found in Table 2.4. 
A further set of oligonucleotides was ordered with sequences taken from technical 
information sheets of specific transcription factor probes from commercially available 
EMSA kits (Panomics, Affymetrix transcription factor EMSA kits, 
http://www.affymetrix.com/estore/). 
2.2.6.4 Probe preparation: Radioactive labelling and purification 
Sense and antisense oligonucleotides (MWG Operon) were annealed and used as 
unlabelled (cold) probe for competition experiments or labelled with radioactivity. 
Annealing reactions were carried out in a volume of 100µl containing 250pmol of each 
primer and 0.1M NaCl. After heating the mix at 95°C for 1 minute, the tube was left in the 
heating block on the bench to slowly cool down to room temperature. 
2.5pmol of the double stranded probes were labelled using 5U T4 Polynucleotide Kinase 
(Fermentas) and 25-35µCi [γ32P]ATP (Perkin Elmer) in Kinase reaction buffer A (forward, 
Fermentas). The reaction mix was incubated for 30 minutes at 37°C and 20µl 1x TE buffer 
were added afterwards. The probe was purified with a MicroSpin G-25 Column (Illustra, 
GE Healthcare) and the eluate filled up to 100µl total volume with TE buffer. 
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Table 2.4: Double stranded oligonucleotides used for EMSAs, variants indicated in bold. 
 
Probe name Sequence 
 
Enhancer variants  
 
14028T (ancestral) 
5'-ACGTCATAGTTTATAGAGTGCATAAA-3' 
 3'-GCAGTATCAAATATCTCACGTATTTC-5' 
14028C 
5'-ACGTCATAGTTCATAGAGTGCATAAA-3' 
 3'-GCAGTATCAAGTATCTCACGTATTTC-3' 
14011C (ancestral) 
5'-TAGAGTGCATAAAGACGTAAGTTACCATTTA-3' 
 3'-TCTCACGTATTTCTGCATTCAATGGTAAATT-5' 
14011T 
5'-TAGAGTGCATAAAGATGTAAGTTACCATTTA-3' 
 3'-TCTCACGTATTTCTACATTCAATGGTAAATT-5' 
14010C 
5'-TAGAGTGCATAAAGACCTAAGTTACCATTTA-3' 
 3'-TCTCACGTATTTCTGGATTCAATGGTAAATT-5' 
14009G 
5'-TAGAGTGCATAAAGACGGAAGTTACCATTTA-3' 
 3'-TCTCACGTATTTCTGCCTTCAATGGTAAATT-5' 
13779G (ancestral) 
5'-AGTAGTACGAAAGGGCATTCAA-3' 
 3'-CATCATGCTTTCCCGTAAGTTC-5' 
13779C 
5'-AGTAGTACCAAAGGGCATTCAA-3' 
 3'-CATCATGGTTTCCCGTAAGTTC-5' 
 
 TF binding 
competitors 
 SIF1 24 (Cdx-2 binding 
site) 
5'-TGGGTGCAATAAAACTTTATGAGTA-3' 
 3'-CCCACGTTATTTTGAAATACTCATT-5' 
Oct control 
5'-ATGTCGAATGCAAATCACTAGAA-3' 
 3'-ACAGCTTACGTTTAGTGATCTTA-5' 
LPH-CE2c  
(HNF-1α binding site) 
5'-ATAACCCAGTTAAATATTAAGTCTTAAT-3' 
3'-TATTGGGTCAATTTATAATTCAGAATTA-5' 
TREH's HNF4 site  
(HNF-4α binding site) 
5'-CCTCAAAGGCTGGACTTTGGCCGACTTGG-3' 
 3'-CTCAAAGGCTGGACTTTGGCCGACTTGGA-5' 
mut Xbal 13910 site  
(2 GATA binding sites) 
5'-TACAGATAAGATAATTCTAGACCTGGCCTCAAAGGA-3' 
3'-ATGTCTATTCTATTAAGATCTGGACCGGAGTTTCCT-5' 
unspec24 (non-
specific) 
5'-AACGTAGCTGATCGAATCGGTTAC-3' 
 3'-TGCATCGACTAGCTTAGCCAATGA-5' 
  
Newly designed TF 
binding competitors 
(see also Table 4.1) 
 
c-Ets-1  
5'-AATCCTCTACCGGATGTAGGTCGAC-3' 
 3'-TAGGAGATGGCCTACATCCAGCTGA-5' 
Ets/Tel-2 
5'-ATCTTACTACTTCCTCGCTGACCGT-3' 
 3'-AGAATGATGAAGGAGCGACTGGCAA-5' 
NF-kappaB 
5'-AGTGGCGGGGAAAGTCCCCAGAATC-3' 
 3'-CACCGCCCCTTTCAGGGGTCTTAGA-5' 
Pax 
5'-AAGAAGTGGAACTCACGATCGTGCT-3' 
 3'-TCTTCACCTTGAGTGCTAGCACGAA-5' 
Pax4-8 
5'-ACGGCGTTCATGCGTGAGCGACCGT-3' 
 3'-GCCGCAAGTACGCACTCGCTGGCAA-5' 
Pbx 
5'-AGATGGGATTGATGGTAGCCGTATT-3' 
 3'-CTACCCTAACTACCATCGGCATAAA-5' 
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Probe name Sequence 
 
Competitors from 
Affymetrix EMSA kit 
 
Aff_c-Ets-1 
5'-ACCAGGAAGCCAGGAAG-3' 
 3'-GGTCCTTCGGTCCTTCA-5' 
Aff_ETS (1) 
5'-AGGAGGAGGGCTGCTTGAGGAAGTATAAGAAT-3' 
 3'-CCTCCTCCCGACGAACTCCTTCATATTCTTAA-5' 
Aff_ELF 
5'-AGAGTCATCAGAAGAGGAAAAATGAAGGT-3' 
 3'-CTCAGTAGTCTTCTCCTTTTTACTTCCAA-5' 
Aff_Elk-1 
5'-ATTTGCAAAATGCAGGAATTGTTTTCACAGT-3' 
 3'-AAACGTTTTACGTCCTTAACAAAAGTGTCAA-5' 
Aff_LEF1 
5'-ACCCATTTCCATGACGTCATGGTTA-3' 
 3'-GGGTAAAGGTACTGCAGTACCAATA-5' 
Aff_GKLF 
5'-AATGCAGGAGGAGAAAGAAGGGCGTAGTATCTACTAG-3' 
 3'-TACGTCCTCCTCTTTCTTCCCGCATCATAGATGATCA-5' 
Aff_AML1 
5'-AATCTCTATGTGGGTGTGGGTGTGGGAATCAT-3' 
 3'-TAGAGATACACCCACACCCACACCCTTAGTAA-5' 
Aff_GATA3 
5'-AGTTATTTATCTCTTAGTTGTAGTTATTTATCTCTTAGTTGTA-3' 
 3'-CAATAAATAGAGAATCAACATCAATAAATAGAGAATCAACATA-5' 
Aff_GATA4 
5'-AGCCTAAGCCAAGTGATAAGCAGCCAGACAA-3' 
 3'-CGGATTCGGTTCACTATTCGTCGGTCTGTTA-5' 
 
2.2.6.5 Protein binding reaction 
A reaction mix, containing both the extract and radioactive end-labelled DNA fragments 
was prepared. Binding reactions for EMSA experiments were usually performed with 4.5-
9µg differentiated Caco-2 nuclear extract, 4µl dialysis buffer, 10µl gelshift buffer. Each 
reaction also contained 0.25µg Poly (deoxyinosinic-deoxycytidylic) acid sodium salt (poly 
dI-dC, Sigma-Aldrich) and 2.5 pmol unlabelled oligonucleotides to prevent nonspecific 
DNA binding for clearer bands on the gel pictures. 
Most reactions showed both specific and non-specific binding proteins. To specify further 
which protein of the extract is binding, competition and supershift experiments were 
performed. For competition assays, 2.5pmol of the unlabeled annealed competitor 
oligonucleotide was added to the reaction mix and for supershift assays 1-2µl of the 
antibodies Cdx-2 (BioGenex), Oct-1, HNF-ͳȽ, (NF-4Ƚ, Ets-1/2, Ets-1, GATA-6 (all Santa 
Cruz).  
After incubation of the mixture for 10 minutes on ice 2.5 fmol of probe was added, mixed 
and incubated on ice for at least further 20 minutes.  
2.2.6.6 Polyacrylamide (PAA) gel electrophoresis and analysis 
For electrophoresis, 5% nondenaturing polyacrylamide gels (30% 
acrylamide:bisacrylamide 29:1, Sigma-Aldrich) were prepared. The PAA-gel was pre-run 
at 4°C for 1 hour using 0.5x TBE buffer before the mixes of the binding reactions, resolved 
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in 2µl EMSA loading buffer, were loaded and run at 4°C. Following electrophoresis the gel 
was transfered onto Whatman paper and vacuum dried for at least 2 hours at about 80°C. 
The gel-paper was exposed to a phosphoimaging screen for at least 2 hours which was 
then scanned with a Storm scanner and analysed using the Imagequant software (version 
5.1, GE Healthcare). 
2.2.7 Transfection studies 
Transfection studies were performed to examine the effect of the different LCT enhancer 
and promoter variants, introduced in a reporter gene construct, on the expression of the 
reporter gene luciferase. Figure 2.2 summarises the cloning strategies described below. 
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Figure 2.2: Summary of the different strategies for site directed mutagenesis and insertion of 
LCT promoter fragments (left) and enhancer fragments (right) into the luciferase reporter 
gene plasmids. LCT promoter variants were created in one PCR step and inserted via SacI and XhoI 
into a plasmid, containing the ancestral enhancer region (pGL3 hLPH1085-13910*C (Troelsen et al. 
2003)). LCT enhancer variants were generated in a two step PCR amplification and inserted via 
BamHI and SalI into the pGL3vector containing the ancestral promoter region (pGL3 hLPH1085 
(Troelsen et al. 2003)). Vector maps were created using Vector NTI Advance software (version 11.5, 
Invitrogen). 
 
2.2.7.1 Preparation of the LCT enhancer fragments 
The LCT enhancer variants were generated via site directed mutagenesis in a two step PCR 
amplification of the pGL3 hLPH1085-13910C enhancer plasmid construct (Troelsen et al. 
2003). Primers designed to add an upstream 5' BamHI and downstream 3' SalI restriction 
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site to the 450 bp enhancer fragment were used together with the overlapping primers 
designed for EMSA experiments to insert the variants (see Table 2.5). 
First, the region was amplified in two separate PCRs to generate a left and right fragment 
(with the BamHI site including primer and the reverse variant EMSA primer for the left 
fragment and the primer including the SalI site and the forward variant EMSA primer for 
the right fragment). PCR reactions contained 1x Pfu Buffer with MgSO4, 200µM dNTPs, 
2.5U recombinant Pfu DNA polymerase, all Fermentas), 0.4µM of each primer (MWG 
Operon) and about 37ng of the pGL3 hLPH1085-13910*C plasmid as template. Cycling 
conditions are described below (2.2.7.3). 
 
The two fragments, in form of 1µl of the purified left and right fragment, were then 
annealed to create an overlap at the mutated position with a denaturation step at 94°C for 
1 minute and an annealing step at 72°C for 3 minutes prior the second PCR (for cycling 
conditions see 2.2.7.3). The flanking BamHI and SalI site containing primers were then 
used to amplify the whole enhancer fragment.  
2.2.7.2 Preparation of the LCT promoter fragments 
The LCT promoter variants were created in one PCR step with the mutations directly 
included in the 3' primers, also with the pGL3 hLPH1085-13910C plasmid as template. 
Primers containing the -36*T and -17*T variants and a 3' XhoI restriction site were 
designed and used together with a previous designed 5' primer to create a fragment 
containing a SacI restriction site via PCR.  
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Table 2.5: Primers used for PCRs to create fragments to be inserted into reporter gene 
plasmids (mutated bases are indicated in bold). 
 
Genetic region Primer name  Primer sequence (5'-3') 
  
 
  
LCT enhancer 14028C_Fwd  ACGTCATAGTTCATAGAGTGCATAAA 
  14028C_Rev  CTTTATGCACTCTATGAACTATGACG 
  14011T_Fwd  TAGAGTGCATAAAGATGTAAGTTACCATTTA 
  14011T_Rev  TTAAATGGTAACTTACATCTTTATGCACTCT 
  14009G_Fwd  TATAGTGCATAAAGACGGAAGTTACCATTTA 
  14009G_Rev  TTAAATGGTAACTTCCGTCTTTATGCACTCT 
  13779C_Fwd  AGTAGTACCAAAGGGCATTCAA 
  13779C_Rev  CTTGAATGCCCTTTGGTACTAC 
  pcr14_5_131bp+ (BamHI)  GGATCCTTTATGTAACTGTTGAATGC 
  pcr14_3_149bp- (SalI)  GTCGACTTTCAAAGACGACCTTACAT 
  
 
  
LCT promoter 5 pGL3 primer 3  CTAGCAAAATAGGCTGTCCC 
  LPH_pro_36C>T_rev  CTCGAGATGTGGAACCCTTACTTTATAACTACAACT 
  LPH_pro_17C>T_rev  CTCGAGATGTGAAACCCTTACTTTATAACTGC 
    Sequencing 
primer Primer name  Primer sequence (5'-3') 
 
lucsal  GTCATAAGTGCGGCGACGATAGT 
  3pGL3 primer 1  CTTTATGTTTTTGGCGTCTTCCA 
  5 pGL3 primer 3  CTAGCAAAATAGGCTGTCCC 
 
2.2.7.3 PCR and gel purification 
The PCR reactions to amplify the promoter fragments and the full enhancer (second PCR) 
were performed in a 25µl volume using the Advantage-GC cDNA PCR kit (Fermentas), 
which also creates a 5' overhang to the amplified product, important for later cloning. The 
reactions contained 1x cDNA PCR reaction buffer, 1x dNTP mix (200µM), 1x Advantage-GC 
cDNA polymerase mix, 0.2µM of each primer (MWG Operon) and about 37ng of the pGL3 
hLPH1085-13910*C plasmid (or as template instead 2µl of the annealed enhancer 
fragment (section 2.2.7.1) or picked bacterial clones for colony PCR (section 2.2.7.5)).  
 
The general procedure for the PCR included an initial denaturation step at 95°C for 1 
minute followed by 25 cycles of denaturation (95°C for 30sec), annealing (55°C for 30sec) 
and elongation (72°C for 1min for enhancer or 2 min for promoter PCR) and a final 
elongation step for 5 minutes at 72°C.  
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The PCR products were run on a 1.5% agarose gel (as described in 2.2.4.3) with a marker 
lane (usually GeneRuler 100 bp, 100 bp Plus or 1 kb DNA Ladder, Fermentas). Bands of the 
right size were cut out of the gel and purified using the NucleoSpin Extract II kit (Macherey & NagelȌ and the protocol for ǮDNA extraction from agarose gelsǮ. Briefly, the agarose gel 
slice and 200µl Buffer NT (high salt buffer) per 100mg gel were incubated in a tube at 
50°C and vortexed every 2-3 minutes until the gel piece was dissolved completely. Then 
the mixture was placed on a prepared NucleoSpin Column and centrifuged for 1 minute at 
11000x g to bind the plasmid DNA to the silica membrane of the column. In the following 
washing step all contaminants were removed. 600µl Buffer NT3 (96-100% ethanol) were 
added and the column centrifuged at 11000x g for 1 minute, after removing of the flow-
through a further centrifugation step for 2 minutes followed. The column membrane was 
incubated with 15µl Buffer NE (5mM Tris-HCl, pH 8.5) for 1 minute and the DNA eluted in 
a new tube by centrifuging at 11000x g for 1 minute.  
2.2.7.4 Cloning of PCR products  
All purified enhancer and promoter fragments were TA-cloned into the pCR 2.1-TOPO 
plasmid using the TOPO-TA Cloning kit (Invitrogen). The 3'T overhang of the active 
plasmid vector was ligated to the 5'A of the PCR product with the help of Topoisomerase I, 
bound to the vector.  
4µl of the purified PCR product and 1µl Salt Solution was added to 10ng of the pCR 2.1-
TOPO plasmid DNA. After mixing and incubation at room temperature for 5 min, the 
mixture was transferred on ice. 
 
The transformation into One Shot TOP10 E.coli competent cells (genotype: F- mcrA Δ(mrr-
hsdRMS-mcrBC) Ȱ80lacZΔM15 Δlacȱ74 recA1 araD139 Δ(araleu) 7697 galU galK rpsL 
(StrR) endA1 nupG) was performed with 2µl of each TOPO cloning reaction added to a vial 
containing 25µl cells. After gentle mixing and incubation on ice for 30 minutes the cells 
were heat shocked for 30 seconds at 42°C to permeabilize the cell membrane for plasmid 
uptake, and transferred back on ice. 250µl Super Optimal broth with Catabolite Repression 
(S.O.C.) medium was added to the cells and the tubes placed on a shaking platform 
(170rpm) to incubate for 1 hour at 37°C.  
 
Each cell solution was then divided and spread on two pre-warmed agar plates (20ml LB 
agar, Sigma-Aldrich), containing 50µg/ml ampicillin and 40µg/ml 5-bromo-4-chloro-3-
indolyl-Ⱦ-D-galactopyranoside (X-gal, Invitrogen), and incubated at 37°C and 5% CO2 over 
night. The plates were screened for blue and white colonies the next day. 5 white colonies 
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were picked per variant clone and incubated over night (37 °C, 5% CO2) in 3ml LB medium 
(Lennox LB Broth, Sigma-Aldrich), containing 50µg/ml ampicillin. 
2.2.7.5 Plasmid preparation (Miniprep) 
1.5ml of each bacterial culture was used for a miniprep using the GenElute Plasmid 
Miniprep Kit (Sigma-Aldrich) following the protocol provided. All centrifugation steps 
were performed at 12000x g if not stated otherwise. Bacterial cells were pelleted for 1 
minute and the supernatant discarded. The cells were completely resuspended in 200µl 
Resuspension solution and 200µl Lysis solution was added. The tube was inverted 6-8 
times to mix gently. After the mixture became clear and viscous 350µl Neutralisation 
solution was added and gently mixed by inverting the tube 4-6 times to precipitate cell 
debris, proteins, lipids, salts and chromosomal DNA. By centrifuging for 10 minutes the 
debris was pelleted. The cleared lysate supernatant containing the plasmid DNA was 
transferred to a prepared binding column and centrifuged at 16000x g for 1 minute. The 
flow-through was removed and the column washed with 750µl Wash solution under 
centrifugation for 1 minute to remove contaminants. The flow-through was discarded and 
the columns dried in a further 1 minute centrifugation step. The purified plasmid DNA was 
eluted in a new collection tube with the addition of 100µl Elution solution to the column 
and a centrifugation for 1 minute.  
 
The inserts of the plasmids were checked to be the right sized fragments on agarose gels 
subsequent to either restriction enzyme digest within the ligation preparation step (see 
below) or PCR of individual colonies. Agarose gel purification followed as described in 
section 2.2.7.3.  
2.2.7.6 Enzyme digest, ligation and transformation of the pGL3 plasmids 
The promoter fragments were inserted into the pGL3 hLPH1085-13910*C plasmid using 
SacI and XhoI digestion and enhancer fragments were inserted into pGL3 hLPH1085 with 
SalI and BamHI digest. Both pGL3 plasmids needed to be opened prior to ligation and the 
mutated LCT enhancer and promoter fragments cut out of the plasmid via restriction 
enzyme digestion.  
The optimal conditions for the digestion with two restriction enzymes were calculated 
using Fermentas' DoubleDigest web tool (June 2010, now Thermo Scientific).  
Reactions with BamHI and Sal) were carried out in a ʹͲµl volume with ͳͲµl ǮminipreppedǮ 
plasmid DNA containing the mutated LCT enhancer, 1U BamHI and 2U SalI in 1x Buffer 
BamHI (all Fermentas) or in a 40µl reaction with ~2µg pGL3 hLPH1085 plasmid DNA and 
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2U BamHI and 4USalI in 1x Buffer BamHI respectively. The mixture was incubated at 37°C 
for at least 1 hour. 
Restriction digests with SacI and XhoI were carried out in 2 steps. First, ͳͲµl ǮminipreppedǮ 
plasmid DNA containing the mutated promoter fragments was digested with 2U SacI in a 
reaction volume of 20µl 1x Tango Buffer or ~2µg of the pGL3 hLPH1085-13910*C with 4U 
SacI in 40µl 1x Tango Buffer. After incubation for 1 hour at 37°C 1U Xho1 was added to the 
promoter plasmid digest reaction and 2U XhoI to the pGL3 hLPH1085-13910*C digest. 
Both reaction volumes were made up with Tango buffer to a 1x concentration. A further 
incubation step at 37°C for at least 1 hour followed. 
 
The digested enhancer and promoter and linearised vector fragments were separated on 
gels and fragments of the right size cut out of the gel and purified as described above. The 
5 digestion products (from the 5 different clones) for each mutated enhancer/promoter 
fragment were gel purified together. 
The DNA concentration of the eluate was measured using a NanoDrop Spectrophotometer 
and was between 10.1 and 17.5ng/µl for the enhancer and promoter fragments and 
51ng/µl for pGL3 hLPH1085-13910*C and 20ng/µl for pGL3 hLPH1085 for subsequent 
ligation and transformation. 
 
A sticky end ligation of enhancer/promoter fragments with the linear vector DNA was 
performed with the help of T4 DNA ligase (Fermentas) in a total volume of 20µl 1x T4 DNA 
Ligase Buffer (Fermentas). The reactions were carried out with a 5:1 ratio of the 
enhancer/promoter fragment DNA over the linear vector DNA with 1U T4 DNA ligase. 
After 10 minutes incubation at room temperature the plasmids were either used for 
transformation or frozen at -20°C. 
 
5µl of the plasmid ligation mix was transformed into 40µl (1:4 diluted) XL1-Blue E.coli 
competent cells (genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZΔMͷ5 Tn10 (Tetr)], Stratagene) and these spread on agar plates following the same 
protocol as for cloning of PCR products into TOP10 cells above (2.2.7.4).  
 
As many as possible colonies were picked and checked for successful insertion of the right 
sized fragments by colony PCR (section 2.2.7.3). All clones containing inserts were chosen and grown in ͵ml LB medium and ǮminipreppedǮ as above or stored in 50% glycerol 
cultures at -80°C. Gel purified plasmid DNA was sent out for sequencing using the Eurofins 
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MWG Operon sequencing service. Sequences were verified in both directions using 
sequencing primers flanking the inserted regions (see Table 2.5). 
2.2.7.7 Plasmid preparation (Maxiprep) 
One clone for each mutated plasmid, with the right sequence, was chosen and 50µl of the 
bacterial glycerol culture was grown in 200ml LB medium (containing 1µl/ml ampicillin) 
and incubated on a shaking platform (170rpm) for 16 hours (37°C, 5% CO2). Maxipreps 
were performed using the NucleoBond Xtra plasmid purification kit (Macherey & Nagel) following the corresponding protocol Ǯ(igh-copy plasmid purification ȋMidi, MaxiȌǮ.  
The cells from each culture were transferred to a centrifuge flask and harvested in a 
centrifugation step at 6000x g and 4°C for 15 minutes. After discarding the supernatant, 
the cell pellet was completely re-suspended in 10ml re-suspension Buffer RES, containing 
RNase A to degrade RNA in the solution. 10ml lysis Buffer LYS (containing NaOH and SDS) 
was added to denature proteins, chromosomal and plasmid DNA. The solution was gently 
mixed and incubated for 5 minutes at room temperature. To precipitate salts, proteins, 
chromosomal DNA and put the plasmid DNA back into its supercoiled state in the solution, 
10ml neutralisation Buffer NEU (containing potassium acetate) was added. Following 
gentle mixing, the lysate was applied to the inserted filter of the NucleoBond Xtra column, 
prepared with equilibration buffer (20ml Buffer EQU). The column was then washed by 
adding 10ml Buffer EQU to the filter rim and the filter containing unwanted contaminants 
discarded. The column containing silica resin was washed again with 20ml Buffer WASH 
and the plasmid DNA eluted from the column in 10ml elution Buffer ELU, collected in a 
15ml falcon tube. The plasmid DNA was precipitated with 7ml room-temperature 100% 
isopropanol. The isopropanol-eluate mix was vortexed, incubated for 2 minutes and 
centrifuged at 15000x g for 30 minutes. The supernatant was carefully discarded and the 
pellet left to air dry for 10 minutes. Finally the pellet was re-dissolved in 200µl TE buffer. 
The DNA concentration of the mutated and control luciferase reporter plasmids was 
photometrically measured and was between 1.2 and 2.5µg/µl. 
2.2.7.8 Transfections into Caco-2 cells 
Caco-2 cells were grown to 80% confluence and plated in 24-well plates the day before 
transfection, with each well containing about 5x104 Caco-2 cells. The medium was 
changed with 1ml fresh full culture medium before transfection.  
Each transfection experiment was carried out in 4 or 8 fold repeats. A DNA mix was 
prepared for each well with 0.2µg luciferase reporter gene plasmid, 0.1µg pCMV-lacZ plasmid ȋfor Ⱦ-galactosidase expression, Promega), 0.9µg pBluescript SK+ plasmid (to 
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adjust the total DNA amount to 0.3µg, Stratagene) in a 25µl volume containing 15mM NaCl. 
25µl of transfection reagent containing 2µM polyethyleneimine (PEI) in form of Exgen 500 
(22kDa, Fermentas) in 120mM NaCl solution or PEI25 (25kDa, Alfa Aesar) were added to 
the DNA mix and incubated at room temperature for 1 hour. 
The mixture was slowly added to the cells and the plates centrifuged for 5 minutes at 
1200rpm to settle the reagent on the cell surface. The plates were incubated at 37°C and 
5% CO2. The medium was changed the first day after transfection and later when 
necessary. 
2.2.7.9 Reporter gene assay analysis 
After 2 and 9 days of transfection the Caco-2 cells were harvested at an undifferentiated and differentiated stage respectively and luciferase and Ⱦ-galactosidase activity were 
measured using the Dual-Light System chemiluminescent reporter gene assay (ABI, 
Bronstein et al. 1997; Martin et al. 1996) following the Ǯluciferase and Ⱦ-galactosidase detection protocolǮ.  
The wells with the Caco-2 cell cultures were rinsed with 1ml room temperature PBS, 
which was completely removed by inverting the plate onto a paper towel and pipetting the 
remaining PBS from the side of the well. 130µl Lysis solution (containing 0.5mM DTT) was 
added to each well to cover the cells and after incubation for 5 minutes on a shaking 
platform the plates were placed on ice. 10µl of the cell extract was transferred to a 
luminometer vial. 25µl Buffer A was added to the bottom of the vial and it was placed in 
the luminometer immediately afterwards. 100µl Buffer B (containing luciferin and 1:100 
Tropix Galacton-Plus substrate) was automatically added by the luminometer and the 
luciferase signal read for 5 seconds after a 2 second delay. The signal from the Ⱦ-
galactosidase reaction is negligible at that stage due to the lack of turnover time and an 
enhancer and a non optimal pH. The tubes were further incubated at room temperature 
for 30-60 minutes and 100µl Accelerator-II was added to raise the pH of the solution and provide a luminescence enhancer for Ⱦ-galactosidase. After automatically adding of the 
Accelarator-II solution by the luminometer the luciferase signal was read again with a 2 
second delay for 5 seconds. 
 
Luciferase activity was normalised against Ⱦ-galactosidase activity by calculating relative luciferase/Ⱦ-galactosidase ratios for each well and significance between the transfection 
results tested with a student unpaired t test in Excel. 
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2.3 Statistical methods/Bioinformatic analyses 
2.3.1 Deviation from Hardy-Weinberg equilibrium (HWE) 
In a randomly mating population the expected genotype proportions from a determined 
allele frequency should follow the Hardy-Weinberg-theorem as they remain constant over 
generations in a stable population. The HWE is described by the formula: p²+2pq+q²=1, 
where p represents the major allele frequency and the minor allele frequency can be 
calculated by q=1-p.  
Deviations from HWE might be observed due to factors like non-random mating, 
population stratification, presence of selection (though unlikely to be detected in small 
sample sets), deletions and duplications (CNV), or even technical issues with collecting 
and analysing the data in the lab. In this project, tests for deviation from HWE were mainly 
used to check data for errors caused by allelic dropout or sampling problems. 
All genotype data from enhancer and haplotype markers were tested for deviation from 
HWE with the software Arlequin (version 3.5.1.3, Excoffier and Lischer 2010), which uses 
a kind of Fisherǯs exact test for each locus separately (Guo and Thompson 1992). 
2.3.2 Haplotype inference  
As all samples typed for this project are unrelated individuals, a statistical approach is 
needed to reconstruct haplotypes. The software PHASE (Stephens and Donnelly 2003; 
Stephens et al. 2001) applies a Bayesian statistical method to infer haplotypes from 
population genotype data. The programme uses a Markov chain-Monte Carlo algorithm, 
called Gibbs sampling, to calculate an expected pattern of haplotype distribution taking 
into account observed information of the dataset. Known haplotypes, occurring in 
homozygous individuals for example are fully informative and can be used for the 
calculation of unresolved haplotype pairs and those that are even then not resolvable are 
assumed more likely to include ones most similar to known haplotypes. The haplotypes 
for each individual are then reconstructed as most likely haplotypes estimated from the 
calculated posterior distributions by constructing a Markov chain.  
Version 2.1.1 of the PHASE package (Stephens and Scheet 2005), which was used in this 
study, can additionally take into account order and genetic distances between the 
genotyped markers and the resulting estimated decay of linkage disequilibrium. The 
PHASE output was checked by eye for possible anomalies. Default settings were used for 
most of the analysis, only for extended haplotype analysis (chapter 5) the number of 
iterations was reduced to 50. 
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2.3.3 Haplotype networks  
Haplotype information analysed by PHASE was used to construct a haplotype network 
with the software Network (version 4.6.1.1, http://www.fluxus-engineering.com). Allelic 
composition of each haplotype occurring at more than 4 chromosomes and haplotype 
frequencies were entered into the program and manually rooted to an ancestral haplotype 
(ancestral alleles inferred as described above, 2.2.4.6). The median-joining algorithm 
(Bandelt et al. 1999) was used to calculate the networks. It can deal with all types of data 
and constructs rooted networks with the shortest possible trees and reduces unnecessary 
cross links.  
2.3.4 Linkage disequilibrium 
Haplotype information was also used to estimate the level of linkage disequilibrium 
between alleles, which describes the non-random association between them (see also 
chapter 1). Pairwise linkage disequilibrium D between two alleles at different loci (A and 
B) of a haplotype is calculated with the formula D=pAB-(pA*pB), in subtracting the observed 
haplotype frequency from this expected under linkage equilibrium when pAB=pA*pB 
(whereas p is the frequency of one of the alleles at A and B). To be able to compare the 
values of two loci, the D parameter, which is highly dependent on allele frequencies, needs 
to be normalised. In dividing D by the theoretical maximum for the allele frequencies 
observed, D' can be calculated as proposed by Lewontin (1964). The values for D' lay 
between one (complete LD) and zero, values in between indicate a disruption of LD. 
Linkage disequilibrium was calculated using D' with PowerMarker (version 3.25, Liu and 
Muse 2005) and results were also checked in DnaSP (version 5.10.01, Librado and Rozas 
2009). Both programs apply a chi-square test to assess the significance of associations 
between loci, whereas the Bonferroni corrected significance levels DnaSP calculates were 
used to mark significant values in the tables. 
2.3.5 Linkage disequilibrium unit (LDU) maps  
A high resolution LDU map for chromosome 2 was constructed with the help of Winston 
Lau using LDMAP software (Lau et al. 2007) with a method that was initially developed by 
Maniatis et al. (2002) and extended by Morton et al. (2007). The method is based on the 
Malecot model which describes the isolation by distance of two SNPs. The probability (ρ) 
of an association between two SNPs is given by the modified Malecot equation (Morton et 
al. 2001):  
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where L is the association level at large distance (LD asymptote), M the association level at 
no distance (initial value before LD decays) and εi the decline of association which 
happens exponentially with physical distance di, measured in kb between the ith pair of 
SNPs. LDU distances between SNPs are given by εidi that is equivalent to θt, the product of 
recombination θ and t the time in generations this recombination has accumulated after 
population bottleneck(s). In summary εd provides a more useful measure for LD as it is 
more accurately known than θt. LDU can also reflect effects of population bottleneck 
events that can cause differences in LD patterns between populations but it is also 
influenced by evolutionary forces such as selection and mutation (Tapper 2007). 
LD units for chromosome 2 were calculated by Winston Lau and values extracted for the 
region of interest. LDU were plotted as LDU/kb and LDU/Mb against distance (kb) in 
Excel. 
2.3.6 Test for extended haplotype homozygosity (EHH)  
Long range haplotype tests such as EHH tests use the principle that an allele under 
positive selection rises quickly in frequency and creates a region of extended 
homozygosity, as time would have been too short to break down LD of the region (details 
in chapter 1). The EHH test was applied in chapter 5 to compare haplotype data over a 
region of about 1.8 Mb, using Sweep software (version 1.1, Sabeti et al. 2002). EHH data 
for selected cores was exported in order to plot graphs of EHH decay using R, with a 
modified code from Pascale Gerbault. 
2.3.7 Genetic distances between populations (FST) 
FST is a measure of genetic distances between subpopulations of a meta-population with 
divergence in time. It measures the deviation between the observed and expected 
heterozygote frequencies under the Hardy-Weinberg theorem. It takes into account that in 
a metapopulation the heterozygosity level is reduced with the divergence of 
subpopulations and in the subpopulations an excess of homozygotes appears, which is 
known as the Wahlund effect (Jobling et al. 2013). FST describes the differences between 
the average expected heterozygosity of sub-populations (HS) and the expected total 
heterozygosity of the meta-population (HT): FST=(HT-HS)/HT. When high gene flow and little 
differentiation between the subpopulations are apparent, it is close to zero. It is close to 
one when the genetic diversity of the metapopulation is much higher than in any of the 
subpopulations, due to their high differentiation. 
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For comparison between two populations pairwise FST is calculated as FST=Vp/p(1-p) with 
p and V being mean and variance of allele frequencies. Pairwise FST values were calculated 
with the Arlequin software (version 3.5.1.3, Excoffier and Lischer 2010).  
2.3.8 Principal co-ordinates analysis (PCO) 
The genetic distances between populations calculated as pairwise FST values were 
graphically represented in principal co-ordinates (PCO) plots (Gower 1966), in which 
multiple dimensions are reduced to be displayed on axes known as principal co-ordinates 
or eigenvectors.  
These axes are extracted one after another to capture as much of the remaining variation 
as possible, with each axis being independent and orthogonal to the previous one. Plotted 
are the first two axes with the highest proportion of total variation that they account for. 
PCO plots were constructed using the R statistical environment (version 2.6.2., 
http://www.r-project.org/) using a code written by Christopher Plaster to convert the 
calculated pairwise FST values.  
2.3.9 Diversity measures 
Population diversity analyses were performed using DnaSP (version 5.10.01, Librado and 
Rozas 2009).  
To prepare input files for these programs it was necessary to convert the haplotypes 
inferred by PHASE (and checked visually) to a full length haplotype sequences. Human 
reference sequences were downloaded as described in section 2.2.4.6. and manually 
edited and converted into FASTA format in BioEdit (version 7.0.9.0, Hall 1999) to only 
include the readable sequence length (559 bp) for the LCT enhancer region (chapter 3) 
and a combined sequence (1401 bp) of intron 4, enhancer and hapdef region (chapter 5). 
FASTA sequences for all haplotypes were created by assigning the nucleotides of a 
particular haplotype to their position on the FASTA reference sequences in using a Java 
code written by Maxim Scheremetjew. Individuals were assigned to their two haplotype 
sequences in using the most probable haplotype combination for each individual 
calculated by PHASE and connecting them to the haplotype FASTA sequences with Python 
using a code written by Mirna Kovacevic.  
 
Haplotype diversity H (or gene diversity, heterozygosity) was measured using Nei's H 
(Nei 1987), which calculates the probability that two randomly taken sequences from a 
population are different from each other with the formula: .  
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Where n are the numbers of chromosomes (sample size), K are the number of different 
haplotypes and x the relative frequency of haplotype i. Values for H lie between zero and 
one, from no diversity to the most.  
 
Another diversity measure calculated was the nucleotide diversity . It is 
the probability that two randomly chosen sequences from a population differ at a certain 
site or simply the average number of nucleotide differences per site: . 
Where n is the numbers of chromosomes (sample size), K is the number of different 
haplotypes, xi and xj are the respective frequencies of the ith and jth sequences, dij is the 
number of nucleotide differences per nucleotide site between sequences i and j. 
Both formulas calculate values that are corrected for sample size. 
2.3.10 Tests of neutrality 
Several statistics were applied to compare the observed diversity patterns with these 
expected under neutral evolution (see also chapter 1). Neutrality tests were conducted 
with DnaSP using phased haplotype data. 
 
Tajima's D (Tajima 1989) calculates the genetic diversity within a population in 
comparing each pair of sequences in taking into account the number of segregating sites ȋSȌ and the average number of nucleotide diversity ȋπȌ, and compares that to the expected 
level of diversity under neutrality. Significant negative Tajima's D values indicate positive 
selection or population growth and positive values could indicate population subdivision 
or balancing selection (Jobling et al. 2013). Tajimas' D should be zero under neutrality. P-
values for of the significance of the Tajima'D values deviating from zero are also calculated 
by DnaSP. 
 
Fu and Li's D* and F* statistics (Fu and Li 1993) were also applied, which test for an 
excess of rare variants in the populations. The D* test measures the proportion of 
singletons compared to the total number of mutations in a population. The F* statistics 
additionally compares the number of singletons to the average number of nucleotide 
differences between sequence pairs in a population. DnaSP indicates the statistical 
significance of both values in taking the critical values obtained by a two tailed test (Fu 
and Li 1993). 
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2.3.11 GenoPheno 
To be able to compare the predicted phenotype data for the different populations in 
chapter 3, estimated from frequencies of lactase persistence associated alleles, with 
published lactase persistence phenotype data of matching populations, the GenoPheno 
test (Mulcare et al. 2004) was applied. GenoPheno, version 1.00, is an R script written by 
Dr. Mike Weale and it is accessible via the TCGA website 
(http://www.ucl.ac.uk/tcga/software/). This method takes sampling errors for genotype 
and phenotype data (summarised in Mulcare et al. 2004) into account and statistically 
tests the discrepancy of predicted and observed phenotype data.  
To briefly describe the method, the predicted frequency of lactose digesters is calculated 
from the combined frequencies of the associated alleles (p²+2p(1-p)) and corrected for 
different kinds of phenotyping error. Then a value for the number of lactose digesters is 
simulated from a Binomial distribution taking into account the numbers of predicted 
digesters and observed digesters. These steps are repeated 100,000 times to get a Monte 
Carlo sampling distribution of the numbers of observed digesters under the null 
hypothesis that genotype data and phenotyping error alone account for the predicted 
lactose digester frequencies. From this simulated distribution a two-tailed p-value is 
obtained. 
 
To create the Old-World genotype-phenotype correlation map the approach of Itan et al. 
(2010) was followed. The program, written in the Python programming language, uses the 
statistical GenoPheno method described above and combines that with surface 
interpolation to cover areas with missing data points. Information about genotype data 
collection points by the group or taken from literature were converted into geographic co-
ordinates in using Google Earth (http://www.google.com/earth/index.html). The 
genotype-phenotype correlation maps were plotted with the help of Pascale Gerbault and 
Yuval Itan using the modified Python code written by Yuval Itan (Itan et al. 2010). 
2.3.12 Fisher's exact test 
The significance of associations between loci of intron 2 of LCT and the lactase persistence 
phenotype (chapter 6) was tested with Fishers exact test. A 2x2 contingency table was 
generated with the observed allele counts at a locus and the existing phenotype data.  
The test calculates the differences between the observed and expected values under the 
null hypothesis that values of rows and columns are not associated. The Graphpad online 
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software (http://graphpad.com/quickcalcs/contingency1.cfm) was used to calculate two 
tailed p-values for the Fishers exact tests. 
2.3.13 Prediction of transcription factor binding sites 
The bioinformatic search for potential transcription factor binding sites was done with 
several different software programs that use different mathematical algorithms to 
compare the input sequence to partly different libraries of known regulatory motifs. All 
results were checked for relevance in filtering for tissue and cell type specificity where 
possible. 
 
The MATCH tool (Kel et al. 2003) uses the TRANSFAC database (TRANSFAC Professional 
version 12.1, BIOBASE Biological Databases) (Matys et al. 2006). With this software it is 
possible to compare DNA sequences with a library of mononucleotide weight matrices, 
matching possible transcription factors. The search can be additionally specified by 
species or tissue profiles. For the analyses done for this project, a vertebrate matrix was 
chosen with a cut-off value that reduces false positive and false negative results. The 
quality of a match is defined by the core similarity score (core match) and the matrix 
similarity score (matrix match). The threshold for the matrix score/match was set to 80% 
to avoid false negative results. 
 
The freely online available tool TFSEARCH (version 1.3, http://www.cbrc.jp/research/ 
db/TFSEARCH.html) also uses the TRANSFAC database, but with a slightly different 
algorithm to match the database entries. No information about the exact method was 
available. The program was used for comparison purposes.  
 
MatInspector (version 8.0.5) accesses its own database (Cartharius et al. 2005). The 
software uses a similar scoring scheme as MATCH to compare a given sequence with the 
position weight matrices of the transcription factor binding sites of the database but 
additionally works with family matrices. The program calculates a matrix similarity score 
of a certain sequence to the matching matrices of the library consisting of information 
about the position weight matrix, a conservation profile and a core region for a 
transcription factor. The matrices of the program are also stored as family matrices to 
minimise redundant matches.  
87 
2.3.14 Further statistical tests or methods 
Spearman Rank correlation tests were performed in Excel to analyse correlations between 
allele frequencies and geographic locations of populations. Therefore the distances 
between the assigned geographic coordinates for the population and 10°W longitude and 
80°N latitude were calculated and converted in km using a converter online program 
(http://www.movable-type.co.uk/scripts/latlong.html).  
 
Mann-Whitney U tests were performed online 
(http://elegans.som.vcu.edu/~leon/stats/utest.cgi). Mean lengths of haplotypes carrying 
derived and ancestral alleles were calculated in bp and tested with a two tailed test.  
 
The geographic map showing the lactase persistence frequencies in chapter 1 was plotted 
with data from Itan et al. (Itan et al. 2010) by Mark Thomas using a Python scripting. The 
other geographic map showing enhancer alleles distribution in chapter 3 was generated in 
R (version 3.0.1) using a modified code written by Pascale Gerbault. 
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2.4 Web resources 
Affymetrix:  http://www.affymetrix.com/estore/ 
Arlequin: http://cmpg.unibe.ch/software/arlequin35/ 
BioEdit: http://www.mbio.ncsu.edu/bioedit/bioedit.html 
ChromasPro:  http://technelysium.com.au/ 
Centre for Comparative genomics: http://www.ucl.ac.uk/gee/research/CCG 
CEPH:  http://www.cephb.fr/en/hgdp/diversity.php 
DnaSP:  http://www.ub.edu/dnasp/ 
DoubleDigest: http://www.thermoscientificbio.com/webtools/doubledigest/ 
Ensembl: http://www.ensembl.org/index.html 
Ethnographic Atlas: http://eclectic.ss.uci.edu/~drwhite/worldcul/atlas.htm 
Ethnologue: http://www.ethnologue.com/ 
FastPCR: http://primerdigital.com/fastpcr.html 
GLAD database: http://www.ucl.ac.uk/mace-lab/resources/glad 
Google Earth: http://www.google.com/earth/index.html 
Graphpad: http://www.graphpad.com/ 
HapMap: http://hapmap.ncbi.nlm.nih.gov/ 
MatInspector: http://www.genomatix.de/solutions/genomatix-software-suite.html 
NCBI:  http://www.ncbi.nlm.nih.gov/ 
Phase:  http://stephenslab.uchicago.edu/software.html 
Powermarker: http://statgen.ncsu.edu/powermarker/ 
R:  http://www.r-project.org/ 
Sweep:  http://www.broadinstitute.org/mpg/sweep/ 
SNPviewer: http://www.lgcgenomics.com/software 
TCGA:  http://www.ucl.ac.uk/tcga/software/ 
TFSEARCH: http://www.cbrc.jp/research/db/TFSEARCH.html 
The intestinal transcription factor target database: 
http://gastro.sund.ku.dk/chipchip/   
TRANSFAC: http://www.biobase-international.com/product/transcription-factor-
binding-sites 
UCSC:  http://genome.ucsc.edu/ 
UniProt: http://www.uniprot.org/ 
Vector NTI: http://www.lifetechnologies.com/uk/en/home/life-
science/cloning/vector-nti-software.html 
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2.5 Laboratory chemicals and equipment 
2.5.1 Labmade solutions  
All pH values are at 25°C. 
2/3 Microclean (HM-MC): 26.7% Polyethylene glycol (PEG 8000), 0.7M NaCl, 1.3mM Tris-
HCl (pH 7.5), 0.13mM EDTA (pH 8.0), 2.3mM MgCl2 
TBE buffer (1x): 89mM Tris-HCl (pH8.0), 89mM boric acid, 2mM EDTA (pH 8.2-8.4) 
TE buffer (1x): 10mM Tris-HCl (pH 8.0), 1mM EDTA (pH 8.0) 
Agarose gel loading buffer: 15% Ficoll (PM400) in H2O, traces (about 0.25%) of Xylene 
cyanol FF (Sigma) and Bromophenol blue (Bio-Rad) 
Slagboom buffer: 10mM EDTA (pH8.0), 100mM NaCl, 10mM Tris-HCl (pH8.0), 0.5% SDS 
and 0.2mg/ml Proteinase K (Sigma) 
Stretch marker: Agarose gel loading buffer containing about 50ng 200, 400 and 800 bp 
PCR products 
Dialysis buffer: 20mM HEPES (pH 7.9), 20% glycerol, 1.5mM MgCl2, 100mM KCl, 0.2mM 
EDTA, 0.5mM dithiothreitol (DTT) 
EMSA loading buffer: 0.2% Bromophenol blue, 10% glycerol, 0.5xTBE buffer  
Gel shift buffer: 25mM Tris-HCl (pH 7.8), 5mM MgCl2, 6mM KCl, 0.5mM EDTA, 1mM DTT, 
1µl/ml protease inhibitor cocktail (Sigma), 5%Ficoll (PM 400), 2.5% glycerol 
High-salt buffer: 20mM HEPES (pH 7.9), 25% glycerol, 1.5mM MgCl2, 1.2M KCl, 0.2mM 
EDTA, 0.5mM DTT, 1µl/ml protease inhibitor cocktail 
Hypotonic buffer: 10mM HEPES (pH 7.9), 1.5mM MgCl2, 10mM KCl, 0.2mM PMSF, 0.5mM 
DTT 
Low-salt buffer: 20mM HEPES (pH 7.9), 25% glycerol, 1.5mM MgCl2, 0.2M KCl, 0.2mM 
EDTA, 0.5mM DTT, 1µl/ml protease inhibitor cocktail 
2.5.2 Commercial solutions 
All pH values are at 25°C 
LB Agar: 9.14g/L tryptone, 4.57g/L yeast extract, 4.57g/L NaCl, 13.72g/L agar, 1.6g/L 
inert tableting aids 
LB medium: 10g/L enzymatic digest of casein, 5g/L yeast extract (low sodium), 5g/L 
sodium chloride, 2g/L inert agents, 22g/L total solids 
Advantage-GC cDNA PCR Kit 
Advantage-GC cDNA Polymerase Mix, recombinant: KlenTaq-1 DNA polymerase and TaqStart Antibody ȋͳ.ͳμg/μlȌ in ͳx buffer: ͳ.Ͳ%Glycerol, 0.8mM Tris-HCl (pH 7.5), 1.0mM 
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KCl, 0.5mM (NH4)2SO4, ʹ.Ͳ μM EDTA, Ͳ.ͳmM β-mercaptoethanol, 0.005%Thesit, Deep 
VentR as minor component  
1x GC cDNA PCR reaction buffer: 40mM Tricine-KOH (pH 9.2 at 25°C), 15mM KOAc, 3.5mM 
Mg(OAc), 2, 5% Dimethyl Sulfoxide ȋDMSOȌ, ͵.͹ͷ μg/ml μg/ml Bovine serum albumin  
dNTP mix (1x): (10mM each of dATP, dCTP, dGTP, and dTTP; 1x concentration: 0.2mM 
each) 
TOPO-TA Cloning kit 
pCR 2.1-TOPO, ͷͶ ng/μl plasmid DNA in: 50% glycerol, 50mM Tris-HCl (pH 7.4), 1mM 
EDTA, 1mM DTT, 0.1% Triton X-ͳͲͲ, ͳͲͲμg/ml BSA, phenol red 
Salt Solution: 1.2M NaCl, 0.06M MgCl2 
S.O.C. medium: 2% Tryptone, 0.5% Yeast Extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 
10mM MgSO4, 20mM glucose 
Restriction enzymes and buffers 
BamHI in 1x buffer: 10mM Tris-HCl (pH 7.4 at 25°C), 200mM NaCl, 1mM DTT, 0.1mM 
EDTA, 0.15% Triton X-100, 0.2mg/mL BSA, and 50% (v/v) glycerol 
Buffer BamHI (1x): 10mM Tris-HCl (pH 8.0 at 37°C), 5mM MgCl2, 100mM KCl, 0.02% Triton 
X-100, and 0.1mg/mL BSA 
Pfu DNA polymerase, recombinant, in 1x buffer: 20mM Tris-HCl (pH 8.2), 1mM DTT, 0.1mM 
EDTA, 100mM KCl, 0.1% (v/v) Nonidet P40, 0.1% (v/v) Tween 20, and 50% (v/v) glycerol 
Pfu Buffer with MgSO4 (10x): 200mM Tris-HCl (pH 8.8), 100mM (NH4)2SO4, 100mM KCl, 
1mg/mL BSA, 1% (v/v) Triton X-100, 20mM MgSO4. 
T4 DNA ligase in 1x buffer: 20mM Tris-HCl (pH 7.5), 50mM KCl, 1mM DTT, 0.1mM EDTA 
and 50% (v/v) glycerol 
T4 DNA Ligase Buffer 10x:400mM Tris-HCl, 100mM MgCl2, 100mM DTT, 5mM ATP (pH 7.8) 
T4 Polynucleotide Kinase in 1x buffer: 20mM Tris-HCl (pH7.5), 25mM KCl, 0.1mM EDTA, 
2mM DTT and 50%(v/v) glycerol 
Kinase reaction buffer A (10x): 500mM Tris-HCl (pH7.6), 100mM MgCl2, 50mM DTT, 1mM 
spermidine 
Taq DNA polymerase in 1x buffer: 100mM KCl, 20mM Tris-HCl, pH 8.0, 0.1mM EDTA, 1mM 
DTT, 0.5% Tween 20, 0.5% Nonidet P40, 50% (v/v) glycerol 
Reaction Buffer IV (10x): 750mM Tris-HCl (pH 8.8), 200mM (NH4)2SO4, 0.1% (v/v) Tween 
20 
SacI, SalI and XhoI in 1x buffer: 10mM Tris-HCl (pH 7.4), 100mM KCl, 1mM DTT, 1mM 
EDTA, 0.2mg/mL BSA, 50% (v/v) glycerol 
Tango Buffer (1x): 33mM Tris-acetate (pH 7.9 at 37°C), 10mM Mg-acetate, 66mM K-
acetate, 0.1mg/mL BSA 
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2.5.3 Equipment 
Centrifuges, general 
ALC Centrifuge PK120 
Biofuge Pico, Heraeus  
Capsule Tomy HF-120 
Centrifuge 5430, Eppendorf 
MSE-Europa 24M, SANJO 
MSE MISTRAL 3000g, SANJO 
Sigma 1-14 
EMSA 
Ole Dich Inmicrocentifuge 157 MP 
SE 250Mighty small II Electrophoresis, Hoefer Scientifis Instr. 
Multitemp II, Thermostatic circulator, Pharmacia LKB 
SlabGEl Dryer SGD4050, Savant 
GelPump GP100, Savant 
Storage Phosphor Screen 20x25, Molecular dynamics, Amersham Biosciences 
Image Eraser, Molecular dynamics, Amersham Biosciences 
Storm Phosphorimager 820  
Series 900 radiation mini-monitor G-M (Coderum) tube, Morgan Mini Instruments Ltd 
Microbiological work 
Centrifuges: Jouan CR 312, Sigma 3-18K, Sorovall SS-34 
Heraeus UB 20 incubator 
Lauda E100 Ecoline waterbath, VWR 
Teche Hybridiser HB-ID 
Berthold Lumat LB9501 Tube Luminometer 
Other equipment 
ABI GeneAmp PCR System 9700 
ABI Veriti 96 well Thermal Cycler 
GeneQuant II photometer, Pharma Biotech, Printer EPSON P-40 
BioPhotometer 6131, Eppendorf 
NanoDrop 1000 Spectrophotometer and -software, version 3.8.1 
Luckham 4RT Rocking platform 
G:BOX EF2, Syngene, Software GeneSnap and GeneTools, Syngene 
UVP UV Transilluminator 
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2.5.4 Suppliers 
AH diagnostics as (Stratagene): Runetoften 18, 8210 Aarhus V, DK 
Autogen Bioclear UK Ltd: Holly Ditch Farm, Mile Elm, Calne SN11 0PY, UK 
BioGenex: 49026 Milmont Drive, Fremont, California 94538, USA. 
BioNordika Denmark A/S: Marielundvej 48, 2730 Herlev, DK 
Bio-Rad Laboratories: Symbion Science Park, Fruebjergvej 3, 2100 København ø, DK 
CareFusion Health UK 232 Ltd (Micro Medical Ltd): The Crescent, Jays Close, Basingstoke 
RG22 4BS, UK  
Eurofins MWG Operon: Anzinger Str. 7a, 85560 Ebersberg, Germany 
Fisher Scientific (Fermentas, Lonza Bioscience, Macherey-Nagel): Postboks 60, Industrivej 3, 
3550 Slangerup, DK 
Fisher Scientific UK Ltd: Bishop Meadow Road, Loughborough LE11 5RG, UK 
GE Healthcare Europe GmbH (Amersham Biosciences): Park Allé 295, 2605 Brondby DK 
Johnson Matthey A/S (Alfa Aesar): Frederikssundsvej 274 D, 2700 Bronshoj, DK 
LGC Genomics Ltd (KBioscience): Units 1 & 2, Trident Industrial Estate, Pindar Road, 
Hoddesdon EN11 0WZ, UK 
Life Technologies Ltd (Applied Biosystems): 3 Fountain Drive, Inchinnan Business Park, 
Paisley PA4 9RF, UK 
Life Technologies Europe BV (Invitrogen): filial Danmark, PO Box 37, 2850 Naerum, DK 
Medicell International Ltd: 239 Liverpool Road, London N1 1LX, UK 
Perkin Elmer: Tonsbakken 16-18, Skovlunde 2740, DK 
QIAGEN (Gentra): Skelton House, Lloyd Street North, Manchester M15 6SH, UK 
Santa Cruz Biotechnology Inc: 2145 Delaware Avenue, Santa Cruz, California 95060, USA 
Sigma-Aldrich Company Ltd: The Old Brickyard, New Road, Gillingham SP8 4XT, UK 
Thermo Fisher Scientific (previous ABgene): Abgene House Blenheim Road, Epsom KT19 
9AP, UK  
VWR: Bie & Berntsen A/S: Transformervej 8, 2730 Herlev, DK 
VWR International Ltd: Hunter Boulevard, Magna Park, Lutterworth LE17 4XN, U
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3 Geographic distribution of LCT enhancer 
variation in Eurasian populations 
3.1 Introduction 
As described in chapter 1, the continued expression of lactase into adulthood is enabled by 
a mechanism cis-acting to LCT (Wang et al. 1995). A relevant regulatory region was found 
in intron 13 of the upstream gene MCM6 that showed influence on LCT promoter activity 
with a transcriptional enhancing effect (Olds and Sibley 2003; Troelsen et al. 2003).  
 
Within this sequence region, the allele -13910*T was shown to nearly completely associate 
with lactase persistence, in Northern Europe (Enattah et al. 2002; Enattah et al. 2007; 
Poulter et al. 2003). -13910C>T genotypes were also associated with a trimodal lactase 
expression pattern in a study on Finns, as one would expect from a cis-acting element 
(Kuokkanen et al. 2003). This general pattern was also seen by Poulter et al. (2003), 
although the pattern was not so clear-cut. This allele is also present at considerable 
frequencies in groups of European descent in America or African groups with a known 
history of admixture with Europeans or Asians (for example Friedrich et al. 2012; Myles et 
al. 2005). 
 
The absence of -13910*T in sub-Saharan African and Middle Eastern populations where 
the lactase persistence phenotype is common (Ingram et al. 2007; Mulcare et al. 2004) led 
to further investigations involving re-sequencing the LCT enhancer region, which revealed 
more variation. Some of these alleles were too rare to assess for association but three 
were shown to associate with lactase persistence, for example - 13915*G, which is 
frequent in the Middle East and East Africa (Enattah et al. 2008; Imtiaz et al. 2007; Ingram 
et al. 2007; Ingram et al. 2009b; Tishkoff et al. 2007). This allele is associated with lactase 
persistence in populations from Saudi Arabia (Imtiaz et al. 2007), Kenya (Tishkoff et al. 
2007), in the Jaali of Sudan (Ingram et al. 2007) and Somali of Ethiopia (Ingram et al. 
2009b).  
In the same Somali, another allele, -13907*G, is also associated with lactase persistence 
(Ingram et al. 2009b) and was shown to be common in several East African populations 
(Tishkoff et al. 2007).  
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About 100 bp upstream and occurring at high frequencies in several populations from 
Kenya and Tanzania another allele, -14010*C showed association with lactase persistence 
too (Tishkoff et al. 2007). It is also relatively common in the South Africa Xhosa 
(Torniainen et al. 2009). A further allele, -14009*G, was associated in the Somali but did 
not reach statistical significance (Ingram et al. 2009b).  
3.2 Chapter aims 
Analysis of the published data on the frequencies of the four confirmed associated alleles 
did not fully explain the distribution of the lactase persistence phenotype.  
The approach by Itan et al. (2010), mentioned in chapter 1 (see also Figure 1.7), illustrates 
this: The geographic mapping of the difference in phenotype distribution predicted from 
genotype information of all four alleles with published observed lactase persistence 
phenotype data showed that there are many geographic regions where the lactase 
persistence phenotype is underrepresented by the genetic data. Whether caused by yet 
undiscovered variants, data errors or simply due to a lack of sampling points, as the map 
shows interpolated values, could not be clarified. Of these regions, Eastern Europe and 
parts of West, Central and South Asia, are of special interest for this thesis.  
 
Although much was known about the worldwide occurrence of -13910*T at the onset of 
this thesis, and even though reasoned to be causal for lactase persistence in Europe, it 
could not completely explain the phenotype distribution in parts of South and East Europe 
(Anagnostou et al. 2009; Itan et al. 2010). These regions were not well covered with 
information about enhancer SNP data and furthermore, if reported at all, the -13910 C>T 
SNP had been mainly studied via RFLP or other genotyping technologies. Only a few 
studies provided data from fully sequenced enhancer regions before the beginning of this 
thesis (Enattah et al. 2008; Imtiaz et al. 2007; Ingram et al. 2007; Ingram et al. 2009b).  
 
Two further examples suggested that the information about lactase persistence alleles in 
Europe was not complete. One variant, -13914 G>A had been reported in two individuals, 
from Germany and Austria (Tag et al. 2008; Tag et al. 2007) and four family members from 
Northern Russia with partly Polish ancestry (Khabarova et al. 2010). Another European 
individual showed a chromosome with high lactase expression (Poulter et al. 2003) and 
carrying a new enhancer variant, -14028*C, but none of the others (Ingram 2008). The 
occurrence of this variant in particular, in other individuals, would be of great interest as it 
showed direct evidence of function. 
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The three other reported lactase persistence associated alleles -13907*G, -13915*G and -
14010*C had mainly been described in African and Middle Eastern populations (Enattah et 
al. 2008; Imtiaz et al. 2007; Ingram et al. 2007; Ingram et al. 2009b; Tishkoff et al. 2007) 
and not much was known about their distribution elsewhere. Also with respect to other 
recently discovered variants (for example Ingram et al. 2009b; Tag et al. 2007) further 
investigations on Eurasian and Middle Eastern populations seemed to be necessary to 
complete the picture of the distribution of known LCT enhancer alleles and to identify new 
variants. It was thus of interest to obtain complete enhancer sequence data in these areas. 
Any novel variants could be subjected to genotype-phenotype association study if at 
sufficient frequency or could be tested in vitro for function. 
 
This chapter aims to describe the variation of enhancer alleles and its distribution in 
Europe, the Middle East and other parts of Asia. In summary, the main questions to answer 
are: 
 What is the distribution of the European -13910*T allele and what is the edge of 
this distribution in southern and southeastern parts of Europe and in the Middle 
East? 
 Can other lactase persistence associated or derived alleles be found in the 
enhancer region of LCT in the available samples and what is their distribution? 
 Can the distribution of lactase persistence associated LCT enhancer alleles now 
explain the phenotypic distribution of reported groups in the same geographic 
areas? 
3.3 Sequencing strategy 
To examine the variation in the LCT enhancer present in populations from all over Europe, 
the Middle East and other parts of Asia, DNA samples were sequenced with the classic 
Sanger method and analysed (see section 2.2.4). Several samples previously genotyped by 
our group for -13910 C>T (Mulcare 2006) or haplotype markers (Hollox et al. 2001; 
Poulter et al. 2003) were also re-analysed via sequencing to ascertain the whole enhancer. 
Of these, samples from India and Southeast Asia were sequenced as part of an 
undergraduate project (Ghosh 2010).  
 
A combination of four primers successfully applied in previous studies (Ingram et al. 2007; 
Ingram et al. 2009b) was first used to amplify the 940 bp region in intron 13 of MCM6 
including the LCT enhancer (Chr2:136608194-136609133, GRCh37/hg19), and sequences 
were readable from bp position -14331 until -13489 from the start of transcription of LCT. 
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Depending on the quality of the DNA it was sometimes necessary to amplify two shorter 
overlapping fragments to get sufficient amounts of products. Details about primer 
sequences can be found in Table 2.3 of chapter 2. 
During the later part of this project the focus was more on the smaller region 3' in MCM6 
(Chr2:136608194-136608899) which was typed for all samples. Of this 706 bp long PCR 
product, it was possible to analyse the enhancer sequences of most of the samples for a 
559 bp region from position -14040 to -13482 from the start of transcription of LCT.  
3.4 Grouping strategy 
The definition of groups for population genetic analyses is always to some extent artificial 
as it depends on the information available. Nevertheless it is essential to aim as far as 
possible for uniformity of groups in the analyses. For this project, the individual samples 
were first grouped according to the geographic region, namely Northwest/Central Europe, 
South Europe, East/Southeast Europe, the Middle East, West Asia, Central/South Asia and 
Central/East/Southeast Asia, and the country they were collected. Samples that could not 
be allocated to one country of that geographic region were classified as Ǯotherǯ. These 
samples were not included in the geographic maps (see below). A further differentiation 
into distinct ethnic groups with a minimum sample size of 10 followed, using self declared 
ethnic background if such information was available or in sub-groupings within countries 
with further information about the sample localization. Otherwise they were grouped by 
country only. 
3.5 Variation of the LCT enhancer  
The LCT enhancer region in intron 13 of MCM6 was successfully sequenced for 2056 
individuals from 52 populations within this project. A total of 25 SNPs was identified, of 
which 10 occurred more than once. Table 3.1 shows these enhancer variants and the allele 
frequencies of non-singleton SNPs for each population. 9 new variants were identified  
(-14145 T>G, -14062 G>A, -14010 G>A, -13964 C>A, -13926 A>C, -13950 A>G, -13771 
A>G, -13744 C>G, -13693 G>A) which are mainly singletons. They were confirmed by 
sequencing of both strands of the products of at least two independent PCRs and the 
ancestral state of these SNPs was determined by sequence comparison with other primate 
species, which was the same as the common allele in humans (see also chapter 2, section 
2.2.4.6). Sequencing chromatograms of some of the new variants are shown in Figure 3.1.  
 
All SNPs were checked for deviation from HWE using the Arlequin software (see also 
chapter 2, section 2.3.1). A few significant deviations were observed but after Bonferroni 
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correction for multiple testing (51 tests) only one, -13910C>T in the Yakuts (p=0.0006) 
remained significant. An underrepresentation of heterozygotes at this position was 
observed which could be the result of population substructure within the group sampled. 
After reassessment of the sampling locations (see also chapter 2, section 2.1.1.5) the group 
was divided into Northern Yakuts and Yakuts which left both groups in HWE.  
 
 
Figure 3.1: Sequence chromatograms showing examples of individuals heterozygous at 
various positions of the LCT enhancer. Note that the second chromatogram shows a third allele 
at the 14010 position which is known to be a G>C SNP (first chromatogram).
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Table 3.1: LCT enhancer variation in the samples sequenced from 52 European and Asian population groups. Allele frequencies for all variants occurring 
more than once and the presence of singletons are indicated. N: number of chromosomes, data marked by * was not included in the geographic map (Figure 3.2).  
 
Region Country Population N 
-14011 
C>T 
-13915 
T>G 
-13910 
C>T 
-13907 
C>G 
-13906 
T>A 
-13779 
G>C 
-13744 
C>G 
-13730 
T>G 
-13603 
C>T 
-13495 
C>T Singletons 
       
                       
Northwest/ Germany Germans 60 - - 0.550 - - - - - - 0.617   
Central  
 
Sorbs 64 - - 0.500 - - - - - - 0.617   
Europe Ireland Irish 68 - - 0.956 - - - - - - 0.969   
  Netherlands Frisians 58 - - 0.810 - - - - - - 0.845   
  Norway Norwegians 88 - - 0.841 - - - - - - 0.875   
  Slovakia Roma 64 - - 0.063 - - - - - - 0.400   
  Sweden Sami 60 0.033 - 0.293 - - - - - - 0.750   
  
 
Swedes 74 - - 0.778 - - - - - - 0.906   
  UK Ashkenazi-Jews 38 - - 0.105 - - - - - - 0.158 -13914 G>A 
  
 
English 102 - - 0.745 - - - - - - 0.784 -14062 G>A, - 14028 T>C 
 
Other* other C/NW Europeans 68 - - 0.691 - - - - - - 0.727   
South Greece Greeks 120 0.008 - 0.150 - - - - 0.008 - 0.306   
Europe Italy Tyroleans Bozen 80 0.013 - 0.150 - - - - - - 0.368   
  
 
Tyroleans Gadertal 76 - - 0.421 - - - - - - 0.514   
  
 
Tyroleans Vinschgau 102 - - 0.363 - - - - - - 0.521   
  Portugal Portuguese 96 - - 0.438 - - - - - - 0.486   
  Spain Catalans 58 - - 0.259 - - - - - - 0.364   
  
 
Spanish 62 - - 0.403 - - - - - - 0.500   
East/ Belarus Belarusians 100 0.010 - 0.230 - - - - - - 0.477   
Southeast  Macedonia Macedonians 100 - - 0.240 - - - - - - 0.398   
Europe Romania Romanians 118 - - 0.169 - - - - - - 0.278 -13753 C>T 
  Russia Erzya 42 - - 0.143 - - - - - - 0.333   
  
 
Moksha 32 0.031 - 0.406 - - - - - - 0.531   
  
 
Russians Perm 46 - - 0.239 - - - - - - 0.395   
  Ukraine Ukrainians 74 0.014 - 0.257 - - - - - - 0.379   
  Other* Other E/SE Europeans 38 - - 0.289 - - - - - - 0.444   
Middle East Cyprus Greek Cypriots 120 - - 0.008 - - - - - - 0.269   
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  Iran Iranians 154 0.006 0.006 0.032 - - - - - - 0.234   
  Kuwait Kuwaiti 66 - 0.250 0.030 - - - - 0.015 0.015 0.141 -14009 T>G, -13693 G>A 
  Syria Syrians 140 - 0.029 0.021 - - 0.007 - - - 0.231 -14145 T>G 
  Turkey Anatolian-Turks 116 - - 0.078 - - - - - - 0.225   
  Yemen Yemeni Hadramaut 166 - 0.241 0.018 0.012 - 0.030 0.006 0.006 - 0.210 -14010 G>C, -13806 A>G 
  
 
Yemeni Sena 68 - 0.294 0.147 - - - 0.059 0.029 0.059 0.294   
  Other* Other Middle Easterns 62 - 0.048 0.065 0.016 - - - - - 0.345   
West Asia Armenia Armenians 102 - - 0.176 - - - - - - 0.333   
  Azerbaijan Azeri 80 - - 0.013 - - - - - - 0.171   
  Georgia Georgians 108 - - 0.075 - - - - - - 0.293   
Central/ Afghanistan Pashtuns/Afghans 32 - - 0.063 - - - - - - 0.375   
South Asia 
 
Tadjiks 28 - - 0.250 - - - - - - 0.464 -13964 C>A 
  
 
Uzbeks 54 - - 0.241 - - - - - - 0.463   
  India North Indians 120 - - 0.200 - - - - - - 0.410   
  
 
South Indians 102 - - 0.118 - - 0.029 - - - 0.450   
  Nepal Nepalese 38 - - 0.342 - 0.026 - - - - 0.526   
  
 
Tharu 80 - - 0.175 - - - - - - 0.321   
  Uzbekistan Uzbeks 76 - - 0.039 - - - - - - 0.269   
  Other* Other C/South Asians 32 - - 0.188 - - - - - - 0.500   
Central/East/ Mongolia Khalka 114 0.009 - 0.026 - - - - - - 0.413   
Southeast  
 
Mongols 52 - - 0.038 - - - - - - 0.417   
Asia Russia Northern Yakuts 22 - - 0.136 - - - - - - 0.500 
 
  
Yakuts 110 - - 0.055 - - - - - - 0.443   
  Singapore Han-Chinese 98 - - 0.041 - 0.010 - - - - 0.382 -13771 A>G 
    Japanese 84 - - - - - - - - - 0.333 -14010 G>A, -13926 A>C 
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Figure 3.2: Geographic distribution of the common LCT enhancer variants (also shown in Table 3.1) in the 52 studied populations (-13495 C>T is not 
included). 
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Figure 3.2 shows the geographic distribution of the common alleles within the (likely) 
functional region of the LCT enhancer in the populations studied and illustrates once more 
the predominance of -13910*T as main enhancer variant in the Europe. -13910*T was 
found in all populations tested except of the Japanese (Table 3.1). The results also broadly 
confirm the decline in allele frequency of -13910*T to the South and East of Europe. It is 
highest in the Irish and Norwegian populations with 96% and 84% respectively and 
lowest in the Tyroleans from Bozen and in Greeks (both at 15%).  
 
Noticeable different frequencies of -13910*T in Northwest and Central Europe are 
observed in the Sami, the Ashkenazi-Jewish and Roma groups where the frequency of the 
*T allele is comparatively low. The Sami are an indigenous population in the far North of 
Europe and are traditional reindeer herders, subsisting mainly from meat and fishing 
(Leonard and Crawford 2002). The Ashkenazi-Jewish and Roma have history of migration 
and were sampled in regions geographically distant from the living places of many of their 
recent ancestors. The recent Eastern European history of many of the Ashkenazi Jews and 
their complex history of migrations as close communities accounts for the overall genetic 
differentiation from the majority of the ethnic English population. The Roma originated in 
India and are likewise known to form a distinct ethnic-cultural minority mainly in 
Southeast and Middle Europe.  
 
Differences in -13910*T frequencies of very closely located groups appear in the Spanish 
and the Catalans with a -13910*T frequency of 40% and 26% respectively and the 
Tyroleans between the German and Ladin speaking groups from Vinschgau and Gadertal 
and the Italian speaking population from Bozen with 36%, 42% and 15% -13910*T 
frequency respectively. The Catalans and Tyroleans are culturally and partly 
geographically quite isolated populations, which could explain these differences probably 
caused by decreased gene flow with neighbouring groups. The low -13910*T frequency of 
the Italian speaking Tyroleans, similar to other Italian regions from further South, reflects 
their recent immigration history into the Alps within the last century (Parteli 1988). The 
German Tyroleans were shown to be genetically influenced by the Ladins and both being 
highly genetically differentiated (Pichler et al. 2006). 
 
The SNP -13495 C>T was polymorphic in all populations tested and has previously shown 
by members of the lab to be is too frequent to be causal of lactase persistence 
(unpublished data). This variant resides outside the functional enhancer examined by 
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Troelsen et al. (2003) and it was shown to be non-functional in reporter gene assays as it 
did not increase activity compared to the ancestral enhancer (Tishkoff et al. 2007).  
 
Table 3.2 shows the distribution of the common enhancer alleles by geographic region. 
The previously observed pattern of a Northwest-Southeast decline in -13910*T frequency 
(Swallow 2003) is slightly disrupted across Asia. The prevalence of -13910*T is higher in 
Central and South Asia than Western Asia including the Middle East. Populations from 
Central and South Asia including Afghans, Indians and Nepalese have a similar -13910*T 
frequency to populations from East and Southeast Europe, for example the Macedonians 
and Belarus. The Georgians and Azeri of the West Asian Caucasus region have very low -
13910*T frequencies comparable to those of their Middle Eastern neighbours.  
 
Table 3.2: Frequency of the common enhancer alleles by geographic region (-13495 C>T 
included). 
Region N 
-14011 
C>T 
-13915 
T>G 
-13910 
C>T  
-13907 
C>G  
-13906 
T>A 
-13779 
G>C 
-13744 
C>G 
-13730 
T>G 
-13603 
C>T 
-13495 
C>T 
 
  
          
NW/C Eur. 740 0.003 - 0.615 - - - - - - 0.688 
S Europe 594 0.003 - 0.305 - - - - 0.002 - 0.359 
E/SE Eur. 550 0.005 - 0.231 - - - - - - 0.358 
Middle East 892 0.001 0.094 0.041 0.003 - 0.007 0.006 0.004 0.006 0.219 
W Asia 288 - - 0.094 - - - - - - 0.247 
C/S Asia 562 - - 0.167 - 0.002 0.005 - - - 0.370 
C/E/SE Asia 480 0.002 - 0.038 - 0.002 - - - - 0.360 
 
 
-13945*T broadly follows the -13910*T distribution pattern. It is also particularly high in 
Northern European populations, even in the Sami as shown in Figure 3.3. To evaluate 
statistically whether the two alleles correlate with each other and follow the same 
Northwest to Southeast decline previously suggested for -13910*T, in the 48 
geographically located populations of this study, Spearman Rank correlation tests were 
performed. The frequencies of the two markers correlate strongly with each other (Rho = 
0.75, p<0.01). A significant negative correlation between -13910*T and -13945*T and 
longitude (distance calculated in km from 10°W) was observed which was less strong for -
13945*T (Rho = -0.39, p<0.01) than for -13910*T (Rho = -0.65, p<0.01). The frequency for 
both alleles also significantly decreases with distance from latitude 80°N (in km). The 
negative correlation was slightly stronger for -13945*T (Rho = -0.52, p<0.01) than for -
13910*T (Rho = -0.45, p<0.01). It should be noted that these results are consistent with the 
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finding that -13945*T forms part of the haplotype on which -13910*T arose as described in 
section 3.6 below. 
The other 3 lactase persistence associated alleles (-14010*C, -13915*G and -13907*G) were 
only found in Middle Eastern populations. -13915*G is at high frequencies in Kuwait (25%) 
and Yemen (Hadramaut: 24%, Sena: 29%). -14010*C was rare, only occurring once in the 
Yemen Hadramaut, as well as -13907*G, found in two individuals from Hadramaut and in 
one other Middle Eastern sample. The two other alleles-14028*C and -13914*A, previously 
found in Europeans (Ingram 2008; Tag et al. 2008; Tag et al. 2007) occurred in one English 
individual and in an English person of Ashkenazi-Jewish background respectively. 
 
Noticeable is the occurrence of another allele -14011*T previously described in 
populations from India, Estonia and Brazil (Friedrich et al. 2012; Gallego Romero et al. 
2012; Lember et al. 2006). Although this allele was rare in any of the Eurasian groups 
tested, it was found scattered across Europe in individuals from Belorussia, Greece, Tyrol, 
Mordovia, Ukraine, Iran, Mongolia respectively and two Sami individuals and one other 
individual of mixed ancestry. It additionally occurred in one Saudi Arabian Bedouin 
sample and one from the phenotyped Italian cohort sequenced for chapter 5.  
 
-13779*C was identified in India, Syria and Yemen. This allele has been reported so far in 
the literature in one Somali individual who was diagnosed as a lactose maldigester 
(Ingram et al. 2009b) but is quite frequent in populations from India as shown in our 
collaborative project (Gallego Romero et al. 2012). Although it might not be associated 
with lactase persistence in these populations, its frequency in a milk drinking country and 
its location in the enhancer sequence part that shows a DNAse footprint (see chapter 4) 
could indicate some functional role. 
 
An interesting case is an additional allelic variant at nucleotide position -14010. A 
Japanese individual carried an A at this position, the same location as the more frequent 
G>C SNP.  
Another new variant is -13744*G, which was found in the Yemeni from Sena (4 
individuals) and additionally in one individual of the Yemeni of Hadramaut. It occurs on a 
haplotype together with the lactase persistence allele -13915*G as shown in section 3.6 
below. 
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Figure 3.3: Allele frequency of -13945*T and -13910*T for the 52 populations tested, shown in order of -13495*T frequency. 
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3.6 Relationship of -13495*T to other enhancer alleles 
To analyse the relationship of -13495*T to other enhancer alleles haplotype inference was 
done using PHASE. All samples with incomplete data at the -13945 nucleotide position 
were excluded which left 1888 samples for analysis. -13495*T occurred on the same 
haplotypes as four other enhancer variants: -14011*T, 13910*T, -13907*G, -13603*T and 
was also present on its own as a derived allele on the ancestral enhancer haplotype 
(Figure 3.4, haplotype no. 2). Chapter 5 will investigate this further in examining -13495*T 
association with the LCT core haplotypes. 
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Figure 3.4: Haplotype analysis of the LCT enhancer region, N: number of chromosomes. 
 
3.7 Population differentiation across the LCT enhancer 
To compare the genetic distance between the groups, pairwise FST values were calculated 
in Arlequin with the enhancer genotype data of the 52 populations studied. Not all 
populations are significantly different in pairwise FST when only taking the enhancer 
region into account (for a full results table, see Appendix D). The -13495 C>T SNP could 
not be included in this analysis because of too much missing data (9.6%). The FST values 
for inter-population differences were used to perform a Principal co-ordinate analysis 
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(PCO) in R and results are illustrated as PCO plot in Figure 3.5. Over 97% of the population 
differences are captured in the two first components. The first co-ordinate seems to be 
highly influenced by -13910*T as the Northwest European populations cluster on the right 
half of the plot and all other populations closely together. The Greek Cypriots are the 
furthest outstanding on the left side as they have the lowest *T allele frequencies and none 
of the other rare derived enhancer alleles. The two Yemeni populations (51 and 52) can be 
seen at the upper edge of the point cloud, which may be explained by the numerous other 
enhancer alleles present in these groups. 
 
 
Figure 3.5: Principal co-ordinates plot of genetic distances between populations from 
pairwise FST values calculated from LCT enhancer genotype data. Populations included: 
1:Anatolian-Turks, 2: Armenians, 3: Ashkenazi-Jews, 4: Azeri, 5: Belarusians, 6: Catalans, 7: English, 
8: Erzja, 9: Frisians, 10: Georgians, 11: Germans, 12: Greek Cypriots, 13: Greeks, 14: Han-Chinese, 
15: Iranians, 16: Irish, 17: Japanese, 18: Khalka, 19: Kuwaiti, 20: Macedonians, 21: Moksha, 22: 
Mongolians, 23: Nepalese, 24: North Indians, 25: Northern Yakuts, 26: Norwegians, 27: other C/NW 
Europeans, 28: other C/South Asians, 29: other E/SE Europeans, 30: other ME, 31: 
Pashtuns/Afghans, 32: Portuguese, 33: Roma, 34: Romanians, 35: Russians Perm, 36: Sami, 37: 
Sorbs, 38: South Indians, 39: Spanish, 40: Swedes, 41: Syrians, 42: Tadjiks Afghanistan, 43: Tharu, 
44: Tyroleans Bozen, 45: Tyroleans Gadertal, 46: Tyroleans Vinschgau, 47: Ukrainians, 48: Uzbeks, 
49: Uzbeks Afghanistan, 50: Yakuts, 51: Yemeni Hadramaut, 52: Yemeni Sena. 
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3.8 Tests of neutrality and diversity measures 
Haplotypes of the enhancer region as inferred by PHASE were used with the DnaSP 
software to calculate haplotype and nucleotide diversity for each population. Several 
neutrality tests were also conducted to detect a possible excess of rare alleles, which might 
signify a selective sweep. Table 3.3 shows the values calculated for each population. The 
only significant deviation from neutrality was seen for Tajimaǯs D in the case of the 
German and Ladin speaking groups and the Portuguese and Spanish. These showed a 
positive value, which is usually taken as a sign of balancing selection (alleles of equal 
frequency). However when excluding the -13495 C>T SNP from analysis none of them 
remained significant (data not shown). 
3.9 Lactase persistence genotype-phenotype correlation  
The frequencies of the lactase persistence associated alleles in the populations tested from 
Europe and Asia give an idea about how the lactase persistence phenotype is distributed. 
To see whether the predicted lactase persistence frequency from genotype data for the 
populations examined fit with observed published phenotype frequencies a GenoPheno 
test (Mulcare et al. 2004) was applied (for details see 1.3.10). Phenotype data from 
matching population samples were extracted from the 'Global Lactase persistence 
Association Database' (GLAD, http://www.ucl.ac.uk/mace-lab/resources/glad) compiled 
from different sources (Itan et al. 2010). Groups were selected as matching when they 
were from the same self-declared cultural identity living in the same or a directly 
neighbouring country.  
 
Table 3.4 shows that for most of the groups studied, the frequencies of lactase persistence 
predicted from genotype data correlates well with published phenotype data. Significant 
differences were however observed in the Roma, English, Greek Cypriots and in Asia in the 
Uzbeks from Afghanistan, North Indians and Japanese, where the predicted frequencies 
were either higher or lower than that those that were reported from phenotypic testing. 
However, taking multiple testing into account (22 tests) only the Uzbeks, North Indians, 
and Greek Cypriots remain significant, with the more stringent p-value threshold of 0.002. 
These differences may in some cases result from sampling of slightly different populations 
for genotype and phenotype data and in others may reflect as yet undiscovered 
persistence alleles. 
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Table 3.3: Diversity and neutrality measures for all 52 tested populations. Significant values 
(p<0.05) are shaded, N: number of chromosomes. 
Region Population N 
Haplotype 
diversity 
(Neis's H) 
(±SD) 
Nucleotide 
diversity 
per site ;πͿ 
Tajima's 
D 
Fu and Li's 
D* 
Fu and Li's 
F* 
  
  
     Northwest/ Germans 60 0.555 (0.001) 0.002 2.213 0.729 1.365 
Central  Sorbs 64 0.603 (0.001) 0.002 2.235 0.723 1.370 
Europe Irish 68 0.086 (0.002) 0.000 -1.091 0.718 0.201 
  Frisians 58 0.324 (0.005) 0.001 0.588 0.733 0.802 
  Norwegians 88 0.279 (0.003) 0.001 0.381 0.696 0.700 
  Roma 64 0.482 (0.003) 0.001 0.574 0.723 0.790 
  Sami 60 0.689 (0.001) 0.002 0.762 0.873 0.979 
  Swedes 74 0.383 (0.004) 0.001 0.816 0.710 0.865 
  Ashkenazi-Jews 38 0.284 (0.008) 0.001 -0.038 0.777 0.627 
  English 102 0.405 (0.003) 0.001 0.519 -0.590 -0.282 
  other C/NW Europeans 68 0.450 (0.003) 0.002 1.690 0.718 1.177 
South Greeks 120 0.474 (0.002) 0.001 -0.101 -1.534 -1.259 
Europe Tyroleans Bozen 80 0.526 (0.003) 0.001 0.427 -0.534 -0.274 
  Tyroleans Gadertal 76 0.585 (0.001) 0.002 2.357 0.708 1.409 
  Tyroleans Vinschgau 102 0.613 (0.001) 0.002 2.336 0.684 1.396 
  Portuguese 96 0.561 (0.000) 0.002 2.440 0.689 1.435 
  Catalans 58 0.525 (0.003) 0.002 1.707 0.733 1.190 
  Spanish 62 0.559 (0.001) 0.002 2.268 0.726 1.383 
East/ Belarusians 100 0.636 (0.001) 0.002 0.940 -0.586 -0.123 
Southeast  Macedonians 100 0.553 (0.002) 0.002 1.842 0.685 1.219 
Europe Romanians 118 0.444 (0.002) 0.001 1.259 0.673 1.002 
  Erzya 42 0.511 (0.005) 0.001 0.968 0.766 0.956 
  Moksha 32 0.625 (0.002) 0.002 1.023 -0.283 0.110 
  Russians Perm 46 0.590 (0.004) 0.002 1.616 0.756 1.170 
  Ukrainians 74 0.529 (0.003) 0.002 0.828 -0.515 -0.115 
  Other E/SE Europeans 38 0.602 (0.003) 0.002 1.827 0.777 1.251 
Middle East Greek Cypriots 120 0.365 (0.002) 0.001 0.017 -1.113 -0.892 
  Iranians 154 0.386 (0.002) 0.001 -0.682 -1.617 -1.548 
  Kuwaiti 66 0.591 (0.003) 0.001 -0.953 -1.549 -1.595 
  Syrians 140 0.402 (0.002) 0.001 -0.708 -0.337 -0.541 
  Anatolian Turks 116 0.340 (0.003) 0.001 0.357 0.674 0.674 
  Yemeni Hadramaut 166 0.661 (0.001) 0.002 -1.059 -1.943 -1.942 
  Yemeni Sena 68 0.773 (0.001) 0.002 0.244 1.151 1.008 
  Other Middle Easterns 62 0.548 (0.003) 0.001 -0.405 -0.153 -0.271 
West Asia Armenians 102 0.505 (0.002) 0.001 1.423 0.684 1.067 
  Azeri 80 0.279 (0.003) 0.001 -0.411 -1.017 -0.971 
  Georgians 108 0.394 (0.003) 0.001 0.505 0.680 0.732 
Central/ Pashtuns/Afghans 32 0.524 (0.004) 0.001 0.438 0.798 0.804 
South Asia Tadjiks Afghanistan 28 0.627 (0.004) 0.002 1.591 0.815 1.192 
  Uzbeks Afghanistan 54 0.616 (0.002) 0.002 1.757 0.740 1.210 
  North Indians 120 0.511 (0.002) 0.001 1.607 0.672 1.128 
  South Indians 102 0.606 (0.001) 0.001 0.583 0.825 0.878 
  Nepalese 38 0.666 (0.002) 0.002 0.968 -0.335 0.056 
  Tharu 80 0.484 (0.003) 0.001 1.288 0.704 1.029 
  Uzbeks 76 0.334 (0.004) 0.001 -0.040 0.708 0.561 
  Other C/South Asians 32 0.605 (0.004) 0.001 1.319 0.798 1.093 
Central/East/ Khalka 114 0.499 (0.001) 0.001 -0.068 -0.615 -0.519 
Southeast  Mongols 52 0.520 (0.002) 0.001 0.494 0.743 0.778 
Asia Northern Yakuts 22 0.619 (0.006) 0.001 0.845 0.851 0.976 
  Yakuts 110 0.535 (0.001) 0.001 0.871 0.678 0.864 
  Han-Chinese 98 0.456 (0.002) 0.001 -0.190 -0.581 -0.537 
  Japanese 82 0.438 (0.001) 0.001 1.413 0.505 0.901 
        
109 
Table 3.4: GenoPheno analysis of studied populations where published lactase persistence or lactose digester frequency data were available. 
Significantly different values are marked in bold, significant values after Bonferroni correction are shaded. 
Population 
No. of 
chromosomes 
Frequency LP 
associated 
alleles 
No. of 
individuals 
reported LP 
frequency 
GenoPheno       
p-value Reference published data 
   
 
          
Germans 60 0.550 221 0.864 0.094 Flatz, G., et al. (1982) Hum.Genet 62, 152. 
Irish 68 0.956 50 0.960 0.553 Fielding et al. (1981) Ir J Med Sci. 150, 276. 
Roma 64 0.063 113 0.442 0.003 Czeizel et al. (1983) HumGenet. 64, 398. 
Sami 60 0.293 50 0.520 1.000 Kozlov (1998) Int J Circumpolar Health. 57, 18. 
Swedes 74 0.778 156 0.827 0.311 Sahi (1974) Scand J Gastroenterol. 9, 303. 
English 102 0.745 150 0.953 0.020 Ferguson et al. (1984) Gut. 25, 163. 
Greeks 120 0.150 200 0.553 0.226 Kanaghinis et al. (1974) Am J Dig Dis. 19, 1021. 
Spanish 62 0.403 338 0.660 0.806 Leis et al. (1997) J Pediatr Gastroenterol Nutr. 25, 296. 
Russians Perm 46 0.239 112 0.500 0.629 Kozlov (1998) Int J Circumpolar Health. 57, 18. 
Greek Cypriots 120 0.008 50 0.340 0.002 Kanaghinis et al. (1974) Am J Dig Dis. 19, 1021. 
Iranians 154 0.039 21 0.143 1.000 Sadre et al. (1979) Am J Clin Nutr. 32, 1948. 
Kuwaiti 66 0.295 70 0.529 0.920 Sanae et al. (2003) Med Princ Pract. 12, 160. 
Anatolian-Turks 116 0.078 104 0.288 0.271 Flatz et al. (1986) Am J Hum Genet. 38, 515. 
Yemeni Hadramaut 166 0.277 17 0.530 0.972 Dissanayake et al. (1990) Ann Saudi Med. 10, 598. 
Yemeni Sena 68 0.441 17 0.530 0.357 Dissanayake et al. (1990) Ann Saudi Med. 10, 598. 
Pashtuns/Afghans 32 0.063 71 0.211 0.971 Rahimi et al. (1976) Hum Genet. 34, 57. 
Tadjiks Afghanistan 28 0.250 79 0.177 0.006 Rahimi et al. (1976) Hum Genet. 34, 57. 
Uzbeks Afghanistan 54 0.241 16 0.000 0.001 Rahimi et al. (1976) Hum Genet. 34, 57. 
North Indians 120 0.200 70 0.729 0.000 Gupta et al. (1971) J Trop Med Hyg. 74, 225. 
South Indians 102 0.118 100 0.360 0.309 Desai et al. (1970) Indian J Med Sci. 24, 729. 
Han-Chinese 98 0.041 248 0.077 0.052 Yongfa et al. (1984) Hum Genet. 67, 103. 
Japanese 84 0.000 40 0.275 0.028 Yoshida et al. (1975) Gastroenterol Jpn. 10, 29. 
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3.9.1 Worldwide genotype-phenotype correlation 
Itan et al. (2010) devised a method for comparing lactase persistence genotype and 
phenotype data using interpolated values for regions with data lacking one or the other 
type of information. Since the original publication of this approach in 2010, more 
publications giving genotype data for the LCT enhancer have become available and very 
recently a variant with previously reported borderline association, -14009*G (Ingram et al. 
2009b), was shown by our group to be significantly associated with lactase persistence in 
a larger Ethiopians cohort (Jones et al. 2013).  
 
A new interpolated lactase persistence genotype-phenotype correlation map of the Old 
World was constructed, with the help of Pascale Gerbault and Yuval Itan using the same 
Python code as in the original publication (Itan et al. 2010), to see whether the data 
collected in this thesis, the additional lactase persistence associated allele and the newly 
published data change the association patterns of the map. A literature review was 
necessary to update the GLAD database used for the original publication (Itan et al. 2010), 
this also included correction of coordinates of some data collection points. Tables with the 
full updated genotype and phenotype data are shown in Appendix B. Figure 3.6 and Figure 
3.7 show the new lactase persistence genotype-phenotype correlation maps in 
comparison with the originally published maps by Itan et al. (2010). 
 
The new data has contributed considerably to the density of genotype data points across 
Europe, South Asia and East Africa. The new genotype data for Oman (Al-Abri et al. 2012) 
has added to the areas where the lactase persistence phenotype was overpredicted by 
genetics. Areas where observed lactase persistence frequencies were not fully predicted 
from genotype data were slightly reduced but could not completely be resolved, such as in 
West Africa, the centre of Italy, some Eastern European areas and South Asian areas 
around Pakistan and North India. However, information about lactase persistence 
phenotype and genotype data is still rare in North and East Asia, the North and other parts 
of Africa and Australia and South East Asia 
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a) 
 
b) 
 
Figure 3.6: LP genotype-phenotype substractive map of the Old World. The map shows 
quantitative differences between observed LP phenotype data and these predicted from genotype 
data (both interpolated). Allele frequencies of the alleles -14010*C, -14009*G, -13915*G, -13910*T 
and -13907*G were taken into account to predict LP phenotype frequencies, which were subtracted 
from the observed LP phenotype frequencies. For geographic regions where no phenotype or 
genotype data were available, values were interpolated. a) shows the map originally published in 
Itan et al. (2010) and b) the newly calculated map. Colour key on the right: + values represent the 
genotype under-predicting phenotype at a certain location and - values over-predicting it, 
respectively. Note that the colour codes as shown in the scales on the right differ slightly between 
the maps, because of the greater range in the second map. Data collection points:  -13910*T, x all 4 
or 5 LP alleles, ● LP phenotype.  
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a) 
 
b) 
 
Figure 3.7: P-value contour map corresponding to the LP genotype-phenotype subtractive 
map of the Old World, shown in Figure 3.6. The colours represent the p-values obtained by the 
GenoPheno test: A highly significant difference is shown in red (p<0.01), yellow shows p-values of Ͳ.ͲͳζͲ.Ͳͷ and blue indicates p ηͲ.Ͳͷ. Data collection points:  -13910*T only, x all 4 or 5 LP alleles, 
● LP phenotype.   
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3.10 Discussion 
At the outset of this project European and Asian populations had mainly been typed 
specifically for the -13910 C>T SNP and only a few studies provided full enhancer 
sequencing data. Although more data are now available (see Appendix B for a full 
literature survey), this study represents one of the widest geographic surveys to date of 
the LCT enhancer sequence variation across Eurasia obtained via sequencing.  
 
The results show that -13910*T is present in all populations tested except the Japanese, 
even in the Middle East at low frequencies. The allele is most prevalent in Northwest 
Europe and declines in frequency to the South and East as previously shown (Swallow 
2003). However, deviating from this general pattern some of the Central and South Asian 
populations show similar -13910*T frequencies to Southern Europeans.  
The other lactase persistence associated alleles on the other hand were only found in the 
Middle Eastern populations and of these mainly -13915*G, the others being surprisingly 
rare. -14010*T only occurred as a singleton as did -14009*G. 
 
In contrast to this -13495*T was present in all populations at considerable frequencies. It 
broadly follows the Northwest to Southeast frequency decline of -13910*T, which could be 
explained by the fact that it occurs on the same haplotype background as -13910*T. It also 
occurs in combination with -13907*G and -14011*T, which might suggest it to be an 
evolutionary older variant. It was previously reported on a much smaller dataset to be in 
strong LD with -13910*T and -13907*G (Ingram 2008) and in association with the A 
haplotype but it was too frequent to be causal of lactase persistence. Further study of its 
pattern of association with the classical LCT haplotype markers in a wider–ranging set of 
populations, including some African groups should give better insight into the 
evolutionary relationship of this allele to the known haplotypes and is described in 
chapter 5. 
 
Most of the newly discovered variants are rare and only one case of each of-14028*C and -
13914*A were present in the European data. -13914*A was recently reported in one 
individual with high lactase activity in biopsy material (Khabarova et al. 2010) which did 
not carry other enhancer alleles thus could be, like 14028*C, a candidate for causing 
lactase persistence. 
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-14011*T is rare as well, but can be found in various European populations, which is of 
interest. Further study of the haplotype background of this allele might give insight into its 
origins, and this is also described in chapter 5. 
 
None of the novel alleles occurred at frequencies high enough in any particular population 
to make new association studies a sensible option, but several of the alleles could be tested 
for function in vitro (chapter 4). 
 
Several tests were conducted to investigate possible signs of selection in the enhancer 
region of the populations studied. Diversity measures as haplotype and nucleotide 
diversity as well as test for deviation from neutrality did not reveal any results that 
pointed to positive selection. It is most likely that the 559 bp enhancer region is too short 
to detect selection with these methods. The only clear genetic differentiation of the 
populations, as measured by pairwise FST, highlighted Northwestern Europeans as 
different, most probably because of their high -13910*T frequency. 
 
Previously collected lactase persistence data, which was updated with new published 
information, and genetic data collected for this chapter were used to construct new 
interpolated maps showing the difference between reported lactase persistence and 
lactase persistence predicted from genotype, and of statistical significance of these 
differences calculated by the GenoPheno approach. Compared with the original 
publication (Itan et al. 2010) new data considerably increase the density of the data points 
and therefore the quality of the information that can be obtained by such an approach. 
However it did not decrease the areas with largest discrepancies nor change very much. 
The weaknesses of the interpolated GenoPheno approach were discussed extensively in 
Itan et al. (2010). The main issue in the case of lactase seems to be sampling from 
neighbouring populations with completely different lactase persistence frequencies. The 
interpolation approach is nevertheless a powerful tool to compare geno- and phenotypic 
information where it is not possible to collect both in the same populations, and the more 
data there are the more the effect of heterogeneity is reduced. 
 
The new sequence data obtained in thesis has added considerably to the knowledge of the 
lactase persistence associated alleles in Eastern Europe and Asia. It was also shown that 
lacking information for lactase persistence enhancer alleles other than  
-13910*T was not the reason for the under-predicted phenotype from genotype data in the 
areas studied. There are still parts of East and South Europe and Asia, namely the regions 
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of West Russia, Italy and Pakistan and parts of Asia, where genotype data cannot explain 
the frequency of lactase persistence, which leads to speculations about other genetic 
influences on the lactase persistence trait. It is possible that further alleles have a 
functional effect. The next chapter will look further at some of the promising candidate 
alleles as they were tested in in vitro assays.
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4 Functional studies of enhancer variation 
4.1 Introduction 
As discussed in chapter 3, a number of variants have by now been described within the 
sequence shown by Troelsen et al. (for example 2003) to have enhancer function. Several 
of these have been subjected to functional studies and showed differences in protein 
binding affinity and/or expression levels. These variants and the transcription factor 
binding sites identified so far are shown in Figure 4.1. 
 
 
Figure 4.1: Positions in the 450 bp LCT enhancer of transcription factor binding sites and 
SNPs studied functionally. Indicated in boxes: black: transcription factor binding sites as shown in 
experiments before the outset of this thesis (Lewinsky et al. 2005); red: transcription factor binding 
sites as shown in experiments during the time of this thesis (Jensen et al. 2011); blue shadowed: 
SNPs previously examined functionally (Enattah et al. 2008; Ingram et al. 2007; Olds et al. 2011; 
Tishkoff et al. 2007); red shadowed: SNPs examined functionally within this thesis. EMSA probes 
used in this thesis are indicated with red lines. 
 The ǮEuropeanǯ allele -13910*T was the first proposed to influence the level of enzymatic 
activity and to prevent the post-weaning decline of lactase, by preventing down-regulation 
of transcription, with evidence from reporter gene experiments and with the findings of 
increased Oct-1 transcription factor binding in EMSA studies (Ingram et al. 2007; 
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Lewinsky et al. 2005; Olds and Sibley 2003; Troelsen et al. 2003) (see also chapter 1). The 
causal role of -13910*T for lactase persistence is now even more evident as in vitro data 
were supported by the demonstration of its function in mice (Fang et al. 2012). Fang and 
colleagues established three transgenic mouse lines carrying a pGL3 luciferase reporter 
gene plasmid DNA, which included 218 bp of the LCT enhancer with either -13910*T or *C, 
fused to a 2 kb rat LCT promoter. As demonstrated previously (Lee et al. 2002) the 
construct carrying the ancestral variant was able to create the typical lactase spatial and 
temporal expression pattern in mice, shown by in vivo bioluminescent detection and 
luciferase expression measurements. The two other mouse lines carrying different copy 
numbers of the -13910*T construct showed continued expression into adulthood (Fang et 
al. 2012). 
 
Several other alleles in close proximity to -13910*T have also been studied since their 
location in and near the same Oct-1 binding site (see Figure 4.1) suggested a similar 
functional effect.  
The lactase persistence associated alleles -13915*G and -13907*G, as well as -13913*C, 
which has only recently been shown to not be associated with lactose digester status 
(Jones et al. 2013), were tested in gel shift assays (Enattah et al. 2008; Ingram et al. 2007; 
Olds et al. 2011). The results of various investigators were slightly different. Compared 
with -13910*T, only minor Oct-1 protein binding of oligonucleotides carrying -13907*G 
was detected by Ingram et al. (2007), and was similar to that of the ancestral allele, 
whereas no binding at all was seen for -13915*G and -13913*C. Enattah and colleagues 
(2008) also showed no or very weak binding to -13915*G and -13913*C but their 
experiments revealed Oct-1 binding to the -13907*G probe at a level similar to -13910*T. 
Yet another study claimed to show binding of -13915*G to proteins of the nuclear extract, 
identified as partly being Oct-1 with competition and supershift experiments (Olds et al. 
2011).  
 
Transcription factor binding capacity in vitro is clearly complex so that gel shifts assays 
only give hints of differences between the alleles but results of transfection experiments 
provide further functional evidence. -13915*G and -13907*G alleles were shown clearly by 
several groups to increase reporter gene expression compared to the ancestral constructs 
(Enattah et al. 2008; Olds et al. 2011; Tishkoff et al. 2007). The Tishkoff study also 
included the lactase persistence associated allele -14010*C, which was shown to drive a 
higher LCT promoter expression too (Tishkoff et al. 2007). However, the influence of 
118 
transcription factor binding of the -14010 G>C SNP had only been tested in preliminary 
experiments at the outset of this thesis.  
The -14010*C variant was further examined in a project I was involved in, lead by Tine 
Jensen of the Troelsen group in Copenhagen. It was shown that the derived allele at -
14010 G>C increased reporter gene expression compared to the ancestral variant. Gel shift 
assays located the SNP between an Oct-1 and HNF-ͳȽ transcription factor binding site and 
stronger binding of -14010*C to Oct-1 was reported (Jensen et al. 2011), see Appendix G. 
The functional region of the 450 bp enhancer described previously (Lewinsky et al. 2005; 
Troelsen et al. 2003) was investigated once more and it was shown that the 5' part of the 
enhancer region (-14133 to -13990) negatively influenced enhancer function, since the 
deletion of this part increased the activity of the remaining enhancer. 
 
4.2 Choice of candidate functional variants 
The focus in chapter 3 was on the search for new LCT enhancer variant alleles in 
European, Middle Eastern and other Asian populations that could tentatively be involved 
in lactase persistence and which would be further studied in vitro. Although some new 
alleles were found, they are quite rare, so it was not possible as a consequence to collect 
phenotypic data to test for association. Therefore four variants (-14009*G, -14011*T, -
14028*C, -13779*G) were instead chosen to conduct in vitro functional assays, after a 
review of other studies in combination with the information in chapter 3.  
 
-14009*G  
-14009*G was found only once in the samples studied in chapter 3. However the 
association of -14009*G with lactase persistence had previously been shown to be of 
borderline significance in the Somali of Ethiopia (Ingram et al. 2009b). This allele is quite 
common in Ethiopia and Sudan and was noteworthy for being adjacent to a known lactase 
persistence variant, -14010*C. As described in the previous chapter, -14009*G has recently 
been confirmed to be associated with lactose digester status in a larger Ethiopian cohort 
(Jones et al. 2013).  
 
-14011*T 
-14011*T is rare but appears in several Eurasian groups as well as in a populations of Iran, 
Ethiopia and Brazil (Friedrich et al. 2012; Jones et al. 2013; Lember et al. 2006 and several 
groups in chapter 3 of this thesis) and like -14009*G is adjacent to a reported lactase 
persistence allele, which lead to speculations about possible function. 
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-14028*C  
Another particularly interesting variant, -14028*C, was found in a European individual 
with two high lactase expressing alleles but only one chromosome containing -13910*T 
(Poulter et al. 2003), and a further individual of English descent in this study. Lewinsky et 
al. (2005) had found a Cdx-2 binding site overlapping with this position (see Figure 4.1), 
which was another reason to investigate the influence of this SNP more in detail. 
 
-13779*G  
In the present study a further allele, -13779*G, was found in India, Syria and Yemen (see 
chapter 3) and it was quite frequent in other populations from India as concurrently 
shown in a collaborative project (Gallego Romero et al. 2012). The preliminary suggestion 
that its frequency was higher in certain pastoralist than non-pastoralist Indian groups 
(Gallego Romero, personal communication 2009) motivated the choice of this allele but 
in fact this could not confirmed with the final data of the paper (Gallego Romero et al. 
2012). However, additional evidence made this SNP interesting to examine.  
Figure 4.2 shows a photograph of a DNase I footprint analysis of the LCT enhancer. Around 
nucleotide position -13800 a footprint of an unknown factor can be seen, suggesting some 
transcription factor binding there, which could be influenced by the -13779 C>G SNP.  
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Figure 4.2: Autoradiograph picture of a DNase I footprint analysis done by denaturating 
polyacrylamide gel electrophoresis (PAGE), kindly provided by Jesper Troelsen. Blue bars 
indicate footprints with already identified transcription factor binding sites or unknown factors 
binding. Bp positions upstream of the transcription start of LCT are shown in red. With an increase 
of nuclear extract (NE) footprints get visible as light shaded areas, caused by binding of NE-proteins 
to the DNA and inhibition of DNase I cleavage. 
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4.3 Chapter aims 
In summary, four LCT enhancer variants, -14028*C, -13779*G, -14011*T and -14009*G were 
selected for in vitro functional studies. These would be tested in comparison with the 
ancestral alleles and the lactase persistence alleles -13910*T and -14010*C. The 
combination of results from electrophoretic mobility shift essays and luciferase reporter 
gene assays should provide evidence as to whether these alleles are likely to be involved 
in the alteration of function of the LCT enhancer. 
 
This chapter aims to investigate the influence of the four chosen allelic variants 
bioinformatically and in vitro by: 
 Predicting transcription factors binding to the variants and the surrounding DNA 
regions, especially differences that occur for each allele of a SNP, by using different 
software tools, 
 Conducting EMSA experiments to evaluate differences in binding of proteins of the 
nuclear extract to DNA sequences containing the variants and test specifically for 
binding of the predicted transcription factors, 
 Transfecting Caco-2 cells with mutated plasmid DNA and measuring differences in 
expression of a reporter gene. 
All experiments were conducted in collaboration with Jesper Troelsen and colleagues from 
Roskilde University and the University of Copenhagen in Denmark. 
 
4.4 Prediction of transcription factor binding 
A first step before conducting functional experiments was to analyse in silico the genetic 
region including 10 bp either side of a SNP or the full length sequence of the designed 
oligonucleotides for possible transcription factors binding. This was done by using 
different programs to compare these sequences with matrices of preferred targets for 
transcription factor binding as curated from literature (for more details see chapter 2, 
section 2.3.13). An important aspect was the matrix specificity to vertebrate species as 
considered in MATCH and TFSEARCH, both using the TRANSFAC database but with slightly 
different statistical algorithms and MatInspector.  
 
As expected, the predicted results overlap to a great extent between the three programs, 
results are shown in the summary table in Appendix E. Candidate transcription factors 
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were those with different matrix matches/scores for the ancestral and derived variant and 
oligonucleotides were chosen to be tested in EMSAs if associated with expression in the 
digestive system (information from literature or MatInspector) and/or Caco-2 cells 
(information from 'The intestinal transcription factor target database' of the Copenhagen 
University, http://gastro.sund.ku.dk/chipchip/, with Caco-2 expression data from 
GeneChip analysis). As time for the experiments was limited, the transcription factors 
known to be involved in lactase expression, such as Cdx-2, Oct-1 and HNF-ͳȽ were tested 
first. 
 
Matching competitor oligonucleotides were designed using information about binding site 
motifs from of the TRANSFAC database (see Table 4.1 below). For some of the predicted 
transcription factors, information about matching competitor oligonucleotides was 
available from the Affymetrix EMSA kit and these used to prepare oligonucleotides for 
competition experiments as described in chapter 2. 
 
4.5 Transcription factor binding affinity of LCT enhancer variants 
EMSAs were performed as described in section 2.2.6. For all LCT enhancer variant probes 
examined, binding specificity to proteins of the Caco-2 nuclear extract was confirmed if 
the DNA-protein complex could be competed with an excess of unlabelled oligonucleotides 
with the same sequences. The effect of competitor oligonucleotides for Cdx-2, Oct-1 and 
HNF-ͳȽ was in most cases tested, since these TFs have been shown to play an important 
role in the function of the LCT enhancer, as well as other specific probes selected from the 
in silico predictions. By adding target antibodies and specific competitors with a confirmed 
transcription factor binding sequence, several different factors were identified to bind to 
the variant probes (as summarised in Table 4.2 and Appendix E).  
4.5.1 The influence of -14028 T>C on transcription factor binding 
Both alleles of the -14028 T>C SNP bind similarly strongly to proteins of the nuclear 
extract. This binding could in both cases be competed with unlabelled oligonucleotides 
containing Oct-1 and HNF-ͳȽ binding sites (not shown). The binding of Oct-1 was 
expected as the probe sequence overlaps 3'with an Oct-1 site recently reported (Jensen et 
al. 2011)(see also Figure 4.1). The competition with the HNF-ͳȽ competitor suggests that 
this is probably another factor involved in the function of the -14133 to -14020 gene-
regulatory region, which has been shown to decrease enhancer function in reporter gene 
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assays (Jensen et al. 2011). However, binding of these transcription factors could not be 
shown in supershift experiments.  
 
The location of the -14028 position in a Cdx-2 binding site as proposed by Lewinsky et al. 
(2005) was confirmed. Both allelic probes of the SNP were competed with the same 
unlabelled Cdx-2 oligonucleotide but the ancestral variant much more strongly than the 
derived one. A clear supershift could be seen for 14028T with a Cdx-2 antibody (Figure 
4.3a).  
 
DNA-protein bands with 14028C were decreased with the addition of an HNF-ͶȽ 
competitor (Figure 4.3b). A supershift with the HNF-ͶȽ antibody confirmed that this 
transcription factor is binding to the 14028C probe. 
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-14028 T>C 
a)   
 
 
 
 
 
 
                         
 
b)   
 
 
 
 
 
                          
 
Figure 4.3: EMSAs of both variants of the -14028 T>C SNP in direct comparison. The 
phosphoimaging pictures of PAA gelshift assays show the binding of the labelled probes to proteins 
of the Caco-2 nuclear extract. Competition experiments (Comp.) with unlabelled variant 
oligonucleotides for a specific competitor for Cdx-2 (a) or HNF-Ͷ Ƚ (b) indicate binding specifity of 
these TFs, which is shown further by supershift experiments with antibodies (Anti-) against Cdx-2 
(a) and HNF-Ͷ Ƚ ȋbȌ. A non-specific antibody was used as negative control (b). Note that lanes were 
cut out of the gel pictures but lanes are from the same gels. Bands were classified as non-specific 
binding when they were only present on some of the gels and were reduced or removed with the 
use of less extract.  
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4.5.2 Transcription factor binding at -13779 G>C  
As can be seen in Figure 4.4, both variants of the -13779 G>C SNP gave similar strong 
DNA-protein bands that could be competed with the unlabeled probe containing the 
ancestral or derived allele in a similar way.  
 
Both variant probes show a slight competition with the Cdx-2 (Figure 4.4a) and only the 
ancestral allele showed a minor change in band intensity with the Oct-1 and HNF-ͳȽ 
competitors. A complete displacement was in contrast seen with the oligonucleotide 
containing an HNF-ͶȽ binding site and binding of this transcription factor could be 
confirmed with the supershift of the complex formed with the HNF-ͶȽ antibody. The shift 
was slightly stronger for the derived variant 13779C probe on Figure 4.4b but this could 
be due to the general stronger probe on that gel. 
 
Further competition experiments with Affymetrix competitor oligonucleodites for the 
predicted transcription factors LEF-1, GKLF-1 and AML-1 only revealed a slight 
competition with the GKLF-1 and AML-1 competitors similar for both, the ancestral and 
derived allele probes (not shown). 
 
-13779G>C 
a)      b) 
 
 
     
  
Figure 4.4: EMSA pictures of competition and supershift experiments for the ancestral (a) 
and derived (b) variant probes of the -13779G>C SNP. Competition experiments with unlabelled 
variant oligonucleotides, oligonucleotides with a non-specific sequence and binding sequences for 
different TFs are shown. These, as well as an antibody (Anti-) against the HNF-ͶȽ TF for a 
supershift experiment, were used as indicated above the pictures. The specific DNA probe-protein 
complex could be clearly supershifted with this antibody (strong band on top of the gel).  
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4.5.3 Transcription factor binding at the positions -14011, -14010 and -
14009 
In a collaborative project, lead by Tine Jensen of the Copenhagen lab, we had identified 
transcription factor binding sites surrounding -14010G>C. The SNP is located in an Oct-1 
binding site (-14021 to 14009) and resides close to an HNF-ͳȽ binding site (-14007 to -
13993). The lactase persistence associated -14010*C showed stronger binding to Oct-1 
than the ancestral allele. However, this effect could only be shown with oligonucleotides 
spanning both transcription factors, indicating that it is mediated by HNF-1Ƚ (Jensen et al. 
2011). 
 
Since -14011*T and -14009*G are located adjacent to that variant and are part of the same 
Oct-1 binding site, it seemed likely they would cause a similar effect. The oligonucleotides 
carrying the two alleles were therefore designed to cover the same length of sequence, 
including the Oct-1 and HNF-ͳȽ binding sites as the 14010C probe (Jensen et al. 2011), 
and this probe was added to the assays for comparison.  
  
Gel shift analysis indeed revealed similarities of all variant probes in forming protein 
complexes, visible as several bands on the gels. The upper band was competed in a similar 
way for the ancestral probe and the three variant probes with unlabelled Cdx-2, HNF-ͳȽ 
and Oct-1 competitors (partly shown in Figure 4.5a). The strongest competition was 
visible with the HNF-ͳȽ oligonucleotide, followed by the one containing an Oct-1 site and 
only minor competition was shown with the Cdx-2 competitor.  
 
The 14011T probe showed the same strong protein binding as the 14010C probe, a 
slightly more intense band than the ancestral variant probe (14011C). Additionally, the 
supershift with an Oct-1 antibody, generated with all variant probes, was slightly stronger 
for the derived 14011T probe, similar to 14010C (Figure 4.5b). With the Cdx-2 and HNF-ͳȽ antibodies a slight inhibition of the formation protein probe complex for all probes and 
in a similar way (not shown).  
 
A slight difference seen for 14011T, compared to the other probes, was a slightly faster 
migrating DNA-protein complex visible as the lower band on the gels. Additional binding 
of GATA-3 and 4 to -14011*T was predicted bioinformatically and gelshift assays were 
performed to test this. Preliminary results show a competition of both 14011 probes with 
different GATA competitor oligonucleotides, which mainly affected the upper bands on the 
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gels (not shown). However this has not yet been confirmed with further experiments or in 
supershifts. 
 
The 14009G probe showed a very interesting pattern that differed from the three other 
probes tested. In addition to a weak upper band, which could be shifted with the Oct-1 
antibody and slightly inhibited with the Cdx2 and HNF-ͳȽ antibodies, another DNA-
protein complex was formed (shown by blue arrows in Figure 4.5). This suggests that 
besides the two other transcription factors binding to the 14009G probe, another protein 
in the nuclear extract is specifically binding to the -14009*G containing sequence..  
 
-14011/10/09 
a)      b) 
 
 
 
 
 
                
 
Figure 4.5: Phosphoimaging pictures of gelshift assays of competition (a) and supershift 
experiments (b) for the 14011T, 14010C and 14009G variant probes compared to the 
ancestral version. Competitors (Comp.) covering known binding sequences for TFs and antibodies 
(Anti-) were used as indicated above the gel images, a non-specific antibody was used as negative 
control. Different specific probe-protein complexes were formed of which the upper ones could be 
competed with Oct-1 and HNF-ͳȽ competitors ȋaȌ and supershifted ȋbȌ with an Oct-1 antibody (red 
arrow) for all 4 probes, whereas the DNA-protein complex formed with the 14009G probe (blue 
arrow) was not shifted. A slightly different binding pattern was seen for the lower band for 14011T 
(orange arrow). 
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4.5.4 Binding of an Ets transcription factor to -14009*G 
Bioinformatic analyses with different software programs (see section 2.3.13) predicted 
additional possible transcription factors that would bind to the 14009G oligonucleotide 
sequence, mainly members of the Ets transcription factor family. Further investigation of 
this sequence with the TRANSFAC database with a decreased matrix match threshold of 
0.70 revealed further candidate transcription factors, as shown Appendix E, that 
potentially bind to the derived but not the ancestral variant probe for the 14009T>G SNP 
and are expressed in Caco-2 cells. Competitor oligonucleotides were designed taking into 
account specific transcription factor binding motifs, found in TRANSFAC (Table 4.1, 
above). 
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Table 4.1: Design of competitor oligonucleotides for EMSA experiments examining the -14009 T>G SNP. Information about candidate transcription factors, 
with high differences in MATCH scores between the ancestral and derived variant, were taken from the TRANSFAC database. Letters in capitals represent the core 
sequence of the binding matrix of a certain TF stored as identifier sequence in TRANSFAC. 
 
Transcription 
factor 
TRANSFAC consensus 
sequence 
Matrix 
accession 
number Identifier 
Designed  
Oligonucleotide sequence Name 
 
  
    c-Ets-1 (p54) NNNRCCGGAWRYNNNN M01078 V$CETS1P54_03 aatccTCTACCGGAtGTAGGTcgac c-Ets-1 
  NNACMGGAWRTNN 
 
V$CETS1P54_02 
 
  
Ets ACTTCCTS M00971 V$ETS_Q6 atcttactACTTCCTCgctgaccgt Ets/Tel-2 
NF-kappaB NNNNKGGRAANTCCCN M00774 V$NFKB_Q6_01 agtGGCGGGGAAAgTCCCCagaatc NF-kappaB 
Pax CTGGAACTMAC M00808 V$PAX_Q6 aagaagTGGAACTCACgatcgtgct  Pax  
Pax-4 NGNVGTCANGCGTGNNSNNYN M00373 V$PAX4_01 acGGCGTTCATGCGTGAGCGACCgt PAx4-8 
Pbx GATTGATKGNNS M00998 V$PBX_Q3 agatggGATTGATGGTAGccgtatt Pbx 
Tel-2 YTACTTCCTG M00678 V$TEL2_Q6 see Ets   
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Figure 4.6 shows the EMSA experiments with the first set of oligonucleotide competitors. 
It can clearly be seen that the upper DNA-protein complex could be competed with the 
ancestral sequence on both variant probes. The lower complex band with the -14009G 
probe could not be competed with the ancestral variant competitor, which confirms the 
specificity of the factor binding to the derived allele. The c-Ets-1 sequence was only one 
that competed strongly with the lower complex of 14009G. A slight competition of the 
binding of both variant probes to the upper band was seen for NF-kappaB, Pax, Pax4-8 and 
Pbx. 
 
From the Affymetrix competitor set two oligonucleotides competed with the 14009G 
specific band: Aff_c-Ets-1 and Aff_ELK-1. However, the protein binding to the ancestral 
probe 14011C (shown as band for the specific DNA-protein complex in Figure 4.6a) was 
also competed with the Aff_ELK-1 competitor and slightly with Aff_ELF and Aff_ETS (1) 
competitors (not shown).  
The reciprocal experiments, using c-Ets-1 and Aff_ELK-1 as probes showed that Aff-ELK-1 
was competed with both competitor sequences, 14011C and 14009G, whereas the c-Ets-1 
probe could only be completely competed with 14009G and only slightly with the 
ancestral version (not shown). So far it was not possible to confirm this in supershift 
experiments when an antibody for Ets1/2 or Ets-1 was added to the assay.  
 
-14009 T>G 
a)      b) 
 
 
                             
 
Figure 4.6: Images of gelshift assays of competition experiments for the ancestral (a) and 
derived (b) variant probes of the -14009 SNP. Competitors were used as indicated above the 
pictures. The specific DNA-protein complex for 14009G (blue arrow) could not be competed with 
the ancestral sequence competitor but was with competitor oligonucleotides of the Ets family. 
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4.6 Experimental strategy for reporter gene assays 
Different strategies were pursued for the insertion of the LCT enhancer and the promoter 
variants into the reporter gene plasmids, upstream of the firefly luciferase gene (luc+), as 
described in chapter 2. Results for the experiments with the LCT promoter variants are 
discussed in chapter 6. Enhancer variants were generated via site directed mutagenesis 
and inserted via enzyme digest into the luciferase reporter vector pGL3 hLPH1085 
(Troelsen et al. 2003) as shown in Figure 4.7, about 2.8 kb upstream of the human LCT 
promoter, already present in the construct. Transient transfections of Caco-2 cells were 
conducted as described in chapter 2 (section 2.2.7). 
 
 
Figure 4.7: Summary of the site directed mutagenesis and insertion of LCT enhancer 
fragments into the luciferase reporter gene plasmids, as described in detail in section 2.2.7 
(modification of Figure 2.2 of chapter 2). LCT enhancer variants were generated in a two step 
PCR amplification and inserted via BamHI and SalI into the pGL3vector containing the ancestral 
promoter region (pGL3 hLPH1085 (Troelsen et al. 2003)). 
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4.7 The influence of LCT enhancer variants on reporter gene 
expression 
Luciferase reporter gene expression of the different enhancer variant constructs was 
measured in undifferentiated (2 days after transfection) and differentiated Caco-2 cells (9 
days after transfection) and results of one experiment are shown in Figure 4.8. The -
13910*T and -14010*C constructs were used as controls since they had previously been 
reported to influence reporter gene expression, at least in undifferentiated cells (Tishkoff 
et al. 2007; Troelsen et al. 2003).  
The function of the 450 bp region carrying the ancestral alleles (Lewinsky et al. 2005; 
Troelsen et al. 2003) was confirmed since it enhanced LCT promoter function 7 fold in 
undifferentiated and 13 fold in differentiated cells compared to the promoter only 
constructs. 
 
Significant differences in luciferase expression compared to the ancestral -13910*C 
constructs were demonstrated for all four newly tested variants in undifferentiated Caco-2 
cells (Figure 4.8). The expression was about 1.3 times higher for the -13910*T, -14009*G 
and -14028*C reporter gene plasmids than the ancestral construct. For -14010*C and -
14011*C this difference was even larger, up to about 1.4 fold expression compared to the 
ancestral version and the construct with -13779*C shows about twice the activity of the 
ancestral enhancer.  
 
The picture changes slightly with the measurements in the differentiated cells, harvested 9 
days after transfection. Only the activities for the control plasmids, -13910*T and -14010*C 
and those carrying -14009*G and -14011*T stayed significant (Figure 4.8). -13910*T 
increased luciferase activity to 1.8 fold compared to the ancestral enhancer and the effect 
of -14010*C was even bigger. It increases enhancer activity up to 2.8 fold in differentiated 
cells.  
The effect of -14009*G on reporter gene expression resulted in a 2 fold increase in activity. 
The significant effects of -14009*G and -14010*C were also confirmed in another 9 day 
experiment, which was recently published (Jones et al. 2013).  
The enhancer with the -14011*T variant is 1.4 (2 days) to 2 fold (9 days) more active than 
the ancestral version, which was also confirmed in another 9 day experiment (not shown). 
 
These results support those of the gel shifts and suggest that both alleles (-14009 and 
14011) alter lactase expression. 
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Although the constructs with -14028*C and -13779*C showed a 1.3 and 2 fold increased 
expression in the 2 day experiments, they did not show a significant increase in activity in 
the 9 day experiments. Both variants also revealed a high variation in luciferase activity in 
further experiments (data not shown) so it was not possible to confirm these results in the 
undifferentiated stage. 
 
  
 
Figure 4.8: Result of luciferase reporter gene assays for LCT enhancer variants after 2 and 9 
days of transfecting the Caco-2 cells. Luciferase activity of enhancer variant constructs are shown 
relative to the promoter only construct. Luciferase activities (means±SD, n=4) were corrected for 
transfection efficiency against ß-galactosidase and normalised to the expression of pGL3 hLPH1085 
(promoter only). Significant differences of luciferase activity compared to the ancestral variant 
were calculated using a student t test and are shown by ** (p<0.01) and * (p<0.05).  
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4.8 Summary and discussion of the functional studies  
Functional evidence for the 4 variants -14028*C, -14011*T, - 14009*G and -13779*C in 
comparison to their ancestral alleles, obtained from EMSA and transfection experiments 
that were conducted during this thesis work are summarised in Table 4.2. A more detailed 
summary of the experimental outcome and bioinformatic investigations for each of these 
variants can be found in Appendix E. 
 
Table 4.2: Summary of the main outcome of the functional studies conducted during this 
thesis. Abbreviations: +: variant has an effect on reporter gene expression or shows binding to a 
certain transcription factor, bold crosses: strong effect, - no effect, (+) weak effect respectively, n/a 
not applicable. 
    -14028*T -14028*C -14011*C -14011*T -14009*G -13779*G -13779*C 
Transfections 
          2 days control + control + + control + 
  9 days control - control + + control - 
EMSAs 
 
  
 
  
  
  
 Cdx-2   + + + + + (+) (+) 
Oct-1 
 
+ + + + + (+) - 
HNF-1α 
 
+ + + + + (+) - 
HNF-4α 
 
- +   + + 
c-Ets-1 
 
n/a n/a - n/a + n/a n/a 
ELK-1, ETS   n/a n/a + n/a + n/a n/a 
 
 
It was clearly shown that sequences containing the two alleles, -14011*T and-14009*G 
differ functionally from their ancestral forms in vitro, as concluded from transfection 
experiments and evidence from EMSAs. The high activity of the enhancer constructs 
carrying those alleles, compared to the ancestral variant, could be explained by an altered 
binding to different transcription factors in each case: Slightly stronger binding of -
14011*T to Oct-1 and probably also stronger binding to a GATA factor and the binding of -
14009*G to an additional transcription factor, most probably a member of the Ets family.  
 
Binding of -14009*G to the Ets-1 transcription factor could not be confirmed in EMSA 
experiments with either of the Ets-1/2 and Ets-1 antibodies. However, these commercially 
available antibodies might not be specific enough or even suitable for EMSA experiments 
and at the time no other Ets antibody was available that did have confirmed function in 
binding to Ets-1 in EMSA studies.  
Although direct evidence from supershift assays is missing the competition with 
commercially available and target designed competitors strongly suggest the binding to c-
Ets-1 or a member of the same transcription factor family. Ets (E26 transformation-
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specific) factors play an important role in the differentiation, survival and proliferation of 
cells. These factors usually interact with other factors to regulate DNA-binding or 
transcription (for example Sharrocks 2001) and could well play a role in the regulation of 
LCT expression. 
 
The -14028 variant tested apparently slightly influenced LCT promoter activity in 
luciferase reporter gene assays (but only significantly in undifferentiated Caco2 cells) and 
the results were not replicated during the course of this work. There was however some 
evidence for alteration of transcription factor binding in EMSAs. It could be shown that the 
derived -14028*C leads to a loss of binding to Cdx-2 and seems to create a HNF-ͶȽ binding 
site, but it can be concluded that this does not seem to change enhancer activity 
dramatically in vitro, at least under the conditions tested.  
 
In contrast to all other variants tested, a direct functional effect was not supported for -
13779 G>C. The probes were shown to contain an HNF-ͶȽ binding site, which is probably 
the cause for the footprint around that position shown in Figure 4.2, but the -13779 G>C polymorphism doesnǯt seem to have an effect on protein binding. Mutation analysis might 
be useful to define the exact binding site of this transcription factor along sequence the 
studied here, but there is no real hint that this particular substitution has any effect. The 
suggestive evidence for a functional role of -13779*C had been not very strong as it mainly 
came from its relatively high frequencies in milk drinking populations in India, but it had 
in fact previously been reported in one Somali individual who was diagnosed as a lactose 
maldigester (Ingram et al. 2009b).  
 
The results show that -14011*T and-14009*G, at least, give clear evidence of a difference in 
vitro but it should always kept in mind that this does not necessarily prove a functional 
difference in vivo. Physiological conditions are different in the living organism and other 
factors influence DNA-protein binding, such as chromatin structure or other flanking 
sequences of importance that cannot be mimicked in EMSA experiments or transfection 
studies. It might also be that in vivo function of the variants is even larger as in the 
transfection experiments as Caco2 is only capable of expressing a small amounts of lactase 
in comparison to the cells of the small intestine (Rousset 1986). In the case of -14009*G, 
the association with lactase persistence further confirms its likely functional role. 
Unfortunately -14011*T was not frequent enough in any one population to make this 
approach a possibility. 
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Techniques based on chromatin-immunoprecipitation such as ChIP-chip (chromatin 
immunoprecipitation coupled to microarray hybridisation) or ChIP-Seq (chromatin 
immunoprecipitation coupled to high throughput sequencing) give a better insight to 
specific transcription factor DNA targets and their networks in the intestine (reviewed 
Olsen et al. 2012) and could be useful to further examine the influence of the LCT enhancer 
alleles on transcription factor binding. 
 
Further experiments would also be necessary to investigate the interaction of the 
identified transcription factors with other factors involved in lactase expression. Previous 
studies revealed interesting results. For example was luciferase activity highest for 
constructs containing -13915*G under simultaneous over-expression of Oct-1 and HNF-ͳȽ 
but less with HNF-ͳȽ and Oct-1 alone (Enattah et al. 2008). A similar interaction of these 
two transcription factors in mediating LCT enhancer activity was previously shown for 
constructs containing the -13910C>T polymorphism (Lewinsky et al. 2005).  
 
The transcription factors predicted bioinformatically only overlap to a certain extent with 
those successful confirmed experimentally. Bioinformatic tools are useful in searching for 
candidate transcription factors for functional tests, nevertheless they have their 
limitations as most of the binding matrixes are collected from different organisms and cell 
types. However, data about transcription factor binding sites will increase dramatically in 
the next years with the application of new techniques and large scale investigations of 
functional elements in a great range of cell types in project such as ENCODE (Hoffmann et 
al. 2012), which will make predictions more accurate. 
 
During the course of this project the question was posed as to whether there were any 
other polymorphic changes (reflecting the different haplotype background of the variants) 
that might influence the level of expression in our in vitro experiments. To check this the 
sequence of the promoter used as part of the construct was reviewed in detail and was 
shown to derive from a B haplotype chromosome. It should thus be noted that only -
14028*C is tested in a construct with a promoter sequence reflecting its in vivo situation, 
with a T* allele at position 958, which is part of the B haplotype background of the variant. 
All other reporter-gene-constructs that were used to test the effect of certain enhancer 
variants were done using the same pGL3 hLPH1085 vector (Troelsen et al. 2003). Since it 
had been reported previously that this SNP alters transcription factor binding in gel shift 
assays (Hollox et al. 1999) this site was inspected bioinformatically and shown to be 
located within a predicted Oct-1 site. Experiments were therefore conducted to attempt to 
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replicate the gel shifts. These showed a gel shift which was stronger for the ancestral then 
the derived variant and could be slightly competed with Oct-1 competitor 
oligonucleotides. However, these results are only preliminary and would need further 
confirmation.  
A clear line for future research would be to analyse the possible combinatorial effect of 
this allele with the various enhancer alleles.  
 
Lactase is only fully expressed in differentiated cells and therefore the activity 
measurements of the cells harvested 9 days after transfection might better represent the 
influence of the variants. The differences in expression from 2 to 9 days for all enhancer 
variants tested show that the mean luciferase activity rises more than 2 fold from the 
undifferentiated to the differentiated cell state for these variants showing a significantly 
different expression to the ancestral variant of the enhancer. One can speculated that it is 
the ability of a variant to up-regulate expression during the differentiation process that is 
the crucial effect for lactase persistence. Unfortunately, it is not possible to study the 
maturation of cells and the influence of the lactase persistence associated alleles on 
expression during that development in vitro. Model organisms could be used to study this 
as recently done for -13910*T in mice (Fang et al. 2012). However for cost and logistic 
reasons the only practical ways to study several novel alleles is the combination of in vitro 
functional studies, as was done here. For any that are more frequent, phenotype 
association studies, perhaps in combination with mRNA expression, is highly informative 
but cannot provide direct evidence because of linkage disequilibrium
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5 Evolutionary background of LCT enhancer 
variants 
5.1 Introduction 
In chapter 3, a number of different derived enhancer variants were documented, in a large 
number of European and Asian populations. This chapter aims to combine information 
from several sources, about the common enhancer variants and determine their haplotype 
background to get a better picture about their evolution and possible signatures of 
selection in the genetic regions examined.  
 
Previous studies by different members of our group, which attempted to determine the 
core LCT haplotype background of the different LCT enhancer variants used slightly 
different combinations of genetic markers, and more limited sample sets (Ingram et al. 
2009b; Jones et al. 2013; Poulter et al. 2003). The next step in getting a better and more 
consistent picture about the haplotype background of enhancer variants would be to add 
more and missing markers and to combine more information about populations from 
Africa, Europe, the Middle East and other parts of Asia in the analysis.  
 
It is widely agreed that the lactase persistence associated alleles occur on more than one 
haplotype, which was part of the evidence that lactase persistence evolved independently 
several times (Enattah et al. 2008; Ingram 2008; Ingram et al. 2007; Tishkoff et al. 2007), 
but it is less clear whether the same mutations might have recurred. One publication 
claimed a different haplotype background for some of the -13910*T alleles in groups of 
Russia and Iran and therefore concluded that this site had mutated more than once 
(Enattah et al. 2007). It is of interest to see if there is any evidence for that from looking at 
similar extended haplotypes in a different dataset, but including Iranians, which might or 
might not support this suggestion. 
 
The B haplotype, which is quite common across the globe (Hollox et al. 2001), showed 
evidence of a frequent extended haplotype across at least 500 kb in a collaborative study 
focussing on South Asia (Gallego Romero et al. 2012), see Appendix G. My contribution to 
this work involved extracting SNP data from families of the 'Human Genome Diversity 
Panel-Centre dǯEtude du Polymorphisme Humain ' (CEPH) (Dausset et al. 1990) from 
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previous work in our lab and merging it with public data for the CEPH (CEU) samples from 
the HapMap project (http://hapmap.ncbi.nlm.nih.gov/) in order to infer which were the B 
haplotypes.  
We were curious that this haplotype was so frequent yet and did not carry any of the main 
derived lactase persistence associated alleles. Only the -14028*C variant on a high lactase 
expressing chromosome was associated with the core B haplotype (Poulter et al. 2003), 
but as seen in chapter 3 it is not frequent in any of the populations studied. This led to 
suggestions that the length of chromosome known as the B haplotype might have been 
selected for by another advantageous mutation located on this sequence.  
5.2 Chapter aims 
Thus this chapter aims to examine the extended haplotype background of the derived 
enhancer variants in this combined dataset from various geographic regions, with the 
target of obtaining further insight into the demographic history and origin of these alleles. 
I also investigate the distribution of the extended B haplotype to get insights into the 
selective or demographic explanations for its frequent appearance. I examine patterns of 
linkage disequilibrium and also test methods to detect evidence for different types of 
selection.  
5.3 Population selection 
Of the new dataset described in chapter 3, the Middle Eastern populations showed the 
most variation across the LCT enhancer region. Middle Eastern sample sets (Bedouin 
groups, Israel and Palestinian Arabs) previously analysed by our group (Ingram et al. 
2007) were also included for further analysis as well as randomly chosen samples from 
several African populations (Afar, Beni Amer, Chagga) that showed high frequencies of 
lactase persistence associated alleles (Jones 2012). Of interest were also populations 
(Asante, Chewa, Mambila, Shabo) that do not have a pastoralist lifestyle (see also chapter 
2, Table 2.2), in which enhancer variation was mainly absent (Jones 2012). 
To get a wider picture of the haplotype distribution, several European and Asian groups, 
analysed in chapter 3 were included in the sample set. 
 
To look specifically at differences between lactase persistent and non-persistent 
individuals and compare with previous findings, phenotyped samples for Europe 
(Northern Europeans and Italians) and Africa (Amhara, Oromo, Jaali) were also part of the 
dataset.  
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5.4 Sequencing/Genotyping strategy 
Five regions in and around the LCT gene were included in the initial haplotype analysis 
spanning a region of about 80 kb, as shown in Figure 5.1. 
 
 
Figure 5.1: Sequence regions and SNPs included in haplotype analysis, spanning a region of 
80kb. 
 
To obtain as much as possible of the LCT core haplotype information as described by 
Hollox (2001) the haplotype defining region upstream of LCT, called the 'hapdef' region 
within this thesis as it was in Jones et al. (2013), was sequenced and information about the 
two haplotype markers in exon 2 and exon 17 of LCT, 666 G>A and 5579 T>C mainly 
obtained via genotyping was also collected as described below. The MCM6 intron 4 region 
also described in Jones et al. (2013) was also sequenced to get haplotype information in 
relation to intron 13 of MCM6. The hapdef and intron 4 information was also used to serve 
as control regions for the enhancer to compare for diversity. Both regions are located near 
enough to the enhancer to share a similar history, with low recombination between them 
and little difference in mutation rates (Jones et al. 2013). 
 
All sequencing data used in this chapter that formed part of previous projects of the group 
were re-analysed and sequencing repeated to get complete datasets, for example to extend 
the LCT enhancer region further 3', or if readable sequences were not found. All Middle 
Eastern samples analysed by Kate Ingram (Ingram et al. 2007) and those of chapter 3, the 
European and Asian groups with complete enhancer data were sequenced for the MCM6 
intron 4 and LCT hapdef regions specifically for this project. Additional samples of the 
Saudi Bedouins were included as well and sequenced for all regions. 
 
The hapdef sequence region upstream of the LCT promoter spans 701 bp 
(Chr2:136595212-136595912, GRCh37/hg19). This region was successfully amplified 
with primers applied previously (Jones et al. 2013) and sequences were readable for all 
samples from bp position -1100 until -630 from the start of transcription of LCT. An InDel 
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at the 3' end of the sequence and the consequent need for a different internal sequencing 
primer restricted the length of evaluable sequence region. The control region of MCM6 
intron 4 covers a 683 bp region (chr2:136624515-136625197, GRCh37/hg19) and 
sequences were readable from bp position -30292 to -29922 upstream of the LCT 
transcription start. The sequences for the LCT enhancer region were obtained as described 
in chapter 3.  
The haplotype markers 666 G>A and 5579 T>C were part of the marker set (see below), 
genotyped by LGC Genomics (KBioscience). The regions of exon 2 and 17 of LCT were also 
subjected to sequencing for a subset of the Middle Eastern samples within an 
undergraduate project of Lana Couzens (Couzens 2011). These data were used to 
crosscheck for quality of the genotype data delivered by LGC Genomics and to complement 
missing data. 
Details about all primer sequences can be found in Table 2.3 of chapter 2. 
5.4.1 Marker selection for extended haplotype analysis 
Markers for extended haplotype analysis were chosen to span a sequence region of about 
1.8 Mb around LCT. Certain criteria were deployed to get an informative marker selection. 
All SNPs are part of the Illumina 650k platform typed for most of the HapMap populations 
but also used for the haplotype analysis in our recently published paper about Indian and 
European cattle herders (Gallego Romero et al. 2012). With the haplotype information of 
these data it was possible to exclude close SNPs in complete LD with each other. To further 
guide the choice of markers LDU maps were constructed (see below, 5.5.8.3), that were 
particularly useful in the region downstream of LCT where there is a long region of very 
high LD between the genes R3HDM1and RAB3GAP1. 
 
The first set of markers was chosen to be broadly 50 kb apart, with the distance increasing 
for the outer SNPs, to have a minor allele frequency of at least about 8% and to be as 
different as possible in frequency between the CEPH (European), Yoruban and Han-
Chinese HapMap populations. Downstream of LCT the region was extended up to about 
position 135.8 Mb (b37, hg 19) on chromosome 2 to include the region where a sharp 
drop in extended haplotype homozygosity (EHH) was seen in European and Asian 
populations (Gallego Romero et al. 2012). Later the LCT haplotype SNPs 666 G>A 
(rs3754689) and 5579 C>T (rs2278544) were also included, as well as the lactase 
persistence associated SNP 22kb upstream of LCT (-22018 G>A, rs182549). 
The chromosomal location and further information about the 36 SNPs chosen can be 
found in Figure 5.2 and Table 5.1. 
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Figure 5.2: Location of the SNPs chosen for extended haplotype analysis. The broad position 
on chromosome 2 of all SNPs is indicated by arrows. The picture shows all genes documented 
on Ensembl for the chosen region and their position in chromosomal+ direction (b37), taken and 
modified from the Ensembl website (http://www.ensembl.org). Note that LCT and MCM6 are 
transcribed from the chromosomal negative strand accounting for the location of LCT (highlighted 
in green) on the left of MCM6. 
 
Table 5.1: Chromosomal location and allelic information about all 36 SNPs chosen for 
extended haplotype analysis. 
 
  Position on Chromosome Dist. SNP Anc. MAF MAF in HapMap pop. 
No. SNP b36 (Kb) b37 (kb) (kb) (Chr +) allele 1000 genomes CEU YRI CHB 
                    
1 rs1446525 135354.317 135637.847   A/G A G = 0.288/629 0.60 0.16 0.07 
2 rs4954209 135454.378 135737.908 100 G/T T T = 0.348/761 0.18 0.37 0.62 
3 rs2874739 135535.377 135818.907 81 C/T T T = 0.347/757 0.12 0.75 0.20 
4 rs1869829 135594.032 135877.562 59 A/G G A = 0.385/840 0.81 0.02 0.38 
5 rs2305248 135644.782 135928.312 51 A/G G G = 0.343/748 0.12 0.74 0.20 
6 rs1900741 135718.970 136002.500 74 C/T T C = 0.431/941 0.91 0.25 0.14 
7 rs1561277 135808.531 136092.061 90 A/C A C = 0.264/577 0.74 1.00 1.00 
8 rs9798267 135846.261 136129.791 38 A/G A G = 0.277/604 0.08 0.66 0.15 
9 rs6709132 135949.042 136232.572 103 A/G G G = 0.211/460 0.08 0.31 0.15 
10 rs3806502 136004.743 136288.273 56 C/T T T = 0.327/714 0.12 0.76 0.15 
11 rs4954265 136040.695 136324.225 36 A/G G G = 0.270/590 0.06 0.67 0.15 
12 rs961360 136110.128 136393.658 69 A/G A G = 0.315/687 0.08 0.30 0.43 
13 rs4954278 136124.761 136408.291 15 C/T C T = 0.181/396 0.08 0.38 0.15 
14 rs6430585 136223.397 136506.927 99 A/C C A = 0.292/637 0.14 0.30 0.22 
15 rs10188066 136255.983 136539.513 33 A/G G G = 0.455/993 0.17 0.79 0.34 
16 rs2278544 136262.580 136546.110 7 A/G A G = 0.492/1074 0.82 0.21 0.40 
17 rs2304370 136278.205 136561.735 16 A/G G A = 0.254/555 0.11 0.38 0.20 
18 rs3754689 136307.216 136590.746 29 C/T C T = 0.339/740 0.09 0.49 0.41 
19 rs182549 136333.224 136616.754 26 C/T C T = 0.234/510 - - - 
20 rs309152 136373.722 136657.252 40 A/G G G = 0.321/702 0.08 0.44 0.42 
21 rs6430594 136435.643 136719.173 62 A/G A G = 0.198/432 0.09 0.09 0.16 
22 rs309137 136482.421 136765.951 47 C/T C T = 0.376/821 0.79 0.02 0.35 
23 rs2090660 136535.189 136818.719 53 C/T C T = 0.269/588 0.20 0.11 0.23 
24 rs6430600 136552.835 136836.365 18 A/G A A = 0.343/749 0.29 0.62 0.19 
25 rs12691874 136596.944 136880.474 44 A/G G A = 0.339/740 0.60 0.10 0.19 
26 rs953387 136623.640 136907.170 27 A/C A T = 0.460/1004 0.71 0.56 0.16 
27 rs1016269 136657.132 136940.662 33 A/G G A = 0.279/610 0.17 0.24 0.38 
28 rs7371043 136693.406 136976.936 36 C/T T T = 0.158/344 0.08 0.18 0.30 
29 rs4074120 136743.057 137026.587 50 C/T T C = 0.371/810 0.20 0.28 0.51 
30 rs12465599 136791.320 137074.850 48 A/G G G = 0.439/958 0.61 0.55 0.27 
31 rs6715450 136838.201 137121.731 47 A/G A A = 0.346/756 0.27 0.35 0.40 
32 rs543721 136878.027 137161.557 40 G/T G T = 0.411/897 0.37 0.26 0.58 
33 rs12618749 136921.944 137205.474 44 C/T C T = 0.228/497 0.09 0.20 0.41 
34 rs16834591 136979.740 137263.270 58 A/G A A = 0.260/567 0.09 0.31 0.37 
35 rs580879 137030.609 137314.139 51 C/T T T = 0.257/562 0.19 0.53 0.14 
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36 rs6711718 137123.482 137407.012 93 C/T T C = 0.451/985 0.50 0.48 0.20 
           
5.5 Results 
5.5.1 Distribution of the variation of LCT enhancer and flanking regions in a 
combined population set 
Full data for the three sequenced regions (intron 4 and intron 13 of MCM6 and the 
haplotype defining region hapdef of the LCT promoter) and the additional two haplotype 
markers 666 G>A and 5579 T>C were obtained from a final dataset of 872 samples. This 
sample set also contained 7 single individuals from different sample groups with rare 
enhancer SNPs, which were included in later haplotype analyses. 865 samples belonging 
to 28 populations were analysed with the Arlequin software and all variants were 
checked, in each of the 28 populations, for deviation from HWE, mainly to reassure the 
exclusion of sampling bias and genotyping problems. Only in four populations was a 
borderline p-value observed for single SNPs, which did not remain significant after 
Bonferroni correction for 28 tests.  
Table 5.2 toTable 5.4 summarise the allele frequencies for the SNPs within the three 
sequenced regions and the two haplotype SNPs for the 28 populations. 
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Table 5.2: Allele frequencies for the SNPs in the MCM6 intron 4 region in the combined sample set of 28 populations, N: Number of chromosomes. 
 
   
  rs1435577 - - rs56263017 - - rs4988172 
Region Country  Populations N -30210 G>C -30203 G>Del  -30196 A>G -30182 A>G -30160 A>T -30071/70 TC>AA -29949 G>C 
   
  
       Africa Cameroon Mambila 40 0.950 - - 0.200 - - 0.075 
  Ethiopia Afar 124 0.677 - - 0.242 - - - 
  
 
Amhara 80 0.588 0.025 - 0.250 - - - 
  
 
Oromo 124 0.500 - - 0.210 - - 0.024 
  
 
Shabo 44 0.841 - 0.023 0.318 0.091 - 0.159 
  Ghana Asante 40 0.825 - - 0.200 - - 0.175 
  Malawi Chewa 40 0.875 - - 0.350 - 0.025 0.150 
  Sudan Beni Amer 130 0.800 - - 0.346 - 0.008 0.008 
  
 
Jaali 76 0.750 - - 0.329 - - 0.026 
  Tanzania Chagga 82 0.646 - - 0.159 - - 0.110 
Central Asia Mongolia Khalka 38 0.789 - - 0.132 - - 0.053 
  Nepal Tharu 40 0.750 - - 0.125 0.025 - 0.050 
Europe 
 
Northern Europeans 40 0.900 - - 0.125 - - 0.050 
 
Italy Italians 32 0.656 - - 0.219 0.063 - 0.063 
 
Norway Norwegians 40 0.975 - - 0.100 - - - 
  Romania Romanians 40 0.675 - - 0.275 0.025 - 0.025 
  Ukraine Ukrainians 40 0.675 - - 0.075 - - 0.125 
Middle East Iran Iranians 78 0.579 - - 0.355 0.026 - 0.026 
  Israel Israeli Arabs 40 0.575 - - 0.200 0.075 0.025 0.050 
  
 
Israeli Bedouin 32 0.719 - - 0.375 - - 0.063 
  
 
Palestinians 38 0.632 - 0.026 0.316 - 0.026 0.105 
  Jordan Jordanian Bedouin 44 0.682 - - 0.409 - - - 
  Kuwait Kuwaiti 62 0.714 - - 0.519 - - 0.018 
  Saudi Arabia Saudi Bedouin 40 0.725 - - 0.500 - - - 
  Syria Syrians 82 0.512 - - 0.232 - - 0.037 
  Turkey Anatolian-Turks 40 0.500 - - 0.200 0.050 - 0.125 
  Yemen Yemeni Hadramaut 156 0.756 0.013 - 0.467 0.006 - 0.026 
    Yemeni Sena 68 0.853 - - 0.382 0.074 - 0.060 
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Table 5.3: Allele frequencies for the SNPs in the LCT 'hapdef’ region and two haplotype markers in the combined sample set of 28 populations, N: Number 
of chromosomes. 
 
    
rs56064699 
 
rs148142676 
 
rs78205226 
  
rs56211644 rs3754689 rs2278544 
Region Country  Populations N -958 C>T -943 C>G -943/42 TC>Del -931 T>C -875 G>A -815 A>G -811 A>G -678 A>G 666 G>A 5579 T>C 
   
  
          Africa Cameroon Mambila 40 - - 0.525 - - - - 0.200 0.575 0.325 
  Ethiopia Afar 124 0.290 - 0.040 - - - - 0.242 0.363 0.351 
  
 
Amhara 80 0.388 - 0.063 - - - - 0.238 0.500 0.171 
  
 
Oromo 124 0.452 - 0.113 - 0.008 0.008 - 0.205 0.607 0.237 
  
 
Shabo 44 0.024 - 0.167 - - - - 0.333 0.295 0.432 
  Ghana Asante 40 0.100 - 0.350 - - - - 0.200 0.500 0.325 
  Malawi Chewa 40 0.025 - 0.300 - - - - 0.375 0.425 0.300 
  Sudan Beni Amer 130 0.138 - 0.146 - - - 0.015 0.362 0.346 0.349 
  
 
Jaali 76 0.211 - 0.132 - 0.026 - - 0.329 0.382 0.276 
  Tanzania Chagga 82 0.098 - 0.341 - - - - 0.159 0.695 0.200 
Central Asia Mongolia Khalka 38 0.211 - 0.211 - - - - 0.132 0.375 0.500 
  Nepal Tharu 40 0.289 0.026 0.289 - - - - 0.118 0.600 0.300 
Europe 
 
Northern Europeans 40 0.100 - - - - - - 0.100 0.111 0.789 
  Italy Italians 32 0.313 - - - 0.063 - - 0.250 0.333 0.467 
  Norway Norwegians 40 0.025 - - - - - - 0.100 0.025 0.875 
  Romania Romanians 40 0.325 - - - 0.100 - - 0.225 0.325 0.500 
  Ukraine Ukrainians 40 0.325 - - - 0.025 - - 0.075 0.316 0.600 
Middle East Iran Iranians 78 0.410 - - - 0.013 - - 0.308 0.410 0.333 
  Israel Israeli Arabs 40 0.400 - 0.025 - - - - 0.200 0.450 0.400 
  
 
Israeli Bedouin 32 0.250 - 0.031 - - - - 0.375 0.313 0.313 
  
 
Palestinians 38 0.342 - 0.053 - 0.026 - - 0.237 0.421 0.306 
  Jordan Jordanian Bedouin 44 0.318 - - - 0.068 - - 0.409 0.341 0.250 
  Kuwait Kuwaiti 62 0.293 - 0.067 - 0.019 - - 0.481 0.397 0.172 
  Saudi Arabia Saudi Bedouin 40 0.250 - 0.050 - - - - 0.475 0.316 0.200 
  Syria Syrians 82 0.488 0.012 - - 0.037 - - 0.220 0.488 0.408 
  Turkey Anatolian-Turks 40 0.450 - - - 0.025 - - 0.225 0.450 0.425 
  Yemen Yemeni Hadramaut 156 0.237 - 0.064 0.013 0.038 - - 0.436 0.314 0.264 
    Yemeni Sena 68 0.152 - 0.015 - - - - 0.333 0.152 0.438 
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Table 5.4: Allele frequencies for the SNPs in the LCT enhancer region in the combined sample set of 28 populations, N: Number of chromosomes. 
 
 
  - rs4988233 rs145946881 ss820486563 ss820496524 rs41380347 rs41456145 rs4988235 rs41525747 ss820496565 rs144412793 - - rs4954492 rs56348046 rs4954490 
Populations N 
-14028 
T>C 
-14011 
C>T 
-14010 
G>C 
-14009 
T>G 
-13957 
A>G 
-13915 
T>G 
-13913 
T>C 
-13910 
C>T 
-13907 
C>G 
-13806 
A>G 
-13800 
G>T 
-13779 
G>C 
-13744 
C>G 
-13730 
T>G 
-13603 
C>T 
-13495 
C>T 
 
  
                Mambila 40 - - - - - - - - - - - - - 0.075 0.050 0.125 
Afar 124 - - - 0.008 0.008 0.185 0.008 - 0.274 0.032 - - - 0.040 - 0.360 
Amhara 80 - - - 0.038 - 0.050 0.013 - 0.025 0.025 - - - 0.050 - 0.241 
Oromo 124 - - 0.008 0.024 - 0.145 0.016 - 0.048 0.032 - - - 0.024 0.025 0.162 
Shabo 44 - - - - 0.023 - - - - - 0.023 - - 0.023 - 0.114 
Asante 40 - - - - - - - - - - - - - 0.075 - 0.075 
Chewa 40 - - - - - - - - - - - - - 0.025 0.025 0.125 
Beni Amer 130 - - - 0.138 - 0.262 - - 0.169 - - - - 0.047 - 0.230 
Jaali 76 - - - 0.092 - 0.197 0.013 0.013 0.013 - - - - 0.079 0.039 0.172 
Chagga 82 - - 0.146 - - - - - - - 0.012 - - 0.061 - 0.063 
Khalka 38 - 0.026 - - - - - 0.026 - - - - - - - 0.421 
Tharu 40 - - - - - - - 0.075 - - - - - - - 0.211 
Northern Europeans 40 0.025 - - - - - - 0.650 - - - - - - - 0.737 
Italians 32 - 0.031 - - - - - 0.031 - - - - - - - 0.344 
Norwegians 40 - - - - - - - 0.850 - - - - - - - 0.875 
Romanians 40 - - - - - - - 0.150 - - - - - - - 0.200 
Ukrainians 40 - 0.025 - - - - - 0.300 - - - - - - - 0.444 
Iranians 78 - 0.013 - - - - - 0.026 - - - - - - - 0.231 
Israeli Arabs 40 - - - 0.025 - 0.025 0.050 0.025 - 0.025 - - - 0.025 - 0.200 
Israeli Bedouin 32 - - - - - 0.188 - 0.031 - - - - - 0.031 0.031 0.219 
Palestinians 38 - - - - - 0.026 - 0.026 - - - - - - - 0.237 
Jordanian Bedouin 44 - - - - - 0.386 - 0.068 - - - - - - 0.114 0.273 
Kuwaiti 62 - - - 0.016 - 0.267 - 0.032 - - - - - 0.016 0.016 0.133 
Saudi Bedouin 40 - 0.025 - - - 0.450 0.025 - - - - - - 0.025 - 0.150 
Syrians 82 - - - - - 0.037 - - - - - - - - - 0.244 
Anatolian-Turks 40 - - - - - - - 0.075 - - - - - - - 0.125 
Yemeni Hadramaut 156 - - 0.006 - - 0.237 - 0.019 0.013 0.006 - 0.032 0.006 0.006 - 0.221 
Yemeni Sena 68 - - - - - 0.294 - 0.147 - - - - 0.059 0.029 0.059 0.294 
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5.5.2 Population differentiation 
Pairwise FST values were calculated in Arlequin with genotype data for the three 
sequenced regions and the 2 additional haplotype SNPs. Genotype data for the variant at 
 -13495 were excluded because of too much missing data. Genetic distances between 
populations are visualised in the PCO plot of Figure 5.3, which shows the first two 
coordinates as calculated in R. 
 
The Northern European populations are displaced to the right, whereas all other 
populations are clustered closer together to the left. The Middle Eastern populations are 
seen together with the Ethiopian and Sudanese samples in the upper part of the cluster. 
The Asante, Chewa, Chagga and Mambila, which are geographically more distant from 
Ethiopia and Sudan are located away from the other African populations in the lower part 
of the plot. 
 
Figure 5.3: Principal co-ordinates plot of genetic distances between populations from 
pairwise FST values calculated from genotype data of LCT enhancer and the flanking regions. 
Populations included: 1: Anatolian-Turks, 2: Afar, 3: Shabo, 4: Amhara, 5: Oromo, 6: Asante, 7: Saudi 
Bedouin, 8: Italians, 9: Israeli Arabs, 10: Israeli Bedouin, 11:Iranians, 12: Jordanian Bedouin, 13: 
Kuwaiti, 14: Northern Europeans, 15: Chewa, 16: Khalka, 17: Norwegians, 18: Palestinians, 19: 
Romanians, 20: Beni Amer, 21: Jaali, 22: Syrians, 23: Mambila, 24: Chagga, 25: Tharu, 26: 
Ukrainians, 27: Yemeni Hadramaut, 28:Yemeni Sena. Colour code: red: European, green: Central 
Asian, blue: Middle Eastern, yellow: African populations. 
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5.5.3 Molecular diversity and neutrality tests 
Diversity and neutrality measures were calculated using DnaSP with haplotype 
information of 855 individuals of 28 populations inferred by PHASE (see 5.5.4 below). A 
combined sequence of the readable sequence parts of 3 regions was compared: 371 bp of 
MCM6 intron 4, 559 bp of the LCT enhancer region in intron 13 of MCM6 and 471 bp of the 
haplotype defining region (hapdef) upstream of LCT.  
 
Table 5.5: Haplotype diversity measures for 28 populations across the two control regions 
and the LCT enhancer. N: number of chromosomes, Comp.: Graphic comparison of the 
regions shows the values for haplotype diversity (Neis'H) for all populations examined. 
For this analysis -13945 C>T was included as it was possible to infer missing data at that 
position with PHASE. As previously shown in Jones (2012) but with a shorter enhancer 
sequence which notably excludes -13495, the non milk drinking African groups (Asante, 
Chewa, Mambila and Shabo) have a lower heterozygosity level across the enhancer 
compared to the two flanking regions. However lower heterozygosity of the enhancer can 
be also seen in some of the European and Asian and Middle Eastern groups as Italians, 
Romanians, Tharu, Anatolian Turks, Israeli Arabs, Palestinians and Syrians. 
 
A full table with all diversity measures and outcomes of neutrality tests can be found in 
Appendix C1. Significant values for deviation from neutrality were only obtained for the 
Israeli Arabs for the enhancer region and the Jordanian Bedouins for the whole sequence 
for Fu and Li's F statistic and the Yemen Sena for Fu and Li's D for the whole sequence. It is 
noticeable that values for Tajima's D are usually much lower (although not significantly) in 
the enhancer than the two flanking regions, except in some European populations such as 
the Norwegians, Northern Europeans, Ukrainians and Romanians, and also the Beni Amer 
of Africa. 
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Table 5.5: Haplotype diversity measures for 28 populations across the two control regions 
and the LCT enhancer. N: number of chromosomes, Comp.: Graphic comparison of the regions. 
 
 
 
 
The comparison of haplotype diversity between lactose digesters and non-digesters of 
European and African populations shows a clear difference between these populations as 
well as between the three sequence regions in phenotyped Ethiopians that we have 
published so far (Jones et al. 2013). Whereas heterozygosity is reduced across the LCT 
enhancer compared to the flanking regions in the non-digester Ethiopian groups, as 
previously reported, it is not different for the Europeans. Furthermore, compared to 
Africans groups, which show similar diversity in the digesters and non digesters, the 
Europeans show a higher diversity of the flanking regions in the non-digesters than in the 
digesters (see Appendix C1). This difference in pattern seems to reflect the two different 
types of selection acting on that region.  
Region Population N Intron 4 Enhancer Hapdef Comp.
Africa Afar 124 0.653 (0.000) 0.754 (0.000) 0.644 (0.000)
Amhara 80 0.662 (0.000) 0.600 (0.003) 0.661 (0.003)
Asante 40 0.714 (0.002) 0.273 (0.008) 0.472 (0.006)
Beni  Amer 128 0.654 (0.000) 0.786 (0.000) 0.612 (0.001)
Chagga 82 0.703 (0.001) 0.459 (0.004) 0.417 (0.004)
Chewa 40 0.733 (0.001) 0.273 (0.008) 0.512 (0.002)
Jaa l i 76 0.682 (0.000) 0.752 (0.001) 0.654 (0.001)
Mambi la 40 0.509 (0.006) 0.355 (0.008) 0.328 (0.006)
Oromo 124 0.643 (0.001) 0.598 (0.002) 0.655 (0.000)
Shabo 42 0.791 (0.001) 0.297 (0.007) 0.487 (0.003)
Centra l  As ia Khalka 38 0.585 (0.005) 0.542 (0.003) 0.519 (0.006)
Tharu 36 0.668 (0.003) 0.341 (0.009) 0.595 (0.003)
Europe Ita l ians 32 0.752 (0.001) 0.504 (0.006) 0.702 (0.002)
N. Europeans 40 0.458 (0.008) 0.522 (0.005) 0.349 (0.008)
Norwegians 40 0.229 (0.007) 0.268 (0.007) 0.229 (0.007)
Romanians 40 0.713 (0.001) 0.344 (0.007) 0.704 (0.002)
Ukra inians 40 0.664 (0.002) 0.627 (0.003) 0.558 (0.004)
Middle East Anatol ian Turks 40 0.694 (0.003) 0.232 (0.007) 0.679 (0.001)
Iranians 76 0.675 (0.001) 0.362 (0.003) 0.674 (0.000)
Is rael i  Arabs 40 0.736 (0.002) 0.555 (0.007) 0.656 (0.001)
Is rael i  Bedouin 32 0.720 (0.001) 0.641 (0.006) 0.677 (0.001)
Jordanian Bedouin 44 0.672 (0.001) 0.725 (0.002) 0.707 (0.001)
Kuwaiti 56 0.647 (0.002) 0.639 (0.003) 0.662 (0.001)
Palestinians 38 0.758 (0.001) 0.422 (0.007) 0.684 (0.001)
Saudi  Bedouin 40 0.640 (0.002) 0.674 (0.002) 0.653 (0.001)
Syrians 82 0.656 (0.001) 0.427 (0.002) 0.680 (0.001)
Yemeni  Hadramaut 154 0.660 (0.000) 0.675 (0.001) 0.680 (0.000)
Yemeni  Sena 66 0.716 (0.001) 0.770 (0.001) 0.610 (0.001)
Haplotype diversity (Neis'H) (± SD)
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The greater haplotype diversity of the enhancer in the digester Africans than in the non-
digesters, is likely to be caused by the co-occurrence of several functional alleles in the 
digesters due probably to their co-selection (so-called soft selective sweep) but could 
possibly be due to a reduction in purifying selection. The lower haplotype diversity in the 
regions flanking the enhancer in the European lactose digesters as compared with the 
non-digesters instead reflects the much talked about 'hard' selective sweep, caused by 
increased homozygosity of the extended haplotype carrying the single selected mutation. 
A full table with results of neutrality tests and diversity measures compared between 
digesters and non-digesters can be found in Appendix C2. 
 
5.5.4 Haplotype analysis of the LCT enhancer and flanking regions 
Haplotypes were reconstructed with PHASE from the combined genotype data for the tree 
sequencing regions (intron 4 and intron 13 of MCM6 and the hapdef region of the LCT 
promoter) and the two additional haplotype markers 666 G>A and 5579 T>C, spanning a 
region of about 80 kb, see Figure 5.4. Positions with alleles occurring only once, as well as 
samples with missing data at more than 4 of the remaining 31 positions were excluded 
from the PHASE analysis. This left 862 individuals for haplotype analysis, including 7 
individuals carrying rare alleles (-14028*C, -14011*T and-13914*A) who were selected for 
inclusion and did not strictly belong to any of the 28 population samples. 
 
 
Figure 5.4: Variants included in haplotype analysis of the 80 kb region and their position in 
relation to the sequenced regions. 
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Eight of the 11 core haplotype markers, previously defined by Hollox et al. (2001), were 
used to define the LCT haplotype background. One of the set of markers was also the SNP 
at -946 A>G, but as all samples were homozygous A at that position this was not included 
in PHASE analysis. The haplotypes inferred by PHASE, especially the rarer ones, were 
inspected by eye for anomalies and obvious wrong assignments, which left 76 haplotypes 
(HT) for further analysis. Common haplotypes, linked to the LCT core haplotypes, are 
shown in Table 5.6 and the appearance of the most frequent haplotypes in the populations 
tested is shown in Table 5.7.  
 
The most frequent haplotype found in this Ǯglobalǯ population is that previously described 
as B (HT 71 containing -30210*C, which does not carry any derived enhancer allele). The B 
haplotype is relatively frequent across all four geographic regions but most frequent in the 
Middle East and Asia and the Afro-Asiatic speaking African groups tested (see Figure 5.5 
and Table 5.7). The C haplotype containing the derived allele -13915*G (HT 56, -13915*G, -
30182*G) is most common in the Saudi and Jordanian Bedouin and only found in the 
Middle East, Ethiopia and Sudan whereas the ancestral C haplotype (HT 43, -30182*G) is 
present in all populations with highest frequencies in the Shabo and Chewa. The ancestral 
A haplotype (HT 10) carrying the -13495*T allele can be also found across all populations 
and is most frequent in the Khalka of Mongolia. As expected the -13910*T carrying A 
haplotype (HT 24, -13910*T, -13495*T) is most prevalent in the Northern Europeans but 
also present in other European, Asian and Middle Eastern populations, except the Saudi 
Bedouin and Syrians. In the Africans in this dataset it can be only found in the Jaali, 
whereas the -13907*G carrying A haplotype (HT 21, -13907*G, -13495*T) is restricted to 
the Afro-Asiatic speaking African populations and the Yemeni from Hadramaut. 
 
152 
Table 5.6: Inferred haplotypes by PHASE. Low frequency haplotypes (<5) are not shown. Haplotypes in bold are the most probable equivalents (Hollox et al. 
2001). N: number of chromosomes. The colour scheme is consistent with the pie charts and network diagram below. 
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71 C . . . . . . . . . . . . . . . . . . . . . T . . . . . . A . 388 B, G 
56 . . . G . . . . . . . G . . . . . . . . . . . . . . . . G . . 204 C, M, j, k 
43 . . . G . . . . . . . . . . . . . . . . . . . . . . . . G . . 200 C, M, j, k 
10 . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . C 173 A, J 
24 . . . . . . . . . . . . . T . . . . . . . T . . . . . . . . C 110 A, J 
7 . . . . . . . . . . . . . . . . . . . . . . . 2 . . . . . A . 83 O, S, U, f, g, p 
21 . . . . . . . . . . . . . . G . . . . . . T . . . . . . . . C 63 A, J 
31 . . . . . . C . . . . . . . . . . . . . . . . . . . . . . . C 56 A, J 
66 C . . . . . . . . . . . . . . . . . . . . . . . . . . . . A . 48 P, W, Y 
17 . . . . . . . . . . . . . . . . . . . G . . . . . . . . . . . 41 H, K, Q, Z 
26 . . . . . . . . . . G . . . . . . . . . . . . 2 . . . . . A C 33 X, m, n 
6 . . . . . . . . . . . . . . . . . . . . . . . 2 . . . . . A C 30 X, m, n 
42 . . . G . . . . . . . . . . . . . . . . . . . . . . . . G . C 27 E 
75 C . . . . . . . . . . . . . . . . . . . . . T . . A . . . A . 26 D 
15 . . . . . . . . . . . . . . . . . . . . T T . . . . . . . . C 19 A, J 
37 . . . . T . . . . . . . . . . . . . . . . . . . . . . . . . C 19 A, J 
11 . . . . . . . . . . . . . . . . . . . . . T . . . . . . . . . 17 H, K, Q, Z 
82 C . . . . . . . . C . . . . . . . . . . . . . . . . . . . A . 14 P, W, Y 
49 . . . G . . . . . . . . . . . . . . . . . T . . . . . . . . C 14 A, J 
33 . . . . . . C . . . . . . . . . . . . . . . . 2 . . . . . A C 14 X, m, n 
70 C . . . . . . . . . . . . . . . . . . . . . T . . . . . . A C 13 F, I 
53 . . . G . . . . . . . . . . . G . . . . . . . . . . . . G . . 12 C, M, j, k 
2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C 10 A, J 
80 C . . . . . . . . . . . C . . . . . . . . . T . . . . . . A . 8 B, G 
12 . . . . . . . . . . . . . . . . . . . . . T . . . . . . . A . 6 P, W, Y 
30 . . . . . . . . T . . . . . . . . . . . . T . . . . . . . . C 6 A, J 
52 . . . G . . . . . . . . . . . . . C . . . . . . . . . . G . . 5 C, M, j, k 
34 . . . . . . C . . . . . . . . . . . . . . . . 2 . . . . . A . 5 O, S, U, f, g, p 
41 . . . G . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 H, K, Q, Z 
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Table 5.7: Distribution of the most common haplotypes across 28 populations studied. Abbreviations for language families: NC: Niger-Congo, AA: Afro-
Asiatic, NS: Nilo-Saharan, A: Altaic, IE: Indo-European. N: Number of chromosomes. 
    
  71 56 43 10 24 7 21 31 66 17 26 6 
Region Country  Populations 
Lang. 
family N (B,G) 
(C, M, j, k) 
-30182*G, 
-13915*G 
(C, M, j, k) 
-30182*G 
(A, J)  
-13495*T 
(A,J)  
-13910*T,  
-13495*T 
(O, S, U, f, 
g, p) 
(A,J)  
-13907*G, 
-13495*T 
(A,J)  
-29949*C 
(P, W, Y)  
-30210*C 
(H, K, Q, 
Z) 
 -13730*G 
(X, m, n)  
-14009*G (X, m, n) 
                                  
Africa Cameroon Mambila NC 40 - - 0.200 0.075 - 0.325 - 0.025 0.050 0.075 - 0.150 
  Ethiopia Afar AA 124 0.274 0.185 0.024 0.065 - 0.024 0.242 - 0.032 0.032 0.008 0.008 
  
 
Amhara AA 80 0.375 0.050 0.138 0.125 - 0.013 0.025 - 0.025 0.050 0.038 0.013 
  
 
Oromo AA 124 0.403 0.145 0.024 0.065 - 0.032 0.048 0.024 0.032 0.024 0.024 0.032 
  
 
Shabo NS 42 0.024 - 0.310 0.071 - 0.071 - 0.143 0.071 0.024 - 0.071 
  Ghana Asante NC 40 0.100 - 0.175 0.075 - 0.175 - 0.075 0.075 0.075 - 0.050 
  Malawi Chewa NC 40 0.025 - 0.325 0.100 - 0.125 - 0.050 0.100 0.025 - 0.075 
  Sudan BeniAmer AA 128 0.125 0.266 0.078 0.047 - - 0.172 0.008 0.063 0.039 0.133 0.008 
  
 
Jaali AA 76 0.171 0.197 0.118 0.053 0.013 0.013 0.013 0.026 0.039 0.079 0.092 0.026 
  Tanzania Chagga NC 82 0.085 - 0.146 0.049 - 0.195 - 0.037 0.110 0.049 - 0.049 
Central  Mongolia Khalka A 38 0.211 - 0.105 0.342 0.026 0.211 - 0.026 - - - - 
Asia Nepal Tharu IE 36 0.250 - 0.111 0.111 0.083 0.278 - 0.056 - - - - 
Europe 
 
N. Europeans IE 40 0.075 - 0.075 0.050 0.650 - - 0.025 - - - - 
  Italy Italians IE 32 0.219 - 0.156 0.219 0.031 - - 0.063 - - - - 
  Norway Norwegians IE 40 0.025 - 0.100 0.025 0.850 - - - - - - - 
  Romania Romanians IE 40 0.225 - 0.150 0.050 0.150 - - 0.025 - - - - 
  Ukraine Ukrainians IE 40 0.300 - 0.075 0.150 0.300 - - 0.125 - - - - 
Middle  Iran Iranians IE 76 0.395 - 0.263 0.145 0.026 - - 0.026 - - - - 
East Israel Israeli Arabs AA 40 0.325 0.025 0.100 0.175 0.025 - - 0.050 0.025 0.025 0.025 - 
  
 
Israeli Bedouin AA 32 0.250 0.188 0.125 0.125 0.031 0.031 - 0.063 0.031 0.031 - - 
  
 
Palestinians AA 38 0.316 0.026 0.105 0.158 0.026 0.026 - 0.105 0.026 - - - 
  Jordan Jordanian Bedouin AA 44 0.250 0.386 0.023 0.068 0.068 - - - - - - - 
  Kuwait Kuwaiti AA 56 0.268 0.268 0.161 0.054 0.036 0.036 - - - 0.018 0.018 - 
  Saudi Arabia Saudi Bedouin AA 40 0.150 0.425 0.050 0.100 - 0.025 - - 0.050 0.025 - 0.025 
  Syria Syrians AA 82 0.390 0.037 0.122 0.232 - - - 0.024 - - - - 
  Turkey AnatolianTurks A 40 0.375 - 0.150 0.050 0.075 - - 0.125 - - - - 
  Yemen Yemeni Hadramaut AA 154 0.182 0.234 0.117 0.136 0.019 0.045 0.013 0.013 0.006 0.006 - 0.006 
    Yemeni Sena AA 66 0.152 0.212 0.061 0.076 0.136 - - 0.061 - 0.030 - 0.015 
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Figure 5.5: Distribution of haplotypes in Africa, Europe, Middle East and Central Asia (within the map) as well as haplotype distribution, classified by 
language groups. N: Number of chromosomes. Derived enhancer alleles and most probable haplotypes are shown in bold. The colour scheme broadly corresponds 
to that used in Table 5.6.
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5.5.5 Haplotype association of derived LCT enhancer alleles 
Table 5.6 and Table 5.8 show the relationship of the derived LCT enhancer alleles to their 
haplotype background and to the most common 80 kb haplotypes investigated. Consistent 
with previous studies (Bersaglieri et al. 2004; Coelho et al. 2005; Mulcare 2006; Poulter et 
al. 2003) nearly all -13910*T alleles were on the same 80 kb A haplotype (HT 24, -13910*T, 
-13495*T). Only one *T allele resided on a P haplotype (or W, Y), which is most likely 
caused by a recombination event between the hapdef region (-678 A>G) and exon 2 (666 
G>A) of LCT, as the haplotype is the same as HT 24 (A, -13910*T, -13495*T) up to position -
678, as indicated in Table 5.8. Myles et al. (2005) found 8 similar cases in Moroccan and 
Algerian Berber populations. 
 
With the combination of markers used in this thesis it was possible to distinguish between 
B and P haplotypes and to re-evaluate the occurrence of -14010*C in the previously 
investigated African samples (Ingram et al. 2009b), as also shown in Jones et al. (2013), 
and include a further 11 cases. -14010*C exclusively lies on a P haplotype (HT 82) 
background.  
 
The vast majority of -13915*G alleles have the C haplotype as background (HT 56), which 
also seems to provide the background for the newly discovered rarer variant -13944*G 
(HT 59). However in 3 cases -13915*G was found on other haplotypes (E, H and L, as 
shown in Table 5.8).  
 
Except for three alleles on the ancestral haplotype H, -13907*G is located on an A 
haplotype background (HT 21), as is-13603*T (HT 15) and most of the -14011*T variants. 
However two -14011*Ts were found on different B haplotype backgrounds and if the 
assignments are correct that might suggest this mutation happened several times 
independently, probably in geographically quite distinct places.  
 
-14009*G mostly occurred on an X haplotype (HT 26) and one on the ancestral H, which is 
also the background of the majority of the -13730*G variants, though 3 cases were found 
on A and C haplotypes. The variants -13806*G and -13779*C exclusively occur on the C 
haplotype background (HT 53 and 52 respectively). -13913*C resides on the B haplotype 
(HT 80). 
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The location of -14028*C, the variant described in functional studies in the previous 
chapter, on a B haplotype, was confirmed for both cases. Another rarer variant, -13800*T, 
has U as background haplotype. 
 
To summarise, the derived enhancer alleles in most cases lie on a characteristic 
haplotype:-13910*T on A haplotype as well as -13907*G and -13603*T, -13913*C on a B 
haplotype,-13915*G and -13806*G on a C haplotype, -14010*C on a P haplotype, -13730*G 
on an H haplotype and-14009*G on an X haplotype (Table 5.6 and Table 5.8).  
However -13495*T, although mostly on A, can in contrast be found on several different 
haplotype backgrounds, and seems to be evolutionarily much older, and there has clearly 
been some recombination between it and markers within LCT (see also network and LD 
analyses below). 
 
These results broadly confirm previous findings (Ingram 2008; Jones 2012) but extends 
them by providing much more information on -13495*T and the rare haplotypes, as well as 
more definitive assignment of -14009*G and -14010*C.
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Table 5.8: Haplotype backgrounds of the lactase persistence associated enhancer alleles. Lactase persistence associated alleles are shown in bold, boxes 
represent possible recombination events. N: Number of chromosomes. Note that haplotype 25 is like haplotype A for much of the lenght. 
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-14010*C
82 C 1 A A A TC G T C C T T T C C A G G C T C C C 1 T G A A A A T 14 P, W, Y
-14009*G
26 G 1 A A A TC G T C G G T T C C A G G C T C C C 2 T G A A A A C 33 X, m, n
27 G 1 A A A TC G T C G G T T C C A G G C T C C C 2 T G A A A A T 1 O, S, U, f, g, p
-13915*G
56 G 1 A G A TC G T C G T G T C C A G G C T C C C 1 T G A A G G T 204 C, M, j, k
59 G 1 A G A TC G T C G T G T C C A G G G T C C C 1 T G A A G G T 4 C, M, j, k
55 G 1 A G A TC G T C G T G T C C A G G C T C C C 1 T G A A G G C 1 E
58 G 1 A G A TC G T C G T G T C C A G G G T C C C 1 T G A A A G T 1 H, K, Q, Z
57 G 1 A G A TC G T C G T G T C C A G G C T C C T 1 T G A A A G T 1 L, i
24 G 1 A A A TC G T C G T T T T C A G G C T C T C 1 T G A A A G C 110 A, J
25 G 1 A A A TC G T C G T T T T C A G G C T C T C 1 T G A A A A T 1 P, W, Y
-13907*G 
21 G 1 A A A TC G T C G T T T C G A G G C T C T C 1 T G A A A G C 63 A, J
20 G 1 A A A TC G T C G T T T C G A G G C T C C C 1 T G A A A G C 1 A, J
22 G 1 A A A TC G T C G T T T C G A G G C T C T C 1 T G A A A G T 3 H, K, Q, Z
-13910*T 
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5.5.6 Haplotype networks 
A network was constructed using the Network software and the haplotype information as 
shown in Table 5.6. The Network is made by assuming single stepwise mutational changes. 
Figure 5.6 illustrate the relationships of the different haplotypes to each other and locates 
the derived enhancer and intron 4 alleles of MCM6. With more than one appearance of a 
mutation, recombination can be inferred, as indicated by the ovals. The two exonic SNPs of 
LCT play a large role in haplotype distinction. The network indicates recombination events 
that could have occurred, especially between the enhancer region and the 5579 SNP in 
exon 17 of LCT, leading to less frequent haplotypes. Most of these events are located 
between the LCT SNPs and position -13495. 
 
 
 
 
Figure 5.6: Maximum parsimony neighbour joining network of the haplotypes shown in 
Table 5.6. Haplotype nomenclature correspondents to the haplotype IDs of Table 5.6 and nodes are 
proportional to haplotype frequency. Names of the most probable LCT core haplotypes and those 
associated with lactase persistence (LP) are indicated, colours represent similar LCT core 
haplotypes and circles indicate recombination events. Note that branch lengths do not represent 
evolutionary scales. 
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5.5.7 Linkage disequilibrium 
Pairwise linkage disequilibrium across the 80 kb haplotype region was examined using 
PowerMarker software and values were also checked in DnaSP. The D' measure was 
calculated with phased haplotype information of 855 individuals. These were grouped in 
various ways and association patterns differed slightly between the groups examined, 
partly reflecting the alleles present. An example of the pairwise calculations is shown in 
Table 5.9, all others in Appendix F.  
 
Linkage disequilibrium was consistently high (D’ of 1) between the MCM6 intron 13 
markers, with the exception of the association of -13945 and the two close SNPs at -13907 
and -13915 in Afro-Asiatic speaking groups. The lack of statistical significance for the 
association of some pairs of markers with Dǯ values of ͳ ȋno evidence of recombinationȌ 
results from low allele frequencies.  
A noticeable drop in LD between the 5579 SNP and the markers of the hapdef region is 
seen in most groups, and also some markers of MCM6 intron 4. Only in the African groups 
were there reduced D’ values between 5579 and some enhancer variants, probably due to 
the higher variability of the enhancer in these groups. D’ values were lower between -
13495 and at least one of the MCM6 intron 4 SNPS in all language groups.  
The Nilo-Saharan population additionally showed reduced D' values between of both 
exonic markers 5579 and 666 and the -13495 enhancer variant, undoubtedly because the -
13495 *T is found on other core haplotypes than A. Both African-Asiatic groups showed a 
drop in LD between the haplotype markers -958 and -943/942 as well as the Niger-Congo 
populations between 666 and -943/942. 
 
A more useful graphical way of presenting a picture of historic recombinations is the 
construction of Linkage Disequilibrium Unit (LDU) maps as was done for extended 
haplotype analysis as shown below (section 5.5.8.3). 
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Table 5.9: Pairwise linkage disequilibrium D' across the 80kb haplotype region. Monomorphic markers were excluded from analysis. Statistically significant 
values after Bonferroni correction for multiple testing for the respective amount of populations per group are shaded in green. 
Africa Afro-Asiatic 
     
 
-30210 -30203 -30182 -30071/70 -29949 -14010 -14009 -13915 -13913 -13910 -13907  -13806 -13730 -13603 -13495 -958 -943/42 -875 -815 -811 -678 666 
     
-30203 1 
                          
-30182 1 0.54 
                         
-30071/70 1 1 1 
                        
-29949 1 1 1 1 
                       
-14010 1 1 1 1 1 
                      
-14009 1 1 1 1 1 1 
                     
-13915 1 1 1 1 1 1 1 
                    
-13913 1 1 1 1 1 1 1 1 
                   
-13910 1 1 1 1 1 1 1 1 1 
                  
-13907  1 1 1 1 1 1 1 1 1 1 
                 
-13806 1 1 1 1 1 1 1 1 1 1 1 
                
-13730 1 1 1 1 1 1 1 1 1 1 1 1 
               
-13603 1 1 1 1 1 1 1 1 1 1 1 1 1 
              
-13495 1 0.14 1 1 1 1 1 1 1 1 0.98 1 1 1 
             
-958 0.99 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
            
-943/42 0.89 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0.94 
           
-875 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
          
-815 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
         
-811 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
        
-678 1 0.54 0.99 1 1 1 1 1 1 1 1 1 0.85 1 0.97 1 1 1 1 1 
       
666 1 1.0 1 1 0.68 1 1 1 1 1 1 1 1 1 0.93 1 1 1 1 1 1 
      
5579 0.96 0.06 0.95 1 0.80 1 0.96 1 1 1 0.93 1 0.86 1 0.78 0.96 0.65 1 1 1 0.95 0.40 
     
161 
5.5.8 Extended haplotype analyses 
To investigate how the LCT haplotypes carrying the lactase persistence associated 
enhancer alleles differ from their ancestral forms and how far they expand beyond LCT in 
the combined sample set, additional markers were selected (see 5.4.1). They extend the 
haplotype analysis across a region of about 1.8 Mb. For 880 individuals 36 markers were 
genotyped by LGC Genomics. After quality control the genotype data of this set were 
merged with the data for MCM6 intron 4 and 13 and the LCT hapdef region of the 
corresponding individuals. All individuals with missing data at more than 6 positions 
across the whole set or more than 3 positions in the hapdef region, as well as SNPs 
occurring twice or less were excluded from further analysis. Haplotypes were inferred 
using PHASE for a final set of 60 SNPs for 837 individuals. 
5.5.8.1 Haplotype background the derived enhancer alleles 
For comparison the haplotype lengths between chromosomes carrying the ancestral and 
derived variants on the same haplotype core background A, B, C, P and X (as defined by 
Hollox et al. 2001) were calculated in bp and plotted.  
  
 
Figure 5.7 shows all A haplotypes carrying the derived -13910*T variant (N=104). The 
region of about 310 kb is identical for all *T carrying chromosomes (except one with the 
ancestral G allele at -22 kb) and spans from SNP rs6430594 located in the DARS gene 
upstream of LCT up to the polymorphism rs4954278 in the gene R3HDM1.  
 
  
 
Figure 5.7: Graphical representation of -13910*T (red) carrying haplotypes. -22018*A (left 
white bar) is on the same haplotype background. All sequences are identical for at least 310 kb. 
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As a further example, Figure 5.8 shows the graphical representation of all X haplotypes 
with ancestral and derived variants at position -14009. The length differences between the 
derived and ancestral forms can clearly be seen. 
 
 
Figure 5.8: Plot of X haplotypes carrying -14009*G (above, with lilac bars) and the ancestral 
version (below). Kb values represent the minimum haplotype length. The white left bar in the 
ancestral haplotypes represent -29949*C and the right bar rs2304370, which is located between the 
LCT haplotype defining SNPs at position 666 and 5579. Gene conversion and/or recombination can 
be inferred for these haplotypes particularly from -29949 upstream which would shorten the 
minimum length of the ancestral haplotype to 55 kb and the mean to 655 kb. 
 
 
The mean lengths were calculated for all haplotypes carrying the derived allele versus all 
others in calculating the haplotype length of each chromosome as sequence region shared 
with the most frequent haplotype (for example shown as broad upper bar in Figure 5.7), 
and results are shown in Table 5.10. For comparison of each of the two groups, a two 
tailed Mann-Whitney U test was performed. The mean lengths of the haplotypes carrying 
the derived lactase persistence associated alleles are significantly longer (p<0.001) than 
those carrying the ancestral alleles on the SNP positions.  
Interestingly, the ancestral B haplotype is also relatively long and the -13913*C variant, 
which is not associated with lactose digester status, also occurs on a slightly longer B 
haplotype, though this difference is not statistically significant (p=0.68). This smaller 
difference presumably indicates that this non-functional mutation is much older than the 
others. 
  
312 kb 
217 kb 
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Table 5.10: Mean haplotype length of core haplotypes carrying derived and ancestral alleles. 
 
  
Haplotype length (kb) 
Haplotype variant derived ancestral 
  
  
 A -13910*T 1342 658 
  -13007*G 1580   
C -13915*G 1473 549 
X -14009*G 1578 675 
P -14010*C 1417 849 
B -13913*C  1076 1004 
 
 
5.5.8.2 Extended haplotype homozygosity (EHH) 
Previous studies of long range haplotypes across the LCT region were mainly done 
considering the -13910 C>T to be functional for lactase persistence (Bersaglieri et al. 
2004; Sabeti et al. 2007). These and other lactase persistence associated alleles were 
compared to all haplotypes carrying the ancestral variant at that position (Enattah et al. 
2008; Tishkoff et al. 2007), i.e. all other LCT core haplotypes combined together. In a more 
recent study we conducted a long range haplotype test on the A carrying 13910*T 
haplotype in comparison with ancestral A, B and C (Gallego Romero et al. 2012). 
Remarkably, the B haplotype carrying none of the associated alleles showed a long stretch 
(500 kb) of relatively high extended haplotype homozygosity (EHH). 
 
To investigate selection patterns in the region around LCT in the combined dataset, EHH 
tests were first conducted using the Sweep software for the different lactase persistence 
associated alleles as reported previously by others, using the single derived allele as core 
and the EHH values plotted in R (see also section 2.3.6 of chapter 2). Figure 5.9 toFigure 
5.11 show the plots of for the decay of EHH against genetic distance from the core SNPs. It 
should be noted that all plots illustrate are shown in the chromosomal + direction, as also 
in Figure 5.2, which is the opposite way round to the previous graphs and tables of this 
chapter, which are shown in the direction of orientation of the LCT and MCM6 genes. 
 
Haplotypes carrying the derived lactase persistence associated alleles were analysed 
against all other haplotypes of the whole sample set, except for -14009*G and -14010*C 
where analyses were done on a subset of samples because of their low frequency in the 
overall sample set, on the African Afro-Asiatic speaking (522 chromosomes) and Niger-
Congo speaking (202 chromosomes) groups respectively. To get more information about 
the B haplotype the same was done for the -958 SNP as core (Figure 5.10).  
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Figure 5.9: Decay of extended haplotype homozygosity for the haplotypes carrying derived 
LP associated alleles of the LCT enhancer compared to those carrying ancestral alleles. For 
varians at-13907, -13910 and -13915 these were compared to all other haplotypes of the set of 
1674 chomosomes and for -14009 and -14010 for a subset of 522 and 202 chromosomes 
respectively.  
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Figure 5.10: EHH decay of the haplotypes carrying -958*T (as key marker for the B 
haplotype) against all other chromosomes of the whole sampleset (n=1674). 
 
All haplotypes carrying the derived enhancer alleles show greater EHH on both sides of 
the core SNPs in comparison to all other haplotypes (Figure 5.9 and Figure 5.10). This 
shows evidence for recent origin of these alleles and is also consistent with selection of 
these variants, and is consistent with previous findings for some of the variants 
(Bersaglieri et al. 2004; Gallego Romero et al. 2012; Poulter et al. 2003; Sabeti et al. 2007; 
Tishkoff et al. 2007; Voight et al. 2006). It should be noted that the EHH decays in a non-
symmetrical manner. It drops more quickly on the right side of core SNP on the 
chromosome (i.e. upstream of the enhancer in LCT gene direction, chromosome -), which 
is particularly apparent for the -13910*T carrying haplotype. It is also of interest that this 
same extended haplotype homozygosity is detectable for -13907*G, , which is located on 
the same haplotype background, even though there are more 13910*T alleles in the 
dataset. 
 
To be able to compare between the LCT core haplotypes with the derived or ancestral 
alleles of the lactase persistence associated enhancer SNPs, the A, C, P and X haplotype 
chromosomes were selected from the data and EHH tests done for each of them separately 
but the results combined as shown in Figure 5.11. In addition to that the B haplotype 
chromosomes were selected from the overall dataset and setting -958 as core SNP against 
all other preselected chromosomes. In this comparison -958*T alleles carried on derived 
and recombinant chromosomes D, F, I, R, N, a, L, i and B -13913*C are excluded. 
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Figure 5.11: EHH decay over physical distance for the haplotypes carrying derived LP 
associated alleles compared to their ancestral haplotypes and all B haplotype carrying 
chromosomes. Note that the derived haplotypes for P and X represent less frequent chromosomes 
of n=13 and n= 31 respectively. The broad location of the genes on the chromosome is indicated 
above the plot. 
 
A large step in EHH decay is located about 230 kb chromosomal upstream of the core SNPs 
(i.e. to the right hand-side on the diagram on Figure 5.11), which is similar for all variant 
haplotypes. To the other side, the haplotypes show a long stretch of EHH at relatively high 
levels, with a small step of decay for the -13910*T and -13907*G carrying haplotypes far 
beyond LCT in gene R3HDM1 and further away about 800 kb in gene RAB3GAP1.  
 
Interestingly this long stretch of EHH can also be seen in the B haplotypes that do not 
carry any of the functional derived alleles. Even in Figure 5.10, where only the SNP at -958 
distinguishes between the haplotypes, a stretch of about 500 kb can be seen in about 60% 
of the chromosomes. Note that in this case of the -958*T carrying haplotypes that the small 
sharp drop in EHH close to the core SNP is probably mainly due to the recombination 
event, which leads to the F haplotype (see Figure 5.6).  
The critical question is whether this pattern is likely to be caused by selection of another 
allele outside of the enhancer but within the 500 kb region, or other factors. There is clear 
evidence that this haplotype is old since it occurs on many continents. 
 
From the Genome Browsers the recombination rates in the tested genomic region are 
shown to be relatively low. The estimated recombination rates between the regions 135-
136 and 136-137 Mb of chromosome 2 show only a minor difference of 0.5 cM/Mb and 0.4 
cM/Mb respectively (deCODE sex averged rates, 0.4 and 1.1 Marshfield and 0.8 both 
Genethon sex averaged rates respectively, UCSC genome browser) but increase to 0.7 (2.0 
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and 1.7 respectively) from 137 Mb upstream. Linkage disequilibrium maps were therefore 
used to get further information about recombination patterns of the examined 1.8 Mb 
region in different HapMap populations.  
 
5.5.8.3 Linkage Disequilibrium Unit (LDU) maps 
The construction of LDU maps is based on the idea that LD decays with distance and 
pairwise LDU for each SNP are calculated using εidi, the product of the exponential decline 
ε of association between SNPs and their distance d in kb (Maniatis et al. 2002, see also 
chapter 2, 2.3.5). The information is combined over many adjacent SNPs sequentially and 
converted to LD units. These units are plotted against distance resulting in a graph that 
shows a series of steps, where the steps in the line represent the breakdown in LD due to 
recombination and the plateaus high LD. LD units can also be plotted as LDU/kb against 
distance to get a series of peaks, which also represent recombination hotspots. With the 
help of Winston Lau this has been done on publically available Hap Map Phase III data of 
release 28. 
 
From Figure 5.12 it can be seen that the patterns of LD and areas of a breakdown of 
linkage are similar in all populations. Where the data are plotted to show LDU/kb against 
kb and it can be seen more clearly that the peaks that represent recombination hotspots 
are also similar. A long stretch of no recombination across ZRANB3 can clearly be seen in 
all populations in these plots, irrespective of whether they are known to have frequent LP 
alleles. This extends in the CEU population until MAP3K19. In the other two populations 
there is a small amount of recombination between ZRANB3 and MAP3K19. The region 
upstream of LCT including MCM6 and DARS also shows relatively low recombination, with 
only a small peak between MCM6 and DARS in the African in European populations. 
Interestingly, there is a high peak of recombination within LCT, at the 3' end of the gene, in 
the Chinese, which is lower for the other populations and which could reflect the region 
around the 5579 SNP. 
 
Even more noteworthy is the observation that the LDU maps show considerable 
correspondence to the EHH plots for the derived alleles and for the B haplotype (Figure 
5.12). These show a large region of haplotype homozygosity that stretches along ZRANB3 
partly including RAB3GAP1 and R3HDM1. On the other side, beyond DARS, haplotypes 
seem to break down, which is similar to the LDU plots. Figure 5.13 shows the same plot 
more focussed on the genotyped region.  
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a)                  
             
 
b) 
 
 
Figure 5.12: Linkage disequilibrium map showing LDU against distance (b) in comparison to 
the EHH plot of -958 C>T (a). The borders on the x-axis of the LD map represent the region 
genotyped for the samples in this chapter. The colour codes represent different HapMap 
populations: ASW: South western Americans with African ancestry, CEU: CEPH, Utah residents with 
Northern and Western European ancestry, CHB: Han-Chinese from Bejing, CHD: Chinese from 
Denver , GIH: Gujarati Indians from Houston, JPT: Japanese, LWK: Luhya from Webuye, Kenya, MEX: 
Mexican ancestry from Los Angeles, MKK: Maasai from Kinyawa, Kenya, TSI: Toscani from Italia, 
YRI: Yoruba from Ibadan, Nigeria. 
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Figure 5.13: LDU against distance plot (upper plot) for the genetic region included in 
extended haplotype analysis and corresponding LDU/Mb against distance plot for several 
HapMap populations (abbreviations in legend Figure 5.12) showing peaks of recombination 
hotspots. 
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5.6 Discussion 
In this chapter genotype and haplotype data from a wide set of samples from different 
continents were collected and interpreted to get further insights into the evolution of the 
LCT enhancer alleles and detect possible signatures of selection. Different approaches 
were used to examine the LCT haplotypes. 
 
The analysis of the 80 kb haplotype around LCT allowed the construction of a Network and 
confirmed a tight association of the lactase persistence associated enhancer variants with 
particular haplotypes as described previously (Enattah et al. 2008; Ingram 2008; Ingram 
et al. 2007; Tishkoff et al. 2007). The patterns of LD and haplotype diversity show 
differences in the various populations, with the least diversity in Northern Europe. 
Comparing the LCT enhancer region with the two regions upstream and downstream, 
shows a reduction in diversity of the flanking regions in lactose digesters in comparison 
with non-digesters, unlike the situation in Africans where the digesters show equivalent or 
more diversity in the enhancer. This pattern reflects the different consequences of positive 
selection for one allele on a single haplotype background, and several alleles on different 
haplotypes (e.g. Bersaglieri et al. 2004; Ingram et al. 2009b; Jones et al. 2013). 
 
The high frequency and wide distribution of the B haplotype, also shown in other studies 
(Gallego Romero et al. 2012; Hollox et al. 2001; Ingram et al. 2007; Jones et al. 2013) was 
confirmed in the combined dataset, and its appearance across the continents suggests that 
this is an old haplotype. 
 
With the extension of the haplotype analysis to about 1.8 Mb it was possible to look 
further for possible signatures of selection for the lactase persistence associated alleles in 
the dataset. Different approaches were used, which came to similar conclusions. It was 
shown that the haplotypes carrying the derived lactase persistence associated alleles are 
much longer than their ancestral haplotypes, as calculated from their mean haplotype 
length. This pattern could also be shown with EHH analysis. The extended haplotype 
homozygosity of the lactase persistence haplotypes spans longer regions compared to all 
other haplotypes of the datasets as well as the haplotypes on which they arose. These 
differences support the recent dating of these variants with lack of time and therefore 
recombination events to occur and break them up (Sabeti et al. 2006). Proper examination 
of their frequency in less heterogeneous datasets would be likely to confirm a signature of 
selection by methods used by others (Sabeti et al. 2006; Voight et al. 2006). However, 
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aside from possible sampling issues, this chapter highlights one problem with the analyses 
reported so far. That is that the comparison of a lactase persistence associated allele 
carrying haplotype against all other haplotypes somewhat exaggerates this effect, because 
the non-carrier chromosomes include a mixture of chromosomes of different the LCT core 
haplotype.  
 
The analysis of derived and ancestral variant haplotypes of the same LCT core haplotype 
(as first shown by Gallego Romero et al. 2012) seemed to be a better way of representing 
the effect of a certain allele. The haplotype lengths of all chromosomes with an A, B, C, P 
and X haplotype backgrounds were calculated from all phased chromosomes clustered 
using the haplotype definition of Hollox et al. (2001) and were shown to be significantly 
different for the functional enhancer alleles. Results from EHH analysis revealed longer 
stretches of haplotype homozygosity for the lactase persistence variant alleles than their 
ancestral alleles (only shown visually). However, extended haplotype homozygosity was 
also observed for the B haplotype, which does not carry any functionally important 
enhancer alleles. This is a pattern that had been noticed before (Gallego Romero et al. 
2012). 
 
Regions of LD as seen in the EHH plots interestingly overlap with those from LDU plots for 
different populations and are similar for all haplotypes. LD decays rapidly upstream of LCT 
(downstream in chromosomal direction), after DARS (aspartyl-tRNA synthetase). 
However, the region of LD to the other side of LCT is much longer and spans across 
ZRANB3 (zinc finger, RNA-binding domain containing 3), up to MAP3K19 (Mitogen-
activated protein kinase kinase 19), where a decay of LD can be seen. 
 
The LDU plots show that ZRANB3 region has not been disrupted by recombination. This 
might somehow have been an effect of selection for reduced recombination due to its 
functional importance. ZRANB3 was shown to be a DNA annealing helicase and 
endonuclease with function for genome stability (UniProtKB, http://www.uniprot.org/). It 
is important for replication stress response and was for example shown to be involved in 
the repair of DNA lesions that block the replication process (Weston et al. 2012). Whether 
or not as a consequence of selection affecting this or another gene, it may be that there is a 
lack of recombination motifs (Myers et al. 2010) or even a structural rearrangement of the 
chromosome in this region. Such repression of recombination will have distorted 
inferences about hard selective sweeps. 
172 
From the combined results of this chapter it can be concluded that all -13910*T alleles 
occur on one haplotype which extends at least 310 kb and in many cases much longer 
(mean length 1.3 Mb). This supports the conclusion of previous findings which suggest one 
single origin of -13910*T and its presence on one selected haplotype (for example 
Bersaglieri et al. 2004; Poulter et al. 2003). Our failure to find -13910*T on any different 
background even in Iran does not provide support for the existence of a convergent 
evolution of the allele as claimed previously (Enattah et al. 2007). Inspection of the 
haplotype networks in that paper make errors in haplotype inference or gene conversion 
more likely, as the 22kb SNP occurred on two different branches of the network.  
 
The same pattern of extended haplotypes is also seen for all other variants that have been 
shown to be functional, apart from-14011 C>T, for which there is some break-up of 
haplotype background. It is of interest to note that in the case of -13913*C, for which there 
is strong evidence that it does not cause lactase persistence, the derived allele is also 
located on a long haplotype in the 7 chromosomes that we had to analyse, but this is not 
significantly longer than that of the ancestral B variant on which it arose, even though its 
low frequency would suggest a very recent origin. So in that case one might speculate that 
the allele was spread by drift. 
 
The observations on the extended region of high LD in all populations, including many 
without LP and of the extended B haplotype, show that new methods ought to be 
developed to examine selection to take demography and recombination into greater 
account
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6 LCT immediate promoter and intron 2 - a search 
for yet undiscovered functional variants 
6.1 Introduction  
The genotype-phenotype comparison maps in chapter 3 show areas where lactase 
persistence frequencies of all 5 variants thought to be causal of the trait, combined, fails to 
match the observed phenotype data. Besides sampling issues and incomplete datasets of 
genotype- or phenotype data these interpolated maps show geographic candidate regions 
where other causes of lactase persistence might yet be uncovered. One example for 
missing lactase persistence alleles, as already mentioned in chapter 1, comes from the 
unexpected lack of enhancer alleles in the Wolof (Ingram et al. 2009b; Jones et al. 2013; 
Mulcare et al. 2004) with half the sample tested being judged lactase persistent by lactose 
tolerance tests (Arnold et al. 1980).  
 
With the discoveries of the last years, revealing more lactase persistence variation in the 
enhancer region of LCT, the doubts about this region being of critical functional 
importance have subsided, but speculations remain that other causes for lactase 
persistence exist and it cannot be excluded, and it is indeed likely, that other sequence 
regions influence lactase expression. 
 
A recent reinvestigation of the exonic region around the active sites of lactase in Africans 
did not reveal any variation (Jones 2012) which might have altered lactase expression and 
all lines of evidence pointed to regulatory variation being more likely to be responsible for 
inter individual difference in adult lactase expression. In an effort to find other variation of 
possible function, a study at the outset of this thesis work showed variation in the 
immediate promoter of the lactase gene in several African individuals, which was slightly 
surprising since this region had been shown to be a quite conserved part of the gene 
(Troelsen 2005). Two alleles, -17*T and -36*T (rs111985625), were of interest as they 
were only found in individuals from milk drinking populations (Jones 2012). 
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6.2 Chapter aims 
These new findings inspired the examination of the immediate promoter region in further 
samples of European and Middle Eastern origin. A further aim of this chapter was to use 
bioinformatic tools and publicly available databases to determine new genomic regions in 
and around the LCT gene with a possible functional influence on lactase persistence. One 
such region would be selected and examined. Depending on the results in vitro 
experiments would be designed to examine the effect of nucleotide changes in one or both 
regions. 
6.3 Strategy 
For the promoter region of LCT previously tested primers were used (Jones 2012) to 
amplify a 675 bp sequence region (Chr2:136594559-136595233, GRCh37/hg19) of which 
a sequence of bp -360 until +82 from the LCT transcription start was readable for all 
samples. Details of primer sequences are shown in Table 2.3, chapter 2. 
 
To identify candidate regions in and around LCT with possible function the UCSC genome 
browser (http://genome.ucsc.edu) was scanned in particular for bioinformatically 
identified transcription factor binding sites and conserved regions between species. 
Especially useful was information from two publications that used a combination of 
chromatin immunoprecipitation and next generation sequencing (ChiP-Seq) to identify 
potential Cdx-2 and HNF-ͶȽ binding sites in Caco-2 cells (Boyd et al. 2009; Boyd et al. 
2010). As mentioned in chapter 4, both transcription factors play an important role in the 
intestine. One region in intron 2 of LCT showed high binding affinity to both transcription 
factors in these assays (as shown in Figure 6.1) and was chosen for further investigation 
via sequencing.  
 
Primers were designed to include the most of the sequence region of interest. With these 
primers a region of 839 bp was amplified (Chr2:136588631-136589469, GRCh37/hg19) 
of which bp positions 5345-6052 of LCT were readable.  
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Figure 6.1: Output of the UCSC Genome Browser of the human sequence 
(http://genome.ucsc.edu, NCBI35/hg17) showing the positions of Cdx-2 and HNF-4α binding 
in intron 2 of LCT in ChIP-Seq assays (Boyd et al. 2009; Boyd et al. 2010). 
 
6.4 Variation of the immediate LCT promoter 
The immediate promoter was successfully sequenced for 1018 individuals from 45 
populations. Table 6.1 shows all variants found in the LCT promoter region. 6 new variants 
were identified (-333 C>T, -294 C>A, -237 G>A, -211 C>T, -204 C>T, 41 T>C) most of which 
are rare. Only -294*A, -211*T and -17*T occur in more than one population. Of the more 
frequent African alleles (Jones 2012) -173*A was found in two Yemeni samples from 
Hadramaut and -17*T in 6 populations of which most are also from the Middle East. 
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Table 6.1: LCT promoter variation (allele counts) in the samples sequenced from 45 
European and Asian population groups, N: number of chromosomes. 
 
 
Region Country Population N 
-333 
C>T 
-294 
C>A 
-237 
G>A 
-211 
C>T 
-204 
C>T 
-173 
G>A 
-17 
C>T 
41 
T>C 
   
          
Northwest/ Germany Germans 60 - - - - - - - 1 
Central Europe 
 
Sorbs 64 - - - - - - - - 
  Ireland Irish 68 - - - - - - - - 
  Netherlands Frisians 54 - - - - - - - - 
  Norway Norwegians 54 - 1 - - - - - - 
  Slovakia Roma 64 - - - - - - - - 
  Sweden Sami 10 - - - - - - - - 
  
 
Swedes 14 - - - - - - - - 
  UK Ashkenazi-Jews 4 - - - - - - - - 
  
 
English 52 - - - - - - - - 
  Other Other C/NW Europeans 44 - - - - - - - - 
South Europe Greece Greeks 40 - - - - - - - - 
  Italy Tyroleans Bozen 62 - - - - - - - - 
  
 
Tyroleans Gadertal 58 - - - - - - - - 
  
 
Tyroleans Vinschgau 60 - - - - - - - - 
  Portugal Portuguese 38 - - - - - - - - 
  Spain Catalans 60 - - - - - - - - 
  
 
Spanish 62 - - - - - - 1 - 
East/ Belarus Belarusians 44 - - - - - - - - 
Southeast  Macedonia Macedonians 64 - - - - - - - - 
Europe Romania Romanians 64 - - - - - - - - 
  Russia Erzja 2 - - - - - - - - 
  
 
Russians Perm 34 - - - - - - - - 
  Ukraine Ukrainians 28 - - - - - - - - 
  Other Other E/SE Europeans 12 - - - - - - - - 
Middle East Cyprus Greek Cypriots 50 1 - - - - - - - 
  Iran Iranians 90 - 1 - - - - - - 
  Kuwait Kuwaiti 50 - - - 3 - - - - 
  Syria Syrians 114 - - - - 1 - 2 - 
  Turkey Anatolian-Turks 40 - - - - - - - - 
  Yemen Yemeni Hadramaut 134 - 1 - - - 2 2 - 
  
 
Yemeni Sena 28 - 4 - - - - 1 - 
  Other Other Middle Easterns 48 - - - - - - 1 - 
West Asia Armenia Armenians 50 - 1 - - - - - - 
  Azerbaijan Azeri 50 - - - 1 - - - - 
  Georgia Georgians 38 - - - - - - 1 - 
Central/ Afghanistan Pashtuns/Afghans 32 - - - - - - - - 
South Asia 
 
Tadjiks  12 - - - - - - - - 
  
 
Uzbeks 12 - - - - - - - - 
  Nepal Nepalese 10 - - - - - - - - 
  
 
Tharu 42 - - - - - - - - 
  Uzbekistan Uzbeks 42 - - 1 - - - - - 
  Other Other C/South Asians 14 - - - - - - - - 
Central/East/ Mongolia Khalka 52 - - - - - - - - 
Southeast Asia   Mongols 12 - - - - - - - - 
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6.5 Reporter gene assays on LCT promoter variants 
Functional studies were conducted to examine the two most interesting LCT promoter 
variants. The variants -17*T and -36*T were chosen for analysis because, as described 
above, -17*T was found in many African and some other populations and -36*T was more 
common in pastoralists groups from Africa (Jones 2012). Their locations in a region of 
binding for several transcription factors (Figure 6.2) also make them interesting for study. 
With the comparison of the promoter region with other primate species (Appendix A, or 
also seen in Figure 6.2) it was recognised that -36*T is actually the ancestral variant for 
this SNP. However, -36*C is the common variant in all populations so far and for 
comparison reasons with previous work (Jones 2012) I will further refer to -36*T as the 
variant. 
 
 
Figure 6.2: Alignment of 150 bp of the proximal LCT promoter showing the location of the 
two variants chosen for transfection experiments (red boxes). Cis-elements are indicated by 
black boxes and transcription factors binding are shown. Picture modified from Troelsen (2005). 
 
The two LCT promoter variants were introduced into the reporter gene plasmids 
containing the ancestral enhancer sequence, upstream of the firefly luciferase gene (luc+) 
(for details see section 2.2.7.2) and transfected into Caco2 cells as described in chapter 2 
(section 2.2.7). Gel shift assays were not conducted since these are inappropriate for 
promoter regions where multiple proteins are binding. 
 
Transfection studies revealed no significant difference in reporter gene expression 
between the control plasmids and the constructs containing the -36*T and -17*T. Figure 
6.3 shows the relative luciferase activity after 2 and 9 days of transfection compared to the 
ancestral promoter only plasmid and also that containing the ancestral enhancer 
sequence, with promoter enhancer construct carrying -17*C and -36*C.  
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Figure 6.3: Result of luciferase reporter gene assay for the LCT promoter variants in 
constructs including the ancestral enhancer sequence, after 2 and 9 days of transfecting the 
Caco-2 cells. Luciferase activity of promoter variant constructs are shown in comparison with the 
promoter only construct. Luciferase activities (means ± SD, n=4) were corrected for transfection 
efficiency and normalised to the expression of pGL3 hLPH1085 (promoter only). Neither variant 
allele showed significantly different expression from the ancestral allele. 
 
6.6 Variation in intron 2 of LCT 
Data for LCT intron 2 were collected for a selection of European and Middle Eastern 
populations from chapter 1 and phenotyped samples from Europe, Asia and Africa. 
The LCT intron 2 region was successfully sequenced for 308 samples and Table 6.2 shows 
the allele frequencies in 11 populations tested. 13 variants were detected, of which 5372 
C>T, 5473 C>T and a 4 bp deletion, around position 5788 from the start of transcription of 
LCT, were present in all populations studied.  
 
To explore a possible association with the lactase persistence phenotype previously 
phenotyped populations (see also chapter 2) from Northern Europe (Harvey et al. 1995a) 
and Italy (Harvey et al. 1998), the Siberian Yakuts (Hollox 2000) and the African Jaali and 
Somali (Ingram et al. 2007; Ingram et al. 2009b) and an additional set of 26 phenotyped 
Finnish individuals (Harvey et al. 1998; Hollox 2000) were further analysed. After 
exclusion of samples with missing data at more than 4 positions in the LCT intron 2 or 
enhancer sequence regions 172 samples were examined.  
 
Allele counts for the entire group and for the group divided into European + Asian and 
African samples are shown in Table 6.3. For simplicity lactase persistent samples as tested 
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by biopsy and lactose digesters tested by breath hydrogen tests were both grouped as 
lactase persistent (and vice versa for non-persistent individuals). Phenotype counts were 
then used to build a 2x2 table to examine association with Fishers exact test. 
 
The two alleles 5473*T and 5586*A show a significant association with lactase persistence 
in the overall sample set, whereas 5372*T and the 4 bp deletion at position 5788 are 
instead associated with lactase non-persistence. Since it seemed to be very likely that 
those associations reflect demographic patterns, samples were split according to their 
origin into a European/Asian and African sample set.  
5473*T was found in both, the European/Asian and African sample sets and is not 
significant associated with persistence when both sets were analysed separately (Table 
6.3). As shown in Table 6.2, 5586 *A was only found in Europeans and 18/21 of the 
chromosomes were in persistent people (Table 6.3). This suggested that it might be 
associated with the -13910*T carrying chromosomes. However, the three 5586*A variants 
occurred in non-persistent individuals who do not carry the *T allele but all of whom were 
previously shown by former members of the lab to carry at least one A haplotype which 
would support the suggestion that 5586*A occurs on an A haplotype background and 
preliminary PHASE analysis points to this. 
 
The 4 bp deletion at position 5788 remained significantly associated with lactase non-
persistence in the African sample subset. This variant was mainly found on a B haplotype 
background (-958*T, 666*A) but was also found on the core A, C and other haplotypes as 
assessed by visual inspection of the data and preliminary PHASE analysis. This result 
would need further confirmation but suggests that some gene conversion has occurred. 
 
Critically, no alleles were found exclusively in persistent people, including those with no 
functional enhancer alleles.  
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Table 6.2: Allele frequencies of LCT all intron 2 variants observed in a subset of European and Middle Eastern populations from chapter 3 and 
additional phenotyped samples, N: Number of chromosomes. 
 
 
  rs11886852 
 
rs9636213 
  
rs10928551 
  
rs10928550 
    
Population N 5372 C>T  
5409 
C>T 
5473 
C>T 
5586 
G>A 
5623 
G>A 
5669 
C>A 
5698 
C>T 
5742 
G>A 
5783 
G>C 
5788 4 bp 
Indel (1=del) 
5807 
C>T 
5810 
C>T 
6013 
C>T 
 
  
             Norwegians 52 0.058 - 0.942 0.019 0.019 - - - - 0.058 - - - 
Greek-Cypriots 56 0.446 - 0.536 0.036 - - - 0.107 - 0.464 - - - 
Kuwaiti 44 0.341 - 0.591 - - 0.023 - 0.068 0.023 0.341 - - 0.023 
Syrians 32 0.406 - 0.594 0.063 - - - 0.031 - 0.375 - - - 
Yemeni Hadramaut 60 0.350 0.017 0.567 0.017 - 0.017 0.033 0.033 0.017 0.317 - - 0.050 
Other_ME 12 0.250 - 0.750 - - - - 0.167 - 0.250 - - - 
Phenotyped samples   
             Northern Europeans 40 0.100 - 0.900 0.425 - - - - - 0.100 - - - 
Italians 32 0.281 - 0.719 0.031 - - - 0.063 - 0.313 - - - 
Yakuts 56 0.143 - 0.821 - - - - - - 0.179 0.018 0.018 - 
Jaali 110 0.382 - 0.564 - - 0.082 0.009 0.036 0.091 0.273 - - 0.018 
Somali 122 0.467 - 0.352 - - 0.098 0.008 - 0.057 0.484 - - 0.008 
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Table 6.3: Allele counts and association of the LCT intron 2 variants. Statistically significant p-values after Bonferroni correction for 11 tests (0.0045) are 
shaded. P: lactase persistent (or lactose digesters), NP: lactase non-persistent (or lactose non-digesters), N: Number of chromosomes. 
 
Group   N 5372 C>T  5473 C>T 5586 G>A 5669 C>A 5698 C>T 5742 G>A 5783 G>C 5788 4 bp Indel 5807 C>T 5810 C>T 6013 C>T 
  
  
           All P 162 35 115 18 6 0 2 6 26 1 1 0 
 
NP 182 73 94 3 9 1 3 6 72 0 0 1 
p-value 
  
<0.001 <0.001 <0.001 0.609 1 1 1 <0.001 0.471 0.471 1 
              
Europeans/ P 82 10 71 18 0 0 1 0 11 1 1 0 
Asians NP 90 24 62 3 0 0 2 0 26 0 0 0 
p-value 
  
0.021 0.015 <0.001` - - 1 - 0.015 0.482 0.482 - 
              
Africans P 80 25 44 0 6 0 1 6 15 0 0 0 
 
NP 94 49 32 0 9 1 1 6 46 0 0 1 
p-value 
  
0.006 0.006 - 0.788 1 1 0.774 <0.001 - - 1 
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6.7 Discussion 
During this study the LCT promoter near to the start of transcription was surveyed in 
many European and Middle Eastern samples. As previously suggested for Europeans, this 
region is quite conserved and only a few variants were found. This same region was also 
studied in a parallel project in Africans (Jones 2012). Of the frequent African variants, -
173*A and -17*T were also present in the sample set of this study, mainly in the Middle 
East, although at low frequencies.  
However, the evidence from the African groups of a possible connection between a 
pastoralist lifestyle and the occurrence of -36*T and -17*T motivated the inclusion of these 
two variants in functional studies. Transfection studies were conducted to test the effect of 
the varying promoter sequences at these positions. No influence on reporter gene 
expression could be detected. This negative finding however agrees with the further 
developments of the parallel African studies, namely association studies with lactose 
digester status in Ethiopians, which failed to show any evidence of association with 
persistence making a functional role unlikely (Jones 2012). 
 
In a search for possible new regions with variation that could be causal for lactase 
persistence, results of ChiP-Seq analysis conducted by our colleagues in the laboratory in 
Copenhagen (Boyd et al. 2009; Boyd et al. 2010) were used to identify a region in intron 2 
of LCT which had been shown to be target for Cdx-2 and HNF-ͶȽ binding.  
 
In contrast to the promoter, the other region of interest, intron 2 of LCT, revealed 
relatively more variations. Some of the alleles were rather frequent and present in both 
persistent and non-persistent people discounting a direct functional role. Some were more 
frequent in lactase non-persistent individuals and others were more frequent in the 
persistent individuals.  
The only possible candidate SNP for function is 5586 G>A since only three individuals 
classed as non-persistent carried the allele. However all 18 derived alleles that occurred in 
persistent individuals also carried at least one -13910*T allele. Clearly not all -13910*T 
allele carrying persistent individuals carry 5586*A – since the allele was at low frequency 
in some places where the *T allele is common, such as Norway. This suggests that it is a 
derived allele on the background of A, -13910*T chromosomes, and thus non-essential for 
lactase persistence. Likewise the three individuals who carry this allele and not -13910*T 
are non-persistent showing that it cannot on its own cause persistence, and indicating 
some recombination/gene conversion has occurred. 
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Nevertheless, it can be speculated that binding of HNF-ͶȽ and Cdx-2 may differ for the 
ancestral and derived allele at this position and this might interplay with the Oct-1 binding 
of the -13910 position and the transcription factors binding to the promoter to modulate 
LCT transcription, possibly causing inter-individual differences in lactase expression and 
persistence. Further functional studies could be conducted to test this in vitro, to search 
for evidence of that SNP altering the binding of specific transcription factors. The case for 
doing that is however not supported by the bioinformatic examination of the effect of the 
SNP on the probability of the predicted Cdx-2 binding which did not differ between the 
derived and ancestral allele. 
 
In summary, no new highly putative causal alleles were found. Disappointingly it was not 
possible to include the Wolof in these DNA analyses since the quality of the remaining DNA 
samples in the lab was poor. The variants in intron 2 appear to disrupt the haplotypes 
described in Chapter 5 in a way that was unexpected, and suggesting gene conversion 
events and this might have merited further examination, but the datasets were not 
completely overlapping and further testing was not warranted by the lack of good 
candidates in this region.
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7 General Discussion 
One of the main aims of this thesis was to examine the genetic regions in and around LCT 
for variation and collect data about known lactase persistence associated alleles in 
geographic regions where there was less dense information available, mainly Eastern 
European and West Asian populations. The vast amount of enhancer variation data 
assembled in chapter 3 should significantly contribute to the knowledge about the 
distribution of LCT enhancer alleles. The Middle East, as contact zone between Europe, 
Africa and Asia revealed variation patterns reflecting influences from all these continents 
in both, the enhancer and the LCT surrounding markers as seen in the haplotype variation.  
 
In chapter 4 it could be shown that two further LCT enhancer alleles alter function in vitro. 
This increases the number of functional variants likely to be responsible for the lactase 
persistence trait to six: -14011*T, -14010*C, -14009*G, -13915*G,-13910*T and -13907*G. 
Our recently published study (Jones et al. 2013) revealed the association of-14009*G with 
lactase persistence in a 350 individuals Ethiopian cohort and confirmed the association of 
-13915*G and -13907*G.  
The functional studies described here show that -14009*G and also -14011*T have a clear 
effect on transcription factor binding in vitro. That in the case of -14009*G is quite different 
from -14010*C and -14011*T, showing that even when a small DNA binding region is 
involved more than one different route can lead to alteration of function. -14011*T is not 
frequent enough to test for association. It was found scattered as a rare variant in several 
populations in Europe and the Middle East in this thesis and in further studies in Estonia, 
Ethiopia and even in indigenous populations from Brazil (Friedrich et al. 2012; Jones et al. 
2013; Lember et al. 2006). This together with the finding of the haplotype analyses of 
chapter 5, that showed both A and B haplotypes as background, leads to the suggestion 
that this allele might have arisen by mutation independently several times. The lack of 
evidence of a single extended haplotype is slightly surprising and is not consistent with 
recent selection. A further allele -14028*C is almost certainly functional as well since it was 
associated with high lactase RNA expression (Poulter et al. 2003). 
 
Further downstream, variants -13806*G and -13730*G were shown not be lactase 
persistence associated (Jones et al. 2013) although located in the same region with 
enhancer function (Troelsen et al. 2003). These and other new variants found in the 
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investigations reported in chapter 3 and 5 are single variants or not frequent enough to be 
worth examining their influence on LCT expression without other reason.  
 
One of the relatively strong candidate functional alleles -13779*C, frequent in Indians 
tested in this thesis and elsewhere (Gallego Romero et al. 2012) showed no difference in 
protein binding in the EMSA studies and no significant difference in reporter gene activity 
in the experiments conducted during this thesis. From this evidence it can be concluded 
that it does not alter function. However, the -13779 position or the surrounding 12 bp 
sequence contains a binding site for HNF-ͶȽ which might not have direct influence on the 
lactase persistence trait but is possibly part of the transcription factor network involved in 
regulation. 
 
It is striking that the functional variants cluster in two regions indicating that these are the Ǯfunctional hotspotsǯ of the enhancer region. (owever this does not per se mean that 
mutations there always influence function, as shown for -13913*C (Enattah et al. 2008; 
Ingram et al. 2007) which is not associated with lactase persistence (Jones et al., 2013). 
This is another example of how very closely located mutations can have a different effect 
of transcription factor binding.  
 
The complex interactions of different transcription factors binding to the enhancer and 
promoter of the LCT gene were reported previously (reviewed in Montgomery et al. 2007) 
and further experiments would be needed to investigate the role of the two SNPs -14011 
C>T and 14009 T>G in this network of cis and trans regulatory elements. This could be 
done for example in further reporter gene essays under the co-transfection of other 
transcription factor proteins, known to be involved in intestinal regulation.  
 
One of the important findings of chapter 4 was the binding of an additional protein to -
14009*G, which is suggested to be an Ets factor, as evidenced from EMSA experiments 
with tailored competitor oligonucleotide sequences. It is quite likely that a factor of this 
protein family is involved in vivo as they play a role in cell differentiation and maintenance 
(Sharrocks 2001). EMSA experiments with further antibodies against c-Ets-1, ELK-1 or 
other Ets factors might be able to confirm an interaction with the variant at -14009. 
Another way of identifying the protein would of course be its isolation from gels, 
purification and protein sequencing, or with the fractionation of the Caco2 nuclear extract 
as done by Lewinsky and colleagues for the -13910*T binding Oct-1 and GAPDH proteins 
in Caco2 and HeLa cells (Lewinsky et al. 2005). However, this requires an enormous 
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amount of time and material and the antibody approach might therefore be the first 
choice.  
 
Of course in vitro studies do have their limitations, as conditions in the living organism 
differ and the complex biochemical settings in a cell of a living organism might differ from 
the in vitro situation, though ideally, the effects of variants are better studied in vivo as 
recently done for -13910*T. A 218 bp enhancer fragment carrying the variant, fused to a 2 
kb rat promoter was sufficient to prevent the down-regulations of lactase in mice (Fang et 
al. 2012).  
However, it is difficult and costly to establish transgenic mouse lines and many aspects of 
LCT regulation are different in the mouse. It might be more appropriate to study lactase 
persistence directly in measuring mRNA levels and chromatin alterations in the human 
proximal jejunum. In projects that collaborate with hospitals outside Europe and collect 
intestinal biopsy material for other reasons, the association of allelic expression levels 
with other enhancer variants could be examined, together with chromatin technologies to 
examine TF/chromatin complexes in the context of development. This way changes in 
transcription factor binding as it occurs in vivo can be confirmed.  
 
Another point was recognised during the experimental phase for chapter 4. As already 
mentioned in the discussion of that chapter, the enhancer variants tested in all the 
transfection studies in the Danish lab were tested in a construct with -958*T in the 
promoter sequence, which does not reflect the in vivo situation for variants other than -
14028*C.  
To exclude possible confounding influence of -958*T and other variable promoter 
positions, experiments should be repeated with a promoter carrying -958*C. This would be 
especially important as the T* allele at that position was shown in previous EMSA 
experiments to disrupt binding of a protein (Hollox et al. 1999), which is probably Oct-1 as 
suggested from experiments of this thesis, and this variant also decreases reporter gene 
expression (Chitkara et al. 2001). For the -13915 T>C variant mutagenesis of the -678*A to 
-678*G should also be considered to mirror the haplotype background of this allele. A 
further mutation of the construct for -14009*G at the InDel position -943/942 is probably 
less important as this was shown to not affect protein binding (Hollox et al. 1999).  
 
However, functional studies of both kinds might also lack genetic regions in the region of 
LCT that could have an influence on expression. The updated GenoPheno correlation map 
of chapter 3 revealed that there are still geographic regions where there is a difference 
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between the lactase persistence genotype and phenotype frequency, which implies the 
possible existence of other functional elements responsible for lactase persistence. 
 
Scanning the genome for transcription factor binding sites is possible with 
immunoprecipitation methods, which can also identify other regulatory influences, such as 
DNA methylation and the binding of RNA polymerase II, which could be helpful in 
identifying possible new target regions (reviewed in Mikkelsen et al. 2007; Olsen et al. 
2012). Data for proteins with a restricted expression in the intestine and therefore 
relevant to lactase can be collected from Caco2 cells as it has been done with HNF-4 and 
Cdx-2 by Boyd and colleagues (2009; 2010). Preliminary experiments failed so far to 
establish a similar assay for Oct-1 (Troelsen, personal communication).  
 
The next generation sequencing technologies allow large scale genome scans for elements 
regulating gene expression, also including the detection of small interfering RNA 
molecules and allelic transcript expression by RNA sequencing (RNA-Seq, for example 
Chia et al. 2010). Further techniques can scan for open chromatin structures such as 
DNase-Seq (DNase I hypersentitivity sequencing) or FAIRE (Formaldehyde-Assisted 
Isolation of Regulatory elements)-Seq (Giresi et al. 2007), which was recently modified to 
work with gene chips (FAIRE-gen) to be suitable for GWAS (Smith et al. 2012). Projects 
like ENCODE (Bernstein et al. 2012, https://genome.ucsc.edu/encode/) have the goal to 
combine and annotate data collected with these techniques and accumulate knowledge 
about regulatory elements and gene expression. 
 
Research in the past focussed on protein structure or exon sequencing to identify genetic 
causes for monogenic or polygenic traits. That this still is case shows the data of one of the 
most popular research projects, the 1000 genomes project. It provides high coverage data 
for exonic regions (at least 20 x) but only low (1-2 times on average) for non-exonic 
regions (Abecasis et al. 2010, http://www.1000genomes.org/), though the coverage is 
higher for the first 100 -200 bp of non-coding regions. It was for example not possible to 
use 1000 genomes data for this thesis as the enhancer region was only covered 2x on 
average for each individual which of course cannot reliably distinguish heterozygotes, 
even an expansion of the data to a data coverage of 4-8x (Tyler-Smith, personal 
communication 2012) would not have been reliable enough. 
 
The haplotype analyses in chapter 5 gave further insights into the occurrence and 
constitution of the haplotypes of the region surrounding LCT. Remarkable was the 
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frequent occurrence of a frequent B haplotype, which was of similar length to those 
haplotypes carrying functional variants and suggested to be the result of selection events. 
Rather surprising was the paucity of derived functional variants on the B haplotype. This 
haplotype forms the background of only two relatively rare derived enhancer alleles: -
13913*C, which does not seem to cause LP, and -14028*C. The latter has been found in two 
European individuals so far (in one sample examined in this thesis) and was shown to 
reside on a high lactase expressing chromosome (Poulter et al. 2003). It was confirmed 
that the -14028 position is part of a Cdx-2 binding site as previously shown (Lewinsky et 
al. 2005). The derived allele leads to a visible loss of binding to that transcription factor in 
the EMSA studies conducted but also gains binding to another transcription factor shown 
to be highly involved in lactase expression, HNF-ͶȽ. However, a functional effect could not 
be shown with the transfection studies conducted in this thesis (chapter 4). 
It should also be noted that the British person carrying -14028*C was only 21 years of age, 
which could mean that the decline of lactase expression had not fully happened, as shown 
for some Finnish individuals at the same age in a different study (Sahi et al. 1983). In this 
context -14028*C may have a function by simply delaying this process.  
 
In chapter 5, the results from EHH analysis showed long stretches of homozygosity in the 
same regions where the linkage disequilibrium maps showed clear evidence of 
suppression of recombination, which exists in populations with and without lactase 
persistence. This leads to the question to what degree methods based on extended 
haplotype homozygosity to detect recent selection events are influenced by historical 
recombination patterns reflected for example in recombination hot or cold spots of the 
genome. It is of noteworthy that LCT is surrounded by genes that are important for cell 
function, translation and replication stress response, which might possibly favour reduced 
diversity. 
Allele specific suppression of recombination in the region around LCT has previously been 
discussed as a possible factor that might create a similar pattern of an extended haplotype 
to that of a recent selection event (Hollox 2005), in the context of the -13910*T allele. A 
different strategy involving examination of microsatellite diversity around LCT did in that 
case however support the evidence for selection (Coelho et al. 2005). 
 
Although MCM6 and LCT are expressed at different developmental stages of an intestinal 
cell, (MCM6 is highest in foetuses and high in intestinal crypts but down regulated when 
lactase activity is highest in the differentiated state), it cannot be excluded that they do not 
influence each other. It was suggested that MCM6 expression in less differentiated cells has 
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an impact as precursor on chromatin packaging that also allows easier accessibility of 
transcription factors to the LCT promoter (Troelsen 2005). Maybe other neighbouring 
genes have an influence on the chromatin state of that region. 
 
LDU maps take current and historical recombination patterns into account when 
comparing linkage disequilibrium between alleles in populations. Regions of similar LDU 
therefore reflect population specific evolutionary influences such as mutation, drift and 
most importantly, selection. It would therefore be desirable to examine the populations 
for the markers used for extended haplotype analyses in chapter 5 with both the LDU 
approach and EHH tests in each of the populations to be able to compare both methods 
and get quantitative calculable evidence for selection (Tapper 2007). The SNP data 
generated here were unfortunately of much lower density than that used for the LDU 
maps. 
 
The main questions that remain unanswered and could be the motivation for future work 
are: Is there something about the B haplotype that impedes adult LCT expression when 
mutations do occur? Does the long region of LD included within the B haplotype give us 
any clues? What is suppressing recombination in this region and could this be allele 
specific? Can we exclude that there is not a large inversion within this long sequence 
region, perhaps on B haplotype chromosomes? 
However, the occurrence of the lactase persistence trait in various parts of the world, 
enabled by different recent variants in the enhancer element of the LCT gene and each on 
long haplotypes, is strongly supportive evidence, of selection triggered by the adaptation 
to a new diet. The question is how this new diet influenced the life of the early Neolithic 
farmers and how milk consumption was so beneficial. 
 
The shift to agriculture was associated with a reduction in diversity of the nutritional 
intake but also an excess of caloric availability, mainly in form of starch (Luca et al. 2010). 
For early Neolithic farmers the transition from a hunter-gatherer lifestyle to farming was 
most probably accompanied by periods of crop failure and domesticated animals built an 
additional food supply during these times. Even when taking the lower productivity of 
early domesticated cows into account and subtracting the milk needed for raising calves, a 
remarkable surplus of milk would have been produced (Gerbault et al. 2011). 
 
Even if evidence for milk use exists in early Neolithic societies from Anatolia and the 
Balkans (Craig et al. 2005; Evershed et al. 2008) it is unlikely that people were able to 
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consume large quantities of fresh milk, as ancient DNA data suggest (Figure 7.1). The 
earliest evidence for the lactase persistence associated allele was found in samples from 
Scandinavian late hunter-gatherers from about 5400-3400 BP with a frequency of 5% 
(Malmstrom et al. 2010) and in Spanish early Neolithic farmers, dated to about 5000-4500 
BP with a T* allele frequency of 11 and 26% (Plantinga et al. 2012). Data from Mesolithic 
and early Neolithic samples of other regions of Europe suggest the absence of the lactase 
persistence trait in these populations (Burger et al. 2007; Lacan et al. 2011a; Lacan et al. 
2011b). 
 
It is very likely that early farmers would have gained nutritional benefits from dairying in 
form of processed milk products such as yoghurt or cheese. This would have also been 
more feasible as these are more durable forms of milk which are easier to transport, 
probably important for early farmers that had rather seasonal settlements (reviewed in 
Leonardi et al. 2012). A recent study on pot shards from Poland dated to about 7400-6800 
BP, which show the shape of sieves used for cheese production and contain ruminant fat 
residues, directly supports this argument (Salque et al. 2013). For the milk residues found 
earlier, 8500 BP in Anatolia and the Balkans from around 7900-7500 BP it was also 
suggested that they could only last this long time if fermented milk was used in these 
vessels (Craig et al. 2005). 
 
The fermentation process would have reduced the amount of lactose, which would have 
also allowed non-persistent farmers to profit from the nutritional value of milk. Therefore 
Burger and Thomas (2011) suggest the rise of -13910*T would have started after 5500 
when dairying practises had been established and with a better supply of fresh milk the 
ability to drink it became more advantageous. 
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Figure 7.1: Frequency of -13910*T as revealed by ancient DNA analysis and location of the 
sample origins. Circle diameter correspond to sample sizes (map kindly provided by P. Gerbault). 
 
The characteristic molecular signatures of purifying and positive selection are a decrease 
in diversity in the adjacent genetic regions of the selected mutation and an increase of this 
diversity for balancing selection and soft selective sweeps. Both are seen for the LCT 
enhancer. However, the ways selection operates to increase, decrease or maintain genetic 
diversity are complex i.e. allele frequencies can be variable and processes involved 
difficult to retrace through space and time. In general, genetic drift and demography affect 
the whole genome whereas selection tends to act on the selected genes or regions only. As 
mentioned earlier, it can be difficult to distinguish selection from demographic events and 
statistical tests can help to build up the evidence for a certain scenario. The combination of 
different tests and simulation models that compare simulated variables with actual data 
from various scientific disciplines such as archaeology and anthropology as described 
above (chapter 1, section 1.2.15) seems to be a good way forward. 
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The most recent study that builds upon that approach was done by Pascale Gerbault 
(2013) also using a coalescent simulation model paired with approximate Bayesian 
computation (ABC) to model the spread and origins of lactase persistence across Europe 
but taking further and weighted data into account. Statistics that fit best with data from 
archaeological records including dairy fat residues in potsherds, and ancient and modern 
DNA data (partly from this thesis) for -13910*T were evaluated. Exchanges between 
hunter-gatherers and farmers were allowed in form of cultural diffusion, gene flow and 
density-dependent competition between hunter-gatherers and farmers. In comparison to 
Itan et al. (2009) this model suggests a more recent time of about 5000 years to be the 
starting point of selection for lactase persistence, placing it in Northern rather than 
Eastern Europe (Gerbault 2013). This shows how sensitive this kind of study is to the 
correct selection of realistic parameters.  
Nevertheless, with the further development of the simulation models it might also be 
possible in the future to take other LCT enhancer alleles into account and model the 
spread of lactase persistence outside of Europe, which might reveal further insights into 
the evolutionary past of this trait and provide answers in relation to the different sweeps 
involved.  
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Appendix A: Sequence alignments of the regions amplified during this thesis. Nucleotide 
positions in relation to the start of transcription of LCT. Positions of variants found are 
highlighted. Aligned species: Homo sapiens (H. sapiens), Pan troglodytes (P. troglod.), 
Gorilla gorilla (G. gorilla) and Pongo abelii (P. abelii).
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Appendix B1: Frequencies of lactase persistence associated alleles, - indicates that not genotyped at that position. 
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Africa Kenya Somali 37.91 -0.02 2 0.00 - 0.50 0.00 0.00 0.50 Tishkoff et al. (2007) Nat Genet. 39, 31 
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Africa Sudan Ama 30.22 12.86 4 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
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Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Africa Sudan Fulani 30.00 20.00 88 - - - 0.48 - 0.48 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Africa Sudan Gaali  32.53 15.59 20 0.00 0.00 0.00 0.00 0.05 0.05 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Africa Sudan Jaali 33.43 16.69 172 0.00 0.06 0.13 0.01 0.01 0.21 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Africa Sudan Koalib 30.22 12.86 2 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Sudan Liguri/Logorik 30.22 12.86 2 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Sudan Mahas  32.53 15.59 30 0.00 0.00 0.17 0.00 0.00 0.17 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Africa Sudan Masalit 30.22 12.86 2 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Sudan Nuer 30.22 12.86 10 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Sudan Shaigi 30.00 20.00 18 0.00 0.17 0.06 0.00 0.00 0.22 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Africa Sudan Shilook 30.22 12.86 16 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Akie 34.89 -6.37 28 0.25 - 0.00 0.00 0.00 0.25 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Burunge 34.89 -6.37 36 0.38 - 0.00 0.00 0.00 0.38 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Chagga 38.05 -5.38 92 0.14 0.00 0.00 0.00 0.00 0.14 Jones (2012) PhD thesis, UCL, unpublished data. 
Africa Tanzania Datog 34.89 -6.37 8 0.63 - 0.00 0.00 0.00 0.63 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Dorobo 34.89 -6.37 20 0.40 - 0.00 0.00 0.00 0.40 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Fiome 34.89 -6.37 24 0.55 - 0.00 0.00 0.00 0.55 Tishkoff et al. (2007) Nat Genet. 39, 31 
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Africa Tanzania Hadza 34.89 -6.37 36 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Iraqw 34.89 -6.37 78 0.58 - 0.00 0.00 0.00 0.58 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Maasai 34.89 -6.37 38 0.45 - 0.00 0.00 0.00 0.45 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Mbugu 34.89 -6.37 60 0.31 - 0.00 0.00 0.00 0.31 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Mbugwe 34.89 -6.37 26 0.27 - 0.04 0.00 0.00 0.31 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Pare 34.89 -6.37 20 0.10 - 0.00 0.00 0.00 0.10 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Rangi 34.89 -6.37 70 0.27 - 0.00 0.00 0.00 0.27 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Samba'a 34.89 -6.37 6 0.00 - 0.00 0.00 0.00 0.00 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Tanzania Sandawe 34.89 -6.37 62 0.13 - 0.00 0.00 0.00 0.13 Tishkoff et al. (2007) Nat Genet. 39, 31 
Africa Uganda Bantu 32.98 0.43 44 - - - 0.00 - 0.00 Mulcare et al. (2004) Am J Hum Genet. 74, 1102. 
Asia Afghanistan Pashtuns/Afghans 68.36 33.56 32 0.00 0.00 0.00 0.06 0.00 0.06 Liebert (2013) this thesis 
Asia Afghanistan Tadjiks 68.71 36.13 28 0.00 0.00 0.00 0.25 0.00 0.25 Liebert (2013) this thesis 
Asia Afghanistan Tadjiks 68.71 36.13 80 - - - 0.08 - 0.08 Mulcare (2006) PhD thesis, UCL 
Asia Afghanistan Uzbeks 67.64 35.50 54 0.00 0.00 0.00 0.24 0.00 0.24 Liebert (2013) this thesis 
Asia Afghanistan Uzbeks 67.64 35.50 30 - - - 0.03 - 0.03 Mulcare (2006) PhD thesis, UCL 
Asia Armenia Armenians 45.04 40.07 88 - - - 0.01 - 0.01 Mulcare (2006) PhD thesis, UCL 
Asia Armenia Armenians 45.04 40.07 102 0.00 0.00 0.00 0.18 0.00 0.18 Liebert (2013) this thesis 
Asia Azerbaijan Azeri 47.58 40.14 80 0.00 0.00 0.00 0.01 0.00 0.01 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Asia Cambodia Cambodian 104.92 11.55 22 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Dai 102.83 24.88 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Daur 87.62 43.83 20 - - - 0.05 - 0.05 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Han 104.21 34.86 90 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Han 104.21 34.86 200 - - - 0.00 - 0.00 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia China Hezhen 132.50 47.70 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Hezhen 132.50 47.70 154 - - - 0.00 - 0.00 Sun et al. (2007) Asia Pac J Clin Nutr. 16, 598. 
Asia China Hezhen 132.50 47.70 196 0.00 - 0.00 - 0.00 0.00 Xu et al. (2010) Scand J Gastroentero. 45, 168. 
Asia China Kazak 81.30 43.90 188 - - - 0.05 - 0.05 Sun et al. (2007) Asia Pac J Clin Nutr. 16, 598. 
Asia China Kazak 81.30 43.90 194 0.00 - 0.00 - 0.00 0.00 Xu et al. (2010) Scand J Gastroentero. 45, 168. 
Asia China Lahu 102.83 24.88 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Man 123.20 40.20 130 - - - 0.00 - 0.00 Sun et al. (2007) Asia Pac J Clin Nutr. 16, 598. 
Asia China Man (Manchu) 123.20 40.20 216 0.00 - 0.00 - 0.00 0.00 Xu et al. (2010) Scand J Gastroentero. 45, 168. 
Asia China Miaozu 106.63 26.65 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Mongols 119.70 29.20 164 - - - 0.02 - 0.02 Sun et al. (2007) Asia Pac J Clin Nutr. 16, 598. 
Asia China Mongols 119.70 29.20 212 0.00 - 0.00 - 0.00 0.00 Xu et al. (2010) Scand J Gastroentero. 45, 168. 
Asia China Mongols 119.70 29.20 20 - - - 0.10 - 0.10 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Naxi 100.23 26.86 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Northern Han 126.53 45.80 138 0.00 - 0.00 - 0.00 0.00 Xu et al. (2010) Scand J Gastroentero. 45, 168. 
Asia China Oroqen 131.00 53.50 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Oroqen 131.00 53.50 90 - - - 0.01 - 0.01 Sun et al. (2007) Asia Pac J Clin Nutr. 16, 598. 
Asia China Oroqen 131.00 53.50 136 0.00 - 0.00 - 0.00 0.00 Xu et al. (2010) Scand J Gastroentero. 45, 168. 
Asia China She 119.65 27.09 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Tibetans (Nagqu) 92.07 31.48 418 0.00 0.00 0.00 0.00 0.00 0.00 Peng et al. (2012) J Hum Genet. 57, 394. 
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Asia China Tibetans (Shigatse) 88.88 29.27 572 0.00 0.00 0.00 0.00 0.00 0.00 Peng et al. (2012) J Hum Genet. 57, 394. 
Asia China Tu 101.78 36.62 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Tujia 112.94 28.23 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Uygur 87.62 43.83 20 - - - 0.05 - 0.05 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Xibo 123.43 41.81 18 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia China Yizu 103.77 29.55 20 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Georgia Georgians 43.35 42.32 108 0.00 0.00 0.00 0.08 0.00 0.08 Liebert (2013) this thesis 
Asia India 
Andaman and Nicobar 
Islands 92.77 11.67 68 0.00 0.00 0.00 0.02 0.00 0.02 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia India Central 79.45 23.84 358 0.00 0.00 0.00 0.06 0.00 0.06 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia India Dawoodi Bohra (Gujarat) 71.19 22.26 100 0.00 0.00 0.00 0.11 0.00 0.11 
Easwaarkanth et al. (2009) Eur J Hum Genet. 18, 
354 
Asia India 
Dawoodi Bohra (Tamil 
Nadu) 78.66 11.13 124 0.00 0.00 0.00 0.14 0.00 0.14 
Easwaarkanth et al. (2009) Eur J Hum Genet. 18, 
354 
Asia India East 85.02 20.80 620 0.00 0.00 0.00 0.02 0.00 0.02 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia India Indian Shia 80.10 27.57 142 0.00 0.00 0.00 0.10 0.00 0.10 
Easwaarkanth et al. (2009) Eur J Hum Genet. 18, 
354 
Asia India Indian Sunni 80.10 27.57 164 0.00 0.00 0.00 0.10 0.00 0.10 
Easwaarkanth et al. (2009) Eur J Hum Genet. 18, 
354 
Asia India Iranian Shia 80.10 17.05 98 0.00 0.00 0.00 0.04 0.00 0.04 
Easwaarkanth et al. (2009) Eur J Hum Genet. 18, 
354 
Asia India Mappla 78.66 11.13 124 0.00 0.00 0.00 0.02 0.00 0.02 
Easwaarkanth et al. (2009) Eur J Hum Genet. 18, 
354 
Asia India North 76.78 30.75 580 0.00 0.00 0.00 0.16 0.00 0.16 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia India North East 95.00 27.48 278 0.00 0.00 0.00 0.01 0.00 0.01 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia India North 77.20 28.60 120 0.00 0.00 0.00 0.20 0.00 0.20 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Asia India North (Lucknow) 80.95 26.85 154 0.00 0.00 0.00 0.19 0.00 0.19 Babu et al. (2010) Am J Clin Nutr. 91, 140 
Asia India South 77.57 12.97 1728 0.00 0.00 0.01 0.09 0.00 0.09 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia India South 80.28 13.08 102 0.00 0.00 0.00 0.12 0.00 0.12 Liebert (2013) this thesis 
Asia India South-Indian (Bangalore) 77.59 12.97 152 0.00 0.00 0.00 0.07 0.00 0.07 Babu et al. (2010) Am J Clin Nutr. 91, 140 
Asia India West 73.68 24.58 936 0.00 0.00 0.00 0.21 0.00 0.21 Galego Romero et al. (2012) Mol Biol Evol. 29, 249. 
Asia Mongolia Khalka 99.05 47.38 114 0.00 0.00 0.00 0.03 0.00 0.03 Liebert (2013) this thesis 
Asia Mongolia Mongols 106.92 47.92 52 0.00 0.00 0.00 0.04 0.00 0.04 Liebert (2013) this thesis 
Asia Nepal Nepalese 84.12 28.39 38 0.00 0.00 0.00 0.34 0.00 0.34 Liebert (2013) this thesis 
Asia Nepal Tharu 80.90 28.83 80 0.00 0.00 0.00 0.18 0.00 0.18 Liebert (2013) this thesis 
Asia Pakistan Balochi 67.02 30.21 50 - - - 0.36 - 0.36 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Balti 74.59 35.95 46 - - - 0.00 - 0.00 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Baluch 65.09 28.49 38 - - - 0.34 - 0.34 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Brahui 67.02 30.21 50 - - - 0.34 - 0.34 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Brahui 67.02 30.21 60 - - - 0.27 - 0.27 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Burusho 74.59 35.95 50 - - - 0.10 - 0.10 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Burusho 74.59 35.95 60 - - - 0.02 - 0.02 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
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Asia Pakistan Hazara 67.02 30.21 28 - - - 0.04 - 0.04 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Hazara 67.02 30.21 50 - - - 0.08 - 0.08 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Kalash 71.78 35.84 60 - - - 0.00 - 0.00 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Kalash 71.78 35.84 50 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Kashmiri 73.94 33.89 40 - - - 0.12 - 0.12 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Makrani   67.02 30.21 50 - - - 0.34 - 0.34 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Makrani Baluch 68.03 26.27 58 - - - 0.17 - 0.17 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Mohannes 68.00 26.00 58 - - - 0.28 - 0.28 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Parsi 68.00 26.00 58 - - - 0.14 - 0.14 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Pathan 69.86 32.67 56 - - - 0.30 - 0.30 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Pakistan Pathan 69.86 32.67 50 - - - 0.30 - 0.30 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Sindhi 67.03 24.89 50 - - - 0.32 - 0.32 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Pakistan Sindhi 67.03 24.89 56 - - - 0.41 - 0.41 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Russia Daghestans mixed 47.12 42.83 46 - - - 0.13 - 0.13 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Russia Druss 47.12 42.83 34 - - - 0.12 - 0.12 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Russia Nenets 49.02 67.66 178 - - - 0.07 - 0.73 Khabarova et al. (2012) Int J Circumpol Heal. 71, 1. 
Asia Russia Nog 47.12 42.83 40 - - - 0.07 - 0.07 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Russia North-Yakuts 146.19 70.77 22 0.00 0.00 0.00 0.14 0.00 0.14 Liebert (2013) this thesis 
Asia Russia Ob-Ugric 68.00 65.00 40 - - - 0.03 - 0.03 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Russia Udmurts 53.18 56.83 60 - - - 0.33 - 0.33 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia Russia Yakuts 129.73 62.03 50 - - - 0.06 - 0.06 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Asia Russia Yakuts 129.73 62.03 110 0.00 0.00 0.00 0.05 0.00 0.05 Liebert (2013) this thesis 
Asia Singapore Han-Chinese 104.21 35.86 98 0.00 0.00 0.00 0.04 0.00 0.04 Liebert (2013) this thesis 
Asia Singapore Japanese 138.24 36.21 84 0.00 0.00 0.00 0.00 0.00 0.00 Liebert (2013) this thesis 
Asia South Korea South Korean 127.00 35.57 46 - - - 0.00 - 0.00 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Asia 
Syria, Iraq, Lebanon, 
West Bank Arabs 40.00 33.00 40 0.00 0.00 0.11 0.13 0.00 0.24 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Asia Uzbekistan Kazakh 63.46 40.13 166 - - - 0.16 - 0.16 Heyer et al. (2011) Hum Biol. 83, 379.  
Asia Uzbekistan Tajiko-Uzbek 64.42 39.77 200 - - - 0.10 - 0.10 Heyer et al. (2011) Hum Biol. 83, 379.  
Asia Uzbekistan Uzbeks 64.59 41.38 76 0.00 0.00 0.00 0.04 0.00 0.04 Liebert (2013) this thesis 
Austalasia Papua New Guinea Papuan 140.71 -5.09 34 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Australasia Solomon Islands Melanesian (NAN) 155.19 -6.05 44 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Belarus Belarusians 27.95 53.71 100 0.00 0.00 0.00 0.23 0.00 0.23 Liebert (2013) this thesis 
Europe England (Central) British -2.76 52.71 1368 - - - 0.76 - 0.76 Davey Smith et al. (2009) Eur J Hum Genet. 17, 357. 
Europe England (Northern) British -1.54 53.99 2336 - - - 0.75 - 0.75 Davey Smith et al. (2009) Eur J Hum Genet. 17, 357. 
Europe 
England 
(Southeastern) British -0.57 51.22 1894 - - - 0.70 - 0.70 Davey Smith et al. (2009) Eur J Hum Genet. 17, 357. 
Europe Estonia Estonians 26.40 59.05 628 0.00 0.00 0.00 0.51 0.00 0.51 Lember (2006) World J Gastroentero. 12, 7329. 
Europe Finland Finns  28.00 65.00 1876 0.00 0.00 0.00 0.58 0.00 0.58 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Europe Finland Saami 26.19 68.26 60 - - - 0.17 - 0.17 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Finland and Sweden Scandinavians 18.05 59.33 360 - - - 0.82 - 0.82 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Finns Finns, eastern 29.00 65.00 154 - - - 0.55 - 0.55 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Finns Finns, western 24.00 64.00 308 - - - 0.62 - 0.62 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
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Europe France Basques -1.45 43.40 48 - - - 0.67 - 0.67 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe France Basques -1.45 43.40 170 - - - 0.66 - 0.66 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe France French 2.22 46.23 58 - - - 0.43 - 0.43 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe France French 2.22 46.23 34 - - - 0.34 - 0.34 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Germany Germans 10.45 51.17 60 0.00 0.00 0.00 0.55 0.00 0.55 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Europe Germany Sorbs 14.31 51.26 64 0.00 0.00 0.00 0.50 0.00 0.50 Liebert (2013) this thesis 
Europe Greece Greeks 21.83 39.07 200 - - - 0.09 - 0.09 Anagnostou et al. (2009) Am J Hum Biol. 21, 217. 
Europe Greece Greeks 21.83 39.07 120 0.00 0.00 0.00 0.15 0.00 0.15 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Europe Hungary Hungarian 20.17 46.25 220 - - - 0.62 - 0.62 Nagy et al. (2009) Eur J Clin Nutr. 63, 909. 
Europe Hungary Hungarian 20.17 46.25 362 - - - 0.36 - 0.36 Nagy et al. (2011) Am J Phys Anthr. 145, 262. 
Europe Ireland Irish -8.00 53.33 68 0.00 0.00 0.00 0.96 0.00 0.96 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Europe Italy Central 12.48 41.90 196 - - - 0.11 - 0.11 Anagnostou et al. (2009) Am J Hum Biol. 21, 217. 
Europe Italy Central-North 11.25 43.77 412 - - - 0.13 - 0.13 Anagnostou et al. (2009) Am J Hum Biol. 21, 217. 
Europe Italy Italians 13.91 42.22 134 - - - 0.13 - 0.13 Coelho et al. (2005) Hum Genet. 117, 329 
Europe Italy North Italian 9.68 45.70 28 - - - 0.36 - 0.36 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Italy North-Eastern 12.33 45.44 438 - - - 0.24 - 0.24 Anagnostou et al. (2009) Am J Hum Biol. 21, 217. 
Europe Italy S. European 12.48 41.90 66 0.00 0.00 0.00 0.09 0.00 0.09 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Europe Italy Sardinian 9.12 39.22 306 - - - 0.07 - 0.07 Anagnostou et al. (2009) Am J Hum Biol. 21, 217. 
Europe Italy Sardinian 9.12 39.22 56 - - - 0.07 - 0.07 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Italy South Italians 16.25 39.30 200 - - - 0.05 - 0.05 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Italy Southern 16.25 39.30 378 - - - 0.08 - 0.08 Anagnostou et al. (2009) Am J Hum Biol. 21, 217. 
Europe Italy Tuscan 10.98 43.57 16 - - - 0.06 - 0.06 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Italy Tyroleans Bozen 11.35 46.50 80 0.00 0.00 0.00 0.15 0.00 0.15 Liebert (2013) this thesis 
Europe Italy Tyroleans Gadertal 11.92 46.72 76 0.00 0.00 0.00 0.42 0.00 0.42 Liebert (2013) this thesis 
Europe Italy Tyroleans Vinschgau 10.77 46.63 102 0.00 0.00 0.00 0.36 0.00 0.36 Liebert (2013) this thesis 
Europe Macedonia Macedonians 21.75 41.61 100 0.00 0.00 0.00 0.24 0.00 0.24 Liebert (2013) this thesis 
Europe Mixed N. European 15.00 54.00 110 0.00 0.00 0.00 0.62 0.00 0.62 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Europe Netherlands Frisians 5.80 53.20 58 0.00 0.00 0.00 0.81 0.00 0.81 Liebert (2013) this thesis 
Europe Norway Norwegians 8.47 60.47 88 0.00 0.00 0.00 0.84 0.00 0.84 Liebert (2013) this thesis 
Europe Poland Ashkenazi-Jews 21.00 52.25 96 - - - 0.08 - 0.08 Mulcare (2006) PhD thesis, UCL 
Europe Poland Polish 19.15 51.92 400 - - - 0.46 - 0.46 Madry et al. (2010) Acta Biochim Pol. 57, 585 
Europe Poland Polish 19.15 51.92 446 - - 0.00 0.30 0.00 0.30 Płoszaj et al. ;ϮϬϭϭͿ Cent Eur J Biol. ϲ, ϭϳϲ. 
Europe Portugal Portuguese -8.22 39.40 96 0.00 0.00 0.00 0.44 0.00 0.44 Liebert (2013) this thesis 
Europe Portugal Portuguese-Centre -7.50 40.28 140 - - - 0.39 - 0.39 Manco et al. (2012) Ann Hum Biol. 40, 205. 
Europe Portugal Portuguese-North -8.42 41.55 128 - - - 0.38 - 0.38 Manco et al. (2012) Ann Hum Biol. 40, 205. 
Europe Portugal Portuguese-North -8.42 41.55 180 - - - 0.37 - 0.37 Coelho et al. (2005) Hum Genet. 117, 329 
Europe Portugal Portuguese-South -7.83 38.52 130 - - - 0.27 - 0.27 Manco et al. (2012) Ann Hum Biol. 40, 205. 
Europe Romania Romanians 24.97 45.94 118 0.00 0.00 0.00 0.17 0.00 0.17 Liebert (2013) this thesis 
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Europe 
Romania (Eastern 
Trasylvania) Seklers 25.79 45.86 130 - - - 0.40 - 0.40 Nagy et al. (2011) Am J Phys Anthr. 145, 262. 
Europe Russia Erzya 43.58 54.21 60 - - - 0.27 - 0.27 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Russia Erzya 43.58 54.21 42 0.00 0.00 0.00 0.14 0.00 0.14 Liebert (2013) this thesis 
Europe Russia Moksha 44.07 54.24 32 0.00 0.00 0.00 0.41 0.00 0.41 Liebert (2013) this thesis 
Europe Russia Moksha 44.07 54.24 60 - - - 0.28 - 0.28 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Russia Russian 37.62 55.75 50 - - - 0.24 - 0.24 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Russia Russians (Northwest) 40.53 64.53 298 0.00 0.00 0.00 0.39 0.00 0.39 
Khabarova et al. (2009) World J Gastroentero. 15, 
1849. 
Europe Russia Russians Perm 56.25 58.01 46 0.00 0.00 0.00 0.24 0.00 0.24 Liebert (2013) this thesis 
Europe 
Russia (Komi 
republic) Komi 54.83 63.86 20 - - - 0.15 - 0.15 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Europe Russian (Caucasus) Adygei 40.08 44.60 34 - - - 0.12 - 0.12 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Scotland British -3.78 56.00 1032 - - - 0.82 - 0.82 Davey Smith et al. (2009) Eur J Hum Genet. 17, 357. 
Europe Slovakia Roma 19.70 48.67 64 0.00 0.00 0.00 0.06 0.00 0.06 Liebert (2013) this thesis 
Europe Slovakia Roma 19.70 48.67 108 - - - 0.11 - 0.11 Mulcare (2006) PhD thesis, UCL 
Europe Spain Catalans 1.52 41.59 58 0.00 0.00 0.00 0.26 0.00 0.26 Liebert (2013) this thesis 
Europe Spain Spanish -3.70 40.51 1718 - - - 0.39 - 0.39 Agueda et al. (2010) Caclif Tissue Int. 87, 14. 
Europe Spain Spanish -3.70 40.51 62 0.00 0.00 0.00 0.40 0.00 0.40 Liebert (2013) this thesis 
Europe Sweden Sami 20.87 67.87 60 0.00 0.00 0.00 0.29 0.00 0.29 Liebert (2013) this thesis 
Europe Sweden Swedes 15.01 60.03 784 - - - 0.74 - 0.74 Almon et al. (2007) Scand J Gastroenterol. 42, 165. 
Europe Sweden Swedes 15.01 60.03 74 0.00 0.00 0.00 0.78 0.00 0.78 Liebert (2013) this thesis 
Europe UK Ashkenazi-Jews -0.30 51.51 38 0.00 0.00 0.00 0.11 0.00 0.11 Liebert (2013) this thesis 
Europe UK English -0.12 51.51 102 0.00 0.00 0.00 0.75 0.00 0.75 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Europe UK Orcadian (Orkney Islands) -3.15 59.04 32 - - - 0.69 - 0.69 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Europe Ukraine Ukrainians 31.17 48.38 92 - - - 0.22 - 0.22 Mulcare (2006) PhD thesis, UCL 
Europe Ukraine Ukrainians 31.17 48.38 74 0.00 0.00 0.00 0.26 0.00 0.26 Liebert (2013) this thesis 
Middle East Cyprus Greek-Cypriots 33.02 34.71 120 0.00 0.00 0.00 0.01 0.00 0.01 Liebert (2013) this thesis 
Middle East Iran Iranians 53.69 32.43 42 0.00 0.00 0.00 0.10 0.00 0.10 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Middle East Iran Iranians 53.69 32.43 154 0.00 0.00 0.01 0.03 0.00 0.04 
Liebert (2013) this thesis, Mulcare (2006) PhD 
thesis, UCL 
Middle East Iran Iranians 53.69 32.43 42 - - - 0.10 - 0.10 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Middle East Iran Qashqai 52.53 29.62 20 - - - 0.05 - 0.05 Enattah et al. (2007) Am J Hum Genet. 81, 615. 
Middle East Israel Ashkenazi-Jews 34.77 32.07 192 - - - 0.09 - 0.09 Raz et al. (2013) Gene. 519, 67. 
Middle East Israel Bedouin 34.88 30.71 98 - - - 0.03 - 0.03 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Middle East Israel Bedouin Israeli 34.77 32.07 38 0.00 0.00 0.13 0.03 0.00 0.16 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Middle East Israel Bedouin Arabs 34.77 32.07 302 - - 0.28 0.02 - 0.02 Raz et al. (2013) Gene. 519, 67. 
Middle East Israel Druze 34.77 32.07 96 - - - 0.02 - 0.02 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Middle East Israel Druze 34.77 32.07 28 0.00 0.00 0.11 0.04 0.00 0.14 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Middle East Israel Iraqi Jews 34.77 32.07 192 - - - 0.04 - 0.04 Raz et al. (2013) Gene. 519, 67. 
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Middle East Israel Moroccan 34.77 32.07 192 - - - 0.09 - 0.09 Raz et al. (2013) Gene. 519, 67. 
Middle East Israel Palestinian Arabs 35.20 31.90 102 - - - 0.04 - 0.04 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Middle East Israel Urban Arabs 34.77 32.07 84.00 0.00 0.01 0.01 0.02 0.00 0.05 Liebert (2013) this thesis 
Middle East Israel Urban Arabs 34.77 32.07 162 0.00 0.01 0.06 0.00 0.00 0.06 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Middle East Israel/PAA Palestinian Arabs 35.20 31.90 36 0.00 0.00 0.00 0.00 0.00 0.00 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Middle East Japan Japanese 138.24 37.21 62 - - - 0.00 - 0.00 Bersaglieri et al. (2004) Am J Hum Genet. 74, 1111.  
Middle East Jordan Jordanian 35.93 31.95 112 0.00 0.00 0.05 0.05 0.00 0.11 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Middle East Jordan Jordanian 36.24 30.59 46 0.00 0.00 0.35 0.00 0.00 0.35 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Middle East Kurwait Ajman 48.00 28.83 74 0.00 0.00 0.06 0.00 0.00 0.06 
Hill et al. (2013) Am J Phys Anthr. (Epub ahead of 
print) 
Middle East Kuwait Kuwaiti 47.48 29.31 66 0.00 0.02 0.25 0.03 0.00 0.30 Liebert (2013) this thesis 
Middle East Kuwait Kuwaiti 47.48 29.31 28 - - - 0.00 - 0.00 Mulcare (2006) PhD thesis, UCL 
Middle East Kuwait Mutran 47.94 29.24 58 0.00 0.00 0.55 0.00 0.03 0.58 
Hill et al. (2013) Am J Phys Anthr. (Epub ahead of 
print) 
Middle East Oman Arabs of Northern Oman 57.01 23.88 684 0.00 0.00 0.14 0.01 0.00 0.15 Al-Abri et al. (2012) Hum Biol. 84, 271. 
Middle East Oman 
Dhofaris Arabs of 
Southern Oman 54.43 18.40 420 0.00 0.00 0.72 0.00 0.00 0.72 Al-Abri et al. (2012) Hum Biol. 84, 271. 
Middle East Oman Omani 58.50 23.53 104 0.00 0.00 0.77 0.03 0.00 0.80 Al-Abri et al. (2013) Oman Med J. 28, 341. 
Middle East Saudi Arabia Bedouin  45.00 23.00 94 0.00 0.00 0.48 0.00 0.00 0.48 
Ingram et al. (2007) Hum Genet. 120, 779, Ingram 
(2008) PhD thesis UCL 
Middle East Saudi Arabia Central  46.72 24.71 180 0.00 0.00 0.61 0.00 0.00 0.61 Imtiaz et al. (2007) J Med Genet. 44, e89. 
Middle East Saudi Arabia Eastern  50.68 22.30 164 0.00 0.00 0.62 0.00 0.00 0.62 Imtiaz et al. (2007) J Med Genet. 44, e89. 
Middle East Saudi Arabia Northern 39.32 29.89 164 0.00 0.00 0.52 0.01 0.00 0.53 Imtiaz et al. (2007) J Med Genet. 44, e89. 
Middle East Saudi Arabia Southern 44.13 17.49 184 0.00 0.00 0.58 0.00 0.00 0.58 Imtiaz et al. (2007) J Med Genet. 44, e89. 
Middle East Saudi Arabia Western 39.82 21.42 172 0.00 0.00 0.65 0.01 0.00 0.65 Imtiaz et al. (2007) J Med Genet. 44, e89. 
Middle East Saudi Arabia  Arabs 45.00 23.00 248 0.00 0.00 0.57 0.00 0.01 0.58 Enattah et al. (2008) Am J Hum Genet. 82, 57. 
Middle East Syria Assyrians 36.30 33.50 80 - - - 0.04 - 0.04 Mulcare (2006) PhD thesis, UCL 
Middle East Syria Syrians 39.00 34.80 140 0.00 0.00 0.03 0.02 0.00 0.05 Liebert (2013) this thesis 
Middle East Turkey Anatolian-Turks 31.33 38.99 98 - - - 0.03 - 0.03 Mulcare (2006) PhD thesis, UCL 
Middle East Turkey Anatolian-Turks 31.33 38.99 116 0.00 0.00 0.00 0.08 0.00 0.08 Liebert (2013) this thesis 
Middle East Yemen Yemeni_Hadramaut 49.37 16.93 166 0.01 0.00 0.24 0.02 0.01 0.28 Liebert (2013) this thesis 
Middle East Yemen Yemeni_Sena 44.21 15.35 68 0.00 0.00 0.29 0.15 0.00 0.44 Liebert (2013) this thesis 
Middle East Yemen 
Yemeni (Sana'a 
University) 44.21 15.35 478 0.00 0.00 0.55 0.00 0.00 0.55 Al-Abri et al. (2012) Hum Biol. 84, 271. 
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Appendix B2: Lactase persistence phenotype data. Test methods: BH: breath hydrogen, BG: blood glucose, UG: urine galactose. 
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Africa Botswana Shua 28.63 -23.04 22.00 0.09 BG Nurse & Jenkins (1974) Br Med J. 2, 728. 
Africa Egypt Cairo and Giza 31.25 30.05 67.00 0.33 BH Hussein et al. (1982) Hum Hered. 32, 94. 
Africa Egypt Nile Delta 32.00 31.50 291.00 0.27 BH Hussein et al. (1982) Hum Hered. 32, 94. 
Africa Egypt Suez Canal Zone 32.50 31.00 16.00 0.31 BH Hussein et al. (1982) Hum Hered. 32, 94. 
Africa Egypt Upper Egypt, North 28.00 31.00 111.00 0.15 BH Hussein et al. (1982) Hum Hered. 32, 94. 
Africa Egypt Upper Egypt, South 28.00 28.00 85.00 0.40 BH Hussein et al. (1982) Hum Hered. 32, 94. 
Africa Ethiopia Amhara (phenotyped) 38.66 9.87 94.00 0.34 BH Jones et al. (2013) Am J Hum Genet. 93, 538. 
Africa Ethiopia Ethiopians 42.13 9.31 294.00 0.45 BH Jones et al. (2013) Am J Hum Genet. 93, 538. 
Africa Ethiopia Oromo (phenotyped) 37.31 7.84 132.00 0.41 BH Jones et al. (2013) Am J Hum Genet. 93, 538. 
Africa Ethiopia Somali 41.86 9.59 90.00 0.24 BH Ingram (2009) J Mol Evol. 69, 579. 
Africa Ethiopia Somali 41.87 9.58 130.00 0.25 BH Jones et al. (2013) Am J Hum Genet. 93, 538. 
Africa Ethiopia Tigray 39.47 13.50 78.00 0.62 BH Jones et al. (2013) Am J Hum Genet. 93, 538. 
Africa Ethiopia Wolayta 37.76 6.84 40.00 0.40 BH Jones et al. (2013) Am J Hum Genet. 93, 538. 
Africa Gabon Bantu 9.45 0.38 20.00 0.40 BH Gendrel et al. (1989) J Pediatr Gastroenterol Nutr. 8, 545. 
Africa Kenya Borana 37.91 -0.02 7.00 0.71 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Burji 37.91 -0.02 6.00 0.50 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya El Molo 37.91 -0.02 6.00 0.67 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Gabra 37.91 -0.02 8.00 1.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Kikuyu 37.91 -0.02 2.00 0.50 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Konso 37.91 -0.02 4.00 0.50 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Maasai 37.91 -0.02 26.00 0.88 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Marakwet 37.91 -0.02 5.00 0.60 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Nandi 37.91 -0.02 2.00 0.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Ogiek 37.91 -0.02 11.00 0.55 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Pokot 37.91 -0.02 10.00 0.60 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Rendille 37.91 -0.02 7.00 0.71 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Sabaot 37.91 -0.02 4.00 0.75 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Samburu 37.91 -0.02 9.00 0.89 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Sengwer 37.91 -0.02 12.00 0.17 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Somali 37.91 -0.02 1.00 1.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Tugen 37.91 -0.02 11.00 0.73 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Turkana 37.91 -0.02 8.00 0.50 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Wata 37.91 -0.02 1.00 0.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Kenya Yaaku 37.91 -0.02 11.00 0.73 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
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Africa Namibia !Kung 20.50 -19.60 40.00 0.03 BG Jenkins et al. (1974) Br Med J. 2, 23. 
Africa Namibia Herero 13.70 -18.30 39.00 0.03 BG Currie et al. (1978) S Afr J Sci. 74, 227. 
Africa Niger  Tuareg 2.12 13.52 118.00 0.87 BH Flatz et al. (1986) Am J Hum Genet. 38, 515. 
Africa Nigeria Hausa/Fulani 3.47 7.23 15.00 0.40 BG Olatunbosun et al. (1971) Am J Dig Dis. 16, 909. 
Africa Nigeria Ibo 3.47 7.23 11.00 0.18 BG Olatunbosun et al. (1971) Am J Dig Dis. 16, 909. 
Africa Nigeria Yoruba 3.47 7.23 48.00 0.17 BG Olatunbosun et al. (1971) Am J Dig Dis. 16, 909. 
Africa Rwanda Hutu-Hutu 29.74 -2.60 36.00 0.58 UG Cox et al. (1974) Am J Dig Dis. 19, 714. 
Africa Rwanda Hutu-Tutsi 29.74 -2.60 11.00 0.45 UG Cox et al. (1974) Am J Dig Dis. 19, 714. 
Africa Rwanda Shi 29.74 -2.60 28.00 0.04 UG Cox et al. (1974) Am J Dig Dis. 19, 714. 
Africa Rwanda Tussi-Tutsi 29.74 -2.60 27.00 0.93 UG Cox et al. (1974) Am J Dig Dis. 19, 714. 
Africa Senegal Diolas -16.25 12.60 40.00 0.73 BG Arnold et al. (1980) C R Seances Soc Biol Fil. 174, 983. 
Africa Senegal Peuhls -15.12 15.40 29.00 1.00 BG Arnold et al. (1980) C R Seances Soc Biol Fil. 174, 983. 
Africa Senegal Sereres -17.43 14.67 38.00 0.71 BG Arnold et al. (1980) C R Seances Soc Biol Fil. 174, 983. 
Africa Senegal Toucouleurs -17.43 14.67 40.00 0.90 BG Arnold et al. (1980) C R Seances Soc Biol Fil. 174, 983. 
Africa Senegal Wolof -17.43 14.67 53.00 0.51 BG Arnold et al. (1980) C R Seances Soc Biol Fil. 174, 983. 
Africa South Africa Shangaan 28.08 -26.20 7.00 0.14 BH Segal et al. (1983) Am J Clin Nutr. 38, 901. 
Africa South Africa Sotho 28.08 -26.20 23.00 0.35 BH Segal et al. (1983) Am J Clin Nutr. 38, 901. 
Africa South Africa Swazi 28.08 -26.20 12.00 0.25 BH Segal et al. (1983) Am J Clin Nutr. 38, 901. 
Africa South Africa Tswana 28.08 -26.20 24.00 0.17 BH Segal et al. (1983) Am J Clin Nutr. 38, 901. 
Africa South Africa Xhosa 28.08 -26.20 17.00 0.18 BH Segal et al. (1983) Am J Clin Nutr. 38, 901. 
Africa South Africa Zulu 31.02 -29.85 47.00 0.11 BG O'Keefe & Adam (1983) S Afr Med J. 63, 778. 
Africa South Africa Zulu 28.08 -26.20 32.00 0.19 BH Segal et al. (1983) Am J Clin Nutr. 38, 901. 
Africa Sudan Ama 30.22 12.86 2.00 0.50 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Amarar 37.22 19.62 82.00 0.87 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Artega 36.22 19.62 22.00 0.82 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Bedja 30.95 18.05 9.00 0.89 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Beja Banuamir 30.22 12.86 6.00 1.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Beja Hadandawa 30.22 12.86 11.00 0.82 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Beni Amir 37.22 19.62 40.00 0.88 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Bisharin 37.22 19.62 22.00 0.86 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Dinka 30.22 12.86 7.00 0.86 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Dinka 33.63 7.67 208.00 0.25 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Dongolawi 30.95 18.05 16.00 0.19 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Gomoeia 30.95 18.05 31.00 0.68 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Habbani 30.35 13.08 19.00 0.47 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Haddendoa 37.22 19.62 137.00 0.80 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Jaali 32.53 15.59 113.00 0.53 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Jaali 33.43 16.69 94.00 0.48 BH Ingram et al. (2007) Hum Genet. 120, 779. 
Africa Sudan Kahli 30.95 18.05 21.00 0.62 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Koalib 30.22 12.86 1.00 1.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Liguri/Logorik 30.22 12.86 1.00 0.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Masalit 30.22 12.86 1.00 1.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Misseri 30.35 13.08 20.00 0.40 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
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Africa Sudan Nilotic 27.67 7.77 18.00 0.33 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Nuba 29.68 16.80 58.00 0.21 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Nubians  30.95 18.05 21.00 0.33 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Nuer 30.22 12.86 2.00 1.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Sudan Nuer 33.63 7.67 23.00 0.22 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Shaygi 30.95 18.05 42.00 0.38 BH Bayoumi et al. (1981) Hum Genet. 57, 279. 
Africa Sudan Shilluk 33.63 7.67 8.00 0.38 BH Bayoumi et al. (1982) Am J Phys Anthropol. 58, 173. 
Africa Sudan Shilook 30.22 12.86 4.00 0.75 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Akie 34.89 -6.37 11.00 0.55 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Burunge 34.89 -6.37 16.00 0.38 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Datog 34.89 -6.37 1.00 0.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Dorobo 34.89 -6.37 6.00 0.67 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Fiome 34.89 -6.37 7.00 0.14 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Hadza 34.89 -6.37 15.00 0.60 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Iraqw 34.89 -6.37 19.00 0.95 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Maasai 34.89 -6.37 15.00 0.67 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Mbugu 34.89 -6.37 23.00 0.43 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Mbugwe 34.89 -6.37 8.00 0.50 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Pare 34.89 -6.37 8.00 0.75 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Rangi 34.89 -6.37 26.00 0.65 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Samba'a 34.89 -6.37 2.00 0.00 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tanzania Sandawe 34.89 -6.37 23.00 0.35 BG Tishkoff et al. (2007) Nat Genet. 39, 31. 
Africa Tunisia Tunisian 10.18 36.80 43.00 0.16 BH Filali et al. (1987) Gastroenterol Clin Biol. 11, 554. 
Africa Uganda Baganda 32.57 0.32 12.00 0.00 BG Cook & Dahlquist (1968) Gastroenterol. 55, 328. 
Africa Uganda Batutsi 32.57 0.32 5.00 1.00 BG Cook & Dahlquist (1968) Gastroenterol. 55, 328. 
Africa Uganda Nilotic 32.57 0.32 9.00 0.56 BG Cook et al. (1966) Lancet. 1, 725. 
Africa Uganda Ugandan Bantu 32.57 0.32 17.00 0.06 BG Cook et al. (1966) Lancet. 1, 725. 
Africa Zambia Bantu of Zambia 28.11 -15.28 26.00 0.00 BG Cook et al. (1973) Gastroenterol. 64, 405. 
Asia Afghanistan Hazara 69.18 34.52 10.00 0.20 BG Rahimi et al. (1976) HumGenet. 34, 57. 
Asia Afghanistan Mixed urban 69.18 34.52 34.00 0.24 BG Rahimi et al. (1976) HumGenet. 34, 57. 
Asia Afghanistan Pasha-I 71.00 36.00 60.00 0.13 BG Rahimi et al. (1976) HumGenet. 34, 57. 
Asia Afghanistan Pashtun 69.18 34.52 71.00 0.21 BG Rahimi et al. (1976) HumGenet. 34, 57. 
Asia Afghanistan Tajik 69.18 34.52 79.00 0.18 BG Rahimi et al. (1976) HumGenet. 34, 57. 
Asia Afghanistan Uzbek 69.18 34.52 16.00 0.00 BG Rahimi et al. (1976) HumGenet. 34, 57. 
Asia China Kazakh 87.58 43.80 195.00 0.24 BH Yongfa et al. (1984) Hum Genet. 67, 103. 
Asia China Mongols 111.65 40.81 198.00 0.12 BH Yongfa et al. (1984) Hum Genet. 67, 103. 
Asia China Northern Han 116.39 39.93 248.00 0.08 BH Yongfa et al. (1984) Hum Genet. 67, 103. 
Asia India Indians 72.83 18.98 100.00 0.36 BG Desai et al. (1970) Indian J Med Sci. 24, 729. 
Asia India Indians 78.47 17.38 18.00 0.39 BG Reddy & Pershad (1972) Am J Clin Nutr. 25, 114. 
Asia India Indians 80.28 13.80 38.00 0.00 Biopsy Swaminathan et al. (1970) Clin Chim Acta. 30, 707. 
Asia India Northern Indians 77.20 28.60 70.00 0.73 BG Gupta et al. (1971) J Trop Med Hyg. 74, 225. 
Asia Japan Japanese 140.47 40.59 40.00 0.28 BG Yoshida et al. (1975) Gastroenterol Jpn. 10, 29. 
Asia Myanmar Burmese 95.96 21.91 50.00 0.08 BG Aung-Than-Batu et al. (1972) Union Burma J Life Sci. 5, 133. 
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Asia Pakistan Baloochi 67.05 24.87 4.00 1.00 BG Rab et al. (1976) Br Med J. 1, 436. 
Asia Pakistan Baluchistani 71.92 32.27 32.00 0.38 BH Ahmad & Flatz (1984) Hum Hered. 34, 69. 
Asia Pakistan Kashmiri 71.92 32.27 27.00 0.30 BH Ahmad & Flatz (1984) Hum Hered. 34, 69. 
Asia Pakistan Mohajir 67.05 24.87 15.00 0.80 BG Rab et al. (1976) Br Med J. 1, 436. 
Asia Pakistan Pathan 67.05 24.87 15.00 1.00 BG Rab et al. (1976) Br Med J. 1, 436. 
Asia Pakistan Punjabi 71.92 32.27 322.00 0.41 BH Ahmad & Flatz (1984) Hum Hered. 34, 69. 
Asia Pakistan Punjabi 67.05 24.87 9.00 1.00 BG Rab et al. (1976) Br Med J. 1, 436. 
Asia Pakistan Punjabi 73.07 33.60 53.00 0.55 BG Abbas & Ahmad (1983) Hum Genet. 64, 277. 
Asia Pakistan Sindhi 71.92 32.27 33.00 0.42 BH Ahmad & Flatz (1984) Hum Hered. 34, 69. 
Asia Pakistan Sindhi 67.05 24.87 12.00 1.00 BG Rab et al. (1976) Br Med J. 1, 436. 
Asia Russia Khanty (Northern) 69.02 61.04 115.00 0.29 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Asia Russia Komi-Izhems 50.81 61.67 56.00 0.38 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Asia Russia Mansi 66.95 56.96 81.00 0.28 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Asia Russia Nenets (West Siberia) 80.86 59.06 9.00 0.22 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Asia Russia Udmurtians 53.23 56.85 30.00 0.60 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Asia Russia West-Siberian 80.86 59.06 47.00 0.51 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Asia Sri Lanka Sri Lankan 80.64 7.30 135.00 0.29 BG Thomas et al. (1990) J Trop Pediatr. 36, 80. 
Asia Sri Lanka Sri Lankans ("Ceylonese") 80.60 7.26 200.00 0.28 BG Senewiratne et al. (1977) Gastroenterol. 72, 1257. 
Asia Taiwan Chinese 121.45 25.02 50.00 0.12 BG Sung et al. (1972) Asian J Med. 8, 149. 
Asia Thailand Thai 100.52 13.75 140.00 0.03 BG Keusch et al. (1969) Am J Clin Nutr. 22, 638. 
Asia Thailand Thai 100.49 13.45 40.00 0.00 BG Troncale et al. (1967) Br Med J. 4, 578. 
Australasia Australia Aboriginal 123.97 -17.30 45.00 0.16 BH Brand et al. (1983) Am J Clin Nutr. 37, 449. 
Australasia New Zealand Maori 174.77 -36.87 28.00 0.36 BH Abbott & Tasman-Jones (1985) N Z Med J. 10, 228. 
Australasia Papua New Guinea Central (inc. Port Moresby) 147.19 -9.46 14.00 0.07 BG Cook (1979) Ann Hum Biol. 6, 55. 
Australasia Papua New Guinea E and W Sepik provinces 143.52 -4.18 35.00 0.23 BH Arnhold et al. (1981) Ann Hum Biol. 5, 481 
Australasia Papua New Guinea Gulf & Western 147.19 -9.46 13.00 0.08 BG Cook (1979) Ann Hum Biol. 6, 55. 
Australasia Papua New Guinea Highlands 147.19 -9.46 13.00 0.00 BG Cook (1979) Ann Hum Biol. 6, 55. 
Australasia Papua New Guinea Huli, Mendi, and Dunai  142.95 -5.70 30.00 0.10 BG Jenkins et al. (1981) Ann Hum Biol. 8, 447. 
Australasia Papua New Guinea Milne Bay 150.60 -10.51 2.00 0.00 BG Cook (1979) Ann Hum Biol. 6, 55. 
Australasia Papua New Guinea Morobe & Northern 147.19 -9.46 5.00 0.00 BG Cook (1979) Ann Hum Biol. 6, 55. 
Australasia Papua New Guinea N. Solomons & E. New Britain 147.19 -9.46 3.00 0.00 BG Cook (1979) Ann Hum Biol. 6, 55. 
Europe Austria Austrian 14.00 47.75 118.00 0.75 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Austria Austrian 14.00 47.75 57.00 0.79 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Austria Austrian 14.00 47.75 88.00 0.80 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Austria Austrian 14.00 47.75 32.00 0.81 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Austria Karnten Austrian 14.31 46.62 46.00 0.80 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Austria Oberosterreich Austrian 14.30 48.30 45.00 0.84 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Austria Tirol Austrian 9.77 47.50 124.00 0.83 BH Rosenkranz et al. (1982) Hum Genet. 62, 158. 
Europe Cyprus Greek Cypriots 33.37 35.17 50.00 0.34 BG Kanaghinis et al. (1974) Am J Dig Dis. 19, 1021. 
Europe Czech Republic Czech 15.50 49.00 17.00 0.82 BG Leichter (1972) Am J Dig Dis. 17, 73. 
Europe Denmark Danes 12.58 55.73 91.00 0.96 BG Busk et al. (1975) Ugeskr Laeger. 137, 2062. 
Europe Estonia Estonian 26.40 59.05 112.00 0.75 BG Lember et al. (1991) Eur J Gastroenterol Hepatol. 3, 479. 
Europe Estonia Setus 27.64 57.96 100.00 0.51 UG Lember et al. (1991) Eur J Gastroenterol Hepatol. 3, 479. 
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Europe Finland Finnish-speaking Finns 21.43 60.60 91.00 0.92 BG Sahi (1974) Scand J Gastroenterol. 9, 303. 
Europe Finland Finns 27.68 62.90 638.00 0.83 Biopsy Jussila (1969) Ann Clin Res. 1, 199. 
Europe Finland Rural Finn 21.93 60.41 159.00 0.83 BG Jussila  et al. (1970) Scand J Gastroenterol. 5, 49. 
Europe Finland Swedish-speaking Finns 21.43 60.60 156.00 0.83 BG Sahi (1974) Scand J Gastroenterol. 9, 303. 
Europe France French 5.82 44.93 102.00 0.76 BH Cloarec et al. (1991) Gastroenterol Clin Biol. 15, 588. 
Europe France French 6.63 49.75 85.00 0.71 BH Cuddenec et al. (1982) Gastroenterol Clin Biol. 6, 776. 
Europe France Maghrebins (Northern African Muslims) 7.25 43.70 55.00 0.22 BG O'Morain et al. (1978) Acta Gastroenterol Belg. 41, 56-63. 
Europe France Northern French 6.63 49.75 76.00 0.78 BH Cuddenec et al. (1982) Gastroenterol Clin Biol. 6, 776. 
Europe France Southern French 6.63 49.75 40.00 0.43 BH Cuddenec et al. (1982) Gastroenterol Clin Biol. 6, 776. 
Europe France Southern French 7.25 43.70 55.00 0.58 BG O'Morain et al. (1978) Acta Gastroenterol Belg. 41, 56-63. 
Europe Germany Baden-Wurttemberg Germans 9.50 48.40 136.00 0.76 BH Flatz et al. (1982) Hum Genet. 62, 152. 
Europe Germany Bayern Germans 12.53 47.80 221.00 0.86 BH Flatz et al. (1982) Hum Genet. 62, 152. 
Europe Germany Eastern Germans 13.75 51.05 246.00 0.78 BH Flatz et al. (1982) Hum Genet. 62, 152. 
Europe Germany Germans 8.52 53.18 60.00 0.87 Biopsy Howell et al. (1980) Hepatogastroenterology 27, 208. 
Europe Germany Northwest Germans 8.80 53.08 341.00 0.91 BH Flatz et al. (1982) Hum Genet. 62, 152. 
Europe Germany Rheinland and Pfalz Germans 8.27 50.00 182.00 0.86 BH Flatz et al. (1982) Hum Genet. 62, 152. 
Europe Germany Schleswig-Holstein Germans 9.55 54.52 100.00 0.94 BH Flatz et al. (1982) Hum Genet. 62, 152. 
Europe Greece Continental Greeks 23.73 37.98 600.00 0.55 BG Kanaghinis et al. (1974) Am J Dig Dis. 19, 1021. 
Europe Greece Cretan Greek 25.13 35.33 50.00 0.44 BG Kanaghinis et al. (1974) Am J Dig Dis. 19, 1021. 
Europe Greece Greek 23.73 37.98 16.00 0.63 BG Spanidou & Petrakis(1972) Lancet. 2, 872. 
Europe Greece Greeks 23.73 37.98 200.00 0.25 BH Ladas et al. (1982) Gut. 23, 968. 
Europe Greece Greeks 23.73 37.98 250.00 0.77 BG Zografos et al. (1973) Lancet. 301,367.    
Europe Hungary Eastern Hungarian 20.08 47.50 70.00 0.71 BH Czeizel et al. (1983) Hum Genet. 64, 398. 
Europe Hungary Hungarian 19.08 47.50 262.00 0.59 BH Czeizel et al. (1983) Hum Genet. 64, 398. 
Europe Hungary Matyo 20.58 47.82 172.00 0.63 BH Czeizel et al. (1983) Hum Genet. 64, 398. 
Europe Hungary Northeastern Hungarian 21.73 47.98 103.00 0.58 BH Czeizel et al. (1983) Hum Genet. 64, 398. 
Europe Hungary Romai 21.72 47.95 113.00 0.44 BH Czeizel et al. (1983) Hum Genet. 64, 398. 
Europe Hungary Western Hungarian 19.08 47.50 100.00 0.72 BH Czeizel et al. (1983) Hum Genet. 64, 398. 
Europe Ireland Native Irish -6.25 53.33 50.00 0.96 BG Fielding et al. (1981) Ir J Med Sci. 150, 276. 
Europe Italy Italians 9.20 45.47 42.00 0.38 BH Bozzani et al. (1986) Dig Dis Sci. 31, 1313. 
Europe Italy Italians 9.20 45.47 89.00 0.48 BG Cavalli-Sforza et al. (1987) Am J Clin Nutr. 45, 748. 
Europe Italy Italians 12.48 41.90 65.00 0.82 BG Cavalli-Sforza et al. (1987) Am J Clin Nutr. 45, 748. 
Europe Italy Italians 14.25 40.83 51.00 0.59 BG Cavalli-Sforza et al. (1987) Am J Clin Nutr. 45, 748. 
Europe Italy Italians 14.25 40.83 44.00 0.23 Biopsy Rossi et al. (1997) Gastroenterology. 112, 1506. 
Europe Italy Italians 9.20 45.47 20.00 0.25 BH Zuccato et al. (1983) Eur J Clin Invest. 13, 261. 
Europe Italy Napolitans 14.25 40.83 99.00 0.46 BH Rinaldi et al. (1984) Lancet. 1, 355. 
Europe Italy Neapolitan 14.25 40.83 9.00 0.00 BG De Ritis et al. (1970) Enzymol Biol Clin. 11, 263. 
Europe Italy Northern Italians 7.67 45.05 208.00 0.49 BH Burgio et al. (1984) Am J Clin Nutr. 39, 100. 
Europe Italy Sardinians 8.56 40.73 50.00 0.14 BH Meloni et al. (2001) Am J Clin Nutr. 73, 582. 
Europe Italy Sardinians 9.00 39.40 47.00 0.15 BH Meloni et al. (1998) Ital J Gastroenterol Hepatol. 30, 490. 
Europe Italy Sardinians 9.00 40.10 53.00 0.11 BH Meloni et al. (1998) Ital J Gastroenterol Hepatol. 30, 490. 
Europe Italy Sardinians 9.00 40.30 38.00 0.18 BH Meloni et al. (1998) Ital J Gastroenterol Hepatol. 30, 490. 
Europe Italy Sicilians 13.37 38.12 100.00 0.29 BH Burgio et al. (1984) Am J Clin Nutr. 39, 100. 
229 
Europe Poland Eastern Polish 23.13 52.03 35.00 0.63 BH Socha et al. (1984) Ann Hum Biol. 11, 311. 
Europe Poland Northeastern Polish 22.35 53.83 34.00 0.59 BH Socha et al. (1984) Ann Hum Biol. 11, 311. 
Europe Poland Polish 21.00 52.25 21.00 0.71 BG Leichter (1972) Am J Dig Dis. 17, 73. 
Europe Poland Polish 19.00 51.73 29.00 0.62 BH Socha et al. (1984) Ann Hum Biol. 11, 311. 
Europe Poland Polish 19.37 52.23 92.00 0.63 BH Socha et al. (1984) Ann Hum Biol. 11, 311. 
Europe Poland Polish 19.37 52.23 85.00 0.64 BH Socha et al. (1984) Ann Hum Biol. 11, 311. 
Europe Russia Kildin Saami 34.30 69.29 50.00 0.52 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Europe Russia Komi-Permiaks 37.59 55.75 112.00 0.50 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Europe Russia Udmurtians 32.00 68.00 75.00 0.41 BG Kozlov (1998) Int J Circumpol Heal. 57, 18. 
Europe Spain Galician -7.28 42.37 338.00 0.66 BH Leis et al. (1997) J Pediatr Gastroenterol Nutr. 25, 296. 
Europe UK British -3.20 55.95 150.00 0.95 BG Ferguson et al. (1984) Gut. 25, 163. 
Europe UK British natives -1.25 51.75 75.00 0.95 Biopsy Ho et al. (1982) Am J Hum Genet. 34, 650. 
Europe UK White British -1.92 52.47 67.00 0.97 Biopsy Iqbal et al. (1993) Br Med J. 306, 1303. 
Europe Uzbekistan Kazakh 63.46 40.13 83.00 0.25 BG+BH Heyer et al. (2011) Hum Biol. 83, 379  
Europe Uzbekistan Tajiko-Uzbek 64.42 39.77 100.00 0.11 BG+BH Heyer et al. (2011) Hum Biol. 83, 379  
Middle East Iran Iranian 51.42 35.67 21.00 0.14 BG Sadre et al. (1979) Am J Clin Nutr. 32, 1948. 
Middle East Israel Arabs 34.95 32.23 67.00 0.19 BG Gilat et al. (1971) Dig Dis. 16, 203  
Middle East Jordan Jordanian Arabs 35.93 31.95 148.00 0.25 BH Hijazi et al. (1983) Trop Geogr Med. 35, 157. 
Middle East Jordan Mediterranean origin Jordanian Arabs 35.93 31.95 56.00 0.23 BG Snook et al. (1976) Trop Geogr Med. 28, 333. 
Middle East Jordan Urban/agricultural Jordanian Arabs 35.93 31.95 162.00 0.76 BH Hijazi et al. (1983) Trop Geogr Med. 35, 157. 
Middle East Kuwait Arab Kuwaiti 47.98 29.37 70.00 0.53 BH Sanae et al. (2003) Med Princ Pract. 12, 160. 
Middle East Kuwait Asian Kuwaiti 47.98 29.37 79.00 0.42 BH Sanae et al. (2003) Med Princ Pract. 12, 160. 
Middle East Lebanon Lebanese 35.51 33.87 74.00 0.22 BG Nasrallah (1979) Am J Clin Nutr. 32, 1994. 
Middle East Oman Omani 58.50 23.53 50.00 0.16 BH Al-Abri et al. (2013) Oman Med J. 28, 341. 
Middle East Saudi Arabia Arabs 50.11 26.43 109.00 0.43 BH Dissanayake et al. (1990) Ann Saudi Med. 10, 598. 
Middle East Saudi Arabia Bedouin  50.11 26.43 21.00 0.81 BH Dissanayake et al. (1990) Ann Saudi Med. 10, 598. 
Middle East Saudi Arabia Beduin and Urban Saudi 46.77 24.64 14.00 0.86 BG Cook & Al Torki (1975) Br Med J.  3, 135. 
Middle East Saudi Arabia Yemenites 50.11 26.43 17.00 0.53 BH Dissanayake et al. (1990) Ann Saudi Med. 10, 598. 
Middle East Turkey Central Anatolia 39.50 34.00 104.00 0.29 BH Flatz et al. (1986) Am J Hum Genet. 38, 515. 
Middle East Turkey Eastern Anatolia 39.50 40.00 122.00 0.26 BH Flatz et al. (1986) Am J Hum Genet. 38, 515. 
Middle East Turkey North Coast of Turkey 34.00 41.50 64.00 0.31 BH Flatz et al. (1986) Am J Hum Genet. 38, 515. 
Middle East Turkey South Coast of Turkey 33.00 36.50 54.00 0.28 BH Flatz et al. (1986) Am J Hum Genet. 38, 515. 
Middle East Turkey Turks 32.86 39.93 30.00 0.63 BG Tuncbilek et al. (1973) Lancet. 21, 151.  
Middle East Turkey Western Anatolia and European Turkey 28.96 41.02 126.00 0.30 BH Flatz et al. (1986) Am J Hum Genet. 38, 515. 
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Appendix C1: Diversity measures and tests of neutrality for the regions included in 
haplotype analysis for phenotyped samples. N: number of chromosomes. 
 
Population N 
Sequence 
region 
Segrega-
ting 
sites 
Haplo-
types 
Haplotype 
diversity, H 
(±SD) 
Nucleotide 
diversity, π 
Tajima's 
D 
Fu & Li's 
D* 
Fu & Li's 
F* 
   
  
      
Europeans D 40 Intron 4 4 5 0.459 (0.008) 0.001 -1.095 -1.103 -1.282 
  
 
Enhancer 3 4 0.500 (0.006) 0.002 0.554 -0.350 -0.096 
  
 
Hapdef 2 3 0.349 (0.008) 0.001 -0.406 0.771 0.498 
  
 
Total 9 10 0.542 (0.009) 0.001 -0.488 -0.520 -0.598 
Europeans ND 30 Intron 4 4 5 0.752 (0.002) 0.003 0.087 0.045 0.066 
  
 
Enhancer 2 3 0.480 (0.005) 0.001 0.088 -0.738 -0.583 
  
 
Hapdef 3 4 0.690 (0.003) 0.002 0.504 0.950 0.952 
  
 
Total 9 9 0.839 (0.001) 0.002 0.298 0.204 0.272 
Amhara D 26 Intron 4 2 3 0.665 (0.002) 0.002 1.178 0.826 1.065 
  
 
Enhancer 6 7 0.806 (0.003) 0.002 -0.689 0.476 0.157 
  
 
Hapdef 2 3 0.665 (0.002) 0.002 1.178 0.826 1.065 
  
 
Total 10 8 0.855 (0.002) 0.002 0.263 0.891 0.819 
Amhara ND 54 Intron 4 2 3 0.653 (0.001) 0.002 1.832 0.740 1.236 
  
 
Enhancer 5 6 0.470 (0.005) 0.001 -1.267 -1.835 -1.940 
  
 
Hapdef 2 3 0.662 (0.001) 0.002 1.723 0.740 1.199 
  
 
Total 9 10 0.760 (0.002) 0.002 0.430 -0.662 -0.358 
Oromo D 50 Intron 4 3 4 0.690 (0.001) 0.003 1.110 0.892 1.115 
  
 
Enhancer 8 9 0.722 (0.002) 0.002 -0.898 -1.554 -1.578 
  
 
Hapdef 3 4 0.688 (0.000) 0.002 0.953 -0.413 -0.001 
  
 
Total 14 12 0.776 (0.002) 0.002 0.079 -0.876 -0.655 
Oromo ND 74 Intron 4 3 5 0.559 (0.002) 0.002 0.223 0.853 0.769 
  
 
Enhancer 6 7 0.397 (0.005) 0.001 -1.449 -0.690 -1.103 
  
 
Hapdef 3 4 0.584 (0.001) 0.001 0.210 -0.515 -0.339 
  
 
Total 12 14 0.738 (0.002) 0.001 -0.692 -0.298 -0.516 
Jaali D 50 Intron 4 3 4 0.664 (0.001) 0.002 0.477 -0.413 -0.168 
  
 
Enhancer 8 9 0.786 (0.001) 0.002 -0.930 -1.554 -1.590 
  
 
Hapdef 3 4 0.611 (0.002) 0.002 0.228 -0.413 -0.256 
  
 
Total 14 14 0.900 (0.000) 0.002 -0.369 -1.360 -1.213 
Jaali ND 26 Intron 4 3 4 0.717 (0.001) 0.003 0.639 -0.216 0.030 
  
 
Enhancer 5 6 0.686 (0.008) 0.002 -0.744 0.308 0.003 
  
 
Hapdef 3 4 0.717 (0.001) 0.002 0.639 -0.216 0.030 
    Total 11 9 0.862 (0.002) 0.002 0.075 -0.001 0.026 
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Appendix C2: Diversity measures and tests of neutrality for the regions included in 
haplotype analysis for the combined dataset of 28 populations. N: number of 
chromosomes, significant values (p<0.05) for neutrality tests are shaded. 
 
Population N 
Sequencing 
region 
Segre-
gating 
sites 
Haplo-
types 
Haplotype 
diversity, 
H (±SD) 
Nucleotide 
diversity, π 
Tajima's 
D 
Fu & Li's 
D* 
FFu & Li's 
F* 
          Afar 124 Intron_4 2 3 0.653 (0.000) 0.002 1.752 0.669 1.180 
  
Enhancer 7 9 0.754 (0.000) 0.002 0.066 -0.622 -0.459 
  
Hapdef 2 3 0.644 (0.000) 0.002 1.651 0.669 1.143 
  
Total 11 12 0.810 (0.000) 0.002 1.108 0.039 0.502 
Amhara 80 Intron_4 2 3 0.662 (0.000) 0.002 1.857 0.704 1.231 
  
Enhancer 7 8 0.600 (0.003) 0.001 -1.154 0.365 -0.165 
  
Hapdef 2 3 0.661 (0.000) 0.002 1.765 0.704 1.198 
  
Total 11 12 0.794 (0.001) 0.002 0.291 0.794 0.735 
Anatolian 40 Intron_4 4 5 0.694 (0.003) 0.003 0.565 1.027 1.034 
Turks 
 
Enhancer 2 3 0.232 (0.007) 0.001 -0.416 0.771 0.495 
  
Hapdef 3 4 0.679 (0.001) 0.002 0.649 -0.350 -0.063 
  
Total 9 9 0.771 (0.003) 0.002 0.454 0.733 0.757 
Asante 40 Intron_4 3 4 0.714 (0.002) 0.002 0.665 0.916 0.978 
  
Enhancer 2 3 0.273 (0.008) 0.001 -0.745 0.771 0.384 
  
Hapdef 2 3 0.472 (0.006) 0.001 0.171 0.771 0.692 
  
Total 7 7 0.833 (0.001) 0.001 0.122 1.256 1.056 
Beni Amer 128 Intron_4 5 5 0.654 (0.000) 0.002 -0.198 -2.266 -1.867 
  
Enhancer 5 6 0.786 (0.000) 0.002 1.026 1.016 1.205 
  
Hapdef 3 4 0.612 (0.001) 0.002 0.591 0.807 0.868 
  
Total 13 14 0.855 (0.000) 0.002 0.614 -0.364 -0.008 
Chagga 82 Intron_4 3 4 0.703 (0.001) 0.003 1.014 0.844 1.050 
  
Enhancer 4 5 0.459 (0.004) 0.001 -0.753 -0.220 -0.457 
  
Hapdef 2 3 0.417 (0.003) 0.001 0.185 0.702 0.635 
  
Total 9 9 0.863 (0.000) 0.001 0.114 0.603 0.517 
Chewa 40 Intron_4 5 5 0.733 (0.001) 0.003 -0.266 -0.736 -0.692 
  
Enhancer 3 4 0.273 (0.008) 0.001 -1.177 -1.616 -1.727 
  
Hapdef 2 3 0.512 (0.002) 0.001 0.243 -0.828 -0.599 
  
Total 10 10 0.829 (0.001) 0.001 -0.562 -1.506 -1.415 
Iranians 76 Intron_4 4 5 0.675 (0.001) 0.003 0.628 0.965 1.007 
  
Enhancer 2 3 0.362 (0.003) 0.001 -0.017 0.708 0.569 
  
Hapdef 3 4 0.674 (0.000) 0.002 1.038 -0.521 -0.044 
  
Total 9 8 0.726 (0.001) 0.002 0.819 0.617 0.811 
Israeli- 40 Intron_4 6 6 0.736 (0.002) 0.003 -0.457 -0.456 -0.533 
Arabs 
 
Enhancer 7 8 0.555 (0.007) 0.001 -1.632 -2.464 -2.5812 
  
Hapdef 2 3 0.656 (0.001) 0.002 1.407 0.771 1.107 
  
Total 15 13 0.837 (0.002) 0.002 -0.778 -1.460 -1.457 
Israeli- 32 Intron_4 3 4 0.720 (0.001) 0.003 0.860 0.942 1.064 
Bedouin 
 
Enhancer 5 6 0.641 (0.006) 0.002 -0.836 -1.526 -1.537 
  
Hapdef 2 3 0.677 (0.001) 0.002 1.515 0.798 1.158 
  
Total 10 10 0.861 (0.001) 0.002 0.333 -0.240 -0.072 
Italians 32 Intron_4 4 5 0.752 (0.001) 0.003 0.171 1.051 0.920 
  
Enhancer 3 4 0.504 (0.006) 0.001 -0.478 -1.508 -1.402 
  
Hapdef 3 4 0.702 (0.002) 0.002 0.641 0.942 0.991 
  
Total 10 12 0.867 (0.001) 0.002 0.151 0.309 0.304 
Jaali 76 Intron_4 3 4 0.682 (0.000) 0.002 0.825 0.851 0.986 
  
Enhancer 8 9 0.752 (0.001) 0.002 -0.829 -1.039 -1.144 
  
Hapdef 3 4 0.654 (0.001) 0.002 0.692 0.851 0.938 
  
Total 14 14 0.891 (0.000) 0.002 -0.042 -0.057 -0.061 
Jordanian 44 Intron_4 2 3 0.672 (0.001) 0.003 1.919 0.761 1.275 
Bedouin 
 
Enhancer 4 5 0.725 (0.002) 0.002 0.781 1.017 1.103 
  
Hapdef 3 4 0.707 (0.001) 0.002 1.170 0.905 1.145 
  
Total 9 7 0.775 (0.002) 0.002 1.616 1.357 1.692 
Khalka 38 Intron_4 3 4 0.585 (0.005) 0.002 -0.110 0.922 0.718 
  
Enhancer 3 4 0.542 (0.003) 0.001 -0.334 -1.592 -1.419 
  
Hapdef 2 3 0.519 (0.006) 0.001 0.403 0.777 0.775 
  
Total 8 8 0.795 (0.001) 0.001 -0.066 -0.030 -0.048 
Kuwaiti 56 Intron_4 3 5 0.647 (0.002) 0.003 0.992 -0.444 -0.008 
  
Enhancer 6 7 0.639 (0.003) 0.002 -0.867 -1.464 -1.495 
  
Hapdef 3 4 0.662 (0.001) 0.002 0.940 -0.444 -0.027 
  
Total 12 12 0.822 (0.001) 0.002 0.190 -1.300 -0.942 
232 
Mambila 40 Intron_4 3 4 0.509 (0.006) 0.002 -0.425 0.916 0.603 
  
Enhancer 3 4 0.355 (0.009) 0.001 -0.745 0.916 0.493 
  
Hapdef 1 2 0.328 (0.006) 0.001 0.565 0.564 0.651 
  
Total 7 7 0.731 (0.004) 0.001 -0.480 1.256 0.836 
Northern 40 Intron_4 3 4 0.458 (0.008) 0.001 -0.615 0.916 0.538 
Europeans 
 
Enhancer 3 4 0.522 (0.005) 0.002 0.681 -0.350 -0.052 
  
Hapdef 2 3 0.349 (0.008) 0.001 -0.406 0.771 0.498 
  
Total 8 8 0.569 (0.008) 0.001 -0.121 0.631 0.463 
Norwegians 40 Intron_4 2 3 0.229 (0.007) 0.001 -0.946 -0.828 -0.999 
  
Enhancer 2 3 0.268 (0.007) 0.001 0.063 0.771 0.656 
  
Hapdef 2 3 0.229 (0.007) 0.001 -0.946 -0.828 -0.999 
  
Total 6 4 0.273 (0.008) 0.001 -0.862 -0.456 -0.680 
Oromo 124 Intron_4 3 5 0.643 (0.001) 0.002 1.041 0.809 1.039 
  
Enhancer 9 10 0.598 (0.002) 0.001 -1.214 0.529 -0.097 
  
Hapdef 4 5 0.655 (0.000) 0.002 0.295 -1.545 -1.116 
  
Total 16 18 0.798 (0.001) 0.002 -0.355 -0.005 -0.162 
Palestinians 38 Intron_4 6 6 0.758 (0.001) 0.003 -0.293 -1.250 -1.118 
  
Enhancer 3 4 0.422 (0.007) 0.001 -0.735 -1.592 -1.555 
  
Hapdef 3 4 0.684 (0.001) 0.002 0.533 -0.335 -0.093 
  
Total 12 13 0.862 (0.001) 0.002 -0.240 -1.541 -1.321 
Romanians 40 Intron_4 4 5 0.713 (0.001) 0.003 0.047 -1.103 -0.882 
  
Enhancer 2 3 0.344 (0.007) 0.001 0.480 0.771 0.796 
  
Hapdef 3 4 0.704 (0.002) 0.002 0.887 0.916 1.054 
  
Total 9 9 0.859 (0.001) 0.002 0.587 0.107 0.304 
Saudi 40 Intron_4 2 3 0.640 (0.002) 0.002 1.814 0.771 1.244 
Bedouin 
 
Enhancer 5 6 0.674 (0.002) 0.002 -0.555 -1.662 -1.546 
  
Hapdef 2 3 0.653 (0.001) 0.002 1.711 0.771 1.209 
  
Total 9 10 0.773 (0.003) 0.002 0.858 -0.520 -0.097 
Shabo 42 Intron_4 5 6 0.791 (0.001) 0.003 0.042 0.178 0.159 
  
Enhancer 3 4 0.297 (0.007) 0.001 -1.196 -1.639 -1.752 
  
Hapdef 2 3 0.487 (0.003) 0.001 0.153 -0.843 -0.641 
  
Total 10 11 0.854 (0.001) 0.001 -0.419 -0.953 -0.919 
Syrians 82 Intron_4 3 4 0.656 (0.001) 0.003 1.035 0.844 1.058 
  
Enhancer 2 3 0.427 (0.003) 0.001 0.171 0.702 0.630 
  
Hapdef 4 5 0.680 (0.001) 0.002 0.371 -0.220 -0.038 
  
Total 9 11 0.736 (0.001) 0.002 0.744 0.603 0.771 
Tharu 36 Intron_4 4 5 0.668 (0.003) 0.002 -0.362 -0.008 -0.132 
  
Enhancer 2 3 0.341 (0.009) 0.001 -0.012 0.783 0.642 
  
Hapdef 2 3 0.595 (0.003) 0.001 0.807 0.783 0.914 
  
Total 8 8 0.825 (0.001) 0.001 0.083 0.653 0.557 
Ukrainians 40 Intron_4 3 4 0.664 (0.002) 0.002 0.344 0.916 0.868 
  
Enhancer 3 4 0.627 (0.003) 0.002 0.887 -0.350 0.018 
  
Hapdef 3 4 0.558 (0.004) 0.001 -0.195 -0.350 -0.353 
  
Total 9 7 0.795 (0.001) 0.002 0.463 0.107 0.258 
Yemeni 154 Intron_4 4 5 0.660 (0.000) 0.003 0.587 -0.356 -0.055 
Hadramaut 
 
Enhancer 9 10 0.675 (0.001) 0.002 -1.041 -1.907 -1.906 
  
Hapdef 4 5 0.680 (0.000) 0.002 0.645 0.905 0.969 
  
Total 17 20 0.867 (0.000) 0.002 -0.209 -1.056 -0.878 
Yemeni 66 Intron_4 4 5 0.716 (0.001) 0.003 0.331 0.978 0.907 
Sena 
 
Enhancer 6 7 0.770 (0.001) 0.002 0.195 1.153 0.992 
  
Hapdef 2 3 0.610 (0.001) 0.002 1.163 0.721 0.994 
  
Total 12 13 0.892 (0.000) 0.002 0.587 1.476 1.387 
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Appendix D: Pairwise FST values (lower triangle) and corresponding p-values (upper 
triangles) for the 52 populations tested in chapter 3. 
 
 
 
 
 
 
 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
1 * 0.045 0.559 0.036 0.000 0.000 0.000 0.270 0.000 0.991 0.000 0.000 0.135 0.297 0.117 0.000 0.009 0.099 0.000 0.000 0.000 0.459 0.000 0.000 0.459
2 0.035 * 0.261 0.000 0.387 0.225 0.000 0.793 0.000 0.090 0.000 0.000 0.739 0.000 0.000 0.000 0.000 0.000 0.000 0.396 0.009 0.018 0.000 0.784 0.721
3 -0.009 0.002 * 0.000 0.171 0.036 0.000 0.676 0.000 0.550 0.000 0.000 0.550 0.216 0.027 0.000 0.009 0.027 0.000 0.090 0.000 0.225 0.027 0.153 0.991
4 0.033 0.124 0.072 * 0.000 0.000 0.000 0.009 0.000 0.072 0.000 0.991 0.000 0.432 0.586 0.000 0.955 0.559 0.000 0.000 0.000 0.477 0.000 0.000 0.135
5 0.077 -0.001 0.029 0.169 * 0.748 0.000 0.234 0.000 0.018 0.000 0.000 0.189 0.000 0.000 0.000 0.000 0.000 0.000 0.991 0.099 0.000 0.153 0.586 0.333
6 0.117 0.007 0.048 0.245 -0.011 * 0.000 0.342 0.000 0.009 0.000 0.000 0.144 0.000 0.000 0.000 0.000 0.000 0.000 0.865 0.117 0.009 0.468 0.396 0.333
7 0.625 0.479 0.528 0.692 0.401 0.367 * 0.000 0.342 0.000 0.018 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
8 0.008 -0.013 -0.017 0.129 0.006 0.019 0.498 * 0.000 0.387 0.000 0.000 0.991 0.045 0.009 0.000 0.000 0.018 0.000 0.351 0.045 0.171 0.072 0.514 0.991
9 0.727 0.570 0.632 0.813 0.484 0.459 -0.003 0.605 * 0.000 0.009 0.000 0.000 0.000 0.000 0.036 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
10 -0.009 0.030 -0.011 0.043 0.070 0.110 0.621 0.004 0.727 * 0.000 0.018 0.234 0.234 0.045 0.000 0.018 0.072 0.000 0.009 0.000 0.360 0.000 0.027 0.730
11 0.452 0.266 0.320 0.554 0.185 0.147 0.068 0.283 0.129 0.446 * 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.270 0.000 0.045 0.000 0.000
12 0.049 0.158 0.111 -0.010 0.208 0.307 0.736 0.180 0.851 0.063 0.621 * 0.009 0.135 0.225 0.000 0.631 0.405 0.000 0.000 0.000 0.189 0.000 0.000 0.054
13 0.015 -0.006 -0.007 0.085 0.010 0.024 0.507 -0.016 0.592 0.011 0.301 0.108 * 0.018 0.009 0.000 0.000 0.000 0.000 0.144 0.000 0.063 0.009 0.441 0.991
14 0.001 0.074 0.016 0.004 0.118 0.170 0.651 0.049 0.755 0.007 0.492 0.014 0.045 * 0.865 0.000 0.162 0.757 0.000 0.000 0.000 0.856 0.000 0.000 0.144
15 0.011 0.102 0.033 -0.002 0.156 0.224 0.703 0.078 0.801 0.015 0.565 0.002 0.066 -0.005 * 0.000 0.081 0.991 0.000 0.000 0.000 0.991 0.000 0.000 0.099
16 0.863 0.742 0.835 0.944 0.668 0.681 0.129 0.816 0.087 0.867 0.363 0.956 0.749 0.888 0.906 * 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
17 0.048 0.139 0.084 -0.017 0.183 0.256 0.695 0.140 0.808 0.057 0.558 -0.005 0.099 0.016 0.010 0.934 * 0.153 0.000 0.000 0.000 0.108 0.000 0.000 0.036
18 0.016 0.107 0.043 -0.005 0.156 0.226 0.694 0.091 0.802 0.021 0.554 -0.003 0.070 -0.006 -0.007 0.920 0.007 * 0.000 0.000 0.000 0.991 0.000 0.000 0.081
19 0.183 0.177 0.130 0.197 0.187 0.192 0.556 0.143 0.607 0.186 0.386 0.242 0.169 0.180 0.216 0.749 0.197 0.211 * 0.000 0.000 0.000 0.000 0.000 0.018
20 0.088 0.002 0.037 0.186 -0.010 -0.013 0.394 0.011 0.479 0.082 0.178 0.228 0.016 0.133 0.173 0.667 0.200 0.173 0.195 * 0.090 0.000 0.243 0.468 0.514
21 0.310 0.115 0.172 0.464 0.051 0.026 0.195 0.135 0.279 0.302 0.015 0.548 0.146 0.363 0.449 0.558 0.464 0.447 0.265 0.046 * 0.000 0.532 0.027 0.081
22 -0.002 0.067 0.012 -0.001 0.106 0.154 0.628 0.047 0.747 0.002 0.457 0.013 0.040 -0.011 -0.012 0.912 0.015 -0.011 0.155 0.120 0.334 * 0.000 0.027 0.216
23 0.221 0.058 0.111 0.369 0.014 -0.004 0.264 0.076 0.350 0.214 0.061 0.449 0.085 0.275 0.353 0.610 0.374 0.352 0.225 0.009 -0.018 0.250 * 0.018 0.198
24 0.052 -0.007 0.014 0.139 -0.006 -0.003 0.450 -0.005 0.536 0.047 0.235 0.172 0.000 0.093 0.123 0.706 0.154 0.125 0.183 -0.005 0.089 0.084 0.038 * 0.541
25 -0.006 -0.022 -0.030 0.156 -0.003 0.011 0.489 -0.036 0.601 -0.010 0.265 0.227 -0.026 0.038 0.069 0.843 0.157 0.090 0.121 0.003 0.116 0.042 0.063 -0.014 *
26 0.745 0.608 0.671 0.817 0.530 0.513 0.016 0.646 -0.011 0.745 0.179 0.848 0.627 0.770 0.808 0.053 0.814 0.808 0.651 0.526 0.345 0.764 0.414 0.576 0.648
27 0.598 0.427 0.479 0.683 0.342 0.304 -0.005 0.446 0.021 0.594 0.026 0.736 0.458 0.629 0.690 0.203 0.684 0.682 0.506 0.335 0.131 0.602 0.196 0.395 0.432
28 0.045 -0.021 -0.002 0.210 -0.016 -0.010 0.442 -0.021 0.548 0.039 0.216 0.281 -0.015 0.100 0.146 0.788 0.211 0.162 0.146 -0.013 0.074 0.098 0.028 -0.020 -0.030
29 0.163 0.020 0.072 0.327 -0.009 -0.020 0.329 0.038 0.425 0.156 0.109 0.406 0.042 0.224 0.292 0.682 0.332 0.299 0.200 -0.012 0.001 0.208 -0.019 0.006 0.029
30 0.003 0.040 -0.001 0.028 0.073 0.099 0.572 0.015 0.665 0.004 0.383 0.046 0.023 0.008 0.011 0.830 0.038 0.019 0.087 0.083 0.240 0.002 0.173 0.055 0.001
31 -0.019 0.030 -0.016 0.025 0.064 0.096 0.577 0.006 0.693 -0.018 0.381 0.054 0.011 -0.014 -0.009 0.892 0.039 -0.003 0.127 0.075 0.242 -0.019 0.171 0.045 -0.007
32 0.294 0.141 0.195 0.385 0.081 0.053 0.167 0.158 0.237 0.286 0.012 0.442 0.171 0.335 0.397 0.447 0.396 0.386 0.286 0.074 -0.019 0.306 0.001 0.116 0.147
33 -0.011 0.043 -0.006 0.023 0.080 0.122 0.611 0.018 0.725 -0.010 0.433 0.042 0.019 -0.006 -0.009 0.887 0.029 -0.003 0.125 0.094 0.295 -0.012 0.216 0.059 0.006
34 0.028 -0.009 0.000 0.107 0.002 0.011 0.485 -0.014 0.572 0.024 0.275 0.135 -0.006 0.064 0.089 0.735 0.122 0.092 0.175 0.006 0.123 0.057 0.065 -0.005 -0.024
35 0.099 -0.003 0.034 0.244 -0.016 -0.019 0.388 0.007 0.485 0.093 0.165 0.311 0.011 0.155 0.209 0.718 0.253 0.217 0.178 -0.016 0.037 0.143 0.002 -0.011 -0.002
36 0.158 0.031 0.077 0.276 -0.001 -0.011 0.313 0.046 0.397 0.150 0.101 0.338 0.051 0.204 0.266 0.621 0.287 0.264 0.209 -0.002 -0.002 0.186 -0.015 0.017 0.036
37 0.391 0.210 0.265 0.495 0.136 0.101 0.110 0.227 0.177 0.383 -0.011 0.562 0.244 0.433 0.506 0.412 0.501 0.495 0.348 0.128 -0.005 0.398 0.028 0.181 0.211
38 0.001 0.006 -0.012 0.059 0.031 0.050 0.539 -0.011 0.627 0.000 0.341 0.081 -0.002 0.026 0.041 0.783 0.073 0.046 0.159 0.038 0.189 0.020 0.121 0.016 -0.024
39 0.280 0.113 0.169 0.397 0.055 0.030 0.204 0.132 0.282 0.272 0.026 0.465 0.143 0.329 0.400 0.520 0.405 0.392 0.278 0.049 -0.022 0.298 -0.013 0.088 0.120
40 0.687 0.530 0.590 0.768 0.445 0.417 -0.010 0.562 -0.011 0.686 0.094 0.809 0.554 0.716 0.764 0.127 0.766 0.762 0.584 0.440 0.237 0.701 0.309 0.496 0.557
41 0.023 0.110 0.043 0.003 0.160 0.221 0.690 0.086 0.785 0.029 0.548 0.009 0.076 0.004 0.000 0.894 0.006 0.002 0.168 0.176 0.429 -0.001 0.339 0.130 0.077
42 0.115 -0.002 0.036 0.286 -0.021 -0.024 0.363 0.008 0.459 0.108 0.138 0.368 0.011 0.175 0.238 0.719 0.286 0.247 0.166 -0.020 0.014 0.162 -0.010 -0.011 -0.002
43 0.035 -0.011 0.001 0.133 -0.002 0.006 0.475 -0.015 0.570 0.029 0.261 0.173 -0.009 0.076 0.107 0.755 0.147 0.113 0.168 0.001 0.112 0.069 0.056 -0.008 -0.024
44 0.016 -0.008 -0.009 0.100 0.008 0.021 0.500 -0.018 0.594 0.011 0.290 0.132 -0.010 0.048 0.074 0.771 0.114 0.080 0.160 0.014 0.139 0.045 0.079 -0.002 -0.029
45 0.289 0.128 0.183 0.392 0.069 0.042 0.185 0.146 0.259 0.281 0.018 0.455 0.158 0.334 0.401 0.483 0.402 0.391 0.291 0.062 -0.020 0.303 -0.006 0.103 0.134
46 0.210 0.075 0.128 0.305 0.031 0.011 0.246 0.093 0.321 0.202 0.056 0.356 0.101 0.254 0.309 0.525 0.317 0.301 0.257 0.025 -0.016 0.230 -0.016 0.056 0.084
47 0.106 0.008 0.045 0.212 -0.010 -0.015 0.365 0.018 0.449 0.098 0.148 0.263 0.022 0.151 0.200 0.654 0.225 0.199 0.189 -0.011 0.026 0.136 -0.002 -0.001 0.009
48 0.001 0.076 0.018 0.002 0.119 0.174 0.652 0.056 0.768 0.005 0.492 0.013 0.045 -0.008 -0.008 0.912 0.017 -0.008 0.170 0.133 0.374 -0.016 0.284 0.093 0.050
49 0.099 -0.001 0.036 0.231 -0.014 -0.017 0.388 0.009 0.482 0.092 0.166 0.293 0.013 0.152 0.204 0.705 0.242 0.209 0.182 -0.014 0.038 0.139 0.003 -0.009 0.000
50 -0.005 0.063 0.006 0.014 0.108 0.162 0.657 0.036 0.764 -0.003 0.498 0.027 0.035 -0.004 -0.003 0.893 0.027 -0.001 0.194 0.123 0.369 -0.012 0.277 0.081 0.025
51 0.137 0.154 0.111 0.131 0.174 0.183 0.547 0.124 0.588 0.138 0.390 0.152 0.145 0.130 0.145 0.698 0.132 0.141 -0.007 0.182 0.271 0.113 0.228 0.167 0.107
52 0.175 0.143 0.110 0.199 0.138 0.124 0.414 0.110 0.439 0.179 0.247 0.242 0.149 0.184 0.231 0.584 0.204 0.216 0.015 0.141 0.148 0.150 0.129 0.139 0.087
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Populations: 1: Anatolian Turks, 2: Armenians, 3: Ashkenazi Jews, 4: Azeri, 5: Belarusians, 6: 
Catalans, 7: English, 8: Erzja, 9: Frisians, 10: Georgians, 11: Germans, 12: Greek Cypriots, 13: Greeks, 
14: Han Chinese, 15: Iranians, 16: Irish, 17: Japanese, 18: Khalka, 19: Kuwaiti, 20: Macedonians, 21: 
Moksha, 22: Mongolians, 23: Nepalese, 24: North Indians, 25: Northern Yakuts, 26: Norwegians, 27: 
other C/NW Europeans, 28: other C/South Asians, 29: other E/SE Europeans, 30: other ME, 31: 
Pashtuns/Afghans, 32: Portuguese, 33: Roma, 34: Romanians, 35: Russians Perm, 36: Sami, 37: 
Sorbs, 38: South Indians, 39: Spanish, 40: Swedes, 41: Syrians, 42: Tadjiks Afghanistan, 43: Tharu, 
44: Tyroleans Bozen, 45: Tyroleans Gadertal, 46: Tyroleans Vinschgau, 47: Ukrainians, 48: Uzbeks, 
49: Uzbeks Afghanistan, 50: Yakuts, 51: Yemeni Hadramaut, 52: Yemeni Sena  
  
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 
1 0.000 0.000 0.090 0.000 0.270 0.991 0.000 0.757 0.045 0.018 0.000 0.000 0.225 0.000 0.000 0.027 0.018 0.045 0.126 0.000 0.000 0.000 0.369 0.000 0.703 0.000 
2 0.000 0.000 0.991 0.216 0.027 0.216 0.000 0.117 0.991 0.532 0.045 0.000 0.225 0.009 0.000 0.000 0.324 0.991 0.541 0.000 0.027 0.198 0.027 0.315 0.027 0.000 
3 0.000 0.000 0.477 0.054 0.441 0.649 0.009 0.342 0.387 0.144 0.009 0.000 0.694 0.000 0.000 0.045 0.090 0.279 0.432 0.000 0.000 0.072 0.108 0.036 0.297 0.000 
4 0.000 0.000 0.009 0.000 0.045 0.189 0.000 0.171 0.000 0.000 0.000 0.000 0.036 0.000 0.000 0.288 0.000 0.000 0.000 0.000 0.000 0.000 0.360 0.000 0.396 0.000 
5 0.000 0.000 0.658 0.559 0.000 0.036 0.000 0.000 0.333 0.991 0.342 0.000 0.081 0.072 0.000 0.000 0.883 0.441 0.225 0.009 0.045 0.811 0.000 0.991 0.009 0.000 
6 0.000 0.000 0.649 0.802 0.018 0.054 0.045 0.000 0.279 0.991 0.622 0.000 0.036 0.162 0.000 0.000 0.892 0.198 0.162 0.081 0.297 0.991 0.000 0.991 0.000 0.000 
7 0.108 0.514 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.739 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
8 0.000 0.000 0.838 0.135 0.252 0.505 0.000 0.243 0.874 0.324 0.099 0.000 0.811 0.009 0.000 0.018 0.315 0.811 0.991 0.000 0.018 0.144 0.099 0.279 0.135 0.000 
9 0.667 0.162 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.568 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
10 0.000 0.000 0.099 0.000 0.378 0.712 0.000 0.658 0.126 0.027 0.000 0.000 0.243 0.000 0.000 0.027 0.009 0.054 0.162 0.000 0.000 0.000 0.333 0.009 0.468 0.000 
11 0.000 0.153 0.000 0.000 0.000 0.000 0.306 0.000 0.000 0.000 0.036 0.676 0.000 0.162 0.018 0.000 0.009 0.000 0.000 0.189 0.027 0.000 0.000 0.000 0.000 0.000 
12 0.000 0.000 0.000 0.000 0.000 0.090 0.000 0.045 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.153 0.000 0.000 0.000 0.000 0.000 0.000 0.279 0.000 0.171 0.000 
13 0.000 0.000 0.766 0.081 0.099 0.234 0.000 0.162 0.757 0.252 0.027 0.000 0.423 0.000 0.000 0.000 0.279 0.793 0.991 0.000 0.000 0.117 0.018 0.162 0.045 0.000 
14 0.000 0.000 0.054 0.000 0.270 0.676 0.000 0.631 0.000 0.000 0.000 0.000 0.081 0.000 0.000 0.288 0.000 0.000 0.027 0.000 0.000 0.000 0.892 0.000 0.559 0.000 
15 0.000 0.000 0.018 0.000 0.189 0.685 0.000 0.775 0.000 0.000 0.000 0.000 0.009 0.000 0.000 0.369 0.000 0.000 0.000 0.000 0.000 0.000 0.991 0.000 0.586 0.000 
16 0.018 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
17 0.000 0.000 0.000 0.000 0.000 0.081 0.000 0.018 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.171 0.000 0.000 0.000 0.000 0.000 0.000 0.126 0.000 0.207 0.000 
18 0.000 0.000 0.000 0.000 0.090 0.595 0.000 0.387 0.000 0.000 0.000 0.000 0.036 0.000 0.000 0.207 0.000 0.000 0.000 0.000 0.000 0.000 0.847 0.000 0.459 0.000 
19 0.000 0.000 0.000 0.000 0.018 0.018 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.793 
20 0.000 0.000 0.640 0.649 0.000 0.054 0.018 0.000 0.324 0.991 0.441 0.000 0.009 0.027 0.000 0.000 0.820 0.387 0.198 0.018 0.126 0.739 0.000 0.991 0.000 0.000 
21 0.000 0.000 0.072 0.252 0.000 0.000 0.829 0.000 0.000 0.153 0.405 0.306 0.000 0.838 0.000 0.000 0.315 0.009 0.000 0.865 0.604 0.126 0.000 0.162 0.000 0.000 
22 0.000 0.000 0.036 0.000 0.523 0.991 0.000 0.739 0.000 0.000 0.000 0.000 0.162 0.000 0.000 0.450 0.000 0.027 0.108 0.000 0.000 0.000 0.991 0.009 0.766 0.000 
23 0.000 0.000 0.171 0.784 0.000 0.009 0.351 0.000 0.045 0.324 0.541 0.090 0.009 0.586 0.000 0.000 0.468 0.009 0.009 0.432 0.739 0.351 0.000 0.297 0.000 0.000 
24 0.000 0.000 0.991 0.333 0.009 0.153 0.000 0.063 0.649 0.685 0.099 0.000 0.099 0.000 0.000 0.000 0.459 0.667 0.450 0.000 0.045 0.396 0.009 0.568 0.000 0.000 
25 0.000 0.000 0.775 0.315 0.432 0.685 0.036 0.450 0.811 0.351 0.081 0.009 0.910 0.045 0.000 0.000 0.550 0.757 0.991 0.000 0.135 0.279 0.261 0.486 0.586 0.000 
26 * 0.036 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.207 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
27 0.050 * 0.000 0.000 0.000 0.000 0.009 0.000 0.000 0.000 0.000 0.063 0.000 0.000 0.315 0.000 0.000 0.000 0.000 0.009 0.000 0.000 0.000 0.000 0.000 0.000 
28 0.599 0.382 * 0.405 0.081 0.333 0.054 0.099 0.991 0.757 0.261 0.000 0.450 0.036 0.000 0.000 0.649 0.991 0.730 0.045 0.108 0.477 0.009 0.703 0.063 0.000 
29 0.485 0.262 -0.001 * 0.000 0.018 0.117 0.000 0.153 0.649 0.775 0.036 0.036 0.324 0.000 0.000 0.721 0.144 0.036 0.216 0.468 0.829 0.000 0.640 0.000 0.000 
30 0.697 0.530 0.040 0.129 * 0.838 0.000 0.910 0.009 0.027 0.000 0.000 0.270 0.000 0.000 0.297 0.000 0.018 0.108 0.000 0.000 0.000 0.333 0.000 0.324 0.000 
31 0.722 0.537 0.039 0.132 -0.011 * 0.000 0.991 0.180 0.144 0.009 0.000 0.505 0.000 0.000 0.225 0.081 0.090 0.324 0.000 0.000 0.009 0.649 0.027 0.991 0.009 
32 0.290 0.110 0.105 0.027 0.249 0.246 * 0.000 0.000 0.018 0.099 0.541 0.000 0.640 0.000 0.000 0.108 0.000 0.000 0.856 0.396 0.036 0.000 0.027 0.000 0.000 
33 0.745 0.582 0.058 0.168 -0.019 -0.024 0.282 * 0.036 0.009 0.000 0.000 0.297 0.000 0.000 0.514 0.000 0.072 0.144 0.000 0.000 0.000 0.694 0.000 0.991 0.000 
34 0.609 0.434 -0.019 0.026 0.035 0.023 0.149 0.035 * 0.486 0.054 0.000 0.234 0.000 0.000 0.000 0.342 0.991 0.838 0.000 0.009 0.207 0.018 0.252 0.027 0.000 
35 0.539 0.325 -0.019 -0.018 0.083 0.082 0.065 0.107 0.000 * 0.523 0.000 0.117 0.117 0.000 0.000 0.856 0.577 0.288 0.054 0.252 0.991 0.000 0.991 0.000 0.000 
36 0.454 0.248 0.009 -0.020 0.131 0.125 0.025 0.151 0.037 -0.009 * 0.027 0.009 0.189 0.000 0.000 0.829 0.072 0.027 0.090 0.414 0.622 0.000 0.378 0.000 0.000 
37 0.231 0.059 0.164 0.067 0.329 0.324 -0.005 0.373 0.219 0.117 0.064 * 0.000 0.306 0.000 0.000 0.018 0.000 0.000 0.414 0.081 0.000 0.000 0.000 0.000 0.000 
38 0.660 0.494 0.000 0.074 0.011 -0.004 0.206 0.006 0.004 0.035 0.083 0.284 * 0.000 0.000 0.000 0.225 0.333 0.441 0.000 0.000 0.018 0.108 0.081 0.099 0.000 
39 0.341 0.142 0.078 0.007 0.232 0.227 -0.011 0.270 0.121 0.041 0.008 0.003 0.182 * 0.000 0.000 0.162 0.000 0.009 0.820 0.595 0.108 0.000 0.072 0.000 0.000 
40 0.004 0.002 0.504 0.382 0.628 0.648 0.199 0.681 0.533 0.443 0.358 0.139 0.590 0.242 * 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
41 0.795 0.674 0.147 0.282 0.006 0.004 0.386 -0.004 0.097 0.207 0.262 0.491 0.047 0.388 0.749 * 0.000 0.000 0.000 0.000 0.000 0.000 0.342 0.000 0.207 0.000 
42 0.521 0.295 -0.020 -0.025 0.088 0.089 0.048 0.122 0.002 -0.026 -0.022 0.094 0.039 0.025 0.418 0.232 * 0.270 0.234 0.126 0.225 0.955 0.000 0.820 0.000 0.000 
43 0.610 0.423 -0.022 0.019 0.038 0.029 0.137 0.043 -0.010 -0.004 0.030 0.205 0.004 0.110 0.529 0.114 -0.004 * 0.847 0.000 0.027 0.189 0.000 0.333 0.009 0.000 
44 0.632 0.450 -0.017 0.039 0.023 0.011 0.163 0.019 -0.008 0.008 0.046 0.234 -0.004 0.136 0.554 0.083 0.008 -0.010 * 0.000 0.009 0.117 0.063 0.243 0.036 0.000 
45 0.315 0.125 0.092 0.017 0.244 0.238 -0.011 0.277 0.136 0.053 0.017 -0.002 0.196 -0.014 0.219 0.391 0.037 0.124 0.151 * 0.514 0.045 0.000 0.045 0.000 0.000 
46 0.374 0.184 0.048 -0.006 0.184 0.176 0.001 0.205 0.082 0.019 -0.004 0.026 0.135 -0.010 0.282 0.306 0.007 0.073 0.096 -0.004 * 0.180 0.000 0.207 0.000 0.000 
47 0.501 0.302 -0.010 -0.017 0.093 0.086 0.055 0.106 0.011 -0.017 -0.011 0.103 0.048 0.032 0.410 0.200 -0.024 0.007 0.020 0.044 0.013 * 0.000 0.991 0.000 0.000 
48 0.780 0.632 0.113 0.235 0.006 -0.017 0.332 -0.009 0.063 0.163 0.210 0.432 0.025 0.329 0.724 0.003 0.188 0.078 0.052 0.332 0.252 0.154 * 0.000 0.784 0.000 
49 0.535 0.326 -0.017 -0.017 0.085 0.081 0.066 0.106 0.002 -0.021 -0.007 0.118 0.037 0.042 0.440 0.202 -0.024 -0.002 0.011 0.054 0.020 -0.015 0.158 * 0.000 0.000 
50 0.776 0.637 0.089 0.219 0.005 -0.020 0.334 -0.012 0.053 0.146 0.201 0.437 0.017 0.329 0.723 0.011 0.169 0.064 0.038 0.333 0.249 0.143 -0.009 0.143 * 0.000 
51 0.623 0.501 0.136 0.195 0.071 0.101 0.287 0.090 0.153 0.169 0.206 0.352 0.130 0.279 0.568 0.113 0.164 0.148 0.138 0.293 0.255 0.183 0.124 0.172 0.137 * 
52 0.497 0.351 0.098 0.117 0.096 0.115 0.176 0.126 0.147 0.114 0.132 0.219 0.148 0.170 0.422 0.196 0.098 0.128 0.133 0.180 0.170 0.125 0.162 0.120 0.193 0.034 
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Appendix E: Summary of the functional studies conducted during this thesis. 
Abbreviations: Comp: Competitior, AB: Antibody. +: has an effect, bold crosses: strong 
effect, - no effect, (+) weak effect in competitions or slight inhibition in supershift. 
 
    -14028*T -14028*C -14011*C -14011*T -14009*G -13779*G -13779*C 
Transfections 
 
  
 
  
  
  
   2 days   +   + +   + 
  9 days   -   + +   - 
EMSAs 
 
  
 
  
  
  
 Cdx-2 Comp + + + + + (+) (+) 
  AB + - (+) (+) (+) - - 
Oct-1 Comp + (+) + + +  (+) - 
  AB - - + + +     
HNF-ϭα Comp + + + + + (+) - 
  AB - - (+) (+) (+)     
HNF-4α Comp - +   + + 
  AB - +   + + 
GATA 3, 4 Comp 
  + +     
c-Ets-1,  Comp 
  - +     
Aff_ELF Comp 
  + -     
Aff_ELK-1 Comp 
  + +     
Aff_ETS (1) Comp 
  (+) +     
Ets/Tel2, Aff_c-Ets-1 Comp 
  - -     
Ets-1, Ets 1/2 AB 
  - -     
NF_kappaB, Pax, 
Pax4-8, Pbx Comp 
  (+) (+)     
LEF-1, Comp   
 
  
  
- - 
GKLF-1, AML-1  Comp           (+) (+) 
         
Bioinf. Pred. 
 
  
 
  
  
  
 
 TRANSFAC 
  CdxA HNF4a Oct, CdxA 
Oct, 
CdxA, 
GATA4 
Oct, CdxA, 
c-Ets-1, 
Ets - HNF4 
 MatInspector 
 
Cdx2, 
others 
 
Oct1, 
HNF1 
GATA3, 
Oct1, 
HNF1 
ELF5, 
Oct1, 
HNFP - 
RU49, 
LEF1, 
GKLF 
 TFSEARCH 
  
CdxA, 
others HNF4a 
Oct1, 
CdxA, 
others 
Oct1, 
CdxA, 
others 
ELK1, 
ELK4, c-
Ets, Oct1, 
CdxA, 
others - AML-1a 
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Appendix F: Pairwise linkage disequilibrium D' across the 80kb haplotype region of the Middle Eastern groups tested. Monomorphic markers were 
excluded from analysis. Statistically significant values after Bonferroni correction for multiple testing for the respective amount of populations per 
group are shaded in green. 
 
Middle East, Afro-Asiatic 
 
-30210 -30203 -30196 -30182 -30160 -30071/70 -29949 -14011 -14010 -14009 -13915 -13913 -13910 -13907  -13806 -13779 -13744 -13730 -13603 -13495 -958 -943 -942 -931 -875 -678 666 
-30203 1 
                          
-30196 1 1 
                         
-30182 0.98 1 1 
                        
-30160 1 1 1 1 
                       
-30071/70 1 1 1 1 1 
                      
-29949 1 1 1 1 1 1 
                     
-14011 1 1 1 1 1 1 1 
                    
-14010 1 1 1 1 1 1 1 1 
                   
-14009 1 1 1 1 1 1 1 1 1 
                  
-13915 1 1 1 1 1 1 1 1 1 1 
                 
-13913 1 1 1 1 1 1 1 1 1 1 1 
                
-13910 1 1 1 1 1 1 1 1 1 1 1 1 
               
-13907  1 1 1 1 1 1 1 1 1 1 1 1 1 
              
-13806 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
             
-13779 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
            
-13744 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
           
-13730 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
          
-13603 0.70 1 1 0.77 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
         
-13495 0.95 1 1 0.77 1 1 0.78 1 1 1 1 1 1 1 1 1 1 1 1 
        
-958 0.96 1 1 0.97 1 1 1 1 1 1 0.97 1 1 1 1 1 1 1 1 1 
       
-943 1 1 1 0.88 1 1 0.12 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
      
-942 0.86 1 1 0.88 1 1 0.12 1 1 1 1 1 1 1 1 1 1 1 1 1 0.85 1 
     
-931 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
    
-875 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
   
-678 1 1 1 1 1 1 1 1 1 1 0.97 1 1 1 1 1 0.69 1 1 0.96 1 1 1 1 1 
  
666 0.97 1 1 0.97 1 1 0.57 1 1 1 1 1 1 1 1 1 1 1 1 0.98 0.99 1 1 1 1 1 
 
5579 0.81 1 1 0.64 1 1 1 1 1 1 0.97 1 1 1 1 1 1 1 1 0.92 0.86 0.10 0.08 1 1 0.77 0.75 
 
237 
Africa, Niger-Congo 
     
 
-30210 -30182 -30071/70 -29949 -14010 -13910 -13800 -13730 -13603 -13495 -943/42 -678 666 
    -30182 1 
                -30071/70 1 1 
               -29949 1 1 1 
              -14010 1 1 1 1 
             -13910 1 1 1 1 1 
            -13800 1 1 1 1 1 1 
           -13730 1 1 1 1 1 1 1 
          -13603 1 1 1 1 1 1 1 1 
         -13495 1 1 1 1 1 1 1 1 1 
        -943/42 0.94 1 1 0.43 1 1 1 1 1 0.79 
       -678 1 1 1 1 1 1 1 1 1 1 1 
      666 1 0.96 1 0.14 1 1 1 1 1 1 0.97 0.96 
     5579 1 0.91 1 0.73 1 1 0.69 1 0.92 1 0.16 0.92 0.18 
    
Africa, Nilo-Saharan 
     
 
-30210 -30196 -30182 -30160 -29949 -13800 -13730 -13495 -958 -943/42 -678 666 
     -30196 1 
                -30182 1 1 
               -30160 1 1 1 
              -29949 1 1 1 1 
             -13800 1 1 1 1 1 
            -13730 1 1 1 1 1 1 
           -13495 0.07 1 1 1 1 1 1 
          -958 1 1 1 1 1 1 1 1 
         -943/42 1 1 1 1 1 1 1 1 1 
        -678 1 1 1 1 1 1 1 1 1 1 
       666 0.53 1 1 1 1 1 1 0.30 1 1 1 
      5579 0.22 1 1 1 1 1 1 0.65 1 0 1 0.42 
     
Middle East, Indo-European 
 
-30210 -30182 -30160 -29949 -13910 -13495 -958 -875 -678 666 
       -30182 1 
                -30160 1 1 
               -29949 1 1 1 
              -13910 1 1 1 1 
             -13495 1 0.34 1 1 1 
            -958 1 1 1 1 1 1 
           -875 1 1 1 1 1 1 1 
          -678 1 1 1 1 1 1 1 1 
         666 1 1 1 1 1 1 1 1 1 
        5579 0.91 0.21 1 1 1 1 0.91 1 0.60 0.91 
       
Europe/Asia, Indo-European 
 
-30210 -30182 -30160 -29949 -14028 -14011 -13910 -13495 -958 -943 -942 -875 -678 666 
   -30182 1 
                -30160 1 1 
               -29949 1 1 1 
              -14028 1 1 1 1 
             -14011 1 1 1 1 1 
            -13910 1 1 1 1 1 1 
           -13495 1 0.88 0.48 1 1 1 1 
          -958 0.98 1 1 1 1 1 1 1 
         -943 1 1 1 1 1 1 1 1 0.60 
        -942 0.65 1 1 1 1 1 1 1 0.29 1 
       -875 1 1 1 1 1 1 1 1 1 1 1 
      -678 0.87 0.93 1 1 1 1 1 1 1 1 1 1 
     666 0.97 1 1 1 1 1 1 1 1 1 1 1 1 
    5579 0.97 0.58 1 0.79 1 1 1 1 0.97 1 1 1 0.70 0.97 
   
238 
Middle East/Asia, Altaic 
 -30210 -30182 -30160 -29949 -14011 -13910 -13495 -958 -943/42 -875 -678 666      
-30182 1                 
-30160 1 1                
-29949 1 1 1               
-14011 1 1 1 1              
-13910 1 1 1 1 1             
-13495 1 1 1 0.47 1 1            
-958 1 1 1 1 1 1 1           
-943/42 1 1 1 1 1 1 1 1          
-875 1 1 1 1 1 1 1 1 1         
-678 0.80 1 1 1 1 1 1 1 1 1        
666 0.87 1 1 1 1 1 1 1 1 1 1       
5579 0.76 0.49 1 1 1 1 1 0.83 1 1 0.52 0.87      
 
 
 
239 
Appendix G: Publications 
 
(Jones et al. 2013) 
(Gallego Romero et al. 2012) 
(Jensen et al. 2011) 
(Gerbault et al. 2011) 
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